Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital.  Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research and Technologies, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the Founder of the Universal Scientific Education and Research Network (USERN). Prof. Rezaei supervised more than two hundred research projects and designed and participated in several international collaborative projects. Prof. Rezaei is the editor, editorial assistant, or editorial board member of more than fifty international journals. He edited more than one hundred international books, presented more than a thousand lectures in congresses/meetings, and published more than 1,500 scientific papers in the international journals.

Brief CV

 

Education: 

M.D. (1995–2002) School of Medicine, Tehran University of Medical Sciences

M.Sc. (2005–2006), School of Medicine and Biomedical Sciences, The University of Sheffield

Ph.D. (2006–2009), School of Medicine and Biomedical Sciences, The University of Sheffield

 

Training: 

2009   Paediatric Immunology and Infectious Diseases & BMT Unit, Newcastle General Hospital, Newcastle upon Tyne, UK (fellowship, awarded by the ESID)

 

Membership:

Members of more than 10 professional societies, including international societies such as EAACI, ESID, AAAAI, FOCIS, ERS, ISID, MPS; and also National Foundation Elite

 

Executive Activities:

Founder of Universal Scientific Education and Research Network (USERN)

Co-Founder and Head of the Research Center for Immunodeficiencies

Editorial Assistant of several national and international journals

Executive Manager of several national congresses

Co-Founder and Head of the Iranian Primary Immunodeficiency Registry

Co-Instructor and President of Iranian Primary Immunodeficiency Association

Vice Dean of Research, School of Medicine, TUMS

 

Awards and Honors:

Distinctive Researcher in Basic Sciences in the 12^th and 18^th Razi Research Festivals on Medical Sciences

Distinctive Editor and Young Researcher in the 10^th and 13^th Avicenna Festivals, respectively

Short-term Fellowship Award from the ESID in Paediatric Immunology and Infectious Diseases & Bone Marrow Transplant Unit in Newcastle General Hospital, UK

The AAAAI Young Investigator Award

Distinctive Medical Student Researcher, Tehran University of Medical Sciences

Distinctive Student in the University of Sheffield

Receiving several grants from international societies (EAACI, ERS, EHA, ESID, IUIS, CIS)

Receiving Honor Fellow Travel from the British Society of Cell Biology (BSCB)

 

Research Grants:

PI of more than 100 research projects in Tehran University of Medical Sciences

Designing and Collaborating in several international collaborative projects

 

Periodicals:

Editorial assistant or board member of more than 30 other international journals

 

Books:

Editor-in-Chief of the books, Primary Immunodeficiency Diseases: Definition, Diagnosis and Management (Springer 2008 and 2017), Cancer Immunology Series (3 volumes, Springer 2015); and Editor of 100 other scientific books

 

Podium Presentations:

Presentation of more than 450 lectures/posters in international and national congresses

 

Articles:

Publication of more than 1200 articles in the international scientific journals (H-index: 100)

 

Education

 

1995 – 2002   M.D.; Medical Doctor

School of Medicine, Tehran University of Medical Sciences and Health Services, Tehran, Iran

 

2005 – 2006  M.Sc.; Molecular and Genetic Medicine

Division of Genomic Medicine, School of Medicine and Biomedical Sciences, The University of Sheffield, UK

 

2006 – 2009  Ph.D.; Clinical Immunology and Human Genetics

Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, UK

 

2009              Fellowship; Clinical Immunology and Bone Marrow Transplantation Paediatric Immunology and Infectious Diseases & Northern Supra Regional Bone Marrow Transplant Unit for SCID and Related Disorders, Newcastle General Hospital, Newcastle upon Tyne, UK (Short-term fellowship, awarded by the ESID)

 

2013              Medical Education Short Course; Educational Development Center, Tehran University of Medical Education, Tehran, Iran

 

2012 – 2014   mini MBA; Health Administration and Hospital Management

                     Hospital Management Research Center, Tehran University of Medical Sciences, Tehran, Iran

 

2016              Visiting Scientist; Allergy and Immunology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA

 

2016 – now    Visiting Scientist; Karolinska Institutet, Stockholm, Sweden

2019 – now    Visiting Scientist; University of Southampton, Southampton, UK

                    

 

 

Scientific visits

June 2005   Division of Rheumatology and Clinical Immunology, University Hospital Freiburg, Freiburg, Germany

June 2005   Division of Immunopathology, Medical University of Vienna, Vienna, Austria

May 2007   Department of Immunology, 2^nd Medical School Charles Univesity and University Hospital Motol, Prague, Csech Republic

May 2011   The Laboratory of Host Defenses, and the Genetic Immunotherapy Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

May 2011   Division of Immunology, and the Jeffrey Modell Endowed Chair of Immunology, Children's Hospital of Philadelphia, School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

May 2011   Division of Immunology, and the Jeffrey Modell Immunology Center at Harvard, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA

June 2011   St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University, New York, NY, USA

June 2011   Center for Immunity and Immunotherapies, and the Jeffrey Modell Chair of Pediatric Immunology Research, Seattle Children's Research Institute, University of Washington, Seattle, WA, USA

June 2011   Type I Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA

January 2012   The Pediatric Department, Children’s University Hospital Bratislava, Comenius University Medical Faculty, Bratislava, Slovak Republic

January 2012   Ce-M-M- Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

January 2012   Department of Pathophysiology and Allergy Research Center for Pathophysiology, Infectology and Immunology, Medical University of Vienna, Vienna, Austria

June 2012   Department of Pathology and Immunology, Geneva Medical Faculty, University of Geneva; and the Department of Genetic and Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland

June 2012   The San Raffaele Telethon Institute for Gene Therapy HSR-TIGET, Milan, Italy

June 2012   The Children's Memorial Health Institute, Warsaw, Poland

June 2012   Department of Immunology-Histocompatibility, and Specific Center & Referral Center for Primary Immunodeficiencies – Paediatric Immunology, "Aghia Sophia" Children's Hospital, Athens, Greece

May 2013    Pediatric Infectious Diseases, and Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon

February 2014  Gene Therapy Laboratory, Universidad Austral, Buenos Aires, Argentina

February 2014  Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo, and Jeffrey Modell Diagnostic and Research Center in São Paulo, São Paulo,Brazil

February 2014  Center of Human Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil

February 2014  Immunology, Allergy & Rheumatology, and The Center for Human Immunobiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA

March 2014       Department of Pediatrics, and Emory Vaccine Center, School of Medicine, Emory University, Atlanta, GA, USA

December 2014             The Laboratory of Research, and Department of Immunology, Institut Pasteur de Tunis, Tunis

December 2014             Al-Bashir Hamzeh Children’s Hospital, Faculty of Medicine, University of Tunis, Tunis

December 2014             Casablanca Children’s Hospital, and Faculty of Medicine, Universite Hassan II Casablanca, Casablanca, Morocco

February 2015  Division of Pediatric Allergy/Immunology, Marmara University Hospital, Marmara University, Istanbul, Turkey

April 2015         Belarusian State Medical University, Minsk Region, Belarus

April 2015         The Belarusian National Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus

October 2015    State Key Laboratory of Agrobiotechnology, China Agricultural University, Beijing, China

January 2016    Tajikistan National Medical Center, Dushanbe, Tajikistan

August 2016     Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA

August 2016     Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

August 2016     Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

August 2016     Massachusetts Institute of Technology (MIT), Boston, MA, USA

August 2016     Schepens Eye Research Institute, Harvard Medical School, Boston, MA, USA

August 2016     Brigham and Women's Hospital, Boston, MA, USA

August 2016     National Institute of Health (NIH), Bethesda, MD, USA

August 2016     Stanford University School of Medicine, Stanford, CA, USA

August 2016     Stanford Medical Center, Stanford, CA, USA

September 2016 Semmelweis University, Budapest, Hungary

December 2016 Kyiv's Municipal Children's Hospital, Kiev, Ukraine

December 2016 Kharkiv National Medical University, Kharkiv, Ukraine

February 2017 University of Maribor, Maribor, Slovenia

February 2017 Alma Mater Europaea, Maribor, Slovenia

March 2017 University of Ljubljana, Maribor, Slovenia

August 2017 Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

August 2017 Faculty of Medicine, Mahidol University, Bangkok, Thailand

September 2017 Section for Immunology and Rheumatology, The Queen Silvia Children's, Hospital, University of Gothenburg, Gothenburg, Sweden

October 2017 National Institute of Pediatrics, Mexico City, Mexico

November 2017 Kharkiv National Medical University, Kharkiv, Ukraine

November 2017 V.N. Karazin Kharkiv National University, Kharkiv, Ukraine

October 2018 Russian-Armenian University, Yerevan, Armenia

November 2018 The Queen Silvia Children's, Hospital, University of Gothenburg, Gothenburg, Sweden

November 2018 Ce–M–M– Research Center for Molecular Medicine, Vienna, Austria

November 2018 University Mediterranea of ​​Reggio Calabria, Reggio Calabria, Italy

November 2018 University of Turin, Turin, Italy

February 2019 Panjab University, Chandigarh, India

February 2019 Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India

February 2019 Mehr Chand Mahajan DAV College for Women, Chandigarh, India

March 2019 Karolinska Institutet, Stockholm, Sweden

May 2019 Azerbaijan Medical University, Baku, Azerbaijan

November 2019 Semmelweis University, Budapest, Hungary

December 2019 Selçuk Üniversitesi, Konya, Turkey

November 2021 Marmara University, Yerevan, Armenia

May 2022 Yerevan Medical State University, Yerevan, Armenia

May 2022 National Institute of Health, Yerevan, Armenia

May 2022 Pediatric Cancer and Blood Disorders Center of Armenia, Yerevan, Armenia

July 2022 Akkon University of Human Sciences, Berlin, Germany

August 2022 University of Lithuania, Vilnius, Lithuania

August 2022 Imagine Institute of Genetic Diseases, Paris, France

August 2022 University of Toronto, Toronto, Canada

August 2022 The Hospital for Sick Children (SickKids), Toronto, Canada

November 2022 Sultan Qaboos University, Muscat, Oman

May 2023 Sidra Medical and Research Center, Doha, Qatar

May 2023 Qatar University, Doha, Qatar

 

 

 

 

 

Affiliations

 

1995 - 1998   Students’ Scientific Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

1998 - 2002  Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran (In collaboration with Department of Clinical Immunology and Allergy)

2002 - 2009   Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran

2005 - 2009   Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, UK

2009 - 2010    Growth and Development Research Center; and Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

2009 - 2018    Honorary Associate Staff: Department of Infection & Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, UK

2010 - 2018    Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran

 

2010 - now    Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

2010 - now    Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

2015 - now    Universal Scientific Education and Research Network (USERN)

2016 – now    Karolinska Institutet, Stockholm, Sweden

2019 – now    University of Southampton, Southampton, UK

 

 

 

 

Membership in Professional Societies

 

2016 - 2023   Association for Cancer Immunotherapy (CIMT)

2018 - 2023   European Academy of Sciences and Arts

2002 - 2023   European Academy of Allergy and Clinical Immunology (EAACI)

2004 - 2023   European Society of Immunodeficiency (ESID)

2004 - 2023   International Society for Infectious Diseases (ISID)

2010 - 2023   American Academy of Allergy, Asthma & Immunology (AAAAI)

2010 - 2023   European Respiratory Society (ERS)

2012 - 2023   World Allergy Organization (WAO)

2011 - 2023   The New York Academy of Sciences

2013 - 2023   Clinical Immunology Society (CIS)

2016 - 2023   Federation of Clinical Immunology Societies (FOCIS)

2010 - 2023   Human Variome Project Consortoium

2010 - 2023   Geneva Foundation for Medical Education and Research

2007 - 2023   Medical Protection Society (MPS, UK)

2004 - 2023   Iranian Society of Immunology and Allergy (ISIA)

2003 - 2023   Iranian Primary Immunodeficiency Association (IPiA)

2007 - 2023   National Foundation Elite

2007 - 2023   Iranian Cochrane Informal Network (ICInet)

2007 - 2023   Iranian Molecular Medicine Network

2007 - 2023   Iranian Genetic Society

2009 - 2023   Iranian Clinical Genetics

European Hematological Association (EHA, 2004)

The Biochemical Society (2006)

British Society for Cell Biology (BSCB, 2008)

 

 

Awards and Honors

2001   Honor student, Tehran University of Medical Sciences

2001   Gold sponsorship from the European Respiratory Society (ERS) for the presented articles, based on the scientific quality of the article

2002   Travel grant from the European Academy of Allergology and Clinical Immunology (EAACI) for the presented articles

2003   The best research project "Iranian PID Registry" in the 4^th Avicenna Festival

2004   Travel grant from the European Hematology Association (EHA) for the presented article, based on the scientific quality of the article

2004   W.B. Educational grant from the European Society for Immunodeficiencies (ESID)

2005   Travel grant from the European Academy of Allergology and Clinical Immunology (EAACI) for the presented articles

2006   The IBC Leading Health Professionals of the World 2006

2006   Distinctive Researcher in Basic Sciences in the 12^th Razi Research Festival on Medical Sciences

2007   Distinctive Researcher; Tehran University of Medical Sciences

2007   The best national Journal of the year "Iranian Journal of Allergy, Asthma and Immunology" in the 8^th Avicenna Festival

2007   Distinctive, National Youth Talent, National Foundation Elite

2007   Distinctive Student in M.Sc. Molecular and Genetic Medicine; Division of Genomic Medicine, School of Medicine and Biomedical Sciences, the University of Sheffield, UK

2008   Honor Fellow Travel award from the British Society of Cell Biology (BSCB)

2009   The best book of the year "Primary Immunodeficiency Diseases" in the 10^th Avicenna Festival

2009   European Society of Clinical Microbiology and Infectious Diseases (ESCMID) grant, 19^th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

2009   Short-term fellowship award from the European Society for Immunodeficiencies (ESID) in Paediatric Immunology and Infectious Diseases & Bone Marrow Transplant Unit in Newcastle General Hospital, UK

2010   The best lecture award during the 10^th International Congress of Immunology and Allergy

2010   Travel Bursary from the International Union of Immunological Societies (IUIS)

2010   ESID (European Society for Immunodeficiencies) Juniors Award 2010 for the activities in the ESID Juniors Working Party

2010   Junior Scientist in Clinical Medicine Award Winner 2010 International Professor Dr. Alireza Yalda Foundation

2011   AAAAI (American Academy of Allergy, Asthma and Immunology) In-Training Member International Travel Grant Scholarship

2011   CIS (Clinical Immunology Society) Travel Grant for the Advanced School in Primary Immune Deficiency

2012   The Best Junior Scientist in Basic Sciences in the 13^th Avicenna Festival

2012   The 3^rd Rank of the Best Article in Basic Sciences in the 2012 Festival of the National Academy of Medical Sciences

2012   One of the Best 10 Scientists of the Country in the Last Decade (2002-2011) in the 2012 Festival of the National Academy of Medical Sciences

2013   Distinctive Researcher in Basic Sciences in the 18^th Razi Research Festival on Medical Sciences

2013   AAAAI (American Academy of Allergy, Asthma and Immunology) International Young Investigator Award

2014   The Best Ranking Newly Established Research Center (Research Center for Immunodeficiencies) in the 19^th Razi Research Festival on Medical Sciences

2014   The 2^nd Rank of the Best Article in Clinical Sciences in the 2014 Festival of the National Academy of Medical Sciences

2014   One of the Best 10 Scientists of the Country in the Last Decade (2004-2013) in the 2014 Festival of the National Academy of Medical Sciences

2014   WinMD Grant, by World Immunodeficiency Network, Jeffrey Modell Foundation

2014   Iran Young Scientist Scopus Award 2014, by Elsevier

2015   The Best Ranking Research Center (Research Center for Immunodeficiencies) in the 20^th Razi Research Festival on Medical Sciences

2015   The best book of the year "Immunology of Aging" in the 16^th Avicenna Festival

2016   The best book of the year "Cancer Immunology" in the 17^th Avicenna Festival

2017   The best researcher in basic sciences of the year in the 18^th Avicenna Festival

2017   The best researcher, 1^st Research Festival of Children's Medical Center

2017   The best scientist of last decade of the country in medical sciences, Iranian Academy of Medical Sciences

2017    Distinguished Researcher, University of Tehran Science and Technology Festival

2019    The best National Researcher, 20^th Abu Reyhan Biruni Research Festival

2021   The Best Ranking Research Center (Research Center for Immunodeficiencies) in the 27^th Razi Research Festival on Medical Sciences

2021   The Best Scientist in the 60^th Alborz Foundation Festival

2022   The Best Ranking Research Center (Research Center for Immunodeficiencies) in the 28^th Razi Research Festival on Medical Sciences

 

Executive Activities

 

1995 – 1998        Student Scientific Research Center, affiliated to Tehran University of Medical Sciences

                                     Director of research division

 Director of conference division group

    Instructor of research and methodology workshops

       Director of research Consultant ward

1999 - 2007   Chief Executive of Iranian Primary Immunodeficiency Registry (IPIDR) database

2004 - 2012   Instructor and Board member of Iranian Primary Immunodeficiency Association

2004 - 2006    Executive Director of UNESCO Chair in Health Education, Tehran University of Medical Sciences

2002 – 2012    Instructor and Manager of Research and methodology workshops, Priority setting in medical research, Problem oriented research methodology workshops, Scientific writings, and Editing an academic book

2004 - 2009   Executive Manager of Iranian Journal of Allergy, Asthma and Immunology

2010 - 2015     Deputy Head of the Children's Medical Center Hospital, Pediatrics Center of Excellence in Iran

2010 - 2015    Chief Executive Director of the Children's Medical Center Hospital, Tehran University of Medical Sciences

2013 - 2015     Committee Member, Deputy of Culture and Talent Affairs, National Foundation Elite

2015 - 2017     Director of Global Academic Program (GAP), Tehran University of Medical Sciences

2015 - 2017     Chief Consultant of International Affairs, Vice Minister of Education, Ministry of Health and Medical Education

2010 - 2019     Co-Founder and Deputy President of Research Center for Immunodeficiencies, Tehran University of Medical Sciences

2019 - now     Head of Research Center for Immunodeficiencies, Tehran University of Medical Sciences

2012 - now     Founder and Leader of J Persia Daughter Project

2014 - now     Co-Founder and Board Member of Charity for Patients with Primary Immunodeficiency Diseases

2014 - 2019     Member of the Committee of Innovation and Inventions in Basic Sciences, Deputy of Research and Technology, Ministry of Health and Medical Education

2014 - 2022     Founding President of Universal Scientific Education and Research Network (USERN)

2014 - now     Founder and President of the Health and Art (HEART) Network

2015 - 2022     Associate Dean of International Affairs, School of Medicine, Tehran University of Medical Sciences

2021 - 2022     Vice Dean of Research, School of Medicine, Tehran University of Medical Sciences

2015 - 2019     Faculty Member of the Higher Council of The Students’ Disciplinary Committee, Ministry of Health and Medical Education

2015 - 2021     Member of the Committee of Communicable Diseases and Immunological Disorders, National Institute of Medical Research Development (NIMAD), Deputy of Research and Technology, Ministry of Health and Medical Education

2015 - now     Member of the Higher Council of TUMS Research Diploma (TUMS-RD), Tehran University of Medical Sciences

2016 - now     Mentor of J PID Juniors, J Juniors, Eastern Europe and Central Asia

2016 - 2022     Member of Commission for Supporting Talent Students, Tehran University of Medical Sciences

2021 - now     Scientific Secretary of National Committee of Students’ Scientific Research and Technology Committees, Ministry of Health and Medical Education

 

 

 

 

Congress Organizer

2000               Collaborator and Member of Executive Managing Committee in 12^th International Congress of Pediatrics, Tehran, Iran

2002 - 2003     Collaborator and Member of Executive Managing Committee in First and Second Symposium of "Pouyandegan Elm and Danesh" in Research week, Tehran, Iran

2004 - 2005     Executive Manager and member of national scientific committee of the First International Congress on Immunodeficiency Disorders, Tehran, Iran

2004 - 2005     Member of executive committee of The 2^nd Iranian Asthma Meeting & The 5^th Biennial Seminar of Iranian Society of Asthma and Allergy, Tehran, Iran

2009               Member of executive committee of International Advanced Course in Clinical Immunology by IUIS, Tehran, Iran

2009               Member of organizing committee of International Pediatric Congress and Immunodeficiency Meeting (J Project), Tehran, Iran

2009               Member of organizing committee of 21^st International Congress of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran

2009               Member of scientific committee of The 3^rd Iranian Asthma Meeting and The 7^th Biennial Seminar of Iranian Society of Asthma & Allergy, Tehran, Iran

2010               Executive Director of the 22^nd International Congress of Pediatrics, Tehran, Iran

2010               Scientific and Executive Director of the 3^rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies, Tehran, Iran

2010               Executive Committee Member of 2^nd Symposium of Metabolic Diseases, Tehran, Iran

2010               Executive Director of the 3^rd Congress of Laboratory and Clinics (Pediatrics), Tehran, Iran

2011               Executive Director of the 23^rd International Congress of Pediatrics, Tehran, Iran

2011               Scientific and Executive Director of the 4^th Meeting on Clinical Immunology and Immunodeficiencies, Tehran, Iran

2011              Director of “Chalenges and Opportunitis in the Health System” and “The Role of Talents in the Health System” Panles in the 5^th Congress of Naional Foundation Elite, Tehran, Iran

2011               Congress Manager of the 2^nd International Congress of International Prof. Dr. Alireza Yalda Academic Foundation in Medical Sciences, Tehran, Iran

2012               Scientific and Executive Director of the World PI Week in Tehran, Iran

2012              Scientific Board Member of 11^th International Congress of Immunology and Allergy of Iran, Tehran, Iran

2012              Faculty member of the 31^st Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI), Geneva, Switzerland

2012               Scientific and Executive Director of the 5^th Meeting on Clinical Immunology and Immunodeficiencies, Tehran, Iran

2012               Executive Director of the 24^th International Congress of Pediatrics, Tehran, Iran

2013               Scientific Director of the 1^st MENA Immunodeficiency Meeting, Dubai, UAE

 

2013               Scientific and Executive Director of the 6^th Meeting on Clinical Immunology and Immunodeficiencies, Tehran, Iran

2013               Executive Director of the 25^th International Congress of Pediatrics, Tehran, Iran

2014               Scientific Committee Member of 100^th J Meeting on Primary Immunodeficiencies, Antalya, Turkey

2014               Scientific Committee Member of 12^th International Congress of Immunology and Allergy, Tehran, Iran

2014               Scientific Committee Member of the 2^nd MENA Immunodeficiency Meeting, Marrakesh, Morocco

2015               Scientific Committee Member of 1^st International and 5^th National Congress on Stem Cells, Tehran, Iran

2015               President of 1^st International Festival of Pediatric Patients’ Paintings (IFPPP), Tehran, Iran

2015               Scientific Committee Member of the 3^rd Middle East Asia Asthma Allergy Immunology Cogress (MEAAIC), Abu Dhabi, UAE

2016               Artistic Director of 4^th National Congress of Medical Ethics, Tehran, Iran

2016               Scientific Committee Member of the 8th International Iranian Congress of Laboratory and Clinic, Tehran, Iran

2016               Executive Director and Scientific Committee Member of 1^st Seminar of Stem Cell Therapy in Neurological Disorders, Tehran, Iran

2016               Scientific Committee Member of 2^nd J Project Congress, Antalya, Turkey

2016               Scientific Committee Member of the 9^th International & 14^th National Congress on Quality Improvement in Clinical Laboratories, Tehran, Iran

2016               Vice-President and Chair of the PID Spring School, Tehran, Iran

2016               Vice-President and Chair of the Scientific Committee of 8^th International Conference on Immunodeficiency Diseases, Tehran, Iran

2016               Scientific Committee Member of the Asia Pacific Society for Immunodeficiencies (APSID) Congress, Hong Kong SAR, China

2016               President and Scientific Secretary of 1^st USERN Congress and Festival

2017               Vice-President and Chair of the Scientific Committee of 9^th International Conference on Primary Immunodeficiency Diseases, Tehran, Iran

2017               Chair of the 2^nd PID Spring School, Tehran, Iran

2017               President and Scientific Secretary of 2^nd USERN Congress and Festival, Kharkiv, Ukraine

2018               Vice-President and Chair of the Scientific Committee of 10^th International Conference on Primary Immunodeficiency Diseases, Tehran, Iran

2018               Chair of the 3^rd PID Spring School, Tehran, Iran

2018               President and Scientific Secretary of 3^rd USERN Congress and Festival, Reggio Calabria, Italy

2018               Scientific Chair of Primary Immunodeficiency Diseases Course, Reggio Calabria, Italy

2019               Vice-President and Chair of the Scientific Committee of 11^th International Conference on Primary Immunodeficiency Diseases, Tehran, Iran

2019               Chair of the 4^th PID Spring School, Tehran, Iran

2020               President and Chair of the Scientific Committee of 12^th International Conference on Primary Immunodeficiency Diseases, Tehran, Iran

2020               President and Scientific Secretary of 5^th USERN Congress and Festival

2021               President and Chair of the Scientific Committee of 13^th International Conference on Primary Immunodeficiency Diseases, Tehran, Iran

2021               President and Scientific Secretary of 6^th USERN Congress and Festival

2022               President and Chair of the Scientific Committee of 14^th International Conference on Primary Immunodeficiency Diseases, Tehran, Iran

2022               President and Scientific Secretary of 7^th USERN Congress and Festival

2023               President and Chair of the Scientific Committee of 15^th International Conference on Primary Immunodeficiency Diseases, Tehran, Iran

 

 

 

 

 

Periodicals (Journal's Editorial)

2015 - 2023  Trends in Medical Research (Editor-in-Chief)

2018 - 2023  Immunology and Genetics Journal (Editor-in-Chief)

2008 - 2023  Avicenna Journal of Medical Biotechnology (Editorial Assistant)

2008 - 2023  Journal of Allergy (Associate Editor)

2008 - 2023  Case Reports in Medicine (Associate Editor)

2007 - 2023  Acta Medica Iranica (Editorial Assistant)

2010 - 2023  Tehran University Medical Journal (Associate Editor)

2010 - 2023  Journal of Reproduction and Infertility (Editorial Manager)

2011 - 2023  Journal of Medical Hypotheses and Ideas (Section Editor)

2011 - 2023  Trends in Molecular Sciences (Regional Editor)

2011 - 2023  Research Journal of Immunology (Regional Editor)

2011 - 2023  American Journal of Biochemistry and Molecular Biology (Regional Editor)

2011 - 2023  American Journal of Drug Discovery and Development (Regional Editor)

2012 - 2023  WebmedCentral (Lead Faculty and advisor in Immunology)

2013 - 2023  Expert Review of Clinical Immunology (Editorial Advisory Panel Member)

2010 - 2023  Frontiers in Primary Immunodeficiencies (Review Editor)

2012 - 2023  Biologics in Therapy (Advisory Board Member)

2012 - 2023  Iranian Journal of Pediatrics (Editorial Board Member)

2007 - 2023  International Journal of Molecular Medicine and Advance Sciences (Editorial Board Member)

2007 - 2023  International Journal of Tropical Medicine (IJTM) (Editorial Board Member)

2007 - 2023  Research Journal of Biological Sciences (Editorial Board Member)

2007 - 2023  Research Journal of Medical Sciences (RJMS) (Editorial Board Member)

2007 - 2023  The Open Allergy Journal (Editorial Advisory Board Member)

2008 - 2023  The Open Immunology Journal (Editorial Board Member)

2008 - 2023  Inflammation and Allergy Drug-Targets (Editorial Board Member)

2010 - 2023  World Journal of Rheumatology (Editorial Board Member)

2012 - 2023  World Journal of Experimental Medicine (Editorial Board Member)

2013 - 2023  Immunity and Diseases (Editorial Board Member)

2013 - 2023  Clinical Anti-Inflammatory & Anti-Allergy Drugs (Editorial Board Member)

2014 - 2023  Vaccine Research (Editorial Board Member)

2015 - 2023  Case Reports in Clinical Practice (Editorial Board Member)

2016 - 2023  Rheumatology Research (Editorial Board Member)

2017 - 2023  Siriraj Medical Journal  (Editorial Board Member)

2013 - 2023  Advances in Medicine (Editorial Board Member)

2018 - 2023  SN Comprehensive Clinical Medicine (Editorial Board Member)

2018 - 2023  Clinical Genetics and Perinatal Diagnostics (Editorial Board Member)

2012 - 2018  International Archives of Allergy and Immunology (Editorial Board Member)

2003 - 2009  Iranian Journal of Allergy, Asthma and Immunology (Executive Manager)

2008 - 2011  The Open Infectious Diseases Journal (Editorial Board Member)

2008 - 2015  European Society for Immunodeficiencies (ESID) Newsletter (Editorial Board Member)

2008 - 2016  Journal of Immunology Research [Clin Develop Immunol] (Associate Editor)

 

Journals' Reviewer

* Lancet Infectious Disease                                            * Lancet Haematology

* Journal of Clinical Immunology                                    * Nature Genetics

* JAMA, the Journal of the American Medical Association                        * UpToDate

* Clinical and Developmental Immunology                      * Pediatrics

* Journal of the European Academy of Dermatology and Venereology      * Drugs

* International Archives of Allergy and Immunology         * Plos One

* ANNALS of the New York Academy of Sciences           * Clinical Immunology

* Expert Reviews of Clinical Immunology                        * Pediatric Allergy and Immunology

* Journal of Investigational Allergology and Clinical Immunology              * Journal of Infection

* International Immunopharmacology                              * Human Immunology

* Journal of Molecular Neuroscience                               * Immunobiology

* European Journal of Clinical Nutrition                           * European Journal of Haematology

* Inflammation and Allergy – Drug Targets                      * BMC Immunology

* Pediatric Hematology and Oncology                             * BMC Infectious Diseases

* Trends in Molecular Medicine                                       * Pediatric Transplantation

* Journal of Post Graduate Medicine                               * Vaccine

* Canadian Journal of Microbiology                                 * Gene

* Journal of Infection and Public Health                           * Clinical Rheumatology

* The Open Infectious Diseases Journal                         * Molecular Biology Reports

* Clinics and Research in Hepatology and Gastroenterology        * Immunotherapy

* DNA and Cell Biology                                                  * Biologics in Therapy

* International Journal of Rheumatic Diseases                 * Inflammation

* International Journal of Biomedical Science                  * Clinics and Practice

* Orphanet Journal of Rare Diseases                              * World Allergy Organization Journal

* Japanese Journal of Infectious Diseases                      * Advances in Therapy

* Indian Journal of Critical Care Medicine                        * Clinical Respiratory Journal

* The Journal of Medical Case Reports                           * Research Journal of Immunology

* Asian Journal of Sport Medicine                                   * The Open Allergy Journal

* Journal of Medical Diagnostic Methods                         * The Open Immunology Journal

* Turkish Journal of Gastroenterology                             * Journal of Allergy

* Iranian Journal of Allergy, Asthma and Immunology      * Italian Journal of Pediatrics

* Journal of Pediatric Neurology                                     * Archives of Iranian Medicine

* Iranian Journal of Pediatrics                                        * Iranian Journal of Immunology     

* Thrita Student Journal of Medical Sciences                   * Annals of Saudi Medicine

* Journal of Research in Medical Sciences                      * Acta Medica Iranica

* International Journal of High Risk Behaviors and Addiction
Books

Rezaei N, Aghamohammadi A, Pourpak Z, Mahmoudi M. The Immune System and Microorganisms, 2005; UNESCO Chair in Health Education, Tehran University of Medical Sciences, TUMS Press (ISBN 964-7445-85-7)

Aghamohammadi A, Pourpak Z, Rezaei N, Farhoudi A, Moin M. Primary Immunodeficiency Disorders in Iran, Tehran University of Medical Sciences 2006, TUMS Press (ISBN 964-8941-37-8)

Mahmoudi M, Pourpak Z, Rezaei N. Atopic Dermatitis, 2006, UNESCO Chair in Health Education, Tehran University of Medical Sciences, TUMS Press (ISBN 964-8941-44-0)

Mahmoudi M, Rezaei N, Pourpak Z. Food Allergy, 2006, UNESCO Chair in Health Education, Tehran University of Medical Sciences, TUMS Press (ISBN 964-8941-49-1)

Moin M, Mahmoudi M, Rezaei N. Guidelines for Allergies (Nose, Sinus, Ear, and Eye), 2007, Hamrah Publisher (ISBN 964-982-66-2)

Moin M, Mahmoudi M, Rezaei N. Asthma: Diagnosis, Treatment, Prevention, 2007, Abadis Publisher (ISBN 978-964-93690-5-1)

Rezaei N, Aghamohammadi A, Notarangelo LD. Primary Immunodeficiency Diseases: Definition, Diagnosis and Management, 2008, Springer (ISBN 978-964-3-540-78537-8)

Aghamohammadi A, Khazaei HA, Rezaei N. Diagnosis and Treatment in Primary Immunodeficiency Disorders, 2010, Azad University Publisher (ISBN 978-964-223-847-7)

Rezaei N. Hodgkin’s Lymphoma, 2012, InTech (ISBN 978-953-51-0402-5)

Aghamohammadi A, Rezaei N. Clinical Cases in Primary Immunodeficiency Diseases: A Problem-Solving Approach, 2012, Springer (ISBN 978-3-642-31784-2)

Rezaei N, Hedayat M. Alleles Frequencies. In: Maloy S, Hughes K (eds.): Brenner's Encyclopedia of Genetics, 2nd edition, 2013, Academic Press (ISBN 978-0-123-74984-0‎)

Massoud A, Rezaei N. Immunology of Aging, 2013, Springer (ISBN 978-3642394942)

Rezaei N, de Vries E, Gambineri E, Haddad E. Common presentations and diagnostic approaches In: Sullivan KE, Stiehm ER (eds.) Stiehm’s Immune Deficiencies: Inborn Errors of Immunity, 1st edition, 2014  (ISBN 9780124058606)

Rezaei N. Cancer Immunology: A Translational Medicine Context, 2015, Springer (ISBN 978-3-662-44006-3)

Rezaei N. Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, 2015, Springer (ISBN 978-3-662-44945-5)

Rezaei N. Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors, 2015, Springer (ISBN 978-3-662-46409-0)

Rezaei N, Aghamohammadi A, Notarangelo LD. Primary Immunodeficiency Diseases: Definition, Diagnosis and Management, 2^nd Edition, 2016, Springer (ISBN 978-3-662-52907-2)

Saghazadeh A, Rezaei N. Immunofluorescence: Dyes and Other Haptens Conjugated with Antibodies. In: eLS. John Wiley & Sons, Ltd: Chichester 2017. DOI: 10.1002/9780470015902.a0002626.pub3

Rezaei N, Section Editor. Advances in Experimental Medicine and Biology (AEMB), 2018-2022, Springer

Rezaei N, Keshavarz-Fathi. Vaccines for Cancer Immunotherapy, 2018, Elsevier (ISBN 978-012-81-4039-0)

Rezaei N. Physiology and Pathology of Immunology, 2018, InTech (ISBN 978-953-51-3691-0)

Mahdaviani A, Rezaei N. Pulmonary Manifestations of Primary Immunodeficiency Diseases, 2018, Springer (ISBN 978-303-00-0879-6)

Mahmoudi M, Rezaei N. Nutrition and Immunity, 2019, Springer (ISBN 978-3-030-16072-2)

Rezaei N, Saghazadh A. Biophysics and Neurophysiology of the Sixth Sense, 2019, Springer (ISBN 978-3-030-10619-5)

Rezaei N. Pediatric Allergy - A Case-Based Collection with MCQs, Volume 1, 2019, Springer (978-3-030-18281-6)

Rezaei N. Pediatric Immunology - A Case-Based Collection with MCQs, Volume 2, 2019, Springer (ISBN 978-3-030-21261-2)

Rahmani F, Rezaei N. Pediatric Autoimmunity and Transplantation - A Case-Based Collection with MCQs, Volume 3, 2020, Springer (ISBN 978-3-030-26279-2)

Rezaei N. Cancer Immunology: A Translational Medicine Context, 2nd edition, 2020, Springer (ISBN 978-3-030-30844-5)

Rezaei N. Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, 2^nd edition, 2020, Springer (ISBN 978-3030502867)

Rezaei N. Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors, 2^nd edition, 2020, Springer (ISBN 978-3030579487)

Rezaei N. Immunogenetics, 2019, InTech (ISBN 978-1-83880-347-6)

Rezaei N. Thymus, 2020, InTech (ISBN 978-1-78985-133-5)

Rezaei N. Toll-Like Receptors, 2019 (ISBN 978-1-78985-391-9)

Rezaei N, de Vries E, Gambineri E, Haddad E. Common presentations and diagnostic approaches In: Sullivan KE, Stiehm ER (eds.) Stiehm’s Immune Deficiencies: Inborn Errors of Immunity, 2nd edition, 2020 (ISBN 9780128167687)

Rezaei N, Rajabi F. The Immunogenetics of Dermatologic Disease, 2022, Springer

Harsini S, Alavi A, Rezaei N. Nuclear Medicine and Immunology, 2022, Springer (ISBN 978-3-030-81260-7)

Rezaei N. Genetic Syndromes: A Comprehensive Reference Guide, 2021-2024, Springer (ISBN 978-3-319-66816-1)

Rezaei N. Coronavirus Disease (COVID-19), 2022, Springer (ISBN 978-3-030-63761-3)

Rezaei N. Encyclopedia of Infection and Immunity, 2022, Elsevier (ISBN 9780128187319)

Rezaei N. Clinical Immunology, 2022, Elsevier (ISBN 9780128180068 )

Rezaei N. Translational Immunology, Book Series 2021-2022, Elsevier

Rezaei N. Translational Autoimmunity: Etiology of Autoimmune Diseases, 2021, Elsevier (ISBN 978-0128225646)

Rezaei N. Translational Autoimmunity: Treatment of Autoimmune Diseases, 2022, Elsevier (ISBN 978-0128243909)

Rezaei N. Translational Autoimmunity: Autoimmune Disease Associated with Different Clinical Features, 2022, Elsevier (ISBN 9780323854153)

Rezaei N. Translational Autoimmunity: Autoimmune Diseases in Different Organs, 2022, Elsevier (ISBN 9780128244661)

Rezaei N. Translational Autoimmunity Challenges for Autoimmune Diseases, 2022, Elsevier (ISBN 9780323853897)

Rezaei N. Translational Autoimmunity: Advances in Autoimmune Rheumatic Diseases, 2023, Elsevier (ISBN 9780323858311)

Rezaei N, Yazdanpanah N. Translational Neuroimmunology: Neuroinflammation, 2023, Elsevier (ISBN 9780323858410)

Rezaei N, Yazdanpanah N. Translational Neuroimmunology: Multiple Sclerosis, 2023, Elsevier (ISBN 9780443185786)

Rezaei N. Updates on Pediatric Health and Disease, Book Series 2021-2022, Bentham

Rezaei N, Samieefar N. Common Pediatric Diseases: an Updated Review: An Updated Review, 2022, Bentham (ISBN 978-981-5039-66-5)

Rezaei N. Updates on Pediatric Health and Disease: Common Pediatric Diseases: Current Challenges, 2022, Bentham

Rezaei N. Updates on Pediatric Health and Disease: Pediatric Infectious Diseases: An Updated Review, 2022, Bentham

Rezaei N. Updates on Pediatric Health and Disease: Pediatric Infectious Diseases: Pediatric Infectious Diseases: Current Challenges, 2022, Bentham

Rezaei N, Jabbar P. Immunoinformatics of Cancers. Practical Machine Learning Approaches Using R, 2022, Elsevier (ISBN 9780128224007)

Rezaei N. Integrated Science, Book Series, 2021-2022, Springer

Rezaei N. Integrated Science: Science Without Borders, 2021, Springer (ISBN 978-3030652722)

Rezaei N. Multidisciplinarity and Interdisciplinarity in Health, 2022, Springer (ISBN 978-3-030-96813-7)

Rezaei N. Thinking: Bioengineering of Science and Art, 2022, Springer (ISBN 978-3-031-04077-1)

Rezaei N. Transdisciplinarity, 2022, Springer (ISBN 978-3-030-94650-0)

Rezaei N. Integrated Education and Learning, 2022, Springer (ISBN 978-3-031-15962-6)

Rezaei N. Brain, Decision Making and Mental Health, 2023, Springer (ISBN 978-3-031-15958-9)

Rezaei N. Tuberculosis: Integrated Studies for a Complex Disease, 2023, Springer (ISBN 978-3-031-15954-1)

Rezaei N. Integrated Science of Global Epidemics, 2023, Springer (ISBN 978-3-031-17777-4)

 

 

International Collaborative Centers

 

* Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom

* Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at the Karolinska University Hospital Huddinge, Stockholm, Sweden

* Division of Rheumatology and Clinical Immunology, Medical Center, Freiburg University Hospital, Freiburg, Germany

* Department of Immunology and Molecular Pathology, Royal Free Hospital & University College Medical School, London, UK

* Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany

* Clinica Pediatrica e Istituto di Medicina Molecolare Angelo Nocivelli, University of Brescia, Brescia, Italy

* Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan

* Department of Immunology and Immunodeficiencies, Hospital Vall d´Hebron, School of Medicine, Barcelona, Spain

* Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, USA

* Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany

* National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

* Type I Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA

* St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University, New York, NY, USA

* Division of Immunology, and the Jeffrey Modell Immunology Center at Harvard, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA

* Division of Immunology, Children's Hospital of Philadelphia, School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

* Center for Immunity and Immunotherapies, and the Jeffrey Modell Chair of Pediatric Immunology Research, Seattle Children's Research Institute, University of Washington, Seattle, WA, USA

* The Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

* The CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

* The Pediatric Department, Children’s University Hospital Bratislava, Comenius University Medical Faculty, Bratislava, Slovak Republic

* The Department of Infectious and Pediatric Immunology, Medical and Health Science Centre, University of Debrecen, Debrecen, Hungary

* Department of Pathology and Immunology, Geneva Medical Faculty, University of Geneva; and the Department of Genetic and Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland

* The Children's Memorial Health Institute, Warsaw, Poland

* Department of Immunology-Histocompatibility, and Specific Center & Referral Center for Primary Immunodeficiencies – Paediatric Immunology, "Aghia Sophia" Children's Hospital, Athens, Greece

* The European Laboratory for the Investigation of Food-Induced Diseases (ELFID), Università degli Studi di Napoli Federico II, Naples, Italy

* Department of Immunology, Azerbaijan Medical School, Baku, Azerbaijan

* The Belarusian National Research Center for Pediatric Oncology, Hematology and Immunology, Minsk Region, Belarus

* The Jeffrey Modell Diagnostic and Research Center in São Paulo, Brazil

* Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo, and Jeffrey Modell Diagnostic and Research Center in São Paulo, Brazil

* Emory Vaccine Center, School of Medicine, Emory University, Atlanta, Georgia, USA

* Department of Immunology, INSERM, Laboratory of Excellence (LabEx) Transplantex, Strasbourg Federation for Translational Medicine (FMTS), Strasbourg School of Medicine and University Teaching Hospitals, University of Strasbourg, Strasbourg, France

* The Laboratory of Research, and Department of Immunology, Institut Pasteur de Tunis, Tunis

* The Clinical Immunology Unit, Casablanca Children’s Hospital, Universite Hassan II Casablanca, Casablanca, Morocco

* Division of Pediatric Allergy/Immunology, Marmara University Hospital, Marmara University, Istanbul, Turkey

* Belarusian State Medical University, Minsk, Belarus

* Tajikistan National Medical Center, Dushanbe, Tajikistan

* University of Santiago de Compostella, Spain

* Hannover Medical School, Germany

* Laboratory of Nonamedicine and Biomaterials, Brighham and Women's hospital, Harvard Medical School, Boston, MA, USA

* Malaysian Society of Allergy and Immunology (MSAI), Malaysia

* Jimma University, Ethiopia

* Semmelweis University, Budapest, Hungary

* Shupyk National Medical Academy of Postgraduate Education, Ukraine

* Rare Immune Diseases, Ukraine

* Ukrainian Association of Pediatric Immunology

* University of Maribor, Maribor, Slovenia

* Alma Mater Europaea, Maribor, Slovenia

* University of Ljubljana, Maribor, Slovenia

* European School of Genetics in Medicine, Bertinoro, Italy

* Institute of Neurogenetics and Neuropharmacology at Institute of Genetic and Biomedical Research (IRGB), Sardinia, Italy

* Division of Allergy and Immunology, Children’s hospital Philadelphia, Philadelphia,USA

* STEM Fellowship, Vancouver, Canada

* Department of Pediatric Allergy and Immunology, the University of South Florida and University of South Florida Board of Trustees, South Florida, USA

* Division of Allergy and Clinical Immunology, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru

* Instituto de Pesquisa Pele Pequeno Principle, Curitiba, Brazil

* Latin America Society for Immunodeficiencies (LASID)

* Clinical Operations & Program Management, Rocket Pharmaceuticals, New York, USA

* University of South Florida at Johns Hopkins All Children’s Hospital, South Florida, USA

* Departamento de Imunologia Institute of Biomedical Sciences, University of São Paulo, Sao Paulo, Brazil

* Brazilian Group for Immunodeficiency (BRAGID), Universidade Federal de Sao Paulo, Sao Paulo, Brazil

* Division of Pediatric Allergology and Clinical Immunology, Sister María Ludovica Children's Hospital, La Plata, Aegentina

* Serviço de Alergia e Imunologia do IPPMG, Departamento de Pediatria da Faculdade de Medicina da, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil

* Allergy and Clinical Immunology Unit, Department of Pediatrics, Al-Sabah Hospital, Kuwait City, Kuwait

* University College London, Great Ormond Street Institute of Child Health, London, UK

* Mexican Foundation for Girls and Boys with Immunodeficiencies, Mexico City, Mexico

* Section of Allergy and Clinical Immunology, Department of Pediatrics, Medical Collegen of Wisconsin, Milwaukee, WI, USA

 

Travels (For SCIENTIFIC VISITS OR as a TOURIST)

* The United States of America	* The United Kingdom	* Germany
* Switzerland	* France	* Italy
* Sweden	* Denmark	* Finland
* Norway	* Hungary	* Austria
* The Netherlands	* Scotland	* Wales
* Portugal	* Czech Republic	* Slovakia
* Spain	* Belgium	* Russia
* Poland	* Greece	* Luxembourg
* Slovenia	* Serbia	* Croatia
* Lichtenstein	* Monaco	* Vatican
* Belarus	* Ukraine	* Argentina
* Brazil	* Mexico	* Chile
* Ecuador	* China	* Japan
* South Korea	* Malaysia	* Singapore
* Thailand	* Hong Kong	* Lebanon
* Turkey	* Saudi Arabia	* UAE
* Qatar	* Tajikistan	* Azerbaijan
* Turkmenistan	* Armenia	* Tunis
* Morocco	* Canada	* Oman

* Lithuania                                    * Latvia                               * Estonia

 

Oral and Poster Presentations

 

	Title of Presentation	Name of Congress	Date	Place
1	Primary immunodeficiency in Iran; First report of Iranian primary immunodeficiency registry	12th International Congress of Pediatrics	October 2000	Tehran , Iran
2	X-linked agammaglobulinemia; clinical and immunological analysis of 27 patients	12th International Congress of Pediatrics	October 2000	Tehran , Iran
3	Clinical and immunologic analysis of 52 patients with common variable immunodeficiency	12th International Congress of Pediatrics	October 2000	Tehran , Iran
4	Primary immunodeficiency in Iran (328 patients)	11th International Congress of Immunology	July 2001	Stockholm, Sweden
5	The clinical spectrum of respiratory diseases in patients with primary humoral immunodeficiency disorders; a survey of patients from Iranian primary immunodeficiency registry	11th European Respiratory Congress	September 2001	Berlin , Germany
6	Lung manifestations of chronic granulomatous disease; a survey of patients from Iranian primary immunodeficiency registry	11th European Respiratory Congress	September 2001	Berlin , Germany
7	Frequency of primary immunodeficiency in Iran	13th International Congress of Pediatrics	October 2001	Tehran , Iran
8	A single center 20 year survey of infectious complications in patients with common variable immunodeficiency	13th International Congress of Pediatrics	October 2001	Tehran , Iran
9	Clinical manifestations of chronic granulomatous disease, a clinical survey of patients of the Iranian primary immunodeficiency registry	13th International Congress of Pediatrics	October 2001	Tehran , Iran
10	Respiratory diseases in patients with primary humoral immunodeficiency disorders	13th International Congress of Pediatrics	October 2001	Tehran , Iran
11	The clinical spectrum of gastrointestinal involvement in patients with primary humoral immunodeficiency; A clinical survey of patients from Iranian primary immunodeficiency registry	British Society of Gastroenterology Annual Meeting	March 2002	London , UK
12	The clinical spectrum of infections in patients with primary humoral immunodeficiency; a clinical survey of patients from Iranian Primary ImmunoDeficiency Registry	12th European Congress of Clinical Microbiology and Infectious Diseases	April 2002	Milan , Italy
13	The clinical spectrum of infections in patients with primary phagocytic disorders; a clinical survey of patients from Iranian Primary ImmunoDeficiency Registry	12th European Congress of Clinical Microbiology and Infectious Diseases	April 2002	Milan , Italy
14	Primary immunodeficiencies in Children’s Medical Center	6th Iranian Congress of Immunology and Allergy	May 2002	Tehran , Iran
15	The clinical spectrum of infections in patients with primary antibody immunodeficiency	6th Iranian Congress of Immunology and Allergy	May 2002	Tehran , Iran
16	Consanguinity in primary immunodeficient patients	6th Iranian Congress of Immunology and Allergy	May 2002	Tehran , Iran
17	Primary immunodeficiency diseases in Iran: the report of the national registry in children and adults (440 patients)	21st Congress of the European Academy of Allergology and Clinical Immunology	June 2002	Naples, Italy
18	X-linked Agammaglobulinemia in Iran: Clinical and immunologic analysis of 29 patients	21st Congress of the European Academy of Allergology and Clinical Immunology	June 2002	Naples, Italy
19	The frequency of consanguinity in primary immunodeficient patients, registered in Iranian Primary Immunodeficiency Registry	21st Congress of the European Academy of Allergology and Clinical Immunology	June 2002	Naples, Italy
20	A survey of infectious complication in 64 Iranian patients with common variable immunodeficiency	21st Congress of the European Academy of Allergology and Clinical Immunology	June 2002	Naples, Italy
21	Clinical manifestations of chronic granulomatous disease in Iran	21st Congress of the European Academy of Allergology and Clinical Immunology	June 2002	Naples, Italy
22	Efficacy of intravenous immunoglobulin in patients with  agammaglobulinemia	14th International Congress of Pediatrics	October 2002	Tehran , Iran
23	The study of liver enzyme abnormality in pediatrics with brucellosis in Emam hospital	14th International Congress of Pediatrics	October 2002	Tehran , Iran
24	Frequency of primary immunodeficiencies in Children’s Medical Center	10th Meeting of European Society for Immunodeficiencies	October 2002	Weimar, Germany
25	Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with X-linked agammaglobulinemia	10th Meeting of European Society for Immunodeficiencies	October 2002	Weimar, Germany
26	Adverse reactions of intravenous immunoglobulin therapy	4th Iranian Congress of Asthma and Allergy	May 2003	Shiraz, Iran
27	Human leukocyte antigen class I and II, in Iranian patients with common variable immunodeficiency	17th European Histocompatibility Conference- 11th Annual Meeting German Society of Immunogenetics	May 2003	Baden-Baden, Germany
28	Adverse reactions of 955 prophylactic intravenous immunoglobulin therapy in patients with antibody deficiencies	22nd Congress of the European Academy of Allergology and Clinical Immunology	June 2003	Paris, France
29	Ear, Nose, and Throat manifestations in patients with primary antibody deficiencies	World Allergy Organization Congress- XVIII ICACI	September 2003	Vancouver, Canada
30	Molecular diagnosis of antibody deficiencies patients	15th International Congress of Pediatrics	October 2003	Tehran, Iran
31	Iranian children with atopic dermatitis: severity scoring of atopic dermatitis, total serum IgE and eosinophil count in different age groups	15th International Congress of Pediatrics	October 2003	Tehran, Iran
32	Prevalence of common allergens in patients with allergic disorders in the Southeast of Iran	The Week of Allergy (ISBAAR-meeting, EAACI-ENT section meeting, SERIN meeting)	November 2003	Ghent, Belgium
33	Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with Common variable immunodeficiency	The First International Congress on Pulmonary Diseases, Intensive Care and Tuberculosis	December 2003	Tehran, Iran
34	The common allergens spectrum in South-east of Iran	33rd Annual Scientific Meeting of the Australasian Society for Immunology	December 2003	Perth, Australia
35	Pneumonia in Iranian pediatric patients with agammaglobulinemia	6th International Congress on Pediatric Pulmonology	February 2004	Lisbon, Portugal
36	Brucellosis and liver enzyme complications; A six-year study on 188 patients in Tehran	15th Congress of Iranian Internal Medicine	May 2004	Tehran, Iran
37	Survey of primary immunodeficiency patients with congenital neutropenia	The 7th Iranian Congress of Immunology and Allergy	May 2004	Mashhad, Iran
38	Primary immunodeficiency disorders and adverse effects of intravenous immunoglobulin therapy	The 7th Iranian Congress of Immunology and Allergy	May 2004	Mashhad, Iran
39	X-linked agammaglobulinemia in Iran	The 7th Iranian Congress of Immunology and Allergy	May 2004	Mashhad, Iran
40	Gastrointestinal manifestations of cow's milk allergy	The 7th Iranian Congress of Immunology and Allergy	May 2004	Mashhad, Iran
41	The prevalence of type I allergy among Zahedan Population	The 7th Iranian Congress of Immunology and Allergy	May 2004	Mashhad, Iran
42	Infections in Iranian pediatrics with Common Variable Immunodeficiency	22nd Annual Meeting of the European Society for Paediatric Infectious Diseases	May 2004	Tampere, Finland
43	Evaluation of the immune system in Iranian children with atopic dermatitis	II World Congress on Immunopathology & Respiratory Allergy	May 2004	Moscow, Russia
44	Congenital neutropenia and primary immunodeficiency disorders: a survey of 26 Iranian patients	9th Congress of the European Haematology Association	June 2004	Geneva, Switzerland
45	The comparative study between the incidence of adverse reactions following intravenous immunoglobulin infusion in various immunodeficiency disorders	23rd Congress of the European Academy of Allergology and Clinical Immunology	June 2004	Amsterdam, Netherlands
46	Human leukocyte antigen profile in the Baloch ethnic group living in the South-East region of Iran	23rd Congress of the European Academy of Allergology and Clinical Immunology	June 2004	Amsterdam, Netherlands
47	Comparision of the severity scoring of atopic dermatiiis, total serum IgE and eosinophil count based on different age group in Iranian children with atopic dermatitis	23rd Congress of the European Academy of Allergology and Clinical Immunology	June 2004	Amsterdam, Netherlands
48	Clinical manifestations of Iranian patients with Cyclic neutropenia	12th International Congress of Immunology and the 4th Annual Conference of the Federation of Clinical Immunology Societies	July 2004	Montreal, Canada
49	A 22-year survey of infectious complications in Iranian patients with X-linked agammaglobulinemia	12th International Congress of Immunology and the 4th Annual Conference of the Federation of Clinical Immunology Societies	July 2004	Montreal, Canada
50	Common variable immunodeficiency: Clinical   and immunological features of 61 patients	12th International Congress of Immunology and the 4th Annual Conference of the Federation of Clinical Immunology Societies	July 2004	Montreal, Canada
51	Major histocompatibility complex class I and II antigens frequencies in Zaboli ethnic group living in the South-East region of Iran	12th International Congress of Immunology and the 4th Annual Conference of the Federation of Clinical Immunology Societies	July 2004	Montreal, Canada
52	Involvement of gastrointestinal system in patients with cow's milk allergy	12th International Congress of Immunology and the 4th Annual Conference of the Federation of Clinical Immunology Societies	July 2004	Montreal, Canada
53	Efficacy of intravenous immunoglobulin therapy on the incidence of pneumonia in Iranian patients with common variable immunodeficiency	14th European Respiratory Congress	September 2004	Glasgow, Scotland
54	Prevalence of allergic rhinitis, eczema and asthma among school children in Tehran, Iran	II European Asthma Congress	October 2004	Tbilisi, Republic of Georgia
55	Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a four-year follow up study	1st International Congress on Basic and Clinical Immunogenomics	October 2004	Budapest, Hungary
56	Neutropenia in pediatric patients with primary humoral immunodeficiencies	16th International Congress of Pediatrics	October 2004	Tehran, Iran
57	Prevalence of allergic rhinitis in school-age children in Tehran	16th International Congress of Pediatrics	October 2004	Tehran, Iran
58	The clinical manifestations of 68 children with cow’s milk allergy	16th International Congress of Pediatrics	October 2004	Tehran, Iran
59	The Iranian national registry	XIth Meeting for the European Society for Immunodeficiencies	October 2004	Versailles, France
60	Neutropenia in Iranian patients with predominant antibody deficiency disorders	XIth Meeting for the European Society for Immunodeficiencies	October 2004	Versailles, France
61	Gastrointestinal complications in Common Variable Immunodeficiency: Endoscopic and pathologic findings	XIth Meeting for the European Society for Immunodeficiencies	October 2004	Versailles, France
62	Hodgkin’s lymphoma in two siblings with Common Variable Immunodeficiency	XIth Meeting for the European Society for Immunodeficiencies	October 2004	Versailles, France
63	An asymptomatic adult case with primary complement deficiency	XIth Meeting for the European Society for Immunodeficiencies	October 2004	Versailles, France
64	Complement deficiency in a patient with hyper IgM syndrome	XIth Meeting for the European Society for Immunodeficiencies	October 2004	Versailles, France
65	Recurrent and persistant neutropenia in patient with X-Linked Hyper IgM syndrome	XIth Meeting for the European Society for Immunodeficiencies	October 2004	Versailles, France
66	Mortality in primary immunodeficient patients, registered in Iranian primary Immunodeficiency Registry	XIth Meeting for the European Society for Immunodeficiencies	October 2004	Versailles, France
67	Congenital ophthalmic defects in a patient with X-linked agammaglobulinemia	XIth Meeting for the European Society for Immunodeficiencies	October 2004	Versailles, France
68	Distribution of T-cell immunodeficiency disorders diagnosed in Children's Medical Center in Iran	XIth Meeting for the European Society for Immunodeficiencies	October 2004	Versailles, France
69	The prevalence of asthma in Iranian school-aged children in the city of Tehran during 2002-2003	ACAAI Annual Scientific Meeting	November 2004	Boston, MA, USA
70	Prevalence of allergic rhinitis in school-aged children in Tehran, Iran	9th Asian Research Symposium in Rhinology & 10th Biennial Congress of the Trans-Pacific Allergy & Immunology Society	November 2004	Mumbai, India
71	The Registry of Primary Immunodeficiency Disorders in Iran	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
72	Iranian Primary Immunodeficiency Registry (IPIDR): From the Past to the Future	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
73	Mortality in Iranian Patients with Primary Immunodeficiency Disorders	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
74	The Frequency of Consanguinity in Primary Immunodeficient Patients; the Report from Iranian Primary Immunodeficiency Registry	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
75	Distribution of Primary Immunodeficiency Disorders Diagnosed in Children's Medical Center in Iran	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
76	Pulmonary Complications in Patients with Primary Hypogammaglobulinemia: A Survey by High Resolution CT Scan and Pulmonary Function Test	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
77	Ear, Nose and Throat Manifestations in Patients with Primary Antibody Deficiencies	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
78	Gastrointestinal Problems in Iranian Patients with Common Variable Immunodeficiency	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
79	The Clinical and Laboratory Findings of Patients with Antibody Deficiency Disorders Associated Neutropenia	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
80	Human Leukocyte Antigens Class I and II, in Iranian Patients with Common Variable Immunodeficiency	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
81	Clinical and Immunological Features of 65 Iranian Patients with Common Variable Immunodeficiency	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
82	Common Variable Immunodeficiency: Clinical and Immunological Features of 39 Iranian Pediatrics	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
83	Classification of Common Variable Immunodeficiency Based on Numbers of Switched Memory B–Cells	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
84	X-Linked Agammaglobulinemia: Clinical and Laboratory Findings of Patients in Children’s Medical Center	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
85	Identification of the Bruton Tyrosine Kinase Gene Mutations in 13 Iranian Patients with Presumed X-Linked Agammaglobulinemia	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
86	Lymphoma of Mucosa Associated Lymphoid Tissue in a Patient with Common Variable Immunodeficiency	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
87	Hodgkin’s Lymphoma in Common Variable Immunodeficiency	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
88	Gastrointestinal Complications in Two Patients with Common Variable Immunodeficiency	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
89	Ataxia-Telangiectasia: Immunological and Clinical Features of 79 Iranian Patients	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
90	The Report of Iranian Patients with Chronic Granulomatous Disease (CGD) from Two Referral Centers of Tehran	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
91	Primary Complement Deficiency in Patients with Recurrent Infections, Immune Complex Diseases or Angioedema	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
92	Clinical Manifestations of Iranian Patients with Primary Complement Deficiency	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
93	Primary Complement Deficiency in an Asymptomatic Adult Case	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
94	Hyper IgM Syndrome or Complement Deficiency? (A Case Report)	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
95	The Report of Acquired Immune Deficiency Syndrome (AIDS) in Zabol	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
96	Cytokine Gene Polymorphism in Iranian Patients with Chronic Myelogenous Leukemia	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
97	Efficacy of Intravenous Immunoglobulin on the Prevention of Pneumonia in Patients with Agammaglobulinemia	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
98	The Effect of Intravenous Immunoglobulin Therapy on Prevention of Pneumonia in Patients with Common Variable Immunodeficiency	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
99	Adverse Reactions of Prophylactic Intravenous Immunoglobulin Infusions in Iranian Patients with Primary Immunodeficiency	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
100	Successful Management of Neutropenia in Hyper IgM Syndrome by Regular Intravenous Immunoglobulin Infusion	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
101	Scientific Output of Iran at the Threshold of the 21st Century	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
102	Major Histocompatibility Complex Class I and II Antigens Frequencies in Baloch Ethnic Group Living in the Southeast Region of Iran	First International Congress on Immunodeficiency Disorders	February-March 2005	Tehran, Iran
103	Clinical and laboratory manifestations of patients with primary immunodeficiency disorders associated neutropenia; the report from Iranian Primary Immunodeficiency Registry	10th Congress of the European Hematology Association	June 2005	Stockholm, Sweden
104	Primary immunodeficiency disorders in Iran	The University of Vienna	June 2005	Vienna, Austria
105	Primary immunodeficiency disorders in Iran: Incidence, diagnostic and treatment options	The University of Freiburg	June 2005	Freiburg, Germany
106	Frequency of primary immunodeficiency disorders in Iran; the second report from Iranian Primary Immunodeficiency Registry	The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology	June-July 2005	Munich, Germany
107	Relative marriage in Iranian patients with primary immunodeficiency disorders	The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology	June-July 2005	Munich, Germany
108	The clinical manifestations of cow’s milk allergy in Iranian children	The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology	June-July 2005	Munich, Germany
109	The clinical manifestations of Iranian patients with primary complement deficiency	The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology	June-July 2005	Munich, Germany
110	Primary complement deficiency in Iranian patients with recurrent infections, immune complex diseases or angioedema	The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology	June-July 2005	Munich, Germany
111	Ear, nose and throat manifestations in patients with primary antibody deficiencies	The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology	June-July 2005	Munich, Germany
112	Ataxia-Telangiectasia: immunological and clinical features of 79 Iranian patients	The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology	June-July 2005	Munich, Germany
113	One year survey of infection in primary immunodeficient patients receiving intravenous immunoglobulin	The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology	June-July 2005	Munich, Germany
114	The prevalence of asthma in Iranian school-aged children in the city of Tehran during 2002-2003	2nd Asthma Meeting	November 2005	Tehran , Iran
115	Gastrointestinal (GI) Involvement in Iranian Patients with Chronic Granulomatous Disease (CGD)	AAAAI Annual Meeting	March 2006	Miami Beach, FL, USA
116	The Clinical and Laboratory Survey of Patients with Severe Congenital Neutropenia (Kostman Syndrome)	The 8th Iranian Congress of Immunology and Allergy	May 2006	Tehran , Iran
117	The Clinical and Laboratory Survey of Patients with Hyper IgE Syndrome	The 8th Iranian Congress of Immunology and Allergy	May 2006	Tehran , Iran
118	The Comparison of Human Leukocyte Antigen antigens frequencies in Zaboli and Balochi ethnic groups	The 8th Iranian Congress of Immunology and Allergy	May 2006	Tehran , Iran
119	Hereditary and acquired angioedema	The 8th Iranian Congress of Immunology and Allergy	May 2006	Tehran , Iran
120	The clinical and laboratory survey of hyper IgE syndrome	25th Congress of the European Academy of Allergology and Clinical Immunology	June 2006	Vienna , Austria
121	Severe combined immunodeficiency in Iran	25th Congress of the European Academy of Allergology and Clinical Immunology	June 2006	Vienna , Austria
122	Hereditary and acquired angioedema: serologic screening tests for diagnosis and classification	25th Congress of the European Academy of Allergology and Clinical Immunology	June 2006	Vienna , Austria
123	Human Leukocyte Antigen profile of two ethnic groups living in the southeastern Iran	25th Congress of the European Academy of Allergology and Clinical Immunology	June 2006	Vienna , Austria
124	Chromosomal radiosensitivity in Ataxia-Telangiectasia as a diagnostic test	25th Congress of the European Academy of Allergology and Clinical Immunology	June 2006	Vienna , Austria
125	Clinical and Laboratory Features of Iranian Patients with Kostman Syndrome	XIIth Meeting for the European Society for Immunodeficiencies	October 2006	Budapest, Hungary
126	The Spectrum of Primary Immunodeficiency Diseases in Iran	ESID Spring meeting	May 2007	Prague, Czech Republic
127	Severe Congenital Neutropenia in Iran	ESID Spring meeting	May 2007	Prague, Czech Republic
128	The study of antibody response in patients with primary antibody deficiencies to plain polysaccharide meningococcal c vaccine by serum bactericidal assay	26th Congress of the European Academy of Allergology and Clinical Immunology	June 2007	Goteborg , Sweden
129	High production of IL-18 by dendritic cells induced by sera from patients with primary antibody deficiency	26th Congress of the European Academy of Allergology and Clinical Immunology	June 2007	Goteborg , Sweden
130	Serum Bactericidal Antibody Response to Serogroup C Polysaccharide Meningococcal Vaccination in Children with Primary Antibody Deficiencies	Research Day, The University of Sheffield	June 2007	Sheffield, UK
131	The Clinical And Laboratory Spectrum of Iranian Patients With Severe Congenital Neutropenia	19th International Congress of Pediatrics	November 2007	Tehran, Iran
132	Intravenous immunoglobulin therapy panel (Co-chair)	19th International Congress of Pediatrics	November 2007	Tehran, Iran
133	Mutation analysis in Iranian Patients with Hyper IgE syndrome	The 1st International Congress on Health Genomics and Biotechnology	November 2007	Tehran, Iran
134	Congenital Neutropenia due to Mutation of CD40 Ligand in Hyper IgM Syndrome	The 1st  International Congress on Health Genomics and Biotechnology	November 2007	Tehran, Iran
135	Serum bactericidal antibody response to polysaccharide meningococcal vaccination in common variable immunodeficiency and its clinical implications	18th European Congress of Clinical Microbiology and Infectious Diseases	April 2008	Barcelona, Spain
136	Novel vaccine antigens and host response (Co-chair)	18th European Congress of Clinical Microbiology and Infectious Diseases	April 2008	Barcelona, Spain
137	Western immunoblotting assay of Btk deficiency	27th Congress of the European Academy of Allergology and Clinical Immunology	June 2008	Barcelona, Spain
138	Response to polysaccharide vaccination amongst patients with common variable immunodeficiency correlates with clinical disease	Research Day, The University of Sheffield	June 2008	Sheffield, UK
139	Serum cytokine assay in patients with common variable immunodeficiency	The 9th Iranian Congress of Immunology and Allergy	June 2008	Tehran, Iran
140	Th1 and Th2 cytokine gene polymorphisms in asthma	The 9th Iranian Congress of Immunology and Allergy	June 2008	Tehran, Iran
141	Selective IgA deficiency: association between clinical and immunological findings	The 9th Iranian Congress of Immunology and Allergy	June 2008	Tehran, Iran
142	A 10-year single center survey of pediatric patients with histiocytosis in Iran	24th Annual Meeting of the Histiocyte Society	September- October 2008	Berlin, Germany
143	Abnormal immunoglobulin levels in Iranian patients with hematologic malignancies	8th Iranian Congress in Hematology and Oncology	October 2008	Urmia, Iran
144	Severe congenital neutropenia: definition, diagnosis and management	20th International Congress of Pediatrics	October 2008	Tehran, Iran
145	Primary antibody deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings	13th  Meeting of the European Society for Immunodeficiencies	October 2008	's-Hertogenbosch, The Netherlands
146	Evaluation of humoral immune function in the patients with bronchiectasis	13th  Meeting of the European Society for Immunodeficiencies	October 2008	's-Hertogenbosch, The Netherlands
147	IgA Deficiency: correlation between clinical and immunological manifestations	13th  Meeting of the European Society for Immunodeficiencies	October 2008	's-Hertogenbosch, The Netherlands
148	A novel clinical syndrome associating severe congenital neutropenia and complex developmental aberrations caused by deficiency of G6PC3	13th  Meeting of the European Society for Immunodeficiencies	October 2008	's-Hertogenbosch, The Netherlands
149	Chronic mucocutaneous candidiasis is associated with a homozygous mutation in CARD9	13th  Meeting of the European Society for Immunodeficiencies	October 2008	's-Hertogenbosch, The Netherlands
150	Emerging infections: can we cope with them? (Co-chair)	19th European Congress of Clinical Microbiology and Infectious Diseases	May 2009	Helsinki, Finland
151	Approach to primary immunodeficiency in children and adults: Clinical manifestations (Invited speaker)	19th European Congress of Clinical Microbiology and Infectious Diseases	May 2009	Helsinki, Finland
152	Idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency	14th Annual Meeting of the European-Hematology-Association	June 2009	Berlin, Germany
153	Increased susceptibility to fungal infections/chronic mucocutaneous candidiasis due to a homozygous loss of function mutation in CARD9	2nd European Congress of Immunology	September 2009	Berlin, Germany
154	Primary immunodeficiency diseases associated with neutropenia	21st International Congress of Pediatrics	October 2009	Tehran, Iran
155	Immunology, rheumatology and infectious diseases poster session  (Co-chair)	21st International Congress of Pediatrics	October 2009	Tehran, Iran
156	Clinical characteristics of Iranian children with inflammatory bowel disease	21st International Congress of Pediatrics	October 2009	Tehran, Iran
157	Antibody deficiency to pneumococcal capsular polysaccharide vaccination in patients with chronic kidney disease	21st International Congress of Pediatrics	October 2009	Tehran, Iran
158	Genetic defects in primary immunodeficiency diseases	Iranian Clinical Genetics Meeting	October 2009	Tehran, Iran
159	Susceptibility to fungal infections due to a homozygous mutation in CARD9	UKPIN Immunology Forum	November 2009	Bath, UK
160	Comparison of pulmonary diseases in common variable immunodeficiency and x-linked agammaglobulinemia.	ACAAI Annual Scientific Meeting	November 2009	Miami Beach, FL, US
161	Infectious and non-infectious complications among undiagnosed patients with common variable immunodeficiency compared with early diagnosed and well-treated patients	ACAAI Annual Scientific Meeting	November 2009	Miami Beach, FL, US
162	Different clinical phenotypes of 93 patients with common variable immunodeficiency	ACAAI Annual Scientific Meeting	November 2009	Miami Beach, FL, US
163	New advances in immunology and mechanisms of immunologic injury	CME Meeting for Pathologists	March 2010	Tehran, Iran
164	Novel insights on histocompatibility antigens and transplantation	CME Meeting for Pathologists	March 2010	Tehran, Iran
165	Approach to a patient with neutropenia and primary immunodeficiency	Annual Congress of Iranian Society of Pediatrics	May 2010	Tehran, Iran
166	Clinical characteristics of patients with primary immunodeficiency diseases	10th International Congress of Immunology and Allergy	May 2010	Tehran, Iran
167	Molecular studies in patients with severe congenital neutropenia associated with primary immunodeficiencies	10th International Congress of Immunology and Allergy	May 2010	Tehran, Iran
168	Evaluation of antibody response to polysaccharide vaccination in common variable immunodeficiency	10th International Congress of Immunology and Allergy	May 2010	Tehran, Iran
169	IL-4 and IL-10 gene polymorphisms in irritable bowel syndrome	29th Congress of the European Academy of Allergology and Clinical Immunology	June 2010	London, UK
170	Cytokine gene polymorphisms in common variable immunodeficiency	29th Congress of the European Academy of Allergology and Clinical Immunology	June 2010	London, UK
171	Behaviour abnormality following intravenous immunoglobulin treatment in patients with primary antibody deficiencies	29th Congress of the European Academy of Allergology and Clinical Immunology	June 2010	London, UK
172	Antibody responses to pneumococcal polysaccharide vaccine in splenectomised patients	29th Congress of the European Academy of Allergology and Clinical Immunology	June 2010	London, UK
173	In vitro cytotoxic effects of high dose of oxLDL on peripheral blood mononuclear cells of patients with atherosclerosis	29th Congress of the European Academy of Allergology and Clinical Immunology	June 2010	London, UK
175	Physicians awareness on primary immunodeficiency diseases in Iran	29th Congress of the European Academy of Allergology and Clinical Immunology	June 2010	London, UK
176	Measurement of soluble CD30 in common variable immunodeficiency	29th Congress of the European Academy of Allergology and Clinical Immunology	June 2010	London, UK
177	B- and T-cells cognate interaction assay in common variable immunodeficiency	29th Congress of the European Academy of Allergology and Clinical Immunology	June 2010	London, UK
178	Cutaneous granulomas in common variable immunodeficiency	29th Congress of the European Academy of Allergology and Clinical Immunology	June 2010	London, UK
179	Renal amyloidosis in common variable immunodeficiency	29th Congress of the European Academy of Allergology and Clinical Immunology	June 2010	London, UK
180	Effect of vitamin A supplementation on reducing cytotoxic effect of oxLDL in patients with atherosclerosis	14th International Congress of Immunology	August 2010	Kobe, Japan
181	Switched memory B-cells in patients with IgA deficiency	14th International Congress of Immunology	August 2010	Kobe, Japan
182	Malignancy phenotype in 7 patients with common variable immunodeficiency	14th International Congress of Immunology	August 2010	Kobe, Japan
183	Evaluation of B- and T- cells activation and proliferation in common variable immunodeficiency	14th International Congress of Immunology	August 2010	Kobe, Japan
184	Defective interleukin-2 and interleukin-4 production in a subgroup of patients with common variable immunodeficiency	14th  Meeting of the European Society for Immunodeficiencies	October 2010	Istanbul, Turkey
185	Poor proliferative response to mitogen and defective IL-2 production in patients with coronary artery disease	14th  Meeting of the European Society for Immunodeficiencies	October 2010	Istanbul, Turkey
186	International survey of post-vaccinal BCG infection in patients with severe combined immunodeficiency (SCID): First report from BCG infection in SCID Patients Interest Group	14th  Meeting of the European Society for Immunodeficiencies	October 2010	Istanbul, Turkey
187	Evaluation of naïve CD4+ T cells according to sex in CVID patients and healthy controls	14th  Meeting of the European Society for Immunodeficiencies	October 2010	Istanbul, Turkey
188	Decreased switched memory B cells in IgA deficient patients	14th  Meeting of the European Society for Immunodeficiencies	October 2010	Istanbul, Turkey
189	Physicians awareness on primary immunodeficiency disorders in Iran	14th  Meeting of the European Society for Immunodeficiencies	October 2010	Istanbul, Turkey
190	Characterization of 11 new cases of leukocyte adhesion deficiency type 1 with seven novel mutations in the ITGB2 gene	14th  Meeting of the European Society for Immunodeficiencies	October 2010	Istanbul, Turkey
191	Immunodeficiency diseases oral presenting session  (Co-chair)	3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies	October 2010	Tehran, Iran
192	Clinical phenotypes of primary immunodeficiencies	3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies	October 2010	Tehran, Iran
193	Oral and dental health in Iranian patients with primary antibody deficiency disorders	3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies	October 2010	Tehran, Iran
194	Ataxia-Telangiectasia in three patients presenting with hyper-immunoglobulin M syndrome	3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies	October 2010	Tehran, Iran
195	Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies	3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies	October 2010	Tehran, Iran
196	X-linked lymphoproliferative syndrome: A genetic condition typified by the triad of infection, immunodeficiency and lymphoma	3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies	October 2010	Tehran, Iran
197	Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia	3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies	October 2010	Tehran, Iran
198	Health policy making for common variable immunodeficiency: the burden of the disease	3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies	October 2010	Tehran, Iran
199	Cutaneous granulomas in common variable immunodeficiency	3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies	October 2010	Tehran, Iran
200	Antibody responses to vaccination with pneumococcal polysaccharide vaccine in Splenectomized Patients with Idiopathic Thrombocytopenic Purpura or Trauma	3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies	October 2010	Tehran, Iran
201	Infectious diseases poster presenting session  (Co-chair)	22nd International Congress of Pediatrics	October 2010	Tehran, Iran
202	Approach to a patient with congenital neutropenia	22nd International Congress of Pediatrics	October 2010	Tehran, Iran
203	Challenges in diagnosis of Immunodeficiencies session (Co-chair)	3rd Congress of Laboratory and Clinics (Pediatrics)	November 2010	Tehran, Iran
204	In vitro effect of oxLDL and PHA on lymphocyte proliferation/cytotoxicity and interleukin-2 production in patients with atherosclerosis	AAAAI Annual Meeting	March 2011	San Francisco, CA, USA
205	B-cells and T-cells cognate interaction assay in common variable immunodeficiency	AAAAI Annual Meeting	March 2011	San Francisco, CA, USA
206	Primary immunodeficiency diseases in Iran : a decade of progress in molecular diagnosis of immunodeficient patients	2nd CIS Annual Meeting	May 2011	Chicago, IL, USA
207	Soluble CD30 as a marker of disease severity in common variable immunodeficiency	2nd CIS Annual Meeting	May 2011	Chicago, IL, USA
208	T-helper (Th)1 and Th2 cytokines in atherosclerosis and effects of vitamin A supplementation on Th1/Th2 balance	2nd CIS Annual Meeting	May 2011	Chicago, IL, USA
209	Congenital neutropenias and primary immunodeficiencies	National Institute of Health	May 2011	Bethesda, MD, USA
210	Primary immunodeficiencies in Iran	Children's Hospital of Philadelphia, University of Pennsylvania	May 2011	Philadelphia, PA, USA
211	Recent advances on primary immunodeficiency diseases in Iran	Children's Hospital Boston, Harvard Medical School	May 2011	Boston, MA, USA
212	Primary immunodeficiency diseases in Iran	Seattle Children's Research Institute, University of Washington	June 2011	Seattle, WA, USA
213	The molecular basis of congenital neutropenia	Seattle Children's Research Institute, University of Washington	June 2011	Seattle, WA, USA
214	T-helper 1 and 2 cytokine assay in patients with atherosclerosis	30th Congress of the European Academy of Allergy and Clinical Immunology	June 2011	Istanbul, Turkey
215	In vitro soluble CD30 levels in patients with chronic stable coronary artery disease	30th Congress of the European Academy of Allergy and Clinical Immunology	June 2011	Istanbul, Turkey
216	Polymorphisms in IL-4 and IL-4 RA genes confer susceptibility to asthma	30th Congress of the European Academy of Allergy and Clinical Immunology	June 2011	Istanbul, Turkey
217	Increased soluble CD26 in common variable immunodeficiency and its clinical implications	30th Congress of the European Academy of Allergy and Clinical Immunology	June 2011	Istanbul, Turkey
218	J Project meetings in non-ECE countries	2nd Steering J Project Committee Meeting	January 2012	Budapest, Hungary
219	Approach to congenital neutropenias	Children’s University Hospital Bratislava, Comenius University Medical Faculty	January 2012	Bratislava, Slovakia
220	Primary immunodeficiencies in Iran	Ce-M-M- Research Center for Molecular Medicine of the Austrian Academy of Sciences	January 2012	Vienna, Austria
221	Scientific output related to primary immunodeficiencies in Iran	World PI Week Seminar	April 2012	Tehran, Iran
222	Approach to patients with phagocyte defects	Annual Congress of Iranian Society of Pediatrics, 33rd Memorial Congress of Prof. M. Gharib	April 2012	Tehran, Iran
223	Laboratory evaluation in patients with immunodeficiedncies	ICIA 2012 Advanced Course in Immunology	April 2012	Tehran, Iran
224	Recent update on genetic defects associated with congenital defects of phagocyte	11th International Congress of Immunology and Allergy of Iran	April 2012	Tehran, Iran
225	Scientific research from studentship to professorship	11th International Congress of Immunology and Allergy of Iran	April 2012	Tehran, Iran
226	Classification of CVID patients based on naïve CD4+ T cell levels and clinical features	11th International Congress of Immunology and Allergy of Iran	April 2012	Tehran, Iran
227	Mycobacterium tuberculosis meningitis as the first presentation of chronic granulomatous disease	11th International Congress of Immunology and Allergy of Iran	April 2012	Tehran, Iran
228	Interleukin-10 and TGF-β1 Anti-Inflammatory Cytokine Gene Polymorphisms are Involved in the Pathophysiology of Irritable Bowel Syndrome: A Meta-Analysis	Digestive Disease Week	May 2012	San Diego, US
229	Carriage rate of Hemophilus influenza and Streptococcus pneumonia among under 6 years old children in Tehran, Iran	31st Annual Meeting of the European Society for Paediatric Infectious Diseases	May 2012	Athens, Greece
230	Prevalence of Heemophilus influenza and Streptococcus pneumonia carriers in nasopharyngeal in children under 6 years old in Tehran	EKMUD Congress (Infectious Diseases & and Clinical Microbiology)	May 2012	Istanbul, Turkey
231	Evaluation of regulatory T-cells and autoimmunity in IgA deficiency	Conference on Excellence in Rheumatology	June 2012	Madrid, Spain
232	Approach to clinical cases with immunodeficiencies	Geneva Medical Faculty, University of Geneva	June 2012	Geneva, Switzerland
233	Phagocyte defects. In: Workshop of primary immunodeficiency diseases: new insights	31st Congress of the European Academy of Allergy and Clinical Immunology	June 2012	Geneva, Switzerland
234	Autoimmunity and immunodeficiency session (Co-chair)	31st Congress of the European Academy of Allergy and Clinical Immunology	June 2012	Geneva, Switzerland
235	Phagocyte defects: new insights	31st Congress of the European Academy of Allergy and Clinical Immunology	June 2012	Geneva, Switzerland
236	Ataxia-telangiectasia presenting as hyper-immunoglobulin M syndrome	31st Congress of the European Academy of Allergy and Clinical Immunology	June 2012	Geneva, Switzerland
237	Mycobacterium tuberculosis meningitis as the first presentation of chronic granulomatous disease	31st Congress of the European Academy of Allergy and Clinical Immunology	June 2012	Geneva, Switzerland
238	Progress on immunodeficiencies in Iran	The San Raffaele Telethon Institute for Gene Therapy HSR-TIGET	June 2012	Milan, Italy
239	BCG complications associated with primary immunodeficiency diseases	Meeting on BCG Complications	June 2012	Warsaw, Poland
240	Chronic mucocutaneous candidiasis	Middle East Workshop for Primary Immunodeficiency	June 2012	Athens, Greece
241	Carrier Evaluation of Nasopharyngeal Neisseria spp on children up to 5 years old in Tehran, Iran	13th Iranian and the 2nd International Congress of Microbiology	July 2012	Ardabil, Iran
242	Clinical Presentations and Long-Term Outcome of DOCK8 Deficiency – A Survey of 134 Patients	15th Biennial Meeting of the European Society for Immunodeficiencies (ESID)	October 2012	Florence, Italy
243	Dramatic effect of live vaccines (OPV and BCG) administred in the first year of life in a patient with severe immunodeficiency	15th Biennial Meeting of the European Society for Immunodeficiencies (ESID)	October 2012	Florence, Italy
244	Long term Observation of Children Suffered from Common Variable Immunodeficiency	15th Biennial Meeting of the European Society for Immunodeficiencies (ESID)	October 2012	Florence, Italy
245	Evaluation of Natural Regulatory T Cells in Subjects with Selective IgA Deficiency: From Senior Idea to Novel Opportunities	15th Biennial Meeting of the European Society for Immunodeficiencies (ESID)	October 2012	Florence, Italy
246	Mortality and Morbidity in Patients with X-linked Agammaglobulinemia	15th Biennial Meeting of the European Society for Immunodeficiencies (ESID)	October 2012	Florence, Italy
247	Autoimmune manifestations in patients with common variable immune deficiency	15th Biennial Meeting of the European Society for Immunodeficiencies (ESID)	October 2012	Florence, Italy
248	Otologic Investigation in Primary Immunodeficiency Patients	15th Biennial Meeting of the European Society for Immunodeficiencies (ESID)	October 2012	Florence, Italy
249	Deleterious LRBA mutations in a novel syndrome of immune deficiency and autoimmunity	15th Biennial Meeting of the European Society for Immunodeficiencies (ESID)	October 2012	Florence, Italy
250	Novel Activation-Induced Cytidine Deaminase (AICDA) Gene Mutation in Two Siblings of a Family with Hyper IgM Syndrome	15th Biennial Meeting of the European Society for Immunodeficiencies (ESID)	October 2012	Florence, Italy
251	Identification of a Novel CD40 Ligand Mutation in a Patient with Hyper IgM Phenotype and Neutropenia	15th Biennial Meeting of the European Society for Immunodeficiencies (ESID)	October 2012	Florence, Italy
252	Primary Immunodeficiency Diseases Session (Co-chair)	24th International Congress of Pediatrics & 5th Meeting on Clinical Immunology and Immunodeficiencies	October 2012	Tehran, Iran
253	Approach to a child with congenital neutropenia	24th International Congress of Pediatrics & 5th Meeting on Clinical Immunology and Immunodeficiencies	October 2012	Tehran, Iran
254	Recent Advances on Diagnosis of Primary Immunodeficiencies in Iran	24th International Congress of Pediatrics & 5th Meeting on Clinical Immunology and Immunodeficiencies	October 2012	Tehran, Iran
255	TNF-alpha single nucleotide polymorphisms in atopic dermatitis	24th International Congress of Pediatrics	October 2012	Tehran, Iran
256	Gene polymorphisms of tumor necrosis factor and interleukin-1 gene complex in allergic rhinitis	24th International Congress of Pediatrics	October 2012	Tehran, Iran
257	Serum level of zinc in asthmatic patients; A case-control study	24th International Congress of Pediatrics	October 2012	Tehran, Iran
258	Multiple cancers in a patient with common variable immunodeficiency	24th International Congress of Pediatrics	October 2012	Tehran, Iran
259	Scientific Research during Studentship: From Selecting a Topic to Future Career	24th International Congress of Pediatrics	October 2012	Tehran, Iran
260	Interleukin 6 single nucleotide polymorphisms in allergic rhinitis	24th International Congress of Pediatrics	October 2012	Tehran, Iran
261	Maturity Onset Diabetes of the Young, Type 2 in an asymptomatic child	24th International Congress of Pediatrics	October 2012	Tehran, Iran
262	Effect of nebulized L-epinephrine on the treatment of croup	24th International Congress of Pediatrics	October 2012	Tehran, Iran
263	Study of in vitro chromosomal sensitivity to gamma irradiation in lymphocytes of children with acute lymphoblastic leukemia	24th International Congress of Pediatrics	October 2012	Tehran, Iran
263	How to publish an academic book with international publisher	1st Tabari Festival	December 2012	Sari, Mazandaran
264	Opportunistic infections (Co-chair)	5th Congress of Laboratory and Clinics	December 2012	Tehran, Iran
265	Primary hemophagocytic lymphohistiocytosis and hematopoeitic stem cell transplantation in Iran	BMT Tandem Meetings	February 2013	Salt Lake City, UT, USA
266	Congenital neutropenias	1st MENA Immunodeiciency Meeting	February 2013	Dubai, UAE
267	Proinflammatory cytokine gene polymorphisms in ischemic heart failure	2013 CIS Annual Meeting: Regulation & Dysregulation of Immunity	April 2013	Miami, FL, USA
268	Congenital neutropenia in primary immunodeficiencies	46th Middle East Medical Assembly	May 2013	Beirut, Lebanon
269	Interleukin-2 single nucleotide polymorphisms in autoimmune hepatitis	The 5th International Tehran Hepatitis Congress	May 2013	Tehran, Iran
270	Association of interleukin 4 single nucleotide polymorphism with chronic urticaria	32nd Congress of the European Academy of Allergy and Clinical Immunology	June 2013	Milan, Italy
271	Single nucleotide polymorphisms of proinflammatory cytokines in allergic rhinitis	32nd Congress of the European Academy of Allergy and Clinical Immunology	June 2013	Milan, Italy
272	Normal alleles of rs2237060 of RAD50 in Iranian patients with common variable immunodeficiency and IgA deficiency	32nd Congress of the European Academy of Allergy and Clinical Immunology	June 2013	Milan, Italy
273	Cytokine single nucleotide polymorphisms in patients with ischemic heart failure	32nd Congress of the European Academy of Allergy and Clinical Immunology	June 2013	Milan, Italy
274	TNF-alpha single nucleotide polymorphisms in atopic dermatitis	32nd Congress of the European Academy of Allergy and Clinical Immunology	June 2013	Milan, Italy
275	Gene polymorphisms of Th2 cytokines in allergic rhinitis	32nd Congress of the European Academy of Allergy and Clinical Immunology	June 2013	Milan, Italy
276	IL-17F mutation in recurrent aphthous stomatitis	32nd Congress of the European Academy of Allergy and Clinical Immunology	June 2013	Milan, Italy
277	Update on diagnosis and treatment of PI patients in Iran	Primary Immunodeficiencies JMF Summit	July 2013	Berlin, Germany
278	Immunologic Alterations in Long-Term Divers	15th International Congress of Immunology	August 2013	Milan, Italy
279	Clinical immunology and Immunodeficiencies (Co-chair)	6th Meeting on Clinical Immunology and Immunodeficiencies	October 2013	Tehran, Iran
280	Update on classification of primary immunodeficiencies	6th Meeting on Clinical Immunology and Immunodeficiencies	October 2013	Tehran, Iran
281	IL-17F mutation in recurrent aphthous stomatitis	25th International Congress of Pediatrics	October 2013	Tehran, Iran
282	Cohort of 173 Iranian common variable immunodeficiency patients	25th International Congress of Pediatrics	October 2013	Tehran, Iran
283	Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus	25th International Congress of Pediatrics	October 2013	Tehran, Iran
284	Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus	25th International Congress of Pediatrics	October 2013	Tehran, Iran
285	Does oral administration of immunoglobulin could reduce diarrheal severity in common variable immunodeficiency	25th International Congress of Pediatrics	October 2013	Tehran, Iran
286	In vitro comparison of chromosomal radiosensitivity in common variable immunodeficiency and acute lymphocytic leukemia patients	25th International Congress of Pediatrics	October 2013	Tehran, Iran
287	Association of Interleukin 10(IL-10) and transforming growth factor β(TGF-β) gene polymorphisms with chronic idiopathic urticaria	25th International Congress of Pediatrics	October 2013	Tehran, Iran
288	Interleukin-1 family and interleukin-6 gene polymorphisms in recurrent aphthous stomatitis	25th International Congress of Pediatrics	October 2013	Tehran, Iran
289	Cutaneous reactivity pattern and nasal smear cytology in patients with chronic rhinosinusitis with nasal polyps; is it associated with the course of the disease?	25th International Congress of Pediatrics	October 2013	Tehran, Iran
290	The role of cytokines in pathogenesis of asthma	25th International Congress of Pediatrics	October 2013	Tehran, Iran
291	Interleukin-6 and tumor necrosis factor-alpha gene polymorphisms in chronic idiopathic urticaria	25th International Congress of Pediatrics	October 2013	Tehran, Iran
292	Proinflammatory cytokine gene polymorphisms in autoimmune hepatitis	25th International Congress of Pediatrics	October 2013	Tehran, Iran
293	Co-chair: Primary immunodeficiency and auto inflammatory disorders	9th Biennial Congress of Immunology, Asthma and Allergy	November 2013	Tehran, Iran
294	Key lecture: Scientific reseasch	Research Week Meeting, Alborz Univ Med Sci	December 2013	Karaj, Iran
295	Principles of autommunity in primary immunodeficiency diseases	Meeting of Iranian Society of Asthma and Allergy	December 2013	Tehran, Iran
296	Genetic diagnosis of primary immunodeficiency diseases	PID Meeting	January 2014	Tehran, Iran
297	Congenital neutropenia associated with primary immunodeficiency diseases: Future directions and potential gene therapy	Gene Therapy Laboratory, Universidad Austral	February 2014	Buenos Aires, Argentina
298	Congenital neutropenia and primary immunodeficiency diseases: From bedside to bench and back again!	Texas Children’s Hospital, Baylor College of Medicine	February 2014	Houston, TX, USA
299	Interleukin-4 and transforming growth factor-beta single nucleotide genes polymorphisms confer susceptibility to atopic dermatitis	AAAAI Annual Meeting	February-March 2014	San Diego, CA, USA
300	Polymorphisms of genes encoding interleukin-4 and its receptor are associated with chronic idiopathic urticaria	AAAAI Annual Meeting	February-March 2014	San Diego, CA, USA
301	Association of interleukin-23 receptor single nucleotide polymorphisms with ulcerative colitis	AAAAI Annual Meeting	February-March 2014	San Diego, CA, USA
302	Novel insights in congenital neutropenia	Emory Vaccine Center, Emory University School of Medicine	March 2014	Atlanta, GA, USA
303	Aspirin hypersensitivity in Iranian patients with chronic rhinosinusitis and nasal polyposis: prevalence and comorbid factors	6th Drug Hypersensitivity Meeting	April 2014	Bern, Switzerland
304	Update on classification of primary immunodeficiency diseases	Advanced Course of ICIA	April 2014	Tehran, Iran
305	Humoral immunodeficiency: Co-chair	12th International Congress of Immunology and Allergy	April-May 2014	Tehran, Iran
306	A case series of patients with Hyper IgM syndromes (13 cases) from Mofid hospital during 2005- 2013	12th International Congress of Immunology and Allergy	April-May 2014	Tehran, Iran
307	Defects in B-cell development	12th International Congress of Immunology and Allergy	April-May 2014	Tehran, Iran
308	Association of IL9 gene polymorphisms with asthma in pediatric patients	12th International Congress of Immunology and Allergy	April-May 2014	Tehran, Iran
309	The assessment of IL-1 gene family polymorphisms in Iranian children affected by febrile seizure	12th International Congress of Immunology and Allergy	April-May 2014	Tehran, Iran
310	Interleukin 4 single nucleotide polymorphisms in febrile seizures	12th International Congress of Immunology and Allergy	April-May 2014	Tehran, Iran
311	Association between RAD50 single nucleotide polymorphism and common variable immunodeficiency	12th International Congress of Immunology and Allergy	April-May 2014	Tehran, Iran
312	Association of IL-23 receptor gene polymorphisms with juvenile idiopathic arthritis	12th International Congress of Immunology and Allergy	April-May 2014	Tehran, Iran
313	Association of a proliferation -inducing ligand (APRIL) polymorphism with juvenile systemic lupus erythematous	12th International Congress of Immunology and Allergy	April-May 2014	Tehran, Iran
314	Association between IRF5 polymorphisms and the risk of systemic lupus Erythematous in children	12th International Congress of Immunology and Allergy	April-May 2014	Tehran, Iran
315	Evaluation of proinflammatory cytokine gene polymorphisms in autoimmune hepatitis	12th International Congress of Immunology and Allergy	April-May 2014	Tehran, Iran
316	Update on classification of predominantly antibody deficiency	12th International Congress of Immunology and Allergy	April-May 2014	Tehran, Iran
317	Pharmaceutical cost of primary immunodeficiency diseases during hospital admission	5th Iranian Clinical Pharmacy Congress	May 2014	Tehran, Iran
318	Update on classification of primary immunodeficiency disease	5th International Congress on the Latest Molecular and Clinical Medical Research Achievements	October 2014	Tehran, Iran
319	Co-chair: Primary immunodeficiency diseases	7th Meeting on Clinical Immunology and Immunodeficiencies	October 2014	Tehran, Iran
320	Approach to patients with phagocyte defects	26th International Congress of Pediatrics	October 2014	Tehran, Iran
321	Co-chair: Immunology session	26th International Congress of Pediatrics	October 2014	Tehran, Iran
322	Late-onset familial hemophagocytic lymphohistiocytosis with STXBP2 mutations	26th International Congress of Pediatrics	October 2014	Tehran, Iran
323	Nonhodgkins lymphoma in a patient with leukocyte adhesion deficiency syndrome	26th International Congress of Pediatrics	October 2014	Tehran, Iran
324	Vitamin D deficiency in chronic idiopathic urticaria	26th International Congress of Pediatrics	October 2014	Tehran, Iran
325	Phenotyping and follow up of forty seven Iranian common variable immune deficiency patients	26th International Congress of Pediatrics	October 2014	Tehran, Iran
326	APRIL gene polymorphism and serum sAPRIL and Th1/Th2 cytokines level in children with SLE	26th International Congress of Pediatrics	October 2014	Tehran, Iran
327	Interleukin-1 gene cluster polymorphisms in inflammatory bowel disease	26th International Congress of Pediatrics	October 2014	Tehran, Iran
328	Association of interleukin 4 single nucleotide polymorphisms with febrile seizures	26th International Congress of Pediatrics	October 2014	Tehran, Iran
329	Novel insights into phagocyte defects	2nd MENAID Meeting	December 2014	Marrakesh, Morocco
330	Congenital neutropenia: approach from clinical phenotypes to molecular diagnosis and HSCT opportunities	1st International and 5th National Congress on Stem Cells	January 2015	Tehran, Iran
331	Co-chair: Chain values in hospitals	1st Seminar on Health Technology and Innovations in Hospitals	February 2015	Tehran, Iran
332	Co-chair: Applications of technologies in hospital management	1st Seminar on Health Technology and Innovations in Hospitals	February 2015	Tehran, Iran
333	Recent advances on diagnosis and treatment of immunodeficient patients in Iran	Marmara University Hospital	February 2015	Istanbul, Turkey
334	Current approaches to primary immune deficiencies	2nd Congress of Marmara Pediatrics	February 2015	Istanbul, Turkey
335	Primary immunodeficiency diseases in Iran: past, present, and future	The Belarusian National Research Center for Pediatric Oncology, Hematology and Immunology	April 2015	Minsk Region, Belarus
336	Primary immunodeficiency diseases associated with congenital neutropenia: from diagnostic approach to treatment opportunities	4th International Conference of Primary Immune Deficiencies	April 2015	Minsk, Belarus
337	Update on pediatric phagocyte defects	27th International Congress of Pediatrics	October 2015	Tehran, Iran
338	Evaluation of hematologic parameter of Kawasaki patients in Children’s Medical Center hospital from 2008 to 2013	27th International Congress of Pediatrics	October 2015	Tehran, Iran
339	In vitro comparison of chromosomal radiosensitivity in common variable immunodeficiency and acute lymphocytic leukemia patients	27th International Congress of Pediatrics	October 2015	Tehran, Iran
340	Clinical and laboratory screening of primary immunodeficiency diseases: international effects	XXIV World Allergy Congress	October 2015	Seoul, South Korea
341	Interleukin-9 and interleukin-33 levels in children with asthma	XXIV World Allergy Congress	October 2015	Seoul, South Korea
342	Interleukin-22 gene variation in inflammatory bowel disease	XXIV World Allergy Congress	October 2015	Seoul, South Korea
343	Molecular approach to primary immunodeficiencies	State Key Laboratory of Agrobiotechnology	October 2015	Beijing, China
344	Co-chair: Panel of immunodeficiency	The 10th Biennial Congress of Iranian Society of Asthma and Allergy	October 2015	Shiraz, Iran
345	Immunodeficiency in Iran	The 10th Biennial Congress of Iranian Society of Asthma and Allergy	October 2015	Shiraz, Iran
346	Updates on approach to antibody deficiency	The 10th Biennial Congress of Iranian Society of Asthma and Allergy	October 2015	Shiraz, Iran
347	Primary immunodeficiency diseases: definition, classification, diagnosis, and treatment	Scientific Meeting on Primary and Acquired Immunodeficiency	November 2015	Tehran, Iran
348	Evaluation of patients with congenital neutropenia	6th International Congress on the Newest Research Achievement in Molecular, Cellular and Clinical Medicine	November 2015	Tehran, Iran
349	Primary immunodeficiency diseases in Iran	Iran Day in Spain	November 2015	Santiago de Compostella, Spain
350	Co-chair: Diagnosis of immunodeficiency	3rd Middle East- Asia Allergy Asthma Immunology Congress	December 2015	Abu Dhabi, UAE
351	How to assess the outcomes of screening tests in the clinic	3rd Middle East- Asia Allergy Asthma Immunology Congress	December 2015	Abu Dhabi, UAE
352	Chair: EAACI symposium	3rd Middle East- Asia Allergy Asthma Immunology Congress	December 2015	Abu Dhabi, UAE
353	Immunodeficiency the way forward	3rd Middle East- Asia Allergy Asthma Immunology Congress	December 2015	Abu Dhabi, UAE
354	Immunodeficiency state-of-the-art: case senarios	3rd Middle East- Asia Allergy Asthma Immunology Congress	December 2015	Abu Dhabi, UAE
355	Chair of Panel Discussion on immune defects associated with heart disease in children	The 8th International Iranian Congress of Laboratory and Clinic	February 2016	Tehran, Iran
356	Co-chair: Cell therapy in cerebral palsy, neurometabolic diseases, stroke, ALS	1st Seminar of Stem Cell Therapy in Neurological Disorders	February 2016	Tehran, Iran
357	Diagnostic approach to phagocytic cell deficiencies	2nd J Project Congress	March 2016	Antalya, Turkey
358	Co-chair: Defects of neutrophils and complement	2nd J Project Congress	March 2016	Antalya, Turkey
359	Step by step diagnosis of patients with primary immunodeficiency diseases: case scenarios	The 9th International & 14th National Congress on Quality Improvement in Clinical Laboratories	April 2016	Tehran, Iran
360	Co-chair: The clinical laboratory and immunodeficiency disorders	The 9th International & 14th National Congress on Quality Improvement in Clinical Laboratories	April 2016	Tehran, Iran
361	Cases with primary immunodeficiencies	PID Spring School	April 2016	Tehran, Iran
362	Approach to patients with phagocyte defects	8th International Conference on Immunodeficiency Diseases	April 2016	Tehran, Iran
363	Co-chair: Defects of innate immunity and immunedysregulation	8th International Conference on Immunodeficiency Diseases	April 2016	Tehran, Iran
364	Impact of high consanguinity on PID care in Iran and surrounding regions – data from the Iranian PID Registry	Asia Pacific Society for Immunodeficiencies (APSID) Congress	April-May 2016	Hong Kong SAR, China
365	Association of tumor necrosis factor-alpha G/A -238 and G/A -308 single nucleotide polymorphisms with juvenile idiopathic arthritis	European Academy of Allergy and Clinical Immunology (EAACI) Congress 2016	June 2016	Vienna, Austria
366	Lack of association between PDCD-1 single nucleotide polymorphisms and susceptibility to juvenile idiopathic arthritis	European Academy of Allergy and Clinical Immunology (EAACI) Congress 2016	June 2016	Vienna, Austria
367	Polymorphisms of genes encoding interleukin-4 and its receptor in Iranian patients with juvenile idiopathic arthritis	European Academy of Allergy and Clinical Immunology (EAACI) Congress 2016	June 2016	Vienna, Austria
368	Interleukin-10 and transforming growth factor-beta 1 gene polymorphisms in juvenile idiopathic arthritis	European Academy of Allergy and Clinical Immunology (EAACI) Congress 2016	June 2016	Vienna, Austria
369	Effect of vitamin A supplementation on Th-1 to Th-2 balance in patients with atherosclerosis	Federation of Clinical Immunology Societies (FOCIS) Congress	June 2016	Boston, USA
370	Effect of vitamin A supplementation on Th-1 to Th-2 balance in patients with atherosclerosis	Federation of Clinical Immunology Societies (FOCIS) Congress	June 2016	Boston, USA
371	How to diagnose primary immunodeficiency diseases?	Federation of Clinical Immunology Societies (FOCIS) Congress	June 2016	Boston, USA
372	Approach to patients with immunodeficiencies and congenital neutropenia	Boston Children’s Hospital, Harvard Medical School	August 2016	Boston, USA
373	Primary immunodeficiency diseases in Iran	National Institute of Health (NIH)	August 2016	Bethesda, USA
374	Approach to pediatric patients with phagocyte defects	APAAACI and APAPARI 2016	October 2016	Kuala Lampur
375	Common variable immunodeficiency	APAAACI and APAPARI 2016	October 2016	Kuala Lampur
376	Chair: SEAPID-APSID: PIDs with atopic manifestations symposium	APAAACI and APAPARI 2016	October 2016	Kuala Lampur
377	Challenges in diagnosis of patients with primary immunodeficiency diseases	28th International Congress of Pediatrics	October 2016	Tehran, Iran
378	Co-chair: Immunodeficiency session	28th International Congress of Pediatrics	October 2016	Tehran, Iran
379	Progress of internationalization of medical education in Iran	1st Congress of Internationalization of Medical Education	November 2016	Isfahan, Iran
380	USERN: a model of international network of education and research	1st Congress of Internationalization of Medical Education	November 2016	Isfahan, Iran
381	Primary immunodeficiency diseases in Iran	Kyiv's Municipal Children's Hospital	December 2016	Kiev, Ukraine
382	Approaches to cases with immunodeficiencies	Kharkiv National Medical University	December 2016	Kharkiv, Ukraine
383	Current status of primary immunodeficiencies in Iran	University of Ljubljana	February 2017	Ljubljana, Slovenia
384	Approach to pediatric patients with congenital neutropenia	University of Ljubljana	March 2017	Ljubljana, Slovenia
385	Primary immunodeficiency diseases in Iran (1977-2017)	9th International Conference on Primary Immunodeficiency Diseases	April 2017	Tehran, Iran
386	Co-chair: Head and neck manifestations of primary immunodeficiencies	9th International Conference on Primary Immunodeficiency Diseases	April 2017	Tehran, Iran
387	Approach to patients with phagocytosis defect	9th International Conference on Primary Immunodeficiency Diseases	April 2017	Tehran, Iran
388	Co-chair of panel: National PID network	9th International Conference on Primary Immunodeficiency Diseases	April 2017	Tehran, Iran
389	Co-chair: International research collaboration	Internationalization of Higher Education	April 2017	Tehran, Iran
390	Co-chair of panel: Scientific reference: action plans	18th National Medical Education Congress	April 2017	Tehran, Iran
391	Co-chair of panel: Benefits of internarional collaboration for students	18th National Medical Education Congress	April 2017	Tehran, Iran
392	Approach to patients with phagocyte defects	Faculty of Medicine, Chulalongkorn University	August 2017	Bangkok, Thailand
393	Approach to pediatric patients with phagocyte defects	Faculty of Medicine, Mahidol University	August 2017	Bangkok, Thailand
394	Primary immunodeficiencies: From bench to bedside and back again	6th Singapore and Pediatric and Perinatal Annual Congress (SiPPAC)	August 2017	Singapore, Singapore
395	PID: lessons from high consanguinity population	Latin American Society for Immunodeficiencies (LASID) 2017	October 2017	Sao Paulo, Brazil
396	Challenges to diagnosis and access to treatment for patients with Primary Immunodeficiencies	38th Reunion de Actualizacion en Pediatria	October 2017	Mexico City, Mexico
397	Co-chair: Primary Immunodeficiencies	29th International Congress of Pediatrics	October 2017	Tehran, Iran
398	Translational approach to primary immunodeficiencies for pediatricians	29th International Congress of Pediatrics	October 2017	Tehran, Iran
399	Evolution in diagnosis of immunological disorders	II International USERN Congress	November 2017	Kharkiv, Ukraine
400	Immuno-oncology: a new way in treatment of cancer	2nd International Clinical Oncology Congress	December 2017	Tehran, Iran
401	Co-Chair: Updates in Inborn Errors of Immunity	10th International Conference on Immunodeficiency Diseases	April 2018	Tehran, Iran
402	Co-Chair: National PID network	10th International Conference on Immunodeficiency Diseases	April 2018	Tehran, Iran
403	Inborn Errors of Immunity; from Bench to Bedside	10th International Conference on Immunodeficiency Diseases	April 2018	Tehran, Iran
404	Co-Chair: Primary Immunodeficiencies: Principles and Complications	The 3rd PID Spring School	April 2018	Tehran, Iran
405	Approach to Primary Immunodeficiencies in a Practical Tests	The 3rd PID Spring School	April 2018	Tehran, Iran
406	Respiratory Manifestations in Patients with Hyper IgM Syndrome	The 3rd PID Spring School	April 2018	Tehran, Iran
407	Toll like receptors pathway in common variable immune deficiency (CVID) and X-linked agammaglobulinemia (XLA)	The 3rd PID Spring School	April 2018	Tehran, Iran
408	Evaluation of the TLR Negative Regulatory Network in CVID Patients	The 3rd PID Spring School	April 2018	Tehran, Iran
409	Non-pathogenic Heterozygous Polymorphism in RAB27A Gene in a Case Suspicious to Griscelli Syndrome, Type II	The 3rd PID Spring School	April 2018	Tehran, Iran
410	A Novel Mutation in Interferon-γ Receptor 1 is Associated with Mycobacterial Bone Marrow Involvement and Hemophagocytic Lymphohistiocytosis Manifestations	The 3rd PID Spring School	April 2018	Tehran, Iran
411	The Unsuccessful Outcome of Bone Marrow Transplantation in a Child with Wiskott-Aldrich syndrome	The 3rd PID Spring School	April 2018	Tehran, Iran
412	Screening of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia	The 3rd PID Spring School	April 2018	Tehran, Iran
413	Approach to Immunodeficiency Diseases	Annual Congress of Pediatrics and 39th Memorial Conference of Dr. Gharib	April 2018	Tehran, Iran
414	Co-Chair: Diagnosis of Primary Immunodeficiencies	14th International Congress of Immunology and Allergy (ICIA)	April 2018	Tehran, Iran
415	Updates in PIDs	14th International Congress of Immunology and Allergy (ICIA)	April 2018	Tehran, Iran
416	Evaluation of early and late apoptosis in patients with CVID	14th International Congress of Immunology and Allergy (ICIA)	April 2018	Tehran, Iran
417	Toll like Receptors Pathway in Common Variable Immune Deficiency and X-linked Agammaglobulinemia	14th International Congress of Immunology and Allergy (ICIA)	April 2018	Tehran, Iran
418	Differentiation Classification of CVID Patients Based on B cell Subpopulation	14th International Congress of Immunology and Allergy (ICIA)	April 2018	Tehran, Iran
419	The Potent Suppressive Effect of β-D-mannuronic Acid (M2000) on Molecular Expression of the TLR/ NF-kB Signaling Pathway in Ankylosing Spondylitis Patients	14th International Congress of Immunology and Allergy (ICIA)	April 2018	Tehran, Iran
420	Wharton’s Jelly-Derived Mesenchymal Stem Cell’s Conditioned Media Increase Neutrophils Viability and Function	14th International Congress of Immunology and Allergy (ICIA)	April 2018	Tehran, Iran
421	Bench to Bedside Approach to Inborn Errors of Immunity	30th International Congress of Pediatrics	October 2018	Tehran, Iran
422	Scientific Collaboration in Pediatrics	30th International Congress of Pediatrics	October 2018	Tehran, Iran
423	Primary Immunodeficiency Diseases in Iran	1st PID Meeting in Armenia	October 2018	Yerevan, Armenia
424	Primary Immunodeficiency Diseases: From Bench to Bedside	1st PID Meeting in Armenia	October 2018	Yerevan, Armenia
425	Primary Immunodeficiency Diseases Case Scenarios	Ce–M–M– Research Center for Molecular Medicine	November 2018	Vienna, Austria
426	Bench to Bedside Approach to PIDs	USERN 2018 Congress	November 2018	Reggio Calabria, Italy
427	Obesity Caused Cancer Progression by Affecting Immunity and Inflammation	USERN 2018 Congress	November 2018	Reggio Calabria, Italy
428	Genetics of Primary Immunodeficiency Diseases	University of Turin	November 2018	Reggio Calabria, Italy
429	Introduction on the Immune System and Immune Diseases	14th GIAN Course	February 2019	Chandigarh, India
430	Predominantly Antibody Deficiencies	14th GIAN Course	February 2019	Chandigarh, India
431	Congenital Neutropenias	14th GIAN Course	February 2019	Chandigarh, India
432	Combined Immunodeficiencies	14th GIAN Course	February 2019	Chandigarh, India
433	Syndromic Immunodeficiencies	14th GIAN Course	February 2019	Chandigarh, India
434	Immunological Screening Tests	14th GIAN Course	February 2019	Chandigarh, India
435	Treatment of Immunodeficiency Diseases	14th GIAN Course	February 2019	Chandigarh, India
436	TLR Signaling Defects in Primary Immunodeficiencies	14th GIAN Course	February 2019	Chandigarh, India
437	Bench to Bedside Approach to Primary Immunodeficiency Diseases	Dr. Lata Kumar Lecture, PGIMER	February 2019	Chandigarh, India
438	Clinical Immunology and Primary Immunodeficiencies	Mehr Chand Mahajan DAV College for Women	February 2019	Chandigarh, India
439	Identification of Novel Primary Immunodeficiency Diseases Using Advanced Technology	4th International Student Biotechnology Congress	February 2019	Tehran, Iran
440	Approach to Inborn Errors of Immunity	31st International Congress of Pediatrics	October 2019	Tehran, Iran
441	Approach to Congenital Neutropenias	32nd International Congress of Pediatrics	October 2020	Tehran, Iran
442	Primary Immunodeficiency Diseases	32nd International Congress of Pediatrics	October 2020	Tehran, Iran
443	COVID-19 and Immunity	ISIC 2020	October 2020	Kharkiv, Ukraine
444	Diagnostic Approach to Patients with Inborn Errors of Immunity	15th International Congress of Immunology and Allergy	January 2021	Ahwaz, Iran
445	Approach to Inborn Errors of Immunity	AID Allergy and Immunology Meeting	February 2021	Istanbul, Turkey
446	Therapeutic Approach to Inborn Errors of Immunity	The 6th International Symposium on Pharmaceutical and Biomedical Sciences	May 2022	Gaziantep, Turkey
447	Approach to Patients with Primary Immunodeficiency Diseases	1st Tajik Symposium on Otalaryngology, Allergology, and Immunology	May 2022	Dushanbe, Tajikistan
448	Inborn errors of immune system	Annual meeting of AAMIA 2022	May 2022	Yerevan, Armenia
449	Dermatologic manifestation of inborn errors of immune system	Annual meeting of AAMIA 2022	May 2022	Yerevan, Armenia
450	Endothelial Dysfunction and Toll Like Receptors	World Allergy Congress 2022	October 2022	Istanbul, Turkey
451	Application of flow cytometry and genetic tools in the diagnosis of PID: Real Case Scenarios	8th Annual Clinical Immunology Society Meeting	October 2022	Antalya, Turkey
452	Approach to Pediatric Patients with Primary Immunodeficiency Diseases	34th International Congress of Pediatrics	October 2022	Tehran, Iran
453	Social Responsibility of Immunologists	16th International Congress of Immunology & Allergy of Iran (ICIA2023)	April 2023	Tehran, Iran
454	Inborn errors of immunity and cancer: from clinics to genetics	The First International Congress of Cancer Genomics (CGC2023)	May 2023	Tehran, Iran
455	The Application of Biomedical Technologies in Diagnosis of Inborn Errors of Immunity	Biomaterial, Biosensor and Microfluidics Technologies for Medical Applications	May 2023	Doha, Qatar
456	Approach to Congenital Neutropenias	SIOP Asia XV Congress	May 2023	Yerevan, Armenia

 

 

Published Articles

 

1.          Aghamohammadi A, Moin M, Farhoudi A, Pourpak Z, Movahedi M, Abolmaali K, Rezaei N, Gharagozlou M, Amiri Kordestani L, Habibi Z, Mahmoudi M. The clinical spectrum of respiratory diseases in patients with primary antibody deficiency. Iran J Allergy Asthma Immunol 2000; 1(3): 135-140.

2.          Aghamohammadi A, Jalali F, Farhoudi A, Pourpak Z, Rezaei N, Khazali S, Hosseini Nik H. Ear, nose and throat manifestations in patients with antibody deficiencies. Acta Med Iran 2001; 39(3): 164-168.

3.          Aghamohammadi A, Moein M, Farhoudi A, Pourpak Z, Rezaei N, Abolmaali K, Movahedi M, Gharagozlou M, Ghazi BM, Mahmoudi M, Mansouri D, Arshi S, Trash NJ, Akbari H, Sherkat R, Hosayni RF, Hashemzadeh A, Mohammadzadeh I, Amin R, Kashef S, Alborzi A, Karimi A, Khazaei H. Primary immunodeficiency in Iran; first report of the national registry in children and adults. J Clin Immunol 2002; 22(6): 375-380.

4.          Aghamohammadi A, Farhoudi A, Moin M, Pourpak Z, Rezaei N, Abolmaali K, Movahedi M, Gharagozlou M, Ghazi BMS, Mahmoudi M. A 20-year survey of infectious complications in 64 patients with common variable immunodeficiency. Med J IR Iran 2002; 16(3): 123-128.

5.          Aghamohammadi A, Moin M, Farhoudi A, Pourpak Z, Rezaei N, Abolmaali K, Movahedi M, Gharagozlou M, Mir Saeid Ghazi B, Atarod L, Hojati Ashrafi T, Mahmoudi M, Isaeian A, Mansouri D, Arshi S, Javaher Trash N, Akbari H, Sherkat R, Farid Hosseini MR, Hashemzadeh A, Mohammadzadeh I. The spectrum of primary immunodeficiency in Iran. Acta Med Iran 2002; 40(3): 165-170.

6.          Movahedi M, Aghamohammadi A, Farhoudi A, Moin M, Pourpak Z, Gharagozlou M, Mansouri D, Babaei Jandaghi A, Shahnavaz N, Rezaei N, Abolmaali K, Alizadeh Arasi Sh, Bakhshaei J, Vaziri M. Respiratory manifestations of Chronic Granulomatous Disease; a clinical survey of patients from Iranian Primary Immunodeficiency Registry. Iran J Allergy Asthma Immunol 2003; 2(1): 45-51.

7.          Atarod L, Raissi A, Aghamohammadi A, Farhoudi A, Khodadad A, Moin M, Pourpak Z, Movahedi M, Charagozlou M, Rezaei N. The review of gastrointestinal disorders in patients with primary antibody immunodeficiencies during the 10-year period (1990-2000), in Children's Medical Center. Iran J Allergy Asthma Immunol 2003; 2(2): 75-79.

8.          Ahmadi-Nejad Z, Rasouli-Nejad M, Mahmoudi M, Rezaei N. The survey of liver complications in patients with brucellosis in Imam Hospital during 1995 to 2001.  Tehran Univ Med J. 2003; 61(2): 144-152.

9.          Khazaei HA, Hashemi SR, Aghamohammadi A, Farhoudi F, Rezaei N. Common allergens in patients with allergic disorders in Zahedan. Tabib-e-Shargh 2003; 4(3): 149-154.

10.       Aghamohammadi A, Farhoudi A, Moin M, Pourpak Z, Rezaei N, Nikzad M, Movahedi M, Gharagozlou M, Atarod L, Ahmadi Afshar A, Bazargan N, Abolmaali K, Mahmoudi M. Adverse effects of intravenous immunoglobulin therapy in patients with antibody deficiency. Iran J Allergy Asthma Immunol 2003; 2(3): 121-126.

11.       Khazaei HA, Hashemi SR, Aghamohammadi A, Farhoudi F, Rezaei N. The study of type 1 allergy prevalence among people of South-east of Iran by Skin Prick Test using common allergens. Iran J Allergy Asthma Immunol 2003; 2(3): 165-168.

12.       Farhoudi A, Chavoshzadeh Z, Pourpak Z, Izadyar M, Gharagozlou M, Movahedi M, Aghamohamadi A, Mirsaeid Ghazi B, Moin M, Rezaei N. Report of six cases of Chediak–Higashi Syndrome with regard to clinical and laboratory finding. Iran J Allergy Asthma Immunol 2003; 2(4): 189-192.

13.       Mirsaid Ghazi B, Imamzadehgan R, Aghamohammadi A, Darakhshan Davari R, Rezaei N. Frequency of allergic rhinitis in school-aged children (7-18 years) in Tehran. Iran J Allergy Asthma Immunol 2003; 2(4): 181-184.

14.       Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Ramyar A, Moin M, Gharagozlou M, Movahedi M, Mohammadpour B, Mirsaeid Ghazi B, Izadyar M, Mahmoudi M. Clinical manifestations of Iranian patients with cyclic neutropenia.  Immunology, Medimond 2004; 205-208.

15.       Khazaei HA, Hashemi SR, Aghamohammadi A, Farhoudi F, Rezaei N. Prevalence of common allergens in patients with allergic disorders in the southeast of Iran. Allergy Week, Medimond 2004; 53-56.

16.       Mahmoudi MJ, Nematipour E, Moradmand S, Gharouni M, Mahmoudi M, Rezaei N, Ahmadvand AR, Karimi N. Assessment of cardiac risk factors in medical students of Tehran University. Acta Med Iran. 2004;42(6):402-10.

17.       Givtaj N, Daylami M, Alaie HR, Rezaei N, Khodarahmi M. Survey of fontan and total cavopulmonary connection in patients with single ventricle. Iran Heart J. 2004;5(3):23-9.

18.       Hekmat M, Foroughi M, Taghipour HR, Hasantash SA, Majidi Tehrani MM, Beheshti Monfared M, Arabnia MK, Nobahar MR, Shahzamani M, Kachoueian N, Hallajzadeh AA, Rezaei N. Metastatic sarcoma invasion through pulmonary vein to left atrium; an unusual way of metastasis. Iran Heart J. 2004;5(4):53-6.

19.       Aghamohammadi A, Farhoudi A, Nikzad M, Moin M, Pourpak Z, Rezaei N, Gharagozlou M, Movahedi M, Atarod L, Afshar AA, Bazargan N, Hosseinpoor AR. Adverse reactions of intravenous immunoglobulin therapy in patients with primary immunodeficiencies. Ann Allergy Asthma Immunol. 2004;92(1):60-4.  

20.       Moin M, Aghamohammadi A, Farhoudi A, Pourpak Z, Rezaei N, Movahedi M, Gharagozlou M, Ghazi BM, Zahed A, Abolmaali K, Mahmoudi M, Emami L, Bashashati M. X-linked agammaglobulinemia: A survey of 33 Iranian patients. Immunol Invest. 2004;33(1):81-93. 

21.       Aghamohammadi A, Moin M, Farhoudi A, Rezaei N, Pourpak Z, Movahedi M, Gharagozlou M, Nabavi M, Shahrokhi A. Efficacy of intravenous immunoglobulin in prevention of pneumonia in patients with agammaglobulinemia. FEMS Immunol Med Microbiol. 2004;40(2):113-8.

22.       Amirzargar AA, Yalda A, Hajabolbaghi M, Khosravi F, Jabbari H, Rezaei N, Niknam MH, Ansari B, Moradi B, Nikbin B. The association of HLA-DRB, DQA1, DQB1 alleles and haplotypes frequency in Iranian patients with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2004;8(8):1017-21.

23.       Khazaei HA, Aghamohammadi A, Rezaei N, Nikbin B, Khosravi MA, MiriMoghaddam I. Major histocompatibility complex class I and II antigens frequencies in Baloch ethnic group living in the south-east region of Iran. Transplant Proc. 2004;36(5):1302-4.

24.       Movahedi M, Aghamohammadi A, Rezaei N, Shahnavaz N, Jandaghi AB, Farhoudi A, Pourpak Z, Moin M, Gharagozlou M, Mansouri D. Chronic granulomatous disease; a clinical survey of 41 patients from Iranian primary immunodeficiency registry. Int Arch Allergy Immunol. 2004;134:253-9.

25.       Pourpak Z, Aghamohammadi A, Sedighipour L, Farhoudi A, Movahedi M, Gharagozlou M, Chavoshzadeh Z, Jadid L, Rezaei N, Moin M. Efficacy of intravenous immunoglobulin treatment on the incidence of pneumonia in patients with common variable immunodeficiency. Tehran Univ Med J. 2004;62(5):372-7.

26.       Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Ramyar A, Moin M, Gharagozlou M, Movahedi M, Mohammadpour B, Mirsaeid Ghazi B, Izadyar M, Mahmoudi M. Clinical and laboratory findings in Iranian children with cyclic neutropenia. Iran J Allergy Asthma Immunol. 2004;3(1):37-40.

27.       Mir Saeid Ghazi B, Aghamohammadi A, Kouhi A, Farhoudi A, Moin M, Rezaei N, Shahriar Doost P, Movahedi M, Gharagozlou M, Pourpak Z, Arshi S, Yazdani F, Atarod L, Mohammad Zadeh I, Bazargan N, Ahmadi Afshar A, Mahmoudi M, Tahaei A. Mortality in primary immunodeficient patients, registered in Iranian primary immunodeficiency registry. Iran J Allergy Asthma Immunol. 2004;3(1):31-5.

28.       Khazaei HA, Aghamohammadi A, Rezaei N, Nikbin B, Amirzargar A, Khosravi F, Khosravi MA, Mirimoghaddam I. Human leukocyte antigen profile in the Zaboli ethnic group living in the South-East region of Iran. Iran J Allergy Asthma Immunol. 2004;3(1):13-19.

29.       Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Moin M, Gharagozlou M, Movahedi M, Mirsaeid Ghazi B, Atarod L, Mahmoudi M, Ahmadi Afshar A, Bazargan N, Isaeian A, Nabavi M, Chavoshzadeh Z, Heydarzadeh M, Bemanian MH, Fazlollahi MR. Neutropenia in patients with primary antibody deficiency disorders. Iran J Allergy Asthma Immunol. 2004;3(2):77-81.

30.       Movahedi M, Aghamohammadi A, Rezaei N, Farhoudi A, Pourpak Z, Moin M, Gharagozlou M, Mansouri D, Arshi S, Atarod L, Mirsaeid Ghazi B, Shahnavaz N, Babaei Jandaghi A, Abolmaali K, Mahmoudi M, Bazargan N, Ahmadi Afshar A, Nabavi M. Gastrointestinal manifestations of patients with chronic granulomatous disease. Iran J Allergy Asthma Immunol. 2004;3(2):83-7.

31.       Mirsaeid Ghazi B, Sharifi SH, Goodarzipoor K, Aghamohammadi A, Atarod L, Rezaei N, Kouhi A. The prevalence of asthma among the students (7-18 years old) in Tehran during 2002-2003. Iran J Allergy Asthma Immunol. 2004;3(2):89-92.

32.       Ebrahimi Daryani N, Aghamohammadi A, Mousavi Mirkala MR, Bashashati M, Rezaei N, Haghpanah B, Hashtroudi AA, Sayyah A. Gastrointestinal complications in two patients with Common variable immunodeficiency. Iran J Allergy Asthma Immunol. 2004;3(3):149-52.

33.       Aghamohammadi A, Parvaneh N, Kanegana H, Moin M, Amirzargar AA, Farhoudi A, Pourpak Z, Movahedi M, Gharagozlou M, Rezaei N, Futatani T, Miyawaki T. Screening of the bruton tyrosine kinase (BTK) gene mutations in 13 Iranian patients with presumed X-linked agammaglobulinemia. Iran J Allergy Asthma Immunol. 2004;3(4):175-9.

34.       Aghamohammadi A, Farhoudi A, Hosseini Nik H, Khazali Sh, Pourpak Z, Khosravi F, Sarrafnezhad A, Amir-Zargar AA, Rezaei N, Abolmaali K, Mansouri D, Nikbin B. Human leukocyte class I and II antigens in Iranian patients with common variable immunodeficiency. Acta Med Iran. 2004;42(4):272-6.

35.       Almasi S, Bashashati M, Rezaei N, Markazi-Moghaddam N. Brain metastasis from esophageal carcinoma. Neurol India. 2004;52(4):492-3.

36.       Hekmat M, Taghipoor HR, Rezvan Nobahar M, Beheshti Monfared M, Majidi Tehrani MM, Arabnia MK, Hasantash SA, Hallaj Zadeh AM, Kachoueian N, Foroughi M, Rezaei N. Laparascopic cholecystectomy and open-heart surgery at the same time. J Card Surg. 2005;20:557-9.

37.       Yegane RA, Kheirollahi AR, Bashashati M, Rezaei N, Tarrahi MJ,  Khoshdel JA. The prevalence of penoscrotal abnormalities and inguinal hernia in elementary-school boys in the west of Iran. Int J Urol. 2005;12:479-83.

38.       Moin M, Mahmoudi M, Rezaei N. Scientific output in Iran; on the threshold of the 21st century. Scientometrics. 2005;62(2):239-48.

39.       Amirzargar AA, Tabasi A, Khosravi F, Kheradvar A, Rezaei N, Naroueynejad M, Ansaripour B, Moradi B, Nikbin B. Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a four-year follow up study. Eur J Neurol. 2005;12(1):25-30.

40.       Khazaei HA, Rezaei N, Bagheri GR, Moin AA. A six-year study on Vibrio cholerae in the Southeastern Iran. Jpn J Infect Dis. 2005;58:8-10.

41.       Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Moin M, Movahedi M, Gharagozlou M. Neutropenia in Iranian patients with primary immunodeficiency disorders. Haematologica. 2005;90(4):554-6.

42.       Amirzargar AA, Bagheri M, Ghavamzadeh A, Alimoghadam K, Khosravi F, Rezaei N, Moheydin M, Ansaripour B, Moradi B, Nikbin B. Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukemia. Int J Immunogenet. 2005;32:167-71.

43.       Fazlollahi MR, Farhoudi A, Movahedi M, Gharagozlou M, Mohammadi K, Rezaei N. Chronic mucocutaneous candidiasis; report of three cases with different phenotypes. Iran J Allergy Asthma Immunol. 2005;4(1):39-42.

44.       Farrokhi S, Hojjat-Farsangi M, Noohpisheh MK, Tahmasbi R, Rezaei N. The assessment of immune system in 55 Iranian patients with Vitiligo. J Eur Acad Dermatol Venereol. 2005;19(6):706-11.

45.       Farhoudi A, Aghamohammadi A, Moin M, Rezaei N, Pourpak Z, Movahedi M, Gharagozlou M, Amir Tahaei S, MirSaeid Ghazi B, Mahmoudi M, Kouhi A, Atarod L, Ahmadi Afshar A, Bazargan N, Isaeian A. Distribution of primary immunodeficiency disorders diagnosed in Children's Medical Center in Iran. J Investig Allergol Clin Immunol. 2005;15(3):177-82.

46.       Rezaei N, Farhoudi A, Ramyar A, Pourpak Z, Aghamohammadi A, Mohammadpour B, Moin M, Gharagozlou M, Movahedi M, Ghazi BM, Izadyar M, Mahmoudi M. Congenital neutropenia and primary immunodeficiency disorders: a survey of 26 Iranian patients. J Pediatr Hematol Oncol. 2005;27(7):351-6.

47.       Aghamohammadi A, Farhoudi A, Moin M, Rezaei N, Kouhi A, Pourpak Z, Yaseri N, Movahedi M, Gharagozlou M, Zandieh F, Yazadni F, Arshi S, Mohammadzadeh I, Ghazi BM, Mahmoudi M, Tahaei S, Isaeian A. Common variable immunodeficiency: Clinical and immunological features of 65 Iranian patients. Clin Diagn Lab Immunol. 2005;12(7):825-32.

48.       Khazaei HA, Rezaei N, Bagheri GR, Moin AA. The epidemiology of Vibrio cholerae in Zabol city, south east of Iran. Arch Iran Med. 2005;8(3):197-201.

49.       Khazaei HA, Rezaei N, Bagheri GR, Dankoub MA, Shahryari K, Tahai A, Mahmoudi M. Epidemiology of tuberculosis in the southeastern Iran. Eur J Epidemiol. 2005;20(10):879-83.

50.       Aghamohammadi A, Parvaneh N, Tirgari F, Mahjoob F, Movahedi M, Gharagozlou M, Mansouri M, Kouhi A, Rezaei N, Webster D. Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency. Leuk Lymphoma. 2006;47(2):343-6.

51.       Rezaei N. Therapeutic targeting of pattern-recognition receptors. Int Immunopharmacol. 2006;6:863-9.

52.       Rezaei N. TNF receptor associated periodic syndrome (TRAPS); an autosomal dominant multisystem disorder. Clin Rheumatol. 2006;25(6):773-7.

53.       Pourpak Z, Aghamohammadi A, Sedighipour L, Farhoudi A, Movahedi M, Gharagozlou M, Chavoshzadeh Z, Jadid L, Rezaei N, Moin M. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency. J Microbiol Immunol Infect. 2006; 39(2):114-20.

54.       Rezaei N, Pourpak Z, Aghamohammadi A, Farhoudi A, Movahedi M, Gharagozlou M, Mirsaeid Ghazi B, Atarod L, Abolmaali K, Mahmoudi M, Mansouri D, Arshi S, Tarash NJ, Sherkat R, Amin R, Kashef S, Hosseini RF, Mohammadzadeh I, Shabestari MS, Nabavi M, Moin M. Consanguinity in primary immunodeficiency disorders; the report from Iranian primary immunodeficiency registry. Am J Reprod Immunol. 2006; 56(2):145-51.

55.       Rezaei N. Obituary: Abolhassan Farhoudi (1924-2006). Iran J Allergy Asthma Immunol. 2006;5(1):1.

56.       Fazlollahi MR, Aghamohammadi A, Hosseini RF, Lotfi AS, Khoshdel A, Farhoudi A, Movahedi M, Gharagozlou M, Mozaffari H, Zandieh F, Mansouri M, Ghaffari J, Rezaei N. Study of alpha-1- antitrypsin phenotypes frequencies in primary antibody deficiency patients with and without bronchiectasis. Iran J Allergy Asthma Immunol. 2006;5(2):69-74.

57.       Mirsaeid Ghazi B, Khalesi R, Naseri M, Salamati P, Sotoudeh K, Rezaei N. Sweat test in asthmatic children; a single center study. Iran J Allergy Asthma Immunol. 2006; 5(3):139-42.

58.       Moin M, Rezaei N, Yeganeh M. UNESCO chair in health education: A step toward public health improvement. Iran J Pub Health. 2006;35(2):1-6.

59.       Moin M, Farhoudi A, Movahedi M, Rezaei N, Pourpak Z, Yeganeh M, Gharagozlou M, Mirsaeid Ghazi B, Arshi S, Mansouri D, Sherkat R, Kashef S, Mahmoudi M, Nabavi M, Aghamohammadi A. The clinical and laboratory survey of Iranian Patients with hyper IgE syndrome. Scand J Infect Dis. 2006;38(10):898-903.

60.       Amirzargar AA, Rezaei N, Jabbari H, Danesh AA, Khosravi F, Hajabdolbaghi M, Yalda A, Nikbin B. Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cyt Netw. 2006;17(2):84-9.

61.       Gharagozlou M, Ebrahimi FA, Farhoudi A, Aghamohammadi A, Bemanian MH, Chavoshzadeh Z, Heidarzadeh M, Mehdizadeh M, Moin M, Movahedi M, Nabavi M, Pourpak Z, Rezaei N. Pulmonary complications in primary hypogammaglobulinemia: a survey by high resolution CT scan. Monaldi Arch Chest Dis. 2006;65(2):69-74.

62.       Aghamohammadi A, Fiorini M, Moin M, Parvaneh N, Teimourian S, Yeganeh M, Goffi F, Kanegane H, Amirzargar AA, Pourpak Z, Rezaei N, Salavati A, Pouladi N, Abdollahzade S, Notarangelo LD, Miyawaki T, Plebani A. Clinical, Immunological and Molecular Characteristics of 37 Iranian Patients with X-Linked Agammaglobulinemia. Int Arch Allergy Immunol. 2006;141(4):408-14.

63.       Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, Atarod L, Ghazi BM, Isaeian A, Mahmoudi M, Abolmaali K, Mansouri D, Arshi S, Tarash NJ, Sherkat R, Akbari H, Amin R, Alborzi A, Kashef S, Farid R, Mohammadzadeh I, Shabestari MS, Nabavi M, Farhoudi A. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol. 2006 Nov;26(6):519-32.

64.       Isaian A, Moin M, Pourpak Z, Rezaei N, Aghamohammadi A, Movahedi M, Gharagozlou M, Ghaffari J, Zandieh F, Mansouri M, Farhoudi A. DNA banking of primary immunodeficiency disorders in Iran. Iran J Allergy Asthma Immunol. 2006 Dec;5(4):201-2.

65.       Klein C, Grudzien M, Appaswamy G, Germeshausen M, Sandrock I, Schäffer AA, Rathinam C, Boztug K, Schwinzer B, Rezaei N, Bohn G, Melin M, Carlsson G, Fadeel B, Dahl N, Palmblad J, Henter JI, Zeidler C, Grimbacher B, Welte K. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease).Nat Genet. 2007 Jan;39(1):86-92.

66.       Aghamohammadi A, Pouladi N, Parvaneh N, Yeganeh M, Movahedi M, Gharagolou M, Pourpak Z, Rezaei N, Salavati A, Abdollahzade S, Moin M. Mortality and morbidity in common variable immunodeficiency. J Trop Pediatr. 2007 Feb;53(1):32-8.

67.       Atarod L, Aghamohammadi A, Moin M, Kanegane H, Rezaei N, Rezaei Kalantari K, Amirzagar AA, Futatani T, Miyawaki M. Successful Management of Neutropenia in a Patient with CD40 Ligand Deficiency by Immunoglobulin Replacement Therapy. Iran J Allergy Asthma Immunol 2007 Mar;6(1):37-40.

68.       Khodadad A, Aghamohammadi A, Parvaneh N, Rezaei N, Mahjoob F, Bashashati M, Movahedi M, Fazlollahi MR, Zandieh F, Roohi Z, Abdollahzade S, Salavati A, Kouhi A, Talebpour B, Daryani NE. Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci. 2007 Nov;52(11):2977-83.

69.       Salipante SJ, Benson KF, Luty J, Hadavi V, Kariminejad R, Kariminejad MH, Rezaei N, Horwitz MS. Double de novo mutations of ELA2 in cyclic and severe congenital neutropenia. Hum Mutat. 2007 Sep;28(9):874-81.

70.       Nourizadeh M, Aghamohammadi A, Moazzeni SM, Mahdavi M, Rezaei N, Hadjati J. High production of IL-18 by dendritic cells induced by sera from patients with primary antibody deficiency. Iran J Allergy Asthma Immunol. 2007 Jun;6(2):59-65.

71.       Rezaei N, Aghamohammadi A, Siadat SD, Nejati M, Ahmadi H, Moin M, Pourpak Z, Kamali S, Norouzian D, Tabaraei B, Read RC. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies. Vaccine. 2007 Jul 20;25(29):5308-14.

72.       Rezaei N, Moin M, Pourpak Z, Ramyar A, Izadyar M, Chavoshzadeh Z, Sherkat R, Aghamohammadi A, Yeganeh M, Mahmoudi M, Mahjoub F, Germeshausen M, Grudzien M, Horwitz MS, Klein C, Farhoudi A. The clinical, immunohematological, and molecular study of Iranian patients with severe congenital neutropenia. J Clin Immunol. 2007 Sep;27(5):525-33.

73.       Shabestari MS, Maljaei SH, Baradaran R, Barzegar M, Hashemi F, Mesri A, Rezaei N. Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern Iran. J Clin Immunol. 2007 Sep;27(5):510-6.

74.       Aghamohammadi A, Rezaei N, Gharagozlou M, Ramyar A, Mahjoub F, Rezaei-Kalantari K, Moin M. Hodgkin lymphoma in two siblings with common variable immunodeficiency. Pediatr Hematol Oncol. 2007 Jul-Aug;24(5):337-42.

75.       Moin M, Aghamohammadi A, Kouhi A, Tavassoli S, Rezaei N, Ghaffari SR, Gharagozlou M, Movahedi M, Purpak Z, Mirsaeid Ghazi B, Mahmoudi M, Farhoudi A. Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatr Neurol. 2007 Jul;37(1):21-8.

76.       Rezaei N, Gavalas NG, Weetman AP, Kemp EH. Autoimmunity as an aetiological factor in vitiligo. J Eur Acad Dermatol Venereol. 2007 Aug;21(7):865-76.

77.       Ravanbakhsh M, Sarafnejad A, Aghamohammadi A, Kardar GA, Asgarian Omran H, Atarod L, Rezaei N, Shahrestani T, Hosseini M, Moin M. CD40 Ligand Expression on Stimulated T-Helper Lymphocytes in Patients with Common Variable Immunodeficiency. Iran J Allergy Asthma Immunol. 2007 Sep;6(3):129-35.

78.       Vodjgani M, Aghamohammadi A, Samadi M, Moin M, Hadjati J, Mirahmadian M, Parvaneh N, Salavati A, Abdollahzade S, Rezaei N, Srrafnejad A. Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications. J Investig Allergol Clin Immunol. 2007;17(5):321-8.

79.       Azarang A, Mahmoodi M, Rajabalian S, Shekari MA, Nosratabadi J, Rezaei N. T-helper 1 and 2 serum cytokine assay in chronic opioid addicts. Eur Cytokine Netw. 2007 Nov 12;18(4):33-37.

80.       Khazaei HA, Rezaei N, Aghamohammadi A, Amirzargar AA, Ghasemi K, Mirimoghaddam I, Nikbin B. Human leukocyte antigen profile of two ethnic groups in southeast of Iran. Iran J Allergy Asthma Immunol. 2007 Dec;6(4):223-4.

81.       Yeganeh M, Heidarzade M, Pourpak Z, Parvaneh N, Rezaei N, Gharagozlou M, Movahedi M, Shabestari MS, Mamishi S, Aghamohammadi A, Moin M. Severe combined immunodeficiency: A cohort of 40 patients. Pediatr Allergy Immunol. 2008;19:303-6.

82.       Nourizadeh M, Aghamohammadi A, Moazzeni SM, Mahdavi M, Jalili A, Rezaei N, Hadjati J. Altered dendritic cell function in response to sera of common variable immunodeficiency patients. Inflamm Res. 2007 Dec;56(12):527-32.

83.       Rezaei N, Chavoshzadeh Z, R Alaei O, Sandrock I, Klein C. Association of HAX1 deficiency with neurological disorder. Neuropediatrics. 2007 Oct;38(5):261-3.

84.       Aghamohammadi A, Moazzami K, Rezaei N, Karimi A, Movahedi M, Gharagozlou M, Abdollahzade S, Pouladi N, Kouhi A, Moin M. ENT manifestations in Iranian patients with primary antibody deficiencies. J Laryngol Otol. 2008 Apr;122(4):409-13.

85.       Rezaei N, Haji-Molla-Hoseini M, Aghamohammadi A, Pourfathollah AA, Moghtadaie M, Pourpak Z. Increased Serum Levels of Soluble CD30 in Patients with Common Variable Immunodeficiency and Its Clinical Implications. J Clin Immunol. 2008 Jan;28(1):78-84.

86.       Rezaei N, Aghamohammadi A, Siadat SD, Moin M, Pourpak Z, Nejati M, Ahmadi H, Kamali S, Norouzian D, Tabaraei B, Read RC. Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency. Clin Vaccine Immunol. 2008 Apr;15(4):607-11.

87.       Yeganeh M, Henneke P, Rezaei N, Ehl S, Thiel D, Matamoros N, Pietrogrande C, Espanol T, Litzman J, Franco JL, Sanal O, Kilic SS, Breborowicz A, Plebani A, Renner E, Rothenfusser S, Hawn TR, Woellner C, Grimbacher B. Toll-like receptor stimulation induces higher TNF-alpha secretion in peripheral blood mononuclear cells from patients with hyper IgE syndrome. Int Arch Allergy Immunol. 2008 Feb 11;146(3):190-194.

88.       Safari M, Rezaei N, Hajilooi M, Aghamohammadi A, Pan-Hammarstrom Q, Hammarstrom L. Onychomadesis in a patient with immunoglobulin class switch recombination deficiency. Iran J Allergy Asthma Immunol. 2008 Mar;7(1):41-4.

89.       Germeshausen M, Grudzien M, Zeidler C, Abdollahpour H, Yetgin S, Rezaei N, Ballmaier M, Grimbacher B, Welte K, Klein C. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood. 2008 May 15;111(10):4954-7.

90.       Aghamohammadi A, Moin M, Kouhi A, Mohagheghi MA, Shirazi A, Rezaei N, Tavassoli S, Esfahani M, Cheraghi T, Dastan J, Nersesian J, Ghaffari SR. Chromosomal radiosensitivity in patients with common variable immunodeficiency. Immunobiology. 2008;213(5):447-54.

91.       Aghamohammadi A, Mohammadi J, Parvaneh N, Rezaei N, Moin M, Espanol T, Hammarstrom L. Progression of Selective IgA Deficiency to Common Variable Immunodeficiency. Int Arch Allergy Immunol. 2008 Jun 3;147(2):87-92.

92.       Tabatabaie P, Aghamohammadi A, Mamishi S, Isaeian A, Heidari G, Abdollahzade S, Pirouzi P, Rezaei N, Heidarnazhad H, Mirsaeid Ghazi B, Yeganeh M, Cheraghi T, Abolhasani H, Saghafi S, Alizadeh H, Anaraki MR. Evaluation of humoral immune function in patients with bronchiectasis. Iran J Allergy Asthma Immunol. 2008 Jun;7(2):69-77.

93.       Rezaei N, Aghamohammadi A, Ramyar A, Pan-Hammarstrom Q, Hammarstrom L. Severe congenital neutropenia or hyper-IgM syndrome? A novel mutation of CD40 ligand in a patient with severe neutropenia. Int Arch Allergy Immunol. 2008 Jul 2;147(3):255-259.

94.       Mahmoodi M, Mir MR, Daryaei P, Harirchi I, Rezaei N, Mohagheghi MA, Mousavi-Jarrahi A, Nahavandian B, Kavianpour M, Jafari A. Cytokine response following transthoracic and transhiatal esophagectomy in patients with esophageal cancer. Eur Cytokine Netw. 2008 Jun 1;19(2):92-98.

95.       Amirzargar AA, Naroueynejad M, Khosravi F, Dianat S, Rezaei N, Mytilineos J, Nikbin B. Cytokine single nucleotide polymorphisms in Iranian populations. Eur Cytokine Netw. 2008 Jun 1;19(2):104-112.

96.       Aghamohammadi A, Cheraghi T, Gharagozlou M, Movahedi M, Rezaei N, Yeganeh M, Parvaneh N, Abolhassani H, Pourpak Z, Moin M. IgA deficiency: correlation between clinical and immunological phenotypes. J Clin Immunol. 2009 Jan;29(1):130-6.

97.       Shabestari MS, Rezaei N. Asthma and allergic rhinitis in a patient with BTK deficiency. J Investig Allergol Clin Immunol. 2008;18(4):300-4.

98.       Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S, Amirzargar AA, Movahedi M. Proinflammatory cytokine gene polymorphisms among Iranian patients with asthma. J Clin Immunol. 2009 Jan;29(1):57-62.

99.       Shams S, Amirzargar AA, Yousefi M, Rezaei N, Solgi G, Khosravi F, Ansaripour B, Moradi B, Nikbin B. HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris. J Clin Immunol. 2009 Mar;29(2):175-9.

100.    Ramyar A, Aghamohammadi A, Moazzami K, Rezaei N, Yeganeh M, Cheraghi T, Pouladi N, Heydari G, Abolhassani H, Amirzargar AA, Parvaneh N, Moin M. Presence of idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency. Iran J Allergy Asthma Immunol. 2008 Sep;7(3):169-75.

101.    Shamsian BS, Mansouri D, Pourpak Z, Rezaei N, Chavoshzadeh Z, Jadali F, Gharib A, Alavi S, Eghbali A, Arzanian MT. Autosomal recessive chronic granulomatous disease, IgA deficiency and refractory autoimmune thrombocytopenia responding to anti-CD20 monoclonal antibody. Iran J Allergy Asthma Immunol. 2008 Sep;7(3):181-4.

102.    Fallahi GH, Khorasani EN, Mansouri F, Rezaei N. The effect of omeprazole on asthmatic adolescents with gastroesophageal reflux disease. Allergy Asthma Proc. 2008 Sep-Oct;29(5):517-20.

103.    Movahedi M, Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S, Amirzargar AA. IL-10, TGF-beta, IL-2, IL-12, and IFN-gamma cytokine gene polymorphisms in asthma. J Asthma. 2008 Nov;45(9):790-4.

104.    Aghamohammadi A, Moin M, Karimi A, Naraghi M, Zandieh F, Isaeian A, Tahaei A, Talaei-Khoei M, Kouhi A, Abdollahzade S, Pouladi N, Heidari G, Amirzargar AA, Rezaei N, Sazgar AA. Immunologic evaluation of patients with recurrent ear, nose, and throat infections. Am J Otolaryngol. 2008 Nov-Dec;29(6):385-92.

105.    Naseri S, Sorouri R, Pourpak Z, Rezaei N, Moin M, Parvaneh N, Aghamohammadi A. Correlation of null Btk expression and gene noncoding mutations in XLA patients. Zanjan Univ Med Sci J. 2008; 16(7):11-20.

106.    Rezaei A, Aghamohammadi A, Moradinejad MH, Parvaneh N, Rezaei N, SeyedTabaei R, Asgarian-Omran H, Shahrestani T, Amirzargar AA. B-cell lineage study in patients with juvenile idiopathic arthritis. Iran J Pediatr. 2008 Dec;18(4):343-50.

107.    Rezaei N, Aghamohammadi A, Read RC. Response to polysaccharide vaccination amongst pediatric patients with common variable immunodeficiency correlates with clinical disease. Iran J Allergy Asthma Immunol. 2008 Dec;7(4):237-40.

108.    Rezaei N, Aghamohammadi A, Kardar GA, Nourizadeh M, Pourpak Z. T- helper 1 and 2 cytokine assay in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2008;18(6):449-53.

109.    Fahimzad A, Chavoshzadeh Z, Abdollahpour H, Klein C, Rezaei N. Necrosis of nasal cartilage due to mucormycosis in a patient with severe congenital neutropenia due to HAX1 Deficiency. J Investig Allergol Clin Immunol. 2008;18(6):469-72.

110.    Rezaei N, Amirzargar AA, Shakiba Y, Mahmoudi M, Moradi B, Aghamohammadi A. Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol. 2009 Jan;155(1):21-7.

111.    Boztug K, Appaswamy G, Ashikov A, Schäffer AA, Salzer U, Diestelhorst J, Germeshausen M, Brandes G, Lee-Gossler J, Noyan F, Gatzke AK, Minkov M, Greil J, Kratz C, Petropoulou T, Pellier I, Bellanné-Chantelot C, Rezaei N, Mönkemöller K, Irani-Hakimeh N, Bakker H, Gerardy-Schahn R, Zeidler C, Grimbacher B, Welte K, Klein C. A syndrome with congenital neutropenia and mutations in G6PC3. New Engl J Med. 2009 Jan 1;360(1):32-43.

112.    Armin S, Chavoshzadeh Z, Mohkam M, Rezaei N. Antiepileptic hypersensitivity and DRESS syndrome due to phenytoin in two pediatric cases. Turk J Pediatr. 2009 Jan;51(1):76-7.

113.    Aghamohammadi A, Cheraghi T, Rezaei N, Kanegane H, Abdollahzede S, Talaei-Khoei M, Heidari G, Zandieh F, Moin M, Miyawaki T. Neutropenia associated with x-linked agammaglobulinemia in an Iranian referral center. Iran J Allergy Asthma Immunol. 2009 Mar;8(1):43-7.

114.    Nicknam MH, Mahmoudi M, Amirzargar AA, Jamshidi AR, Rezaei N, Nikbin B. HLA-B27 subtypes and tumor necrosis factor alpha promoter region polymorphism in Iranian patients with ankylosing spondylitis. Eur Cytokine Netw. 2009 Jan 1;20(1):17-20.

115.    Dashti-Khavidaki S, Aghamohammadi A, Farshadi F, Movahedi M, Pouladi N, Moazzami K, Cheraghi T, Mahdaviani SA, Saghafi S, Heydari G, Abdollahzade S, Rezaei N. Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience on 3004 infusions in Iranian patients with primary immunodeficiency diseases. J Investig Allergol Clin Immunol. 2009;19(2):139-45.

116.    Rezaei N, Aghamohammadi A, Shakiba Y, Mahmoudi M, Jalali A, Moradi B, Amirzargar AA. Cytokine gene polymorphisms in common variable immunodeficiency. Int Arch Allergy Immunol. 2009 Apr 2;150(1):1-7.

117.    Fallahi GH, Bazvand F, Eftekhari K, Ahmadi F, Ahmadi M, Rezaei N. Neonatal giant cell hepatitis in an infant with cystic fibrosis. Iran J Pediatr. 2009;19(2):189-92.

118.    Mahmoodi M, Aghamohammadi A, Rezaei N, Lessan-Pezeshki M, Pourmand G, Mohagheghi MA, Abdollahzade S, Pourfarziani V, Mousavi-Jarrahi A. Antibody response to pneumococcal capsular polysaccharide vaccination in patients with chronic kidney disease. Eur Cytokine Netw. 2009 Jun 1;20(2):69-74.

119.    Tabatabaie P, Fallahi GH, Farahmand F, Eftekhari K, Ahmadi M, Ahmadi F, Bazvand F, Rezaei N. Congenital choledochal cyst in an infant with cystic fibrosis. Ann Hepatol. 2009 Apr-Jun;8(2);156-7.

120.    Kashef S, Ghaedian MM, Rezaei N, Karamizadeh Z, Aghamohammadi A, Durandy A, Pan-Hammarstrom Q, Hammarstrom L. Isolated growth hormone deficiency in a patient with immunoglobulin class switch recombination deficiency. J Investig Allergol Clin Immunol. 2009;19(3):233-6.

121.    Shamsian BS, Rezaei N, Arzanian MT, Alavi S, Khojasteh O, Eghbali A. Severe hypochromic microcytic anemia in a patient with congenital atransferrinemia. Pediatr Hematol Oncol. 2009;25(6):502-8.

122.    Mashhadi MA, Khazaei HA, Narouie B, Niazi AA, Moazzami K, Khademi R, Hejazinia F, Rezaei N, Ghasemi-rad M. Abnormal immunoglobulin levels in Iranian patients with hematologic malignancies. Shiraz E-Med J. 2009; 10(3):120-5.

123.    Ramyar A, Shafiei M, Rezaei N, Asgarian-Omran H, Abdar Esfahani S, Moazzami K, Sarafnejad A, Aghamohammadi A. Cytologic phenotypes of B-cell acute lymphoblastic leukemia – a single center study. Iran J Allergy Asthma Immunol. 2009; Jun;8(2):99-106.

124.    Fallahi GH, Moazzami K, Tabatabaeiyan M, Zamani MM, Asgar-Shirazi M, Najafi M, Motamed F, Farahmand F, Khodad A, Khatami GR, Rezaei N. Clinical characteristics of Iranian pediatric patients with inflammatory bowel disease. Act Gastroenterol Belg. 2009 Apr-Jun;72(2):230-4.

125.    Rezaei N, Moazzami K, Aghamohammadi A, Klein C. Neutropenia and primary immunodeficiency diseases. Int Rev Immunol. 2009; 28(5):335-66.

126.    Aghamohammadi A, Foroughi F, Rezaei N, Dianat S, Solgi G, Amirzargar AA. Mannose binding lectin polymorphisms in common variable immunodeficiency. Clin Exp Med. 2009 Dec;9(4):285-90.

127.    Niazi A, Khazaei HA, Narouei B, Moazzami K, Rezaei N. Efficacy of hepatitis B vaccine amongst health-care workers of south-eastern Iran. J Gastrointestin Liver Dis. 2009 Sep;18(3):389-90.

128.    Motamed F, Aghamohammadi A, Soltani M, Mansouri M, Rezaei N, Teimourian S, Pouladi N, Abdollahzadeh S, Parvaneh N. Evaluation of liver diseases in Iranian patients with primary antibody deficiencies. Ann Hepatol. 2009 Jul-Sep;8(3):196-202.

129.    Shakiba Y, Mansouri K, Arshadi D, Rezaei N. Corneal Neovascularization: Molecular Events and Therapeutic Options. Recent Pat Inflamm Allergy Drug Discov. 2009;3(3):221-31.

130.    Rezaei N, Aghamohammadi A, Mahmoudi M, Shakiba Y, Kardar GA, Mahmoudi M, Moradi B, Amirzargar AA. Association of IL-4 and IL-10 gene promoter polymorphisms with common variable immunodeficiency. Immunobiology. 2010;215(1):81-7.

131.    Aghamohammadi A, Parvaneh N, Rezaei N. Common variable immunodeficiency: a heterogeneous group needs further subclassification. Exp Rev Clin Immunol. 2009; 5(6): 629-631.

132.    Sadeghi Shabestari M, Rezaei N. Disseminated bacille Calmette-Guérin in the Iranian children with severe combined immunodeficiency. Int J Infect Dis. 2009 Nov;13(6):e420-3.

133.    Glocker EO, Hennigs A, Nabavi M, Schäffer AA, Woellner C, Salzer U, Pfeifer D, Veelken H, Warnatz K, Tahami F, Jamal S, Manguiat A, Rezaei N, Amirzargar AA, Plebani A, Hannesschläger N, Gross O, Ruland J, Grimbacher B. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med. 2009 Oct 29;361(18):1727-35.

134.    Mohammadi J, Liu C, Aghamohammadi A, Bergbreiter A, Du L, Lu J, Rezaei N, Amirzargar AA, Moin M, Salzer U, Pan-Hammarström Q, Hammarström L. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency. J Clin Immunol. 2009 Nov;29(6):777-85.

135.    Aghamohammadi A, Parvaneh N, Rezaei N, Moazzami K, Kashef S, Abolhassani H, Imanzadeh A, Mohammadi J, Hammarström L. Clinical and laboratory findings in Hyper-IgM syndrome with novel CD40L and AICDA mutations. J Clin Immunol. 2009 Nov;29(6):769-76.

136.    Shokrgozar MA, Sarial S, Amirzargar A, Shokri F, Rezaei N, Arjang Z, Radfar J, Yousefi-Behzadi M, Sahraian MA, Lotfi J. IL-2, IFN-gamma and IL-12 gene polymorphisms and susceptibility to multiple sclerosis. J Clin Immunol. 2009 Nov;29(6):747-51.

137.    Aghamohammadi A, Tavassoli M, Abolhassani H, Parvaneh N, Moazzami K, Allahverdi A, Mahdaviani SA, Atarod L, Rezaei N. Infectious and non-infectious complications among undiagnosed patients with common variable immunodeficiency. Iran J Pediatr. 2009 Dec;19(4)367-75.

138.    Amirzargar AA, Movahedi M, Rezaei N, Moradi B, Dorkhosh S, Mahloji M, Mahdaviani SA. Polymorphisms in IL-4 and IL-4 RA genes confer susceptibility to asthma. J Investig Allergol Clin Immunol. 2009; 19(6):433-8.

139.    Sadeghi-Shabestari M, Vesal S, Jabbarpour Bonyadi M, de villatay JP, Fischer A, Rezaei N. Novel RAG2 mutation in a patient with T- B- severe combined immunodeficiency and disseminated BCG disease. J Investig Allergol Clin Immunol. 2009; 19(6):494-6.

140.    Mamishi S, Esfahani SA, Parvaneh N, Diestelhorst J, Rezaei N. Severe congenital neutropenia in 2 siblings of consanguineous parents. The role of HAX1 deficiency. J Investig Allergol Clin Immunol. 2009; 19(6):500-3.

141.    Kheiandish M, Siadat SD, Norouzian D, Razavi MR, Aghasadeghi MR, Rezaei N, Farazmand A, Mobarakeh JI, Zangeneh M, Moshiri A, Sadat SM, Sharifat Salmani A. Measurement of opsonophagocytic activity of antibodies specific to Neisseria meningitidis serogroup A capsular polysaccharide-serogroup B outer membrane vesicle conjugate in animal mode. Ann Microbiol. 2009 Dec;59(4):801-6.

142.    Moradi S, Chavoshzadeh Z, Izadyar M, Mahjoub F, Rezaei N. Angiocentric nasal T-cell lymphoma in a patient with idiopathic CD4+ lymphocytopenia. Iran J Allergy Asthma Immunol. 2009 Dec;8(4):215-8.

143.    Ahmadi F, Ahmadi M, Yaghmaei B, Nejat F, Rezaei N, Mamishi S. Candida albicans meningitis in an infant with Noonan syndrome. Braz J Infect Dis. 2009 Dec;13(6):460-1.

144.    Isaian A, Bogdanova NV, Houshmand M, Movahadi M, Agamohammadi A, Rezaei N, Atarod L, Sadeghi-Shabestari M, Tonekaboni SH, Chavoshzadeh Z, Seyed Hassani SM, Mirfakhrai R, Cheraghi T, Kalantari N, Ataei M, Dork-Bousset T, Sanati MH. BAK, BAX and NBK/BIK pro-apoptotic gene alterations in Iranian patients with ataxia telangiectasia. J Clin Immunol. 2010 Jan;30(1):132-7.

145.    Barkhordari E, Rezaei N, Ansaripour B, Larki P, Alighardashi M, Ahmadi-Ashtiani HR, Mahmoudi M, Keramati MR, Habibollahi P, Bashashati M, Ebrahimi-Daryani N, Amirzargar AA. Pro-inflammatory cytokine gene polymorphisms in irritable bowel syndrome. J Clin Immunol. 2010 Jan;30(1):74-9.

146.    Mohammadi J, Ramanujam R, Jarefors S, Rezaei N, Aghamohammadi A, Gregersen PK, Hammarström L. IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotype. J Clin Immunol. 2010 Jan;30(1):138-43.

147.    Eghbali A, Eshghi P, Malek F, Abdollahpour H, Rezaei N. HAX1 mutation in an infant with severe congenital neutropenia. Turk J Pediatr. 2010 Jan-Feb;52(1):81-4.

148.    Armin S, Chavoshzadeh Z, Rezaei N. Antiepileptic hypersensitivity syndrome and DRESS syndrome. Turk J Pediatr. 2010 Jan-Feb;52(1):113-4.

149.    Aghamohammadi A, Allahverdi A, Abolhassani H, Moazzami K, Gharagozlou M, Kalantari N, Sajedi V, Shafiei A, Parvaneh N, Karimi N, Salehi Sadaghiani M, Rezaei N. Comparison of pulmonary diseases in common variable immunodeficiency and x-linked agammaglobulinemia. Respirology. 2010 Feb;15(2):289-95.

150.    Salehzadeh M, Aghamohammadi A, Rezaei N. Evaluation of immunoglobulin levels and infection rate in patients with common variable immunodeficiency after immunoglobulin replacement therapy. J Microbiol Immunol Infect. 2010 Feb;43(1):11-17.

151.    Fallahi GH, Ahmadian JH, Rabbani A, Yousefnezhad A, Rezaei N. Screening of celiac disease by anti-tissue transglutaminase antibodies in Iranian diabetic children. Indian Pediatr. 2010 Mar;47(3):268-70.

152.    Aghamohammadi A, Moin M, Rezaei N. History of primary immunodeficiency diseases in Iran. Iran J Pediatr. 2010 Mar;20(1):16-34.

153.    Arzanian MT, Eghbali A, Karimzade P, Ahmadi M, Houshmand M, Rezaei N. mtDNA deletion in an Iranian infant with Pearson Marrow syndrome. Iran J Pediatr. 2010 Mar;20(1):107-12.

154.    Azizi E, Massoud A, Amirzargar AA, Mahmoudi M, Solimanifar N, Rezaei N, Jamshidi AR, Nikbin B, Nicknam MH. Association of CTLA4 gene polymorphism in Iranian patients with ankylosing spondylitis. J Clin Immunol. 2010 Mar;30(2):268-71.

155.    Rezaei N, Wing JB, Aghamohammadi A, Carlring J, Lees A, Asgarian-Omran H, Pourpak Z, Sarrafnejad A, Kardar GA, Shahrestani T, Masoumi F, Zare A, Saghafi S, Sarrafnejad S, Foster RA, Heath AW, Read RC. B-cell- T-cell activation and interaction in common variable immunodeficiency. Hum Immunol. 2010 Apr;71(4)355-62.

156.    Zeinaloo AA, Aghamohammadi A, Shabanian R, Salavati A, Abdollahzadeh S, Rezaei N, Alizadeh H, Zanjani KS, Kiani A. Echocardiographic abnormalities and its correlation with bronchiectasis score in primary antibody deficiencies. J Cardiovasc Med (Hagerstown). 2010 Apr;11(4):244-9.

157.    Rezaei N, Siadat SD, Aghamohammadi A, Moin M, Pourpak Z, Norouzian D, Izadi Mobarakeh J, Aghasadeghi MR, Nejati M, Read RC. Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency. Clin Vaccine Immunol. 2010 Apr;17(4):524-8.

158.    Rezaei N. Immunology: clinical case studies and disease pathophysiology. JAMA. 2010 Apr;303(14):1428-9.

159.    Ashrafi M, Hosseini SA, Abolmaali S, Biglari M, Azizi R, Farghadan M, Saladjegheh N, Rezaei N, Aghamohammadi A. Effect of anti-epileptic drugs on serum immunoglobulin levels in children. Acta Neurol Belg. 2010 Mar;110(1):65-70.

160.    Fallahi GH, Najafi M, Farhmand F, Bazvand F, Ahmadi M, Ahmadi F, Eftekhari K, Khodad A, Motamed F, Khatami G, Aghamohammadi A, Rezaei N. The clinical and laboratory manifestations of Iranian patients with cystic fibrosis. Turk J Pediatr. 2010 Mar;52(2):132-8.

161.    Eghbali A, Eshghi P, Malek F, Rezaei N. Cardiac and renal malformations in a patient with sepsis and severe congenital neutropenia. Iran J Pediatr. 2010 Jun;20(2):225-8.

162.    Rezaei N, Aghamohammadi A, Nourizadeh M, Kardar GA, Pourpak Z, Zare A, Read RC. Cytokine production by activated T cells in common variable immunodeficiency. J Investig Allergol Clin Immunol. 2010 May;20(3):244-51.

163.    Sabouni F, Ferdosian F, Mamishi S, Nejat F, Monnajemzadeh M, Rezaei N. Multiple organ involvement with hydatid cysts. Iran J Parasitology. 2010;5(2):65-70.

164.    Bakhtiyari S, Haghani K, Farhadi E, Soukhtanloo M, Rezaei N, Taghikhani M. A novel monoclonal antibody against A60 antigen of Mycobacterium bovis Bacillus Calmette-Guerin. Hybridoma (Larchmt). 2010 Jun;29(3):211-5.

165.    Saroukhani S, Aghamohammadi A, Mahmoudi-Gharaei J, Abolhassani H, Cheraghi T, Imanzaeh A, Moazzami K, Parvaneh N, Rezaei N. Behavior abnormality following intravenous immunoglobulin treatment in patients with primary antibody deficiencies. Hum Psychopharmacol. 2010 Jun 29;25(5):419-422.

166.    Aghamohammad A, Abolhassani H, Rezaei N, Kalantari N, Tamizifar B, Cheraghi T, Parvaneh N, Yeganeh M, Moazzami K, Ebrahimi-Daryani N, Anaraki MR. Cutaneous granulomas in common variable immunodeficiency: case report and review of literature. Acta Dermatovenerol Croat. 2010 Jul;18(2):107-13.

167.    Rezaei N, Aghamohammadi A. Hyper-IgE syndrome. J Postgrad Med. 2010 Apr-Jun;56(2):63-4.

168.    Motamed F, Famouri F, Najafi M, Moazzami K, Farahmand F, Khodad A, Fallahi GH, Khatami GR, Rezaei N. Response to induction therapy in a pediatric population of inflammatory bowel disease. Z Gastroenterol. 2010 Jul;48(7):748-52.

169.    Aghamohammadi A, Shafiei A, Abolhassani H, Sherkat R, Mahjoub F, Rezaei N. Renal amyloidosis in common variable immunodeficiency. Nefrologia. 2010;30(4):474-6.

170.    Shamsian BS, Goudarzipour K, Alavi S, Jadali F, Gharib A, Aghakhani R, Arzanian MT, Rezaei N. Langerhans cell histiocytosis in a child with non-Hodgkin lymphoma. J Pediatr Hematol Oncol. 2010 Aug;32(6):e245-6.

171.    Mamishi S, Eghbali AN, Rezaei N, Abolhassani H, Parvaneh N, Aghamohammadi A. A single center 14 years study of infectious complications leading to hospitalization of the patients with primary antibody deficiencies. Braz J Infect Dis. 2010 Aug;14(4):351-5.

172.    Ramyar A, Shafiei M, Moazzami K, Rezaei N. Severe valvular toxicity and pericarditis early after radiation therapy in a patient treated for Hodgkin's lymphoma. Turk J Pediatr. 2010 Jul-Aug;52(4):423-5.

173.    Ashrafi M, Hosseini SA, Biglari M, Abolmaali S, Azizi R, Mombeini H, Pourpak Z, Saladjegheh N, Rezaei N, Saghafi S, Aghamohammadi A. Effect of anti-epileptic drugs on serum level of IgG subclasses. Iran J Pediatr. 2010 Sep;20(3)269-76.

174.    Parvaneh N, Mamishi S, Rezaei A, Rezaei N, Tamizifar B, Parvaneh L, Sherkat R, Ghalehbaghi B, Kashef S, Chavoshzadeh Z, Isaeian A, Ashrafi F, Aghamohammadi A. Characterization of 11 new cases of leukocyte adhesion deficiency type 1 with seven novel mutations in the ITGB2 gene. J Clin Immunol. 2010 Sep;30(5):756-60.

175.    Aghamohammadi A, Abolhassani H, Moazzami K, Parvaneh N, Rezaei N. Correlation between common variable immunodeficiency clinical phenotypes and parental consanguinity in children and adults. J Investig Allergol Clin Immunol. 2010 Sep;20(5):372-9.

176.    Aghamohammadi A, Imai K, Moazzami K, Abolhassani H, Tabatabaeiyan M, Parvaneh N, Nasiri N, Nakagawa N, Oshima K, Ohara O, Nonoyama S, Rezaei N. Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome. J Investig Allergol Clin Immunol. 2010 Sep;20(5):442-5.

177.    Mahmoudi M, Siassi F, Mahmoudi MJ, Eshraghian MR, Zarnani AH, Rezaei N, Hedayat M, Shokri F, Saboor-Yaraghi AA. Defective T-cell proliferation and IL-2 production in a subgroup of patients with coronary artery disease. Iran J Allergy Asthma Immunol. 2010 Sep;9(3):133-40.

178.    Shamsian BS, Gharib A, Rezaei N, Esfahani SA, Alavi S, Goudarzipour K, Arzanian MT. Development of secondary T-cell acute lymphoblastic leukemia in a child with hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2010 Oct;55(4):725-6.

179.    Barkhordari E, Rezaei N, Mahmoudi M, Larki P, Ahmadi-Ashtiani HR, Ansaripour B, Alighardashi M, Bashashati M, Amirzargar AA, Ebrahimi-Daryani N. T-helper 1, T-helper 2, and T-regulatory cytokines gene polymorphisms in irritable bowel syndrome. Inflammation. 2010 Oct;33(5):281-6.

180.    Ahmadiafshar A, Mogimi Haji M, Rezaei N. Comparison of effectiveness between beclomethasone dipropionate and fluticasone propionate in treatment of children with moderate asthma. World Allergy Organiz J. 2010 Oct;3(10):250-2.

181.    Hedayat M, Mahmoudi MJ, Rose NR, Rezaei N. Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev. 2010 Nov;15(6):543-62.

182.    Khanbabaee G, Hassas Yeganeh M, Tabatabaei SA, Khatami A, Bazrafshan S, Rezaei N. Langerhans cell histiocytosis with pulmonary involvement and unilateral pneumothorax. Turk J Pediatr. 2010 Nov-Dec;52(6):638-41.

183.    Farrokhi S, Mousavi T, Arshi S, Javahertarash N, Varasteh A, Falak R, Rezaei N, Salekmoghadam A. Effect of treatment with intranasal corticosteroid and oral antihistamine on cytokine profiles of peripheral blood mononuclear cells of patients with allergic rhinitis sensitive to Chenopodium album. Iran J Allergy Asthma Immunol. 2010 Dec;9(4):225-30.

184.    Amirzargar A, Shahram F, Nikoopour E, Rezaei N, Saeedfar K, Ziaei N, Davatchi F. Proinflammatory cytokine gene polymorphisms in Behcet's disease. Eur Cytokine Netw. 2010 Dec 1;21(4):292-6.

185.    Shamsian BS, Norbakhsh K, Rezaei N, Safari A, Gharib A, Pourpak Z, Alavi S, Parvaneh N, Arzanian MT. A novel RAB27A mutation in patient with Griscelli syndrome type 2. J Investig Allergol Clin Immunol. 2010 Dec;20(7):612-5.

186.    Rezaei N, Mahmoudi E, Aghamohammadi A, Das R, Nichols KE. X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma. Brit J Haematol. 2011 Jan;152(1):13-30.

187.    Abdollahzade S, Aghamohammadi A, Soheili H, Salehi Sadaghiani M, Abolhassani H, Rezaei N. The clinical immunological and long-term follow-up of pediatric patients with common variable immunodeficiency. Tehran Univ Med J. 2011 Jan;68(10):600-10.

188.    Rezaei N, Sabbaghian M, Liu Z, Zenker M. Eponym: Johanson-Blizzard syndrome. Eur J Pediatr. 2011 Feb;170(2):179-83.

189.    Fallahi GH, Sabbaghian M, Khalili M, Parvaneh N, Zenker M, Rezaei N. Novel UBR1 gene mutation in a patient with typical phenotype of Johanson-Blizzard syndrome. Eur J Pediatr. 2011 Feb;170(2):233-5.

190.    Movahedi Z, Norouzi S, Mamishi S, Rezaei N. BCGiosis as a presenting feature of a child with chronic granulomatous disease. Braz J Infect Dis. 2011 Feb;15(1):83-6.

191.    Aghamohammadi A, Montazeri A, Abolhassani H, Saroukhani S, Pourjabbar S, Tavassoli M, Darabi B, Imanzadeh A, Parvaneh N, Rezaei N. Health-related quality of life in primary antibody deficiency. Iran J Allergy Asthma Immunol. 2011 Mar;10(1):47-51.

192.    Mahmoudi MJ, Mahmoudi M, Siassi F, Shokri F, Eshraghian MR, Zarnani AH, Chahardoli R, Hedayat M, Khoshnoodi J, Nayeri H, Rezaei N, Saboor-Yaraghi AA. Lymphocyte cytotoxicity of oxLDL in patients with atherosclerosis. Iran J Immunol. 2011 Mar;8(1):27-33.

193.    Kiani-amin M, Daneshi MM, Ayazi P, Mohammadian S, Rezaei N. Serum immunoglobulin levels in splenectomized and non splenectomized patients with major beta-thalassemia. Iran J Pediatr. 2011 Mar;21(1):95-8.

194.    Rezaei N, Aghamohammadi A, Parvaneh N, Mansouri D, Casanova JL. Tuberculosis: a new look at an old disease. Exp Rev Clin Immunol. 2011 Mar;7(2):129-31.

195.    Najafi Sani M, Sabbaghian M, Mahjoob F, Cefalù AB, Averna MR, Rezaei N. Identification of a novel mutation of MTP gene in a patient with abetalipoproteinemia. Ann Hepatol. 2011 Apr;10(2):221-6.

196.    Hadi N, Kashef S, Moazzen M, Shamoon Pour M, Rezaei N. Survey of Mycoplasma pneumoniae in Iranian children with acute lower respiratory tract infections. Braz J Infect Dis. 2011 Apr;15(2):97-101.

197.    Lashgary Z, Khodadadi A, Singh Y, Houshmand SM, Mahjoubi F, Sharma P, Singh S, Seyedin M , Srivastava A, Ataee M, Mohammadi ZS, Rezaei N, Bamezai RN, Sanati MH. Y chromosome diversity among the Iranian religious groups: a reservoir of genetic variation. Ann Hum Biol. 2011 May;38(3):364-71.

198.    Barkhordari E, Amirzargar AA, Ebrahimi-Daryani N, Mahmoudi M, Ansaripour B, Alighardashi M, Ahmadi-Ashtiani HR, Bashashati M, Rezaei N. Lack of association between interleukin 12 C(-1188)A polymorphism and irritable bowel syndrome. Avicenna J Med Biotechnol. 2011 Mar;3(1):45-8.

199.    Shamsian BS, Nikoufar M, Esfahani SA, Shamshiri AR, Arzanian MT, Alavi S, Jadali F, Gharib A, Rezaei N. A 10-year single center survey of pediatric patients with histiocytic disorders in Iran. Turk J Pediatr. 2011 Jan-Feb;53(1):34-42.

200.    Rezaei N, Abolhassani H, Aghamohammadi A, Ochs HD. Indications and safety of intravenous and subcutaneous immunoglobulin therapy. Expert Rev Clin Immunol. 2011 May;7(3):301-16.

201.    Aghamohammadi A, Mahmoodi M, Rezaei N, Safari Z, Heidarnasab D, Divsalar K, Mohagheghi MA. The assessment of antibody response following immunization with polysaccharide vaccine in patients with chronic kidney disease. Tehran Univ Med J. 2011 May;69(2):92-8.

202.    Aghamohammadi A, Bahrami A, Mamishi S, Mohammadi B, Abolhassani H, Parvaneh N, Rezaei N. Impact of delayed diagnosis in children with primary antibody deficiencies. J Microbiol Immunol Infect. 2011 Jun;44(3):229-34.

203.    Farrokhi S, Mousavi T, Arshi S, Varasteh A, Rezaei N, Salekmoghadam A. Co-administration of Chenopodium album allergens and CpG oligodeoxy-nucleotides effects on peripheral blood mononuclear cells of patients with allergic rhinitis treated with intranasal corticosteroids and antihistamines. Iran J Allergy Asthma Immunol. 2011 Jun;10(2):101-10.

204.    Kashef S, Moghtaderi M, Borzouee M, Rezaei N. Giant aneurysm of thoracic and proximal abdominal aorta in a patient with common variable immunodeficiency. Iran J Allergy Asthma Immunol. 2011 Jun;10(2):133-7.

205.    Rezaei N, Hedayat M, Aghamohammadi A, Nichols KE. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J Allergy Clin Immunol. 2011 Jun;127(6):1329-1341.

206.    Bazvand F, Shams S, Esfahani MB, Koochakzadeh L, Monajemzadeh M, Haghi Ashtiani MT, Rezaei N. Total antioxidant status in patients with major β-thalassemia. Iran J Pediatr. 2011 Jun;21(2):159-65.

207.    Chavoshzadeh Z, Golnabi A, Rezaei N, Mehdizadeh M. Laryngeal foreign body aspiration misdiagnosed as asthma: two case reports and a review of the literature. B-ENT. 2011 Jun;7(2):137-40.

208.    Shayanfar N, Mohammadpour M, Haghi-Ashtiani MT, Farahani NN, Abedini M, Rezaei N. Invasive bacteria isolates from children with cerebral shunt and pattern of antimicrobial drug susceptibility in an Iranian referral pediatrics center. Braz J Infect Dis. 2011 Aug;15(4):401-3.

209.    Aghamohammadi A, Abolhassani H, Biglari M, Abolmaali S, Moazzami K, Tabatabaeiyan M, Asgarian-Omran H, Parvaneh N, Mirahmadian M, Rezaei N. Analysis of switched memory B cells in patients with IgA deficiency. Int Arch Allergy Immunol. 2011 Aug 10;156(4):462-468.

210.    Hedayat M, Netea MG, Rezaei N. Targeting of toll-like receptors: a decade of progress in combating infectious diseases. Lancet Infect Dis. 2011 Sep;11(9):702-12.

211.    Farahmand F, Najafi M, Ataee P, Modarresi V, Shahraki T, Rezaei N. Cow's milk allergy among children with gastroesophageal reflux disease. Gut Liver. 2011 Sep;5(3):298-301.

212.    Norouzi S, Movahedi Z, Mamishi S, Monajemzadeh M, Rezaei N. Disseminated BCG as a unique feature of an infant with severe combined immunodeficiency. Turk J Pediatr. 2011 May-Jun;53(3):328-32.

213.    Mahmoodi M, Aghamohammadi A, Ghaderi H, Isaeian A, Zargar M, Khaji A, Rezaei N, Divsalar K, Mohagheghi MA. Antibody responses to vaccination with peneumococal polysaccharide vaccine in splenectomized patients. J Gorgan Univ Med Sci. 2011;12(4):30-6.

214.    Abolhassani H, Aghamohammadi A, Abolhassani F, Eftekhar H, Heidarnia M, Rezaei N. Health policy for common variable immunodeficiency: burden of the disease. J Investig Allergol Clin Immunol. 2011;21(6):454-8.

215.    Shahram F, Nikoopour E, Rezaei N, Saeedfar K, Ziaei N, Davatchi F, Amirzargar A. Association of interleukin-2, interleukin-4 and transforming growth factor-beta gene polymorphisms with Behcet’s disease. Clin Exp Rheumatol. 2011;29(4): S28-31.

216.    Fallah S, Tabatabaei A, Pournasir Z, Chavoshzadeh Z, Rezaei N. Cutaneous cytomegalovirus infection in a child with hyper IgE and specific defects in antibody response to protein vaccines. Braz J Infect Dis. 2011 Oct;15(5):484-5.

217.    Soleimanifar N, Amirzargar AA, Mahmoudi M, Pourfathollah AA, Azizi E, Jamshidi AR, Rezaei N, Tahoori MT, Bidad K, Nikbin B, Nicknam MH. Study of programmed cell death 1 (PDCD1) gene polymorphims in Iranian patients with ankylosing spondylitis. Inflammation. 2011 Dec;34(6):707-12.

218.    Rezaei N, Mohammadinejad P, Aghamohammadi A. The demographics of primary immunodeficiency diseases across the unique ethnic groups in Iran, and approaches to diagnosis and treatment. Ann N Y Acad Sci. 2011 Nov;1238(1):24-32.

219.    Maródi L; J Project Study Group; Avcin T, Bataneant M, Belevtsev M, Bernatowska E, Cerempei L, Chernyshova L, Ciznar P, El-Marsafy A, Erdös M, Gherghina I, Guseva M, Iurian SI, Kondratenko I, Kostyuchenko L, Kuli-Lito G, Litzman J, Mironska K, Mulaosmanovich V, Naumova E, Nashrullayeva G, Pac M, Pasic S, Prokofjeva T, Reisli I, Rezaei N, Richter D, Sediva A, Serban M, Shcherbina A, Szaflarska A, Szolnoky M, Tóth B, Tuzankina I, Velbri S. The creation and progress of the J Project in Eastern and Central Europe. Ann N Y Acad Sci. 2011 Nov;1238:65-73.

220.    Mahmoudi MJ, Hedayat M, Rezaei N, Saboor-Yaraghi AA, Mahmoudi M. In vitro soluble CD30 levels in patients with chronic stable coronary artery disease. Iran J Allergy Asthma Immunol. 2011 Dec;8(4):237-42.

221.    Meighani G, Aghamohammadi A, Javanbakht H, Abolhassani H, Nikayin S, Jafari SM, Shamshiri AR, Rezaei N. Oral and dental health status in patients with primary antibody deficiencies. Iran J Allergy Asthma Immunol. 2011 Dec;8(4):289-93.

222.    Sancho-Shimizu V, Pérez de Diego R, Lorenzo L, Halwani R, Alangari A, Israelsson E, Fabrega S, Cardon A, Maluenda J, Tatematsu M, Mahvelati F, Herman M, Ciancanelli M, Guo Y, Alsum Z, Alkhamis N, Al-Makadma AS, Ghadiri A, Boucherit S, Plancoulaine S, Picard C, Rozenberg F, Tardieu M, Lebon P, Jouanguy E, Rezaei N, Seya T, Matsumoto M, Chaussabel D, Puel A, Zhang SY, Abel L, Al-Muhsen S, Casanova JL. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J Clin Invest. 2011 Dec 1;121(12):4889-902.

223.    Motamed F, Najafi M, Taghvaei M, Moazzami K, Farahmand F, Khodadad A, Fallahi GH, Parvaneh N, Khatami GR, Rezaei N. NOD2 sequencing in Iranian children with crohn's disease. Z Gastroenterol. 2011;49(12):1526-8.

224.    Taghi Haghi-Ashtiani M, Mamishi S, Shayanfar N, Mohammadpour M, Yaghmaei B, Abedini M, Farahani NN, Rezaei N. Antimicrobial susceptibility profiles associated with bacterial meningitis among children: A referral hospital-based study in Iran. Acta Microbiol Immunol Hung. 2011 Dec 1;58(4):273-278.

225.    Mamishi S, Ahmadi F, Ahmadi M, Rezaei N. Liver abscess as the presenting manifestation of chronic granulomatous disease. Acta Microbiol Immunol Hung. 2011 Dec 1;58(4):297-301.

226.    Nasseri S, Sorouri R, Pourpak Z, Yeganeh M, Aghamohammadi A, Fiorini M, Shahkarami S, Mosallaei M, Rezaei N, Parvaneh N. Molecular characterization of Bruton’s tyrosine kinase deficiency in 12 Iranian cases with presumed X-linked agammaglobulinemia. J Investig Allergol Clin Immunol. 2011;21(7):472-4.

227.    Rezaei N. Autoimmune diseases: acute and complex situations. JAMA. 2011: Dec 21;306(23):2620.

228.    Salehi M, Moradi S, Chavoshzadeh Z, Gorji FA, Khoramrooz Z, Rezaei N. A study of home characteristics in children with allergic rhinitis and asthma. Acta Clin Croat. 2011 Jun;50(2):225-7.

229.    de Vries E; European Society for Immunodeficiencies (ESID) members; Alvarez Cardona A, Abdul Latiff AH, Badolato R, Brodszki N, Cant AJ, Carbone J, Casper JT, Čižnár P, Cochino AV, Derfalvi B, Driessen GJ, Elfeky R, El-Ghoneimy D, Espanol T, Etzioni A, Gambineri E, Gilmour K, Gonzalez-Granado LI, Haverkamp MH, Helminen M, Hönig H, Kanariou MG, Kirschfink M, Klein C, Kuijpers TW, Kutukculer N, Martire B, Meyts I, Niehues T, Pignata C, Reda SM, Renner ED, Rezaei N, Rizzi M, Sampalo Lainz MA, Sargur RB, Sediva A, Seidel MG, Seneviratne SL, Soler-Palacín P, Tommasini A, Warnatz K. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2012 Jan;167(1):108-19.

230.    Bashashati M, Rezaei N, Andrews CN, Chen CQ, Daryani NB, Sharkey KA, Storr MA. Cytokines and irritable bowel syndrome: where do we stand? Cytokine. 2012 Feb;57(2):201-9.

231.    Behniafard N, Aghamohammadi A, Abolhassani H, Poujabbar S, Sabouni F, Rezaei N. Autoimmunity in X-linked agammaglobulinemia: Kawasaki disease and review of the literature. Expert Rev Clin Immunol. 2012 Feb;8(2):155-9.

232.    Dehkordy SF, Aghamohammadi A, Ochs HD, Rezaei N. Primary immunodeficiency diseases associated with neurologic manifestations. J Clin Immunol. 2012 Feb;32(1):1-24.

233.    Hedayat M, Takeda K, Rezaei N. Prophylactic and therapeutic implications of toll-like receptor ligands. Med Res Rev. 2012 Mar;32(2):294-325.

234.    Nourijelyani K, Aghamohammadi A, Salehi Sadaghiani M, Behniafard N, Abolhassani H, Pourjabar S, Rezvanizadeh A, Khadamy J, Imanzaeh A, Sedaghat M, Rezaei N. Physicians awareness on primary immunodeficiency disorders in Iran. Iran J Allergy Asthma Immunol. 2012 Mar;11(1):57-64.

235.    Farahmand F, Sajadi N, Haghi-Ashtian MT, Modaresi V, Rezaei N, Pakseresht B. Comparison of classic sweat test and crystallization test in diagnosis of cystic fibrosis. Iran J Pediatr. 2012 Mar:22(1):102-6.

236.    Moghtaderi M, Kashef S, Rezaei N. Interstitial lung disease in a patient with chronic granulomatous disease. Iran J Pediatr. 2012 Mar;22(1):129-32.

237.    Boztug K, Rosenberg PS, Dorda M, Banka S, Moulton T, Curtin J, Rezaei N, Corns J, Innis JW, Avci Z, Tran HC, Pellier I, Pierani P, Fruge R, Parvaneh N, Mamishi S, Mody R, Darbyshire P, Motwani J, Murray J, Buchanan GR, Newman WG, Alter BP, Boxer LA, Donadieu J, Welte K, Klein C. Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia. J Pediatr. 2012 Apr;160(4):679-683.e2.

238.    Mohammadzadeh I, Yeganeh M, Aghamohammadi A, Parvaneh N, Behniafard N, Abolhassani H, Tabassomi F, Hemmat M, Kanegane H, Miyawaki T, Ohara O, Rezaei N. Severe primary antibody deficiency due to a novel mutation of µ heavy chain. J Investig Allergol Clin Immunol. 2012;22(1):78-9.

239.    Sayarifard F, Aghamohammadi A, Haghi-Ashtiani MT, Rajab A, Irani H, Ahmadian J, Zaridoost A, Parvaneh N, Rezaei N, Rabbani A. Evaluation of serum IgA levels in Iranian patients with type 1 diabetes mellitus. Acta Diabetol. 2012;49(2):131-5.

240.    Shamsian BS, Rezaei N, Alavi S, Hedayat M, Amin Asnafi A, Pourpak Z, Gharib A, Jadali F, Arzanian MT. Primary hemophagocytic lymphohistiocytosis in Iran: report from a single referral center. Pediatr Hematol Oncol. 2012 Apr;29(3):215-9.

241.    Mansouri D, Mahdaviani SA, Khalilzadeh S, Mohajerani SA, Hasanzad M, Sadr S, Nadji SA, Karimi S, Droodinia A, Rezaei N, Linka RM, Bienemann K, Borkhardt A, Masjedi MR, Velayati AA. IL-2-inducible T-cell kinase deficiency with pulmonary manifestations due to disseminated epstein-barr virus infection. Int Arch Allergy Immunol. 2012;158(4):418-22.

242.    Aghamohammadi A, Abolhassani H, Hirbod-Mobarakeh A, Ghassemi F, Shahinpour S, Behniafard N, Naghibzadeh G, Imanzadeh A, Rezaei N. The uncommon combination of common variable immunodeficiency, macrophage activation syndrome, and cytomegalovirus retinitis. Viral Immunol. 2012 Apr;25(2):161-5.

243.    Abdollahpour H, Appaswamy G, Kotlarz D, Diestelhorst J, Beier R, Schäffer AA, Gertz EM, Schambach A, Kreipe HH, Pfeifer D, Engelhardt KR, Rezaei N, Grimbacher B, Lohrmann S, Sherkat R, Klein C. The phenotype of human STK4 deficiency. Blood. 2012 Apr 12;119(15):3450-7.

244.    Khanbabaee G, Enayat J, Chavoshzadeh Z, Tabatabaei SA, Gorji FA, Rezaei N. Serum level of specific IgG antibody for Aspergillus and its association with severity of asthma in asthmatic children. Acta Microbiol Immunol Hung. 2012 Mar;59(1):43-50.

245.    Abolhassani A, Aghamohammadi A, Imanzadeh A, Mohammadinejad P, Sadeghi B, Rezaei N. Malignancy phenotype in common variable immunodeficiency. J Investig Allergol Clin Immunol. 2012;22(2):133-4.

246.    Khanbabaee G, Akbarizadeh M, Sayyari A, Ashayeri-panah M, Abdollahgorji F, Sheibani K, Rezaei N. A Survey on pulmonary pathogens and their antibiotic susceptibility among cystic fibrosis patients. Braz J Infect Dis. 2012 Apr;16(2):122-128.

247.    Oraei M, Aghamohammadi A, Rezaei N, Bidad K, Gheflati Z, Amirkhani A, Massoud A. Naïve CD4+ T cells and recent thymic emigrants in common variable immunodeficiency. J Investig Allergol Clin Immunol. 2012;22(3):160-7.

248.    Mohammadinejad P, Aghamohammadi A, Abolhassani H, Sadaghiani MS, Abdollahzade S, Sadeghi B, Soheili H, Tavassoli M, Fathi SM, Tavakol M, Behniafard N, Darabi B, Pourhamdi S, Rezaei N. Pediatric patients with common variable immunodeficiency: long-term follow-up. J Investig Allergol Clin Immunol. 2012;22(3):208-14.

249.    Norouzi S, Aghamohammadi A, Mamishi S, Rosenzweig SD, Rezaei N. Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases. J Infect. 2012 Jun;64(6):543-54.

250.    Lopez-Herrera G, Tampella G, Pan-Hammarström Q, Herholz P, Trujillo-Vargas CM, Phadwal K, Simon AK, Moutschen M, Etzioni A, Mory A, Srugo I, Melamed D, Hultenby K, Liu C, Baronio M, Vitali M, Philippet P, Dideberg V, Aghamohammadi A, Rezaei N, Enright V, Du L, Salzer U, Eibel H, Pfeifer D, Veelken H, Stauss H, Lougaris V, Plebani A, Gertz EM, Schäffer AA, Hammarström L, Grimbacher B. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet. 2012 Jun 8;90(6):986-1001.

251.    Shamsian BS, Kaviani R, Rezaei N, Hedayat M, Alavi S, Safari A, Moradvisi B, Arzanian MT. Splenectomy for hematological disorders in Iranian pediatric patients: a single center study. Iran J Pediatr. 2012 Jun;22(2):275-6.

252.    Mahmoudi MJ, Mahmoudi M, Siassi F, Hedayat M, Pasalar P, Chamari M, Abolhassani H, Rezaei N, Saboor-Yaraghi AA. Circulating retinol-binding protein 4 concentrations in patients with coronary artery disease and patients with type 2 diabetes mellitus. Int J Diabetes Dev Ctries. 2012 Jun;32(2):105-10.

253.    Aghamohammadi A, Abolhassani H, Mohammadinejad P, Rezaei N. The approach to children with recurrent infections. Iran J Allergy Asthma Immunol. 2012 Jun;11(2):89-109.

254.    Mahmoodi M, Alizadeh AM, Sohanaki H, Rezaei N, Amini-Najafi F, Khosravi AR, Hosseini SK, Safari Z, Hydarnasab D, Khori V. Impact of fumonisin B1 on the production of inflammatory cytokines by gastric and colon cell lines. Iran J Allergy Asthma Immunol. 2012 Jun;11(2):165-173.

255.    Shoar S, Shoar N, Rezaei N, Talebian A, Lahgani MJ, Naderan M, Hoseini SS. Cerebral sinovenous thrombosis (CSVT) in a neonate with different manifestations. Acta Med Iran. 2012 Jun;50(6):444-6.

256.    Shamsian BS, Esfahani SA, Milani H, Akhlaghpoor S, Mojtahedzadeh S, Shamshiri AR, Alavi S, Safari A, Rezaei N, Arzanian MT. Magnetic resonance imaging in the evaluation of iron overload: a comparison of MRI, echocardiography and serum ferritin level in patients with beta-thalassemia major. Clin Imaging. 2012 Sep;36(5):483-8.

257.    Mottaghi A, Salehi E, Sezavar H, Keshavarz SA, Eshraghian MR, Rezaei N, Rejali L, Saboor-Yaraghi AA. The in vitro effect of oxidized LDL and PHA on proliferation and gene expression of regulatory T cells of patients with atherosclerosis. Iran J Allergy Asthma Immunol. 2012 Sep;11(3):217-23.

258.    Mohammadzadeh I, Yeganeh M, Khaledi M, Salehiomran MR, Aghamohammadi A, Rezaei N. Debilitating progressive encephalitis in a patient with BTK deficiency. Acta Microbiol Immunol Hung. 2012 Sep;59(3):335-42.

259.    Mahdaviani A, Hirbod-Mobarakeh A, Wang N, Aghamohammadi A, Hammarström L, Masjedi MR, Pan-Hammarström Q, Rezaei N. Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: special review on hyper-immunoglobulin M syndrome. Exp Rev Clin Immunol. 2012 Aug:8(6):539-46.

260.    Soheili H, Abolhassani H, Aghamohammadi A, Arandi N, Shahinpour S, Hirbod-Mobarakeh A, Rezaei N. Evaluation of natural regulatory T cells in subjects with selective IgA deficiency: from senior idea to novel opportunities. Int Arch Allergy Immunol. 2013;160(2):208-14.

261.    Ameli S, Mazaheri M, Zare-shahabadi A, Ozaltin F, Asgarian F, Monajemzadeh M, Bazargani B, Atae N, Hajezadeh N, Isaian A, Madani A, Esfahani T, Zenker M, Rezaei N. NPHS2 gene mutation in an Iranian family with familial steroid-resistant nephrotic syndrome. Nefrologia. 2012 Sep 26;32(5):674-676.

262.    Bijani FM, Vallejo JG, Rezaei N. Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities. Int Rev Immunol. 2012 Oct;31(5):379-95.

263.    Esmaeili A, Dadkhahfar S, Fadakar K, Rezaei N. Post-stroke immunodeficiency: effects of sensitization and tolerization to brain antigens. Int Rev Immunol. 2012 Oct;31(5):396-409.

264.    Rostami P, Sotoudeh A, Nakhaeimoghadam M, Rabbani A, Rezaei N. Insulin edema in a child with diabetes mellitus, type 1. Turk J Pediatr. 2012 May-Jun;54(3):309-11.

265.    Khotaei G, Hirbod-Mobarakeh A, Amirkashani D, Manafi F, Rezaei N. Mycobacterium tuberculosis meningitis as the first presentation of chronic granulomatous disease. Braz J Infect Dis. 2012 Sep;16(5):491-2.

266.    Moossavi S, Rezaei N. Host-microbiota interaction is MyD88-independent in the intestinal tract under physiologic condition. Avicenna J Med Biotechnol. 2012 Oct: 4(4):210-1.

267.    Shahkarami S, Rezaei N. Genetic predisposition to cutaneous sarcoidosis. Acta Med Iran. 2012 Oct;50(10):721-2.

268.    Khaledi M, Rezaei N. Hereditary and sensory autonomic neuropathies. Iran J Pediatr. 2012 Dec:22(4):567-8.

269.    Bashashati M, Rezaei N, Bashashati H, Shafieyoun A, Daryani NE, Sharkey KA, Storr M. Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil. 2012 Dec;24(12):1102-e566.

270.    Abolhassani H, Sadaghiani MS, Aghamohammadi A, Ochs HD, Rezaei N. Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis. J Clin Immunol. 2012:32(6):1180-92.

271.    Moossavi S, Rezaei N. Toll-like receptor expression pattern: clinical application. J Clin Immunol. 2012:32(6):1421-2.

272.    Behniafard N, Gharagozlou M, Farhadi E, Khaledi M, Sotoudeh S, Darabi B, Fathi SM, Gholizadeh Moghaddam Z, Mahmoudi M, Aghamohammadi A, Amirzargar AA, Rezaei N. TNF-alpha single nucleotide polymorphisms in atopic dermatitis. Eur Cytokine Netw. 2012 Nov 1;23(4):163-5.

273.    Khaledi M, Rezaei N. Hereditary and sensory autonomic neuropathies. Iran J Pediatr. 2012 Dec;22(4):567-8.

274.    Shayanfar N, Mohammadpour M, Hashemi-Moghadam SA, Ashtiani MT, Mirzaie AZ, Rezaei N. Group B streptococci urine isolates and their antimicrobial susceptibility profiles in a group of Iranian females: prevalence and seasonal variations. Acta Clin Croat. 2012 Dec;51(4):623-6.

275.    Khalili M, Farahmand F, Hirbod-Mobarakeh A, Yousefi A, Sotoudeh S, Monajemzadeh M, Razaghian A, Rezaei N. Erythropoietic protoporphyria and early onset of cholestasis. Turk J Pediatr. 2012;54(6):645-50.

276.    Najafi M, Zamani MM, Rezaei N, Sabbaghian M. Autoimmunity in inflammatory bowel disease: a case of ulcerative colitis with diabetes mellitus, autoimmune hepatitis and autoimmune hypothyroidism. Turk J Pediatr. 2012:54(6):651-3.

277.    Babaei Jandaghi A, Daliri S, Kikkawa M, Khaledi M, Soleimanifar N, Alizadeh A, Habibzadeh M, Haghi-Ashtiani MT, Seyama K, Rezaei N. The discovery of a Persian family with a form of Birt-Hogg-Dubé syndrome, linked to a mutation of the FLCN gene, lacking the typical cutaneous stigmata of the syndrome. Clin Imaging. 2013 Jan;37(1):111-5.

278.    Rezaei N, Notarangelo LD. Hematopoietic stem cell transplantation for hyper-IgM syndromes. Pediatr Transplant. 2013 Feb;17(1):1-2.

279.    Rostami P, Nakhaeimoghadam M, Bijani FM, Sotoudeh A, Rabbani A, Hilbert P, Rezaei N. AGPAT2 gene mutation in a child with berardinelli-seip congenital lipodystrophy syndrome. Ann Endocrinol (Paris). 2013:74(1):59-61.

280.    Mahdaviani SA, Mohajerani SA, Rezaei N, Casanova JL, Mansouri SD, Velayati A. Pulmonary manifestations of chronic granulomatous disease. Expert Rev Clin Immunol. 2013:9(2):153-60.

281.    Shahkarami S, Rezaei N. Genetics of neonatal diabetes mellitus. Acta Med Iran. 2013 Jan;51(1):73-4.

282.    Mohammadzadeh I, Shahbaznezhad L, Wang N, Farhadi E, Aghamohammadi A, Hammarström L, Rezaei N. A novel CD40 Ligand mutation in a patient with pneumonia, neutropenia, and hyperimmunoglobulin M phenotype. J Investig Allergol Clin Immunol. 2013:23(1):50-1.

283.    Rahiminejad MS, Sadeghi MM, Mohammadinejad P, Sadeghi B, Abolhassani H, Dehghani Firoozabadi MM, Fathi SM, Rezvani H, Bahoush G, Ehsani MA, Faranoush M, Mehrvar A, Ghadiani M, Rezaei N, Aghamohammadi A. Evaluation of humoral immune function in patients with chronic idiopathic thrombocytopenic purpura. Iran J Allergy Asthma Immunol. 2013 Mar;12(1):50-6.

284.    Noorian S, Sayarifard F, Farhadi E, Barbetti F, Rezaei N. GCK mutation in a child with maturity onset diabetes of the young, type 2. Iran J Pediatr. 2013 Apr:23(2):226-8.

285.    Mortazavi H, Babaeijandaghi F, Akbarzadeh M, Rezaei N, Amirzargar AA, Daneshpazhooh M, Jalali A, Hallaji Z. The influence of systemic therapy on the serum levels of IL-6 and IL-8 in pemphigus vulgaris. Eur Acad Dermatol Venereol. 2013:27(3):387-90.

286.    Mahmoudi M, Hedayat M, Aghamohammadi A, Rezaei N. Soluble CD26 and CD30 levels in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2013;23(2):120-4.

287.    Gharagozlou M, Farhadi E, Khaledi M, Behniafard N, Sotoudeh S, Salari R, Darabi B, Fathi SM, Aghamohammadi A, Amirzargar AA, Rezaei N. Association between the interleukin 6 genotype at position -174 and atopic dermatitis. J Investig Allergol Clin Immunol. 2013;23(2):89-93.

288.    Jessen B, Bode SFN, Ammann S, Chakravorty S, Davies G, Diestelhorst J, Frei-Jones M, Gahl WA, Gochuico BR, Griese M, Griffiths G, Janka G, Klein C, Kögl T, Kurnik K, Lehmberg K, Maul-Pavicic A, Mumford AD, Pace D, Parvaneh N, Rezaei N, de Saint Basile G, Schmitt-Graeff A, Schwarz K, Karasu GT, Zieger B, zur Stadt U, Aichele P, Ehl S. The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak Syndrome Type 2. Blood. 2013 Apr 11;121(15):2943-51.

289.    Mortazavi H, Amirzargar AA, Esmaili N, Toofan H, Ehsani AH, Hosseini H, Rezaei N. Association of human leukocyte antigen class I antigens in Iranian patients with pemphigus vulgaris. J Dermatol. 2013 Apr;40(4):244-8.

290.    Moossavi S, Zhang H, Sun J, Rezaei N. Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer. Expert Rev Clin Immunol. 2013 May;9(5):409-22.

291.    Najafi S, Mohammadzadeh M, Monsef Esfahani HR, Meighani G, Rezaei N. Effect of purslane on the treatment of recurrent aphthous stomatitis. Tehran Univ Med J. 2013 May;71(2):102-8.

292.    Jalilian R, Rezaei N. Genetics of Mondini malformation. Acta Med Iran. 2013 May:51(5):345-6.

293.    Abolhassani H, Aghamohammadi A, Pourjabbar S, Salehi Sadaghiani M, Nikayin S, Rabiee A, Imanzadeh A, Mohamoodi Gharaei J, Arbabi M, Rezaei N. Psychiatric aspects of primary immunodeficiency diseases: the parental study. Iran J Allergy Asthma Immunol. 2013 May 15;12(2):176-81.

294.    Canessa C, Romano F, Lippi F, Bianchi L, Kashef S, Rezaei N, Moriondo M, Nieddu F, Martini M, Azzari C. BCGitis and vaccine-derived poliovirus infection in a patient with a novel deletion in RAG1 binding site. Int J Immunopathol Pharmacol. 2013 Apr-Jun;26(2):511-5.

295.    Moossavi S, Rezaei N. Toll-like receptors signalling and their therapeutic targeting in colorectal cancer. Int Immunopharmacol. 2013 Jun;16(2):199-209.

296.    Motamed F, Benabbas R, Ashrafi MR, Aghamohammadi A, Rezaei N. Ataxia-telangiectasia or neurologic Wilson's disease: when strong family history becomes a diagnostic bias. Acta Neurol Belg. 2013 Jun;113(2):195-6.

297.    Zaridoust A, Rabbani A, Sayarifard F, Thiel CT, Rezaei N. Acanthosis nigricans, abnormal facial appearance and dentition in an insulin resistance syndrome. Iran J Pediatr. 2013 Jun;23(3):363-5.

298.    Aryan Z, Comapalati E, Canonica GW, Rezaei N. Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications. Expert Rev Vaccines. 2013 Jun;12(6):639-59.

299.    Fallahi GH, Rezaei N, Sadjadei N. Bloody diarrhea as a presentation manifestation of familial mediterranean fever in a patient with compound heterozygote mutations of the MEFV gene. Gut Liver. 2013 Jul;7(4):497-9.

300.    Salehi Sadaghiani M, Aghamohammadi A, Ashrafi MR, Hosseini F, Abolhassani H, Rezaei N. Autism in a child with common variable immunodeficiency. Iran J Allergy Asthma Immunol. 2013 Jul;12(3):287-289.

301.    Abolhassani H, Sagvand BT, Shokuhfar T, Mirminachi B, Rezaei N, Aghamohammadi A. A review on guidelines for management and treatment of common variable immunodeficiency. Expert Rev Clin Immunol. 2013: Jun;9(6):561-74

302.    Mahmoudi MJ, Rezaei N, Mahmoudi M. Serum ox-LDL level and severity of stenosis in coronary arteries. Acta Med Iran. 2013 Aug 7;51(7):512.

303.    Haghi Ashtiani MT, Mamishi S, Masoomi A, Nasiri N, Hosseini M, Nikmanesh B, Pourakbari B, Rezaei N. Antimicrobial susceptibility associated with bloodstream infections in children: a referral hospital-based study. Braz J Infect Dis. 2013 July - August;17(4):497-499.

304.    Horváth Z, Rezaei N, Reisli I, Tuzankina I, Otarbayev N, Popandopulo P, Maródi L. The spread of the J Project. J Clin Immunol. 2013 Aug;33(6):1037-42.

305.    Aghamohammadi A, Amirkashani D, Abolhassani H, Khazaei HA, Mohammadinejad P, Gharib B, Movahedi M, Gharagozlou M, Rezaei N, Parvaneh N. Autoimmune phenotype in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2013;23(5):323-9.

306.    Rabbani A, Abbasi F, Taghvaei M, Rabbani B, Moradi B, Shakiba Y, Rezaei N, Amirzargar A. HLA-DRB, -DQA, and DQB alleles and haplotypes in Iranian patients with diabetes mellitus type I. Pediatr Diabetes. 2013 Aug;14(5):366-71.

307.    Aryan Z, Rezaei N. Comment on ‘Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican Inter Institutional Group for the Identification of the causes of childhood leukaemia (MIGICCL)’ – Is increased surveillance by hypersensitive immune system a reality or myth? Br J Cancer. 2013 Sep 3;109(5):1386-8.

308.    Rezaei N, Abolhassani H, Kasraian A, Mohammadinejad P, Sadeghi B, Aghamohammadi A. Family study of pediatric patients with primary antibody deficiencies. Iran J Allergy Asthma Immunol. 2013;12(4):177-82.

309.    Khazaei HA, Teymuri B, Nakhaei A, Mohammadi M, Noura M, Khazaei A, Tofiqh N, Rezaei N. Association of haptoglobin phenotypes with clinical features of preterm labor disease. Acta Med Iran. 2013 Sep 9;51(8):554-9.

310.    Najafi M, Najmi Varzaneh F, Khatami G, Khodadad A, Farahmand F, Fallahi G, Motamed F, Mehdizadeh M, Alizadeh H, Rezaei N, Shoaran M. Liver involvement in Iranian children with cystic fibrosis: ultrasonography and biochemical findings. J Compr Ped. 2013;3(4):129-33.

311.    Aalaei-andabili H, Rezaei N. Toll like receptor (TLR)-induced differential expression of MicroRNAs (MiRs) and immune response against infection: a systematic review. J Infection. 2013 Oct 67(4):251-64.

312.    Ameli S, Zenker M, Zare-shahabadi A, Esfahani ST, Madani A, Monajemzadeh M, Ataei N, Hajezadeh N, Rezaei N. Novel NPHS1 gene mutation in an Iranian patient with congenital nephrotic syndrome of the Finnish type. Nefrologia. 2013 Sep 27:33(5):747-9.

313.    Aalaei-Andabili SH, Fabbri M, Rezaei N. Reciprocal effects of toll like receptors (TLRs) and microRNAs (MiRs) on biological processes in human health and diseases: A systematic review. Immunotherapy. 2013 Oct;5(10):1127-42.

314.    Monajemzadeh M, Sarmadi S, Moeini M, Vasei M, Rezaei N, Abbasi A, Shahsiah R, Tanzifi P, Eghbali M. Contributory role of viral infection in congenital tumour development. Ecancermedicalscience. 2013 Sep 9;7:348:1-9.

315.    Najmi Varzandeh F, Rezaei N. Cranial nerve palsy in tuberculous meningitis versus acute bacterial meningitis. Acta Med Iran. 2013 Sep;51(9):661-2.

316.    Mohammadzadeh I, Khaledi M, Rezaei N. Stevens-Johnson syndrome: report on a case with a strange complaint of allergy to bus. Acta Clin Croat. 2013 Sep;52(3):391-4.

317.    Shoaran M, Khodadad A, Mahjoub F, Kiani MA, Rezaei N. Immunoproliferative small intestinal disease presented with ascites and edema. Acta Clin Croat. 2013 Sep;52(3):387-90.

318.    Khanbabaee G, Tabatabaei SA, Rahimpoor F, Khatami A, Sheibani K, Rezaei N. Congenital pulmonary airway malformation. Bratisl Lek Listy. 2013;114(10):587-9.

319.    Monajemzadeh M, Shahsiah R, Vasei M, Tanzifi P, Rezaei N, Najafi M, Soleimanifar N, Eghbali M. Alpha 1 antitrypsin deficiency in infants with neonatal cholestasis. Iran J Pediatr. 2013 Oct;23(5):501-7.

320.    Farhmand F, Soleimani K, Hashemi M, Shafieyoun A, Rezaei N, Yousefi A. Familial congenital hepatic fibrosis: report of a family with three affected children. Acta Med Iran. 2013 Sep 51(9):655-6.

321.    Fallahi G, Motamed F, Yousefi A, Shafieyoun A, Najafi M, Khodadad A, Farhmand F, Ahmadvand A, Rezaei N. The effect of probiotics on fecal calprotectin in patients with cystic fibrosis. Turk J Pediatr. 2013 Sep-Oct;55(5):475-8.

322.    Nakhaeimoghadam M, Rostami P, Zare-shahabadi A, Mehdizadeh M, Rabbani A, Rezaei N. Hypothalamic hamartoma in an unusual case with delayed puberty. Acta Med Iran. 2013 Nov:51(11):819-21.

323.    Movahedi M, Amirzargar AA, Nasiri R, Hirbod-Mobarakeh A, Farhadi E, Behniafard N, Ansaripour B, Moradi B, Zare A, Rezaei N. Gene polymorphisms of interleukin-4 in allergic rhinitis and its association with clinical phenotypes. Am J Otalaryngol. 2013 Nov-Dec;34(6):676-81.

324.    Sayyahfar S, Chavoshzadeh Z, Khaledi M, Madadi F, Hassas Yeganeh M, Sawamura D, Nakano H, Rezaei N. Congenital insensitivity to pain with anhidrosis presenting with palmoplantar keratoderma. Ped Dermatol. 2013 Nov-Dec;30(6):754-6.

325.    Mirghorbani M, Van Gool S, Rezaei N. Myeloid-derived suppressor cells in glioma. Expert Rev Neurother. 2013 Dec;13(12):1395-406.

326.    Zare-Shahabadi A, Renaudineau Y, Rezaei N. MicroRNAs and multiple sclerosis: from physiopathology towards therapy. Expert Opin Ther Targets. 2013 Dec;17(12):1497-507.

327.    Shamsian S, Kajizadi M, Rezaei N, Ghojevand N, Azma R, Rouzrokh M, Kazemiaghdam M, Mesbah SM, Ghazizadeh F, Arzanian MT. Primary intrarenal neuroblastoma with hypertension and disseminated intravascular coagulation. Case Rep Oncol Med. 2013;2013:684939.

328.    Rostami P, Mahmoudi E, Sotoudeh A, Nakhaeimoghadam M, Lurkin I, Zwarthoff EC, Rezaei N. Epidermal nevus in association with some uncommon manifestations. Acta Dermatovenerol Croat. 2013:21(4):268-70.

329.    Nasiri R, Amirzargar AA, Movahedi M, Hirbod-Mobarakeh A, Farhadi E, Behniafard N, Tavakkol M, Ansaripour B, Moradi B, Zare A, Rezaei N. Single-nucleotide polymorphisms of TNFA and IL1 in allergic rhinitis. J Investig Allergol Clin Immunol. 2013 Dec:23(7):455-61.

330.    Shoaran M, Najafi M, Jalilian R, Rezaei N. Granulomatous hepatitis as a rare complication of Bacillus Calmette-Gurin vaccination. Ann Saudi Med. 2013 Nov-Dec;33(6):627-9.

331.    Farahmand F, Khalili M, Shahbaznejad L, Hirbod-Mobarakeh A, Sani MN, Khodadad A, Motamed F, Rezaei N. Clinical presentation of cystic fibrosis at the time of diagnosis: a multicenter study in a region without newborn screening. Turk J Gastroenterol. 2013 Dec;24(6):541-5.

332.    Ashrafi MR, Amirkashani D, Hirbod-Mobarakeh A, Yaghmaei B, Tavassoli A, Manafi F, Rezaei N. Acute disseminated encephalomyelitis mimicking acute meningoencephalitis. Acta Clin Croat. 2013 Dec;52(4):523-8.

333.    Seppänen M, Aghamohammadi A, Rezaei N. Is there a need to redefine the diagnostic criteria for common variable immunodeficiency? Exp Rev Clin Immunol. 2014 Jan;10(1):1-5.

334.    Hirbod-Mobarakeh A, Aghamohammadi A, Rezaei N. Immunoglobulin class switch recombination deficiency type 1 or CD40 ligand deficiency: from bedside to bench and back again. Exp Rev Clin Immunol. 2014 Jan;10(1):91-105.

335.    Fallahi G, Aghamohammadi A, Khodadad A, Hashemi M, Mohammadinejad P, Asgarian-Omran H, Najafi M, Farhmand F, Motamed F, Soleimani K, Soheili H, Parvaneh N, Darabi B, Nasiri Kalmarzi R, Pourhamdi S, Abolhassani H, Mirminachi B, Rezaei N. Evaluation of antibody response to polysaccharide vaccine and switched memory B cells in pediatric patients with inflammatory bowel disease. Gut Liver. 2014 Jan;8(1):24-8.

336.    Hosseinverdi S, Hashemi H, Aghamohammadi A, Ochs HD, Rezaei N. Ocular involvement in primary immunodeficiency diseases. J Clin Immunol. 2014 Jan;34(1):23-38.

337.    Saghazadeh A, Mastrangelo M, Rezaei N. Genetic background of febrile seizures. Rev Neurosci. 2014;25(1):129-61.

338.    Mahmoudi MJ, Hedayat M, Taghvaei M, Nematipour E, Farhadi E, Esfahanian N, Sadr M, Mahmoudi M, Nourijelyani K, Amirzargar AA, Rezaei N. Association of interleukin-4 gene polymorphisms with ischemic heart failure. Cardiol J. 2014:21(1):24-8.

339.    Sabouni F, Movahedi Z, Mehdizadeh M, Rahimi A, Rezaei N. Posterior mediastinal mass: an unusual presentation of pediatric tuberculosis. Turk J Pediatr. 2014;56(1):103-6.

340.    Abolhassani H, Parvaneh N, Rezaei N, Hammarström L, Aghamohammadi A. Genetic defects in B-cell development and their clinical consequences. J Investig Allergol Clin Immunol 2014;24(1):6-22.

341.    Larki P, Khoshbakht S, Rezaei N. Genetics of neoplasia: inherited monogenic defects associated with cancers. Acta Med Iran. 2014 Jan;52(1):91-92.

342.    Harsini S, Beigy M, Akhavan-Sabbagh M, Rezaei N. Toll-like receptors in lymphoid malignancies: double-edged sword. Crit Rev Oncol/Hematol. 2014 Feb:89(2):262-83.

343.    Abolhassani H, Mirminachi B, Daryabeigi M, Agharahimi Z, Aghamohammadi A, Rabbani A, Rezaei N. Evaluation of physicians’ awareness of pediatric diseases in Iran. Iran J Pediatr. 2014 Feb;24(1):87-92.

344.    Zamani G, Tavasoli A, Zare-shahabadi A, Rezaei N, Ahmadvand A. Efficacy of pregabalin in childhood refractory partial seizure. Iran J Pediatr. 2014 Feb;24(1):100-104.

345.    Khalili A, Plebani A, Vitali M, Abolhassani H, Lougaris V, Mirminachi B, Rezaei N, Aghamohammadi A. Autosomal recessive agammaglobulinemia: a novel non-sense mutation in CD79a. J Clin Immunol. 2014 Feb;34(2):138-41.

346.    Khanbabaee G, Omidian A, Imanzadeh F, Adibeshgh F, Ashayeripanah M, Rezaei N. Serum level of zinc in asthmatic patients: A case-control study. Allergol Immunopathol (Madr). 2014 Jan-Feb;42(1):19-21.

347.    Nabavi M, Esmaeilzadeh H, Arshi S, Fallahpour M, Rezaei N. Multiple cancers in a patient with common variable immunodeficiency. Allergol Immunopathol (Madr). 2014 Jan-Feb;42(1):85-7.

348.    Khazaei HA, Teymuri B, Nakhaei A, Mohammadi M, Noura M, Khazaei A, Tofigh N, Rezaei N. Evaluation of haptoglobin phenotypes in association with clinical features of patients suffered from preterm labor disease. Acta Med Iran. 2014 Feb;52(2):106-10.

349.    Saghazadeh A, Gharedaghi M, Meysamie A, Bauer S, Rezaei N. Proinflammatory and anti-inflammatory cytokines in febrile seizures and epilepsy: systematic review and meta-analysis. Rev Neurosci. 2014;25(2):281-305.

350.    Majnoon MT, Mamishi S, Moazzami K, Shahbaznejad L, Izadyar M, Sabouni F, Koochakzadeh L, Ramyar A, Aghamohammadi A, Rezaei N. Spectrum of bone marrow failures of myeloid series: new report of neutropenic patients from a referral pediatric center in Iran. Pediatr Hematol Oncol. 2014 Mar;31(2):109-16.

351.    Zamani G, Shiva S, Mohammadi M, Mahmoudi Gharaie J, Rezaei N. A survey of quality of life in adolescents with epilepsy in Iran. Epilepsy Behav. 2014 Mar 11;33C:69-72.

352.    Avitzur Y, Guo C, Mastropaolo LA, Bahrami E, Chen H, Zhao Z, Elkadri A, Dhillon S, Murchie R, Fattouh R, Huynh H, Walker JL, Wales PW, Cutz E, Kakuta Y, Dudley J, Kammermeier J, Powrie F, Shah N, Walz C, Nathrath M, Kotlarz D, Puchaka J, Krieger J, Racek T, Kirchner T, Walters TD, Brumell JH, Griffiths AM, Rezaei N, Rashtian P, Najafi M, Monajemzadeh M, Pelsue S, McGovern DPB, Uhlig HH, Schadt E, Klein C, Snapper SB, Muise AM. Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. Gastroenterology. 2014 Apr;146(4):1028-39.

353.    Marciano BE, Huang CY, Joshi G, Rezaei N, Carvalho BC, Allwood Z, Ikinciogullari A, Reda SM, Gennery A, Thon V, Espinosa-Rosales F, Al-Herz W, Porras O, Shcherbina A, Szaflarska A, Kiliç S, Franco JL, Gómez Raccio AC, Roxo P Jr, Esteves I, Galal N, Grumach AS, Al-Tamemi S, Yildiran A, Orellana JC, Yamada M, Morio T, Liberatore D, Ohtsuka Y, Lau YL, Nishikomori R, Torres-Lozano C, Mazzucchelli JT, Vilela MM, Tavares FS, Cunha L, Pinto JA, Espinosa-Padilla SE, Hernandez-Nieto L, Elfeky RA, Ariga T, Toshio H, Dogu F, Cipe F, Formankova R, Nuñez-Nuñez ME, Bezrodnik L, Marques JG, Pereira MI, Listello V, Slatter MA, Nademi Z, Kowalczyk D, Fleisher TA, Davies G, Neven B, Rosenzweig SD. BCG vaccination in SCID patients: complications, risks and vaccination policies. J Allergy Clin Immunol. 2014 Apr;133(4):1134-41.

354.    Najafi S, Firooze Moqadam I, Mohammadzadeh M, Bidoki AZ, Yousefi H, Farhadi E, Tonekaboni A, Meighani G, Amirzargar AA, Rezaei N. Interleukin-10 gene polymorphisms in recurrent aphthous stomatitis. Immunol Invest. 2014;43(4):405-9.

355.    Rostami P, Setoodeh A, Rabbani A, Nakhaei-Moghadam M, Najmi-Varzaneh F, Rezaei N. A randomized clinical trial of insulin glargine and aspart, compared to NPH and regular insulin in children with type 1 diabetes mellitus. Iran J Pediatr. 2014 Apr;24(2):173-8.

356.    Routes J, Abinun M, Al-Herz W, Bustamante J, Condino-Neto A, De La Morena MT, Etzioni A, Gambineri E, Haddad E, Kobrynski L, Le Deist F, Nonoyama S, Oliveira JB, Perez E, Picard C, Rezaei N, Sleasman J, Torgerson T. ICON: the early diagnosis of congenital immunodeficiencies. J Clin Immunol. 2014 May;34(4):398-424.

357.    Sukalo M, Fiedler A, Guzmán C, Spranger S, Addor MC, McHeik JN, Benavent MO, Cobben JM, Gillis LA, Shealy AG, Deshpande C, Bozorgmehr B, Everman DB, Stattin EL, Liebelt J, Keller KM, Bertola DR, van Karnebeek CD, Bergmann C, Liu Z, Düker G, Rezaei N, Alkuraya FS, Oğur G, Alrajoudi A, Venegas-Vega CA, Verbeek NE, Richmond EJ, Kirbiyik O, Ranganath P, Singh A, Godbole K, Ali FA, Alves C, Mayerle J, Lerch MM, Witt H, Zenker M. Mutations in the human UBR1 gene and the associated phenotypic spectrum. Hum Mutat. 2014 May;35(5):521-31.

358.    Aryan Z, Holgate ST, Radzioch D, Rezaei N. A new era of targeting the ancient gatekeepers of the immune system: toll-like agonists in the treatment of allergic rhinitis and asthma. Int Arch Allergy Immunol. 2014 May;164(1):46-63.

359.    Aghamohammadi A, Mohammadinejad P, Abolhassani H, Mirminachi B, Movahedi M, Gharagozlou M, Parvaneh N, Ziaee V, Mirsaeed-Ghazi B, Chavoushzadeh Z, Mahdaviani A, Mansouri M, Yousefzadegan S, Sharifi B, Zandieh F, Hedayat E, Nadjafi A, Sherkat R, Shakerian B, Sadeghi-Shabestari M, Farid Hosseini R, Jabbari-Azad F, Ahanchian H, Behmanesh F, Zandkarimi M, Shirkani A, Cherghi T, Fayezi A, Mohammadzadeh I, Amin R, Aleyasin S, Moghtaderi M, Ghaffari J, Arshi S, Javahertrash N, Nabavi M, Bemanian MH, Shafiei A, Kalantari N, Ahmadiafshar A, Khazaei HA, Atarod L, Rezaei N. Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry. J Clin Immunol. 2014 May;34(4):478-90.

360.    Nabavi M, Esmaeilzadeh H, Arshi S, Bemanian MH, Fallahpour M, Bahrami A, Mortazavi N, Kamrava K, Farhadi M, Taghipour R, Rezaei N. Aspirin hypersensitivity in patients with chronic rhinosinusitis and nasal polyposis: frequency and contributing factors. Am J Rhinol Allergy. 2014 May;28(3):239-43.

361.    Behniafard N, Gharagozlou M, Sotoudeh S, Farhadi E, Khaledi M, Gholizadeh Moghaddam Z, Mahmoudi M, Fathi SM, Darabi B, Aghamohammadi A, Amirzargar AA, Rezaei N. Association of single nucleotide polymorphisms of interleukin-1 family with atopic dermatitis. Allergol Immunopathol (Madr). 2014 May-Jun:42(3):212-5.

362.    Ataee P, Najafi M, Gharagozlou M, Aflatounian M, Mahmoudi M, Khodadad A, Farahmand F, Motamed F, Fallahi GH, Kalantari N, Soheili H, Modarresi V, Sabbaghian M, Rezaei N. Effect of supplementary zinc on body mass index, pulmonary function and hospitalization in children with cystic fibrosis. Turk J Pediatr. 2014 Mar-Apr;56(2):127-32.

363.    Yousefi A, Shafieyoun A, Fallahi G, Rezaei N. Probiotics on fecal calprotectin of cystic fibrosis. Turk J Pediatr. 2014 May-June;56(3):333.

364.    Mortazavi H, Esmaili N, Khezri S, Khamesipour A, Vasheghani Farahani I, Daneshpazhooh M, Rezaei N. The effect of conventional immunosuppressive therapy on cytokine serum levels in pemphigus vulgaris patients. Iran J Allergy Asthma Immunol. 2014 Jun;13(3):174-83.

365.    Parsapoor A, Parsapoor MB, Rezaei N, Asghari F. Autonomy of children and adolescents in consent to treatment: ethical, jurisprudential and legal considerations. Iran J Pediatr. 2014 Jun:24(3):241-8.

366.    Ebrahimi Daryani N, Najmi Varzaneh F, Hedayat M, Taher M, Farhadi E, Mahmoudi M, Nicknam MH, Bashashati M, Rezaei N. Interleukin-23 receptor single nucleotide polymorphisms in ulcerative colitis. A study in Iranian populations. Clin Res Hepatol Gastroenterol. 2014 Jun;38(3):360-5.

367.    Abolhassani H, Akbari F, Mirminachi B, Bazregari S, Hedayat E, Rezaei N, Aghamohammadi A. Morbidity and mortality of Iranian patients with Hyper IgM syndrome: a clinical analysis. Iran J Immunol. 2014 Jun;11(2):123-33.

368.    Ziaee V, Tahghighi F, Moradinejad MH, Harsini S, Mahmoudi M, Rezaei A, Soltani S, Sadr M, Aghighi Y, Rezaei N. Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Eur Cytokine Netw. 2014 Jun 1;25(2):35-40.

369.    Varzaneh FN, Keller B, Unger S, Aghamohammadi A, Warnatz K, Rezaei N. Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge. J Clin Immunol. 2014 Jul:34(5):524-43.

370.    Shahrokhi A, Zare-shahabadi A, Soltani S, Ashrafi MR, Zoghi S, Hosseini SA, Heidari M, Yaghmaei B, Pourakbari B, Rezaei N. Association of IL6 single nucleotide polymorphisms with febrile seizures. J Neurol Sci. 2014 Jul:342(1-2):25-8.

371.    Bashashati M, Rezaei N, Shafieyoun A, McKernan DP, Chang L, Öhman L, Quigley EM, Schmulson M, Sharkey KA, Simrén M. Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil. 2014 Jul;26(7):1036-48.

372.    Cheraghi T, Aghamohammadi A, Mirminachi B, Keihanian T, Hedayat E, Abolhassani H, Sagvand BT, Rezaei N. Prediction of the evolution of common variable immunodeficiency: HLA typing for patients with selective IgA deficiency. J Investig Allergol Clin Immunol. 2014;24(3):198-200.

373.    Al-Herz W, Aldhekri H, Barbouche MR, Rezaei N. Consanguinity and primary immunodeficiencies. Hum Hered. 2014;77(1-4):138-43.

374.    Mousavi SMH, Agharahimi Z, Daryabeigi M, Rezaei N. Implementation of clinical governance in hospitals: challenges and the keys for success. Acta Med Iran. 2014 Jul;52(7):493-5.

375.    Aghamohammadi A, Gholizadeh Moghaddam Z, Hallaji Z, Mortazavi H, Pourhamdi S, Mohammadinejad P, Abolhassani H, Rezaei N. Investigation of underlying primary immunodeficiencies in patients with severe atopic dermatitis. Allergol Immunopathol (Madr). 2014 Jul-Aug;42(4):336-41.

376.    Nabavi M, Esmaeilzadeh H, Arshi S, Fallahpour M, Mortazavi N, Rezaei N. Could oral administration of immunoglobulin could reduce diarrheal severity in common variable immunodeficiency? Allergol Immunopathol (Madr). 2014 Jul-Aug;42(4):371-2.

377.    Arshi S, Bahrami A, Faranoush M, Mehrvar A, Rezaei N. Non-Hodgkin’s lymphoma in a patient with leukocyte adhesion deficiency. Allergol Immunopathol (Madr). 2014 Jul-Aug;42(4):379-80.

378.    Bahrami Mahne S, Mahdaviani SA, Rezaei N. Role of the immune cells, mediators and cytokines in pathogenesis of asthma: a review article. Tehran Univ Med J. 2014 Aug;72(5):273-85.

379.    Movahedi M, Tavakol M, Mohammadinejad P, Baiardini I, Braido F, Gharagozlou M, Aghamohammadi A, Nabavi M, Tavakol Z, Afarideh M, Rezaei N. The Persian version of the chronic urticaria quality of life questionnaire: factor analysis, validation, and initial clinical findings. Iran J Allergy Asthma Immunol. 2014 Aug;13(4):278-85.

380.    Khaledi M, Fotouhi A, Farhadi E, Mahdaviani B, Sotoudeh S, Tavakoli M, Behniafard N, Gharagozlou M, Rezaei N. Filaggrin single nucleotide polymorphisms in atopic dermatitis. Acta Dermatovenerol Croat. 2014 Sep;22(3):200-204.

381.    Nasiri R, Movahedi M, Amirzargar AA, Hirbod-Mobarakeh A, Farhadi E, Ansaripour B, Moradi B, Rezaei N. Association of interleukin 6 single nucleotide polymorphisms with allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2014 Sep;78(9):1426-9.

382.    Boztug K, Järvinen PM, Salzer E, Racek T, Mönch S, Garncarz W, Gertz EM, Schäffer AA, Antonopoulos A, Haslam SM, Schieck L, Puchałka J, Diestelhorst J, Appaswamy G, Lescoeur B, Giambruno R, Bigenzahn JW, Elling U, Pfeifer D, Conde CD, Albert MH, Welte K, Brandes G, Sherkat R, van der Werff Ten Bosch J, Rezaei N, Etzioni A, Bellanné-Chantelot C, Superti-Furga G, Penninger JM, Bennett KL, von Blume J, Dell A, Donadieu J, Klein C. JAGN1 deficiency causes aberrant myeloid cell homeostasis and congenital neutropenia. Nat Genet. 2014 Sep;46(9):1021-7.

383.    Taher M, Ebrahimi Daryani N, Hedayat M, Eslamian M, Farhadi E, Mahmoudi M, Shirzad S, Nouri Taromlou MK, Chaharmahali M, Nicknam MH, Bashashati M, Rezaei N. RAC1 single nucleotide polymorphisms in Crohn's disease. Clin Res Hepatol Gastroenterol. 2014 Aug:38(4):75-7.

384.    Farhadi E, Nemati S, Amirzargar AA, Hirbod-Mobarakeh A, Nabavi M, Soltani S, Mahdaviani SA, Shahinpour S, Arshi S, Nikbin B, Aghamohammadi A, Rezaei N. AICDA single nucleotide polymorphism in common variable immunodeficiency and selective IgA deficiency. Allergol Immunopathol (Madr). 2014 Sep-Oct;42(5):422-6..

385.    Mahdaviani SA, Mehrian P, Najafi A, Khalilzadeh S, Eslampanah S, Karam B, Rezaei N, Velayati A. Pulmonary computed tomography scan findings in chronic granulomatous disease. Allergol Immunopathol (Madr). 2014 Sep-Oct;42(5):444-8.

386.    Nabavi M, Arshi S, Bahrami A, Aryan Z, Bemanian MH, Esmaeilzadeh H, Jalali F, Pousti SB, Rezaei N. Increased level of interleukin-13, but not interleukin-4 and interferon-γ in chronic rhinosinusitis with nasal polyps. Allergol Immunopathol (Madr). 2014 Sep-Oct;42(5):465-71.

387.    Gooshe M, Aleyasin AR, Abdolghaffari AH, Rezaei N. Toll like receptors: a new hope on the horizon to treat multiple sclerosis. Expert Rev Clin Immunol. 2014 Oct;10(10):1277-1279.

388.    Aghamohammadi A, Abolhassani H, Latif A, Tabassomi F, Shokuhfar T, Torabi Sagvand B, Shahinpour S, Mirminachi B, Parvaneh N, Movahedi M, Gharagozlou M, Sherkat R, Amin R, Aleyasin S, Faridhosseini R, Jabbari-Azad F, Cheraghi T, Eslamian MH, Khalili A, Kalantari N, Shafiei A, Dabbaghzade A, Khayatzadeh A, Ebrahimi M, Razavinejad D, Bazregari S, Ebrahimi M, Ghaffari J, Bemanian MH, Behniafard N, Kashef S, Mohammadzadeh I, Hammarström L, Rezaei N. Long-term evaluation of a historical cohort of Iranian common variable immunodeficiency patients. Expert Rev Clin Immunol. 2014 Oct;10(10):1405-17.

389.    Koochakzadeh L, Khosravi MH, Pourakbari B, Hosseinverdi S, Aghamohammadi A, Rezaei N. Assessment of immune response following immunization with DTP/Td and MMR vaccines in children treated for acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2014 Oct;31(7):656-63.

390.    Saghazadeh A, Rezaei N. Why has the use of anti-epileptic drugs been increased and may be on-increase yet? Epilepsia. 2014 Oct 55(10):1680-1.

391.    Fadakar K, Dadkhahfar S, Esmaeili A, Rezaei N. The role of toll like receptors (TLRs) in stroke. Rev Neurosci. 2014 Oct;25(5):699-712.

392.    Gooshe M, Abdolghaffari AH, Gambuzza ME, Rezaei N. The role of toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes. Rev Neurosci. 2014 Oct;25(5):713-39.

393.    Tavakol M, Amirzargar AA, Movahedi M, Aryan Z, Zare Bidoki A, Gharagozlou M, Aghamohammadi A, Nabavi M, Ahmadvand A, Behniafard N, Heidari K, Soltani S, Rezaei N. Interleukin-6 and tumor necrosis factor-alpha gene polymorphisms in chronic idiopathic urticaria. Allergol Immunopathol (Madr). 2014 Nov-Dec;42(6):533-8.

394.    Mahmoudi M, Tahghighi Sharbiani F, Ziaee V, Harsini S, Rezaei A, Soltani S, Sadr M, Moradinejad MH, Aghighi Y, Rezaei N. Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Int J Immunogenet. 2014 Dec;41(6):512-7.

395.    Tavakol M, Movahedi M, Amirzargar AA, Aryan Z, Zare Bidoki A, Heidari K, Soltani S, Gharagozlou M, Aghamohammadi A, Nabavi M, Nasiri R, Ahmadvand A, Rezaei N. Association of interleukin 10 and transforming growth factor β gene polymorphisms with chronic idiopathic urticaria. Acta Dermatovenerol Croat. 2014 Dec;22(4):239-45.

396.    Najmi Varzaneh F, Najmi Varzaneh F, Azimi AR, Rezaei N, Sahraian MA. Efficacy of combination therapy with erythropoietin and methylprednisolone in clinical recovery of severe relapse in multiple sclerosis. Acta Neurol Belg. 2014 Dec;114(4):273-8.

397.    Abolhassani H, Wang N, Aghamohammadi A, Rezaei N, Lee YN, Frugoni F, Notarangelo LD, Pan-Hammarström Q, Hammarström L. A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. J Allergy Clin Immunol. 2014 Dec;134(6):1375-80.

398.    Mohammadinejad P, Mirminachi B, Sadeghi B, Movahedi M, Gharagozlou M, Mohammadi J, Abolhassani H, Rezaei N, Aghamohammadi A. Distribution of primary immunodeficiency disorders diagnosed in a tertiary referral center, tehran, iran (2006-2013). Iran J Immunol. 2014 Dec;11(4):282-91.

399.    Ebadi M, Aghamohammadi A, Rezaei N. Primary immunodeficiencies: a decade of shifting paradigms, the current status and the emergence of cutting-edge therapies and diagnostics. Expert Rev Clin Immunol. 2015 Jan;11(1):117-39.

400.    Zamani MR, Akbari Asbagh F, Massoud AH, Salmaninejad A, Massoud A, Rezaei N. Association between a PD-1 gene polymorphism and antisperm antibody-related infertility in Iranian men. J Assist Reprod Genet. 2015 Jan;32(1):103-6.

401.    Esmaeilzadeh H, Bemanian MH, Nabavi M, Arshi S, Fallahpour M, Fuchs I, zur Stadt U, Warnatz K, Ammann S, Ehl S, Lehmberg K, Rezaei N. Novel patient with late-onset familial hemophagocytic lymphohistiocytosis with STXBP2 mutations presenting with autoimmune hepatitis, neurological manifestations and infections associated with hypogammaglobulinemia. J Clin Immunol. 2015 Jan;35(1):22-5.

402.    Abolhassani H, Rezaei N, Mohammadinejad P, Mirminachi B, Hammarstrom L, Aghamohammadi A. Important differences in the diagnostic spectrum of primary immunodeficiency in adults versus children. Expert Rev Clin Immunol. 2015 Feb;11(2):289-302.

403.    Shayanfar N, Bahari L, Safaie-Naraghi Z, Kamyab K, Gheytanchi E, Rezaei N. Negative HER2/neu amplification using immunohistochemistry and chromogenic in situ hybridization techniques in skin melanoma cases. Asian Pac J Cancer Prev. 2015;16(2):421-5.

404.    Aydin SE, Kilic SS, Aytekin C, Kumar A, Porras O, Kainulainen L, Kostyuchenko L, Genel F, Kütükcüler N, Karaca N, Gonzalez-Granado L, Abbott J, Al-Zahrani D, Rezaei N, Baz Z, Thiel J, Ehl S, Marodi L, Orange JS, Sawalle-Belohradsky J, Keles S, Holland SM, Sanal Ö, Ayvaz DC, Tezcan I, Al-Mousa H, Alsum Z, Hawwari A, Metin A, Matthes-Martin S, Hönig M, Schulz A, Picard C, Barlogis V, Gennery A, Ifversen M, van Montfrans J, Kuijpers T, Bredius R, Dückers G, Al-Herz W, Pai SY, Geha R, Notheis G, Schwarze CP, Tavil B, Azik F, Bienemann K, Grimbacher B, Heinz V, Gaspar HB, Aydin R, Hagl B, Gathmann B, Belohradsky BH, Ochs HD, Chatila T, Renner ED, Su H, Freeman AF, Engelhardt K, Albert MH; On behalf of the inborn errors working party of EBMT. DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients. J Clin Immunol. 2015 Feb;35(2):189-98.

405.    Zare-shahabadi A, Soltani S, Ashrafi MR, Shahrokhi A, Zoghi S, Pourakbari B, Zamani GR, Mohammadi M, Rezaei N. Association of IL4 single-nucleotide polymorphisms with febrile seizures. J Child Neurol. 2015 Mar;30(4):423-8.

406.    Movahedi M, Tavakol M, Hirbod-Mobarakeh A, Gharagozlou M, Aghamohammadi A, Tavakol Z, Momenzadeh K, Nabavi M, Dabbaghzade A, Mosallanejad A, Rezaei N. Vitamin D deficiency in chronic idiopathic urticaria. Iran J Allergy Asthma Immunol. 2015 Apr;14(2):222-7.

407.    Ghanadan A, Saghazadeh A, Daneshpazhooh M, Rezaei N. Direct immunofluorescence for immunobullous and other skin diseases. Expert Rev Clin Immunol. 2015 May;11(5):589-96.

408.    Ghanadan A, Saghazadeh A, Jahanzad I, Rezaei N. Clinical aspects of indirect immunofluorescence for autoimmune diseases. Exp Rev Clin Immunol. 2015 May;11(5):597-616.

409.    Sadeghi B, Abolhassani H, Naseri A, Rezaei N, Aghamohammadi A. Economic burden of common variable immunodeficiency: annual cost of disease. Exp Rev Clin Immunol. 2015 May;11(5):681-8.

410.    Farzaei MH, Farzaei F, Gooshe M, Abbasabadi Z, Rezaei N, Abdolghaffari AH. Potentially effective natural drugs in treatment for the most common rheumatic disorder: osteoarthritis. Rheumatol Int. 2015 May;35(5):799-814.

411.    Najafi M, Fallahi GH, Motamed F, Farahmand F, Khodadad A, Ghajarzadeh M, Rezaei N, Mehrabani S. Comparison of one and two-day bowel preparation with polyethylene glycol in pediatric colonoscopy. Turk J Gastroenterol 2015 May;26(3):232-5.

412.    Najafi M, Alimadadi H, Rouhani P, Kiani MA, Khodadad A, Motamed F, Moraveji A, Hooshmand M, Haghi Ashtiani MT, Rezaei N. Genotype-phenotype relationship in Iranian patients with cystic fibrosis. Turk J Gastroenterol 2015 May;26(3):241-3.

413.    Motamed F, Mehrabani S, Monajemzadeh M, Haghi Ashtiani MT, Hosseinverdi S, Houshmand M, Aryani O, Najafi M, Farahmand F, Kiani MA, Khodadad A, Fallahi GH, Khatami G, Rezaei N. Low incidence of alpha 1 antitrypsin deficiency in Iranian patients With neonatal cholestasis. Turk J Gastroenterol 2015 May;26(3):251-3.

414.    Alkhairy OK, Rezaei N, Graham RR, Abolhassani H, Borte S, Hultenby K, Wu C, Aghamohammadi A, Williams DA, Behrens TW, Hammarström L, Pan-Hammarström Q. RAC2 loss-of-function mutation in 2 siblings with characteristics of common variable immunodeficiency. J Allergy Clin Immunol. 2015 May;135(5):1380-4.

415.    Daryani NE, Sadr M, Moossavi S, Shahkarami S, Soltani S, Farhadi E, Rezaei N. Significance of IL-1RA polymorphism in Iranian patients with inflammatory bowel disease. Dig Dis Sci. 2015: May;60(5):1389-95.

416.    Nabavi M, Esmaeilzadeh H, Amirzargar AA, Aryan Z, Arshi S, Bemanian MH, Fallahpour M, Mortazavi N, Rezaei N. HLA-DRB and HLA-DQ genetic variability in patients with aspirin-exacerbated respiratory disease. Am J Rhinol Allergy. 2015 May;29(3):63-9.

417.    Abolhassani H, Gharib B, Shahinpour S, Masoom SN, Havaei A, Mirminachi B, Arandi N, Torabi-Sagvand B, Khazaei HA, Mohammadi J, Rezaei N, Aghamohammadi A. Autoimmunity in patients with selective IgA deficiency. J Investig Allergol Clin Immunol. 2015;25(2):112-9.

418.    Rezaei A, Ziaee V, Tahghighi Sharbiani F, Harsini S, Mahmoudi M, Soltani S, Sadr M, Moradinejad MH, Aghighi Y, Rezaei N. Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms with juvenile-onset systemic lupus erythematosus. Clin Rheumatol. 2015 Jun;34(6):1059-64.

419.    Sodagari HR, Farzaei MH, Bahramsoltani R, Abdolghaffari AH, Mahmoudi M, Rezaei N. Dietary anthocyanins as a complementary medicinal approach for management of inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2015 Jun;9(6):807-20.

420.    Gharagozlou M, Behniafard N, Amirzargar AA, Hosseinverdi S, Sotoudeh S, Farhadi E, Khaledi M, Aryan Z, Moghaddam ZG, Mahmoudi M, Aghamohammadi A, Rezaei N. Association between single nucleotide polymorphisms of the interleukin-4 gene and atopic dermatitis. Acta Dermatovenerol Croat. 2015 Jul;23(2):96-100.

421.    Shahrokhi A, Zare-shahabadi A, Soltani S, Soleimani F, Vameghi R, Rahimi A, Karimi P, Katibeh P, Vafaei M, Zoghi S, Ashrafi MR, Rezaei N. Association of TGFB, but not IL10, single nucleotide polymorphisms with febrile seizures. Seizure. 2015 Jul;29(7):148-52.

422.    Alahgholi-Hajibehzad M, Kasapoglu P, Jafari R, Rezaei N. The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics. Expert Rev Clin Immunol. 2015 Jul;11(7):859-70.

423.    Abolhassani H, Cheraghi T, Rezaei N, Aghamohammadi A, Hammarström L. Common variable immunodeficiency or late-onset combined immunodeficiency: a new hypomorphic JAK3 patient and review of the literature. J Investig Allergol Clin Immunol. 2015;25(3):218-20.

424.    Sanati G, Aryan Z, Barbadi M, Rezaei N. Innate lymphoid cells are pivotal actors in allergic, inflammatory and autoimmune diseases. Exp Rev Clin Immunol. 2015 Aug;11(8):885-95.

425.    Saghazadeh A, Hafizi S, Rezaei N. Inflammation in venous thromboembolism: Cause or consequence? Int Immunopharmacol. 2015 Sep;28(1):655-65.

426.    Namazi S, Ziaee V, Rezaei N. The role of cytokines in systemic lupus erythematosis: review article. Tehran Univ Med J. 2015 Sep;73(6):397-404.

427.    Zare-shahabadi A, Ashrafi MR, Shahrokhi A, Soltani S, Zoghi S, Soleimani F, Vameghi R, Badv RS, Rezaei N. Single nucleotide polymorphisms of TNF-A gene in febrile seizures. J Neurol Sci. 2015 Sep;356(1-2):153-6.

428.    Nemati S, Amirzargar AA, Farhadi E, Hirbod-Mobarakeh A, Nabavi M, Soltani S, Mahdaviani SA, Shahinpour S, Arshi S, MirAhmadian M, Nicknam MH, Aghamohammadi A, Rezaei N. RAD50 single-nucleotide polymorphism in predominantly antibody deficiency. J Investig Allergol Clin Immunol. 2015;25(4):299-301.

429.    Zare-shahabadi A, Masliah E, Johnson GVW, Rezaei N. Autophagy in alzheimer’s disease. Rev Neurosci. 2015;26(4):385-95.

430.    Alkhairy OK, Perez-Becker R, Driessen GJ, Abolhassani H, van Montfrans J, Borte S, Choo S, Wang N, Tesselaar K, Fang M, Bienemann K, Boztug K, Daneva A, Wiesel T, Becker C, Dückers G, Siepermann K, van Zelm MC, Rezaei N, van der Burg M, Aghamohammadi A, Seidel MG, Niehues T, Hammarström L. Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency. J Allergy Clin Immunol. 2015 Sep;136(3):703-712.

431.    Najmi Varzaneh F, Farhadi E, Ebrahimi Daryani N, Taher M, Mahmoudi M, Bashashati M, Hedayat M, Rezaei N. Interleukin-23 receptor single nucleotide polymorphisms in crohn's disease. Clin Res Hepatol Gastroenterol. 2015 Sep;39(4):e51-3.

432.    Parvaneh N, Pourakbari B, Rezaei N, Omidvar A, Sabouni F, Mahmoudi S, Khotaei G, Mamishi S. Impaired in-vitro responses to IL-12 and IFN-γ in Iranian patients with Mendelian susceptibility to mycobacterial disease. Allergol Immunopathol (Madr). 2015 Sep-Oct;43(5):456-60.

433.    Tonekaboni SH, Jafari N, Chavoshzadeh Z, Shamsian BS, Rezaei N. DRESS syndrome presents as leukoencephalopathy. Turk J Pediatr. 2015 Sep-Oct;57(5):543-6.

434.    Mohammadinejad P, Ataeinia B, Kaynejad K, Zeinoddini A, Sadeghi B, Hosseini M, Rezaei N, Aghamohammadi A. Antibiotic resistance in patients with primary immunodeficiency disorders versus immunocompetent patients. Expert Rev Clin Immunol. 2015 Oct;11(10):1163-72.

435.    Andalib MM, Malekzadeh MM, Agharahimi Z, Daryabeigi M, Yaghmaei B, Ashrafi MR, Rabbani A, Rezaei N. Evaluation of educational environment for medical students of a tertiary pediatric hospital in Tehran, using DREEM questionnaire. Iran J Pediatr. 2015 Oct;25(5):e2362.

436.   Hanaie S, Abdollahzade S, Khoshnevisan A, Kepler CK, Rezaei N. Genetic aspects of intervertebral disc degeneration. Rev Neurosci. 2015 Oct;26(5):581-606.

437.    Najafi Sani M, Ahmadi M, Roohani P, Rezaei N. Early onset hepatocellular disease in an infant with Zellweger syndrome. Acta Med Iran. 2015 Oct;53(10):656-8.

438.    Saghazadeh A, Mahmoudi M, Meysamie A, Gharedaghi M, Zamponi GW, Rezaei N. Possible role of trace elements in epilepsy and febrile seizures: a meta-analysis. Nutr Rev. 2015 Nov;73(11):760-79.

439.    Yazdani R, Latif AH, Tabassomi F, Abolhassani H, Azizi G, Rezaei N, Aghamohammadi A. Clinical phenotype classification for selective immunoglobulin A deficiency. Expert Rev Clin Immunol. 2015 Nov;11(11):1245-54.

440.    Abolhassani H, Asgardoon MH, Rezaei N, Hammarstrom L, Aghamohammadi A. Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient? Expert Rev Clin Immunol. 2015 Nov;11(11):1229-43.

441.    Mahmoudi M, Rezaiemanesh A, Salmaninejad A, Harsini S, Poursani S, Bahrami T, Tahghighi F, Ziaee V, Rezaei N. PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus. Autoimmunity. 2015 Nov;48(7):488-93.

442.    Zabetian-Targhi F, Mahmoudi MJ, Rezaei N, Mahmoudi M. Retinol binding protein 4 in relation to diet, inflammation, immunity, and cardiovascular diseases. Adv Nutr. 2015 Nov;6(6):748-62.

443.    Najafi S, Yousefi H, Mohammadzadeh M, Bidoki AZ, Firouze Moqadam I, Farhadi E, Amirzargar AA, Rezaei N. Association study of interleukin-1 family and interleukin-6 gene single nucleotide polymorphisms in recurrent aphthous stomatitis. Int J Immunogenet. 2015 Dec;42(6):428-31.

444.    Koochakzadeh L, Hosseinverdi S, Hedayat M, Farahani F, Tofighi A, Eghbali M, Bidoki AZ, Izadyar M, Rahiminejad MS, Ramyar A, Aghamohammadi A, Rezaei N. Study of immunodeficiency in pediatric patients with lymphoma. Allergol Immunopathol (Madr). 2015 Nov-Dec 43(6):568-70.

445.    Khodadad A, Elahi E, Bani Hassani SS, Rouhani P, Sadeghi B, Rezaei N. Frequency of genotype with ΔF508 mutation in CFTR gene among Iranian cystic fibrosis patients with pancreatic insufficiency. Iran J Pediatr. 2015 Dec;25(6):e3419.

446.    Aryan Z, Rezaei N. Toll-like receptors as targets for allergen immunotherapy. Curr Opin Allergy Clin Immunol. 2015 Dec;15(6):568-74.

447.    Zare-Shahabadi A, Rashidian A, Sahraian MA, Rezaei N. Potential role of immunoglobulin replacement therapy on MRI measures in multiple sclerosis: a systematic review. Expert Rev Clin Immunol. 2015 Dec;11(12):1291-5.

448.    Matin N, Tabatabaie O, Mohammadinejad P, Rezaei N. Therapeutic targeting of toll-like receptors in cutaneous disorders. Expert Opin Ther Targets. 2015 Dec;19(12):1651-63.

449.    Mohammadinejad P, Pourhamdi S, Abolhassani H, Mirminachi B, Havaei A, Masoom SN, Sadeghi B, Ghajar A, Afarideh M, Parvaneh N, Mirsaeed-Ghazi B, Movahedi M, Gharagozlou M, Chavoushzadeh Z, Mahdaviani A, Zandieh F, Sherkat R, Sadeghi-Shabestari M, Faridhosseini R, Jabbari-Azad F, Ahanchian H, Zandkarimi M, Cherghi T, Fayezi A, Mohammadzadeh I, Amin R, Aleyasin S, Moghtaderi M, Ghaffari J, Bemanian M, Shafiei A, Kalantari N, Ahmadiafshar A, Khazaei HA, Mohammadi J, Nabavi M, Rezaei N, Aghamohammadi A. Primary antibody deficiency in a tertiary referral hospital: A 30-year experiment. J Investig Allergol Clin Immunol. 2015;25(6):416-25.

450.    Mosallanejad A, Sayarifard F, Hosseinverdi S, Abbasi F, Shabni Mirzaee H, Rezaei N. Proptosis, micrognathia, low set ear and chest deformity in a patient with extra marker chromosome 22. Acta Med Iran. 2015 Dec;53(12):782-4.

451.    Bahrami Mahneh S, Movahedi M, Aryan Z, Bahar MA, Rezaei A, Sadr M, Rezaei N. Serum IL-33 is elevated in children with asthma and is associated with disease severity. Int Arch Allergy Immunol. 2015;168(3):193-6.

452.    Mahmoudi MJ, Saboor-Yaraghi AA, Zabetian-Targhi F, Siassi F, Zarnani AH, Eshraghian MR, Shokri F, Rezaei N, Kalikias Y, Mahmoudi M. Vitamin A decreases cytotoxicity of oxidized low-density lipoprotein in patients with atherosclerosis. Immunol Invest. 2016 Jan;45(1):52-62.

453.    Bahramsoltani R, Sodagari HR, Farzaei MH, Abdolghaffari AH, Gooshe M, Rezaei N. The preventive and therapeutic potential of natural polyphenols on influenza. Expert Rev Anti Infect Ther. 2016 Jan;14(1):57-80.

454.    Azizi G, Abolhassani H, Asgardoon MH, Shaghaghi S, Negahdari B, Mohammadi J, Rezaei N, Aghamohammadi A. Managing patients with side effects and adverse events to immunoglobulin therapy. Expert Rev Clin Pharmacol. 2016 Jan;9(1):91-102.

455.    Gámez-Díaz L, August D, Stepensky P, Revel-Vilk S, Seidel MG, Noriko M, Morio T, Worth AJ, Blessing J, Van de Veerdonk F, Feuchtinger T, Kanariou M, Schmitt-Graeff A, Jung S, Seneviratne S, Burns S, Belohradsky BH, Rezaei N, Bakhtiar S, Speckmann C, Jordan M, Grimbacher B. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency. J Allergy Clin Immunol. 2016 Jan;137(1):223-30.

456.    Rezaei N. Universal Scientific Education and Research Network (USERN): A new horizon for science. Acta Medica Iranica 2016 Jan;54(1):1-3.

457.    Bahrami Mahneh S, Movahedi M, Aryan Z, Bahar M, Rezaei A, Sadr M, Rezaei N. Serum IL-33 is elevated in children with asthma and is associated with disease severity. Int Arch Allergy Immunol. 2016 Jan;168(3):193-196.

458.    Yaghmaei B, Rostami P, Najmi Varzaneh F, Gharib B, Bazargani B, Rezaei N. Methylmalonic acidemia with emergency hypertension. Nefrologia. 2016 Jan-Feb;36(1):75-6.

459.    Azimi M, Aghamohammadi A, Ochs HD, Rezaei N. Soluble molecules in intravenous immunoglobulin: benefits and limitations. Expert Rev Clin Immunol. 2016 Feb;12(2):99-101.

460.    Sharifi L, Mirshafiey A, Rezaei N, Azizi G, Magaji Hamid K, Amirzargar AA, Asgardoon MH, Aghamohammadi A. The role of toll-like receptors in B-cell development and immunopathogenesis of common variable immunodeficiency. Expert Rev Clin Immunol. 2016 Feb;12(2):195-207.

461.    Yazdani R, Abolhassani H, Rezaei N, Azizi G, Hammarström L, Aghamohammadi A. Evaluation of known defective signaling-associated molecules in patients who primarily diagnosed as common variable immunodeficiency. Int Rev Immunol. 2016 Jan 2;35(1):7-24.

462.    Aalaei-andabili SH, Rezaei N. MicroRNAs (MiRs) precisely regulate immune system development and function in immunosenescence process. Int Rev Immunol. 2016 Jan 2;35(1):57-66.

463.    Yazdani R, Fatholahi M, Ganjalikhani-Hakemi M, Abolhassani H, Azizi G, Magaji Hamid K, Rezaei N, Aghamohammadi A. Role of apoptosis in common variable immunodeficiency and selective immunoglobulin A deficiency. Mol Immunol. 2016 Mar;71:1-9.

464.    Saghazadeh A, Rezaei N. Inflammation as a cause of venous thromboembolism. Crit Rev Oncol/Hematol. 2016 Mar;99:272-85.

465.    Motamed F, Fallahi G, Ahmadi F, Bazvand F, Ahmadi M, Eftekhari K, Rezaei N. Gastroesophageal variceal bleeding as a complication of cystic fibrosis in a 3-month old patient. Acta Med Iran 2016 Mar;54(3):220-1.

466.    Nasiri R, Hirbod-Mobarakeh A, Movahedi M, Farhadi E, Ansaripour B, Amirzargar AA, Rezaei N. Gene polymorphisms of Interleukin-10 and transforming growth factor beta in allergic rhinitis. Allergol Immunopathol (Madr). 2016 Mar-Apr;44(2):125-30.

467.    Aflatounian M, Smith H, Farahani F, Tofighi Naeem A, Zoghi S, Straatman-Iwanowska A, Khatri U, Tajdini P, Fallahi GH, Gissen P, Rezaei N. Novel VIPAS39 mutation in a syndromic patient with arthrogryposis, renal tubular dysfunction and intrahepatic cholestasis. Eur J Med Genet. 2016 Apr;59(4):237-9.

468.    Abolhassani H, Vitali M, Lougaris V, Giliani S, Parvaneh N, Parvaneh L, Mirminachi B, Cheraghi T, Khazaei H, Mahdaviani SA, Kiaei F, Tavakolinia N, Mohammadi J, Negahdari B, Rezaei N, Hammarstrom L, Plebani A, Aghamohammadi A. Cohort of Iranian patients with congenital agammaglobulinemia: mutation analysis and novel gene defects. Expert Rev Clin Immunol. 2016 Apr;12(4):479-86.

469.    Zamani MM, Keshavarz-Fathi M, Fakhri-Bafghi MS, Hirbod-Mobarakeh A, Rezaei N, Bahrami A, Nader ND. Survival benefits of dexmedetomidine used for sedating septic patients in intensive care setting: A systematic review. J Crit Care. 2016 Apr;32:93-100.

470.    Yousefi H, Aghamohammadi A, Rezaei N. Clinical recommendations for oral management of patients with primary antibody deficiencies. Expert Rev Clin Immunol. 2016 Apr;12(4):359-60.

471.    Majdzadeh R, Rezaei N. The knowledge without border. Arch Iran Med 2016 Apr;19(4):307.

472.    Fallahi GH, Latifi S, Mahmoudi M, Kushki D, Haghhi Ashtiani MT, Morteza A, Rezaei N. Growth status and its relationship with serum lipids and albumin in children with cystic fibrosis. Acta Med Iran. 2016 Apr;54(4):276-9.

473.    Sodagari HR, Bahramsoltani R, Farzaei MH, Abdolghaffari AH, Rezaei N, Taylor-Robinson AW. Tea polyphenols as natural products for potential future management of HIV infection - an overview. J Nat Rem. 2016 Apr;16(2):60-72.

474.    Tahernia L, Namazi S, Rezaei N, Ziaee V. Cytokines in systemic lupus erythematosus: their role in pathogenesis of disease and possible therapeutic opportunities. Rheu Res 2016 April;1(2):e7556.

475.    Asgharzadeh A, Shabaninejad H, Rezaei N, Rezapoor A. A comparative study of intravenous immunoglobulin and subcutaneous immunoglobulin in adult patients with primary immunodeficiency diseases: a systematic review and meta-analysis. Expert Rev Clin Immunol. 2016 May;12(5):595-602.

476.    Hadizadeh H, Salehi MM, Khoramnejad S, Vosoughi K, Rezaei N. The association between parental consanguinity and primary immunodeficiency diseases: a systematic review and meta-analysis. Ped Allergy Immunol. 2017 May;28(3):280-287.

477.    Harsini S, Ziaee V, Maddah M, Rezaei A, Sadr M, Zoghi S, Moradinejad MH, Tahghighi F, Aghighi Y, Rezaei N. Interleukin 10 and transforming growth factor beta 1 gene polymorphisms in juvenile idiopathic arthritis. Bratisl Med J. 2016;117(5):258-62.

478.    Yousefi A, Mahmoudi E, Zare Bidoki A, Najmi Varzaneh F, Baradaran Nevoeiry B, Sadr M, Motamed F, Najafi M, Farhmand F, Rezaei N. IL4 gene polymorphisms in Iranian patients with autoimmune hepatitis. Expert Rev Gastroenterol Hepatol. 2016 May;10(5):659-63.

479.    Soltani S, Zare-Shahabadi A, Shahrokhi A, Rezaei A, Zoghi S, Zamani GR, Mohammadi M, Ashrafi MR, Rezaei N. Association of interleukin-1 gene cluster and interleukin-1 receptor polymorphisms with febrile seizures. J Child Neurol. 2016 May;31(6):673-7.

480.    Arshi S, Nabavi M, Bemanian MH, Shakeri R, Taghvaei B, Ghalebaghi B, Babaie D, Bahrami A, Fallahpour M, Esmaeilzadeh H, Rekabi M, Amadian J, Eslami N, Shokri S, Jalali F, Akbarpour N, Molatefi R, Rezaei N. Phenotyping and follow up of forty-seven Iranian patients with common variable immunodeficiency. Allergol Immunopathol (Madr). 2016 May-Jun;44(3):226-31.

481.    Zamani MR, Salmaninejad A, Akbari Asbagh F, Masoud A, Rezaei N. STAT4 single nucleotide gene polymorphisms and susceptibility to endometriosis-related infertility. Eur J Obstet Gynecol Reprod Biol. 2016 May;203:20-4.

482.    Shafieyoun A, Moraveji S, Bashashati M, Rezaei N. Discs large homolog 5 (DLG5) gene polymorphism and crohn’s disease: a meta-analysis of the published studies. Acta Med Iran. 2016 May;54(5):289-95.

483.    Farzaei MH, Bahramsoltani R, Abdolghaffari AH, Sodagari HR, Esfahani SA, Rezaei N. A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2016 Jun;10(6):745-58.

484.    Toubiana J, Okada S, Hiller J, Oleastro M, Lagos Gomez M, Aldave Becerra JC, Ouachée-Chardin M, Fouyssac F, Girisha KM, Etzioni A, Van Montfrans J, Camcioglu Y, Kerns LA, Belohradsky B, Blanche S, Bousfiha A, Rodriguez-Gallego C, Meyts I, Kisand K, Reichenbach J, Renner ED, Rosenzweig S, Grimbacher B, van de Veerdonk FL, Traidl-Hoffmann C, Picard C, Marodi L, Morio T, Kobayashi M, Lilic D, Milner JD, Holland S, Casanova JL, Puel A; International STAT1 Gain-of-Function Study Group. Cypowyj S, Thumerelle C, Toulon A, Bustamante J, Tahuil N, Salhi A, Boiu S, Chopra C, Di Giovanni D, Bezrodnik L, Boutros J, Thomas C, Lacuesta G, Jannier S, Korganow AS, Paillard C, Boutboul, Bué M, Marie-Cardine A, Bayart S, Migaud M, Weiss, Karmochkine M, Garcia-Martinez JM, Stephan JL, Bensaid P, Jeannoel GP, Witte T, Baumann U, Harrer T, Navarrete C, Benjamin AT, Firinu, Pignata C, Picco P, Mendoza D, Lugo Reyes SO, Torres Lozano C, Ortega-Cisneros M, Cortina M, Mesdaghi M, Nabavi M, Español T, Martínez-Saavedra MT, Rezaei N, Zoghi S, Pac M, Barlogis V, Revon-Rivière G, Haimi-Cohen Y, Spiegel R, Miron D, Bouchaib J, Blancas-Galicia L, Toth B, Drexel B, Rohrlich PS, Lesens O, Hoernes M, Drewe E, Abinum M, Sawalle-Belohradsky J, Kindle G, Depner M, Milani L, Nikopensius T, Remm M, Talas UG, Tucker M, Willis M, Leonard S, Meuwissen H, Ferdman RM, Wallace M, Desai MM, Taur P, Badolato R, Soltesz B, Schnopp C, Jansson AF, Ayvaz D, Shabashova N, Chernyshova L, Bondarenko A, Moshous D, Neven B, Boubidi C, Ailal F, Giardino G, Del Giacco S, Bougnoux ME, Imai K, Okawa T, Mizoguchi Y, Ozaki Y, Takeuchi M, Hayakawa A, Lögering B, Reich K, Buhl T, Eyerich K, Schaller M, Arkwright PD, Gennery AR, Cant AJ, Warris A, Henriet S, Mekki N, Barbouche R, Ben Mustapha I, Bodemer, Polak M, Grimprel E, Burgel PR, Fischer A, Hermine O, Debré M, Kocacyk D, Dhalla F, Patel SY, Moens L, Haerynck F, Dullaers, Hoste L, Sanal O, Kilic SS, Roesler J, Lanternier F, Lortholary O, Fieschi C, Church JA, Roifman C, Yuenyongviwat A, Peterson P, Boisson-Dupuis S, Abel L, Marciano BE, Netea MG. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016 Jun 23;127(25):3154-64.

485.    Belkadi A, Pedergnana V, Cobat A, Itan Y, Vincent QB, Abhyankar A, Shang L, El Baghdadi J, Bousfiha A; Exome/Array Consortium, Alcais A (Al-Herz W, Arikan C, Arkwright P, Aydogmus C, Bernard O, Blancas-Galicia L, Boisson-Dupuis S, Bonnet D, Stambouli OB, Boussofara L, Boutros J, Bustamante J, Ciancanelli M, Cole T, Condino-Neto A, Desai M, Fieschi C, Franco JL, Ichai P, Jouanguy E, Keser-Emiroglu M, Kilic SS, Mahdaviani SA, Mahlhoui N, Mansouri D, Parvaneh N, Picard C, Puel A, Raoult D, Rezaei N, Sanal O, Ramon SS, Vandenesch F, Vogt G, Zhang SY), Boisson B, Casanova JL, Abel L. Whole-exome sequencing to analyze population structure, parental inbreeding, and familial linkage. Proc Natl Acad Sci U S A. 2016 Jun;113(24):6713-8.

486.    Maddah M, Harsini S, Rezaei A, Sadr M, Zoghi S, Moradinejad MH, Ziaee V, Rezaei N. Association of interleukin-2, but not interferon-gamma, single nucleotide polymorphisms with juvenile idiopathic arthritis. Allergol Immunopathol (Madr). 2016 Jul;44(4):303-6.

487.    Mohammadzadeh M, Rezaei N, Kamran E, Abdolhoseinpour F, Mohammadzadeh M, Firooze Moqadam I, Najafi S, Hoseini Ahmadabadi M. Evaluation of antioxidant efficacy of purslane extract in patients with recurrent aphthous stomatitis: a randomized, placebo-controlled, triple-blinded, clinical trial. Braz J Oral Sci. 2016 July-Sep;15(3):234-237.

488.    Soltani S, Saghazadeh A, Movahedi M, Tavakkol M, Sadr M, Farhadi E, Rezaei N. FLG single nucleotide polymorphisms in chronic idiopathic urticaria. Allergol Immunopathol (Madr). 2016 Jul;44(4):341-5.

489.    Mahmoudi MJ, Taghvaei M, Harsini S, Amirzargar AA, Hedayat M, Mahmoudi M, Nematipour E, Farhadi E, Esfahanian N, Sadr M, Nourijelyani K, Rezaei N. Association of interleukin 1 gene cluster and interleukin 1 receptor gene polymorphisms with ischemic heart failure. Bratisl Med J. 2016 Jul;117(7):367-70.

490.    Khorasanizadeh MH, Eskian M, Assa'ad AH, Camargo Jr. CA, Rezaei N. Efficacy and safety of benralizumab, a monoclonal antibody against IL-5Rα, in uncontrolled eosinophilic asthma. Int Rev Immunol. 2016 Jul;35(4):294-311.

491.    Kasraianfard A, Watt KD, Lindberg L, Alexopoulos S, Rezaei N. HBIG remains significant in the era of new potent nucleoside analogues for prophylaxis against hepatitis B recurrence after liver transplantation. Int Rev Immunol. 2016 Jul;35(4):312-324.

492.    Ziaee V, Rezaei A, Harsini S, Maddah M, Zoghi S, Sadr M, Tahghighi F, Moradinejad MH, Aghighi Y, Rezaei N. Polymorphisms of genes encoding interleukin-4 and its receptor in Iranian patients with juvenile idiopathic arthritis. Clin Rheumatol. 2016 Aug;35(8):1943-8.

493.    Saghazadeh A, Ferrari CC, Rezaei N. Deciphering variability in the role of interleukin-1β in parkinson’s disease. Rev Neurosci. 2016 Aug;27(6):635-50.

494.    Alizadeh M, Ghasemi Hashtroodi L, Chavoshzadeh Z, Rezaei N. Effect of air pollution in frequency of hospitalizations in asthmatic children. Acta Med Iran. 2016 Aug;54(8):542-546.

495.    Azizi G, Rezaei N, Kiaee F, Tavakolinia N, Yazdani R, Mirshafiey A, Aghamohammadi A. T-cell abnormalities in common variable immunodeficiency. J Investig Allergol Clin Immunol. 2016;26(4):233-43.

496.    Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, Gabriel SB, Belkadi A, Boisson B, Abel L, Clark AG; Greater Middle East Variome Consortium, Rahim SA, Abdel-Hadi S, Abdel-Salam G, Abdel-Salam E, Abdou M, Abhytankar A, Adimi P, Ahmad J, Akcakus M, Aksu G, Hajjar SA, Juamaah SA, Muhsen SA, Sannaa NA, Tameni SA, Al-Aama J, Al-Allawi N, Al-Baradie R, Al-Gazali L, Al-Hashem A, Al-Herz W, Al-Jeaid D, Al-Tawari A, Alangari A, Alcais A, S AlFawaz T, Alsum Z, Ammar-Khodja A, Amouian S, Arikan C, Aryani O, Aslanger A, Aydogmus C, Aytekin C, Azam M, Bansagi B, Barbouche MR, Bastaki L, Ben-Omran T, Bindu PS, Blancas L, Boisson-Dupuis S, Bonnet D, Stambouli OB, Bousfiha A, Boussafara L, Boutros J, Bustamante J, Caksen H, Camcioglu Y, Catherinot E, Celik FC, Ciancanelli M, Cipe FE, Clark G, Cobat A, Comu S, Condie A, Condino-Neto A, Desai M, Dobyns W, Dogu F, Domaia M, Dorum M, Egritas O, Azbaoui SE, Baghdadi JE, Ruby ME, El-Harouni A, Elfeky RA, Elghazali G, Faqeih E, Fenerci E, Fieschi C, Funda C, Gamal I, Gelik U, Genel F, Gezdirici A, M Girisha K, Goldstein A, Grattan-Smith P, Gupta N, Hahn J, Hatipoglu N, Hennekam R, Houshmand M, Ichai P, Ikinciogullari A, Ismail S, Jalas C, Jouanguy E, Kabra M, Kalkan G, Kara M, Karaca N, Karaer K, Kariminejad A, Kayserili H, Keser-Emiroglu M, Kilic SS, Kissani N, Kokron C, Koul R, Kutukculer N, Lanternier F, Mahdaviani A, Mahlaoui N, Mansour L, Mansouri D, Margari L, Valente EM, Marzouki N, Masri A, Megahed A, Megahed H, Mekki N, Mesdaghi M, Mikati M, Mojahedi F, Mulley J, Nampoothiri S, Navarrete C, Omar T, Oraby A, Pandaluz A, Parvaneh N, Patiroglu T, Koc ZP, Pellier I, Picard C, Puel A, Raas-Rothschild A, Rajab A, Raoult D, Reisli I, Rezaei N, Sabri A, Sahin Y, Saleem L, Salem F, AlSediq NS, Sanal O, Sanger T, Shakankiry H, Shang L, Shehata N, Shembesh N, Shkalim V, Softah A, Sogaty S, Soliman N, Sonmez-Aunaci F, Sztriha L, Taibi-Berrah L, Temtamy S, Tonekaboni H, Trauner D, Tuysuz B, Tuysuz B, Varan A, Vogt G, Walsh C, Woods G, Yesil G, Yildiran A, Yildiz B, Yuksel A, Zaki M, Zhang SY, Alkuraya FS, Casanova JL, Gleeson JG. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nat Genet. 2016 Sep;48(9):1071-6.

497.    Saghazadeh A, Esfahani SA, Rezaei N. Genetic polymorphisms and the adequacy of brain stimulation: state of the art. Expert Rev Neurother. 2016 Sep;16(9):1043-54.

498.    Azizi G, Ghanavatinejad A, Abolhassani H, Yazdani R, Rezaei N, Mirshafiey A, Aghamohammadi A. Autoimmunity in primary T-cell immunodeficiencies. Expert Rev Clin Immunol. 2016 Sep;12(9):989-1006.

499.    Khodadad A, Aflatoonian M, Jalilian R, Babaei N, Motamed F, Ebrahime Soltani A, Rasoolzadeh B, Motavasselian F, Rezaei N. Comparison of oral midazolam with intravenous midazolam for sedation children during upper gastrointestinal endoscopy. Acta Med Iran. 2016 Sep;54(9):576-582.

500.    Alipour S, Zoghi S, Khalili N, Hirbod-Mobarakeh A, Emens LA, Rezaei N. Specific immunotherapy in ovarian cancer: a systematic review. Immunotherapy. 2016 Oct;8(10):1193-204.

501.    Shaghaghi­ M­, Shahmahmoodi S, Abolhassani H, Soleyman-jahi S, Parvaneh N, Mahmoudi S, Chavoshzadeh Z, Yazdani R, Zahraei SM, Ebrahimi M, Eslamian MH, Tabatabaie H, Yousefi M, Mollaie Kandelousi Y, Oujaghlou A, Rezaei N­­­, Aghamohammadi A. Vaccine-derived polioviruses and children with primary immunodeficiency, Iran, 1995-2014. Emerg Infect Dis. 2016 Oct;22(10):1712-1719.

502.    Salmaninejad A, Gooshe M, Zamani MR, Golchehre Z, Bereshneh AH, Rezaei N. Cancer/Testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancers. Immunol Invest. 2016 Oct;45(7):619-40.

503.    Shokri S, Nabavi M, Hirschmugl T, Aghamohammadi A, Arshi S, Bemanian MH, Fallahpour M, Molatefi R, Rekabi M, Eslami N, Ahmadian J, Darabi K, Sedighi GR, Monajemzadeh M, Modaresi M, Parvaneh N, Boztug K, Rezaei N. LPS-responsive beige-like anchor gene mutation associated with possible bronchiolitis obliterans organizing pneumonia associated with hypogammaglobulinemia and normal IgM phenotype and low number of B cells. Acta Med Iran. 2016 Oct;54(10):620-623.

504.    Eskian M, Khorasanizadeh M, Kraeber-Bodere F, Rezaei N. Radioimmunotherapy in non-hodgkin lymphoma: prediction and assessment of response. Crit Rev Oncol Hematol. 2016 Nov;107:182-189.

505.    Shabani M, Nichols KE, Rezaei N. Primary immunodeficiencies associated with EBV-induced lymphoproliferative disorders. Crit Rev Oncol/Hematol. 2016 Dec;108:109-127.

506.    Zare-Shahabadi A, Ataei A, Rezaei N. Proteins brighten the brain. Life Sciences. 2016 Dec;167:1-5.

507.    Ziaee V, Maddah M, Harsini S, Rezaei A, Sadr M, Zoghi S, Moradinejad MH, Rezaei N. Association of interleukin-1 family gene polymorphisms with juvenile idiopathic arthritis in Iranian population. Allergol Immunopathol (Madr). 2016 Nov - Dec;44(6):542-546.

508.    Maddah M, Harsini S, Ziaee V, Moradinejad M, Tahghighi F, Rezaei A, Zoghi S, Sadr M, Aghighi Y, Rezaei N. Association of tumour necrosis factor-alpha G/A -238 and G/A -308 single nucleotide polymorphisms with juvenile idiopathic arthritis. Int J Immunogenet. 2016 Dec;43(6):391-396.

509.    Zamani MR, Aslani S, Salmaninejad A, Javan MR, Rezaei N. PD-1/PD-L and autoimmunity: A growing relationship. Cell Immunol. 2016 Dec;310:27-41.

510.    Rahmani F, Rezaei N. Therapeutic targeting of toll-like receptors: a review of toll-like receptors and their signaling pathways in psoriasis. Expert Rev Clin Immunol. 2016 Dec;12(12):1289-1298.

511.    Zaki dizaji M, Rezaei N, Yaghmaie M, Yaseri M, Sayedi SJ, Azizi G, Aghamohammadi A, Akrami SM. Phospho-SMC1 in-cell ELISA based detection of ataxia telangiectasia. Int J Pediatr. 2016 Dec;4(12):3957-3967

512.    Najafi S, Mohammadzadeh M, Zare Bidoki A, Meighani G, Aslani S, Mahmoudi M, Rezaei N. HLA-DRB and HLA-DQB allele and haplotype frequencies in Iranian patients with recurrent aphthous stomatitis. Iran J Allergy Asthma Immunol. 2016 Aug;15(4):289-295.

513.    Fathi SM, Tavakol M, Rezaei N, Movahedi M, Aghamohammadi A, Shariat M, Sadeghi B, Behniafard N, Darabi B, Hajikhani A, Abdollahpour I, Gharagozlou M. Impact of IgE-mediated food allergy on parental quality of life in Iranian patients. Iran J Allergy Asthma Immunol. 2016 Oct;15(5):372-380.

514.    Firouze Moqadam I, Najafi S, Mohammadzadeh M, Zare Bidoki A, Yousefi H, Farhadi E, Tonekaboni A, Meighani G, Mohammadzadeh M, Amirzargar AA, Rezaei N. Lack of association between interleukin-12 gene polymorphisms and recurrent aphthous stomatitis. Avicenna J Med Biotechnol. 2016 Oct-Dec;8(4):200-201.

515.    Azizi G, Ahmadi M, Abolhassani H, Yazdani R, Mohammadi H, Mirshafiey A, Rezaei N, Aghamohammadi A. Autoimmunity in primary antibody deficiencies. Int Arch Allergy Immunol. 2016 Dec;171(3-4):180-193.

516.    Tahghighi F, Ziaee V, Moradinejad MH, Rezaei A, Harsini S, Soltani S, Sadr M, Mahmoudi M, Aghighi Y, Rezaei N. Tumor necrosis factor-alpha single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Hum Immunol. 2015 Aug;76(8):533-6.

517.    Zare Bidoki A, Harsini S, Sadr M, Soltani S, Mohammadzadeh M, Najafi S, Rezaei N. NLRP3 gene polymorphisms in Iranian patients with recurrent aphthous stomatitis. J Oral Pathol Med. 2016 Feb;45(2):136-40.

518.    Bahrami N, Movahedi M, Bahar MA, Rezaei A, Sadr M, Hirbod-Mobarakeh A, Rezaei N. IL9 single nucleotide polymorphism and serum levels of interleukin 9 in children with asthma. Ped Allergy Immunol Pulmonol. 2016 Mar;29(1):34-37.

519.    Yousefi H, Rezaei N. "Post modern medicine" would be "calculable and energy-based medicine". J Med Hypotheses Ideas. 2015 Dec;9(2):104-106.

520.    Alkhairy OK, Abolhassani H, Rezaei N, Fang M, Andersen KK, Chavoshzadeh Z, Mohammadzadeh I, El-Rajab MA, Massaad M, Chou J, Aghamohammadi A, Geha RS, Hammarström L. Spectrum of phenotypes associated with mutations in LRBA. J Clin Immunol. 2016 Jan;36(1):33-45.

521.    Nabavi M, Arshi S, Bemanian MH, Aghamohammadi A, Mansouri D, Hedayat M, Nateghian A, Noorbakhsh S, Ehsanipour F, Faranoush M, Shakeri R, Mesdaghi M, Taghvaei B, Ghalebaghi B, Babaie D, Bahrami A, Fallahpour M, Esmaeilzadeh H, Hamidieh A, Rekabi M, Ahmadian J, Eslami N, Shokri S, Afshar M, Jalali F, Akbarpour N, Molatefi R, Rezaei N. Long-term follow-up of ninety eight Iranian patients with primary immune deficiency in a single tertiary centre. Allergol Immunopathol (Madr). 2016 Jul-Aug;44(4):322-330.

522.    Eghbali M, Sadeghi-Shabestari M, Najmi Varzaneh F, Zare Bidoki A, Rezaei N. Novel WASP mutation in a patient with Wiskott-Aldrich syndrome: Case report and review of the literature. Allergol Immunopathol (Madr). 2016 Sep-Oct;44(5):450-454.

523.    Harsini S, Ziaee V, Tahghighi Sharbiani F, Mahmoudi M, Rezaei A, Soltani S, Sadr M, Moradinejad MH, Aghighi Y, Rezaei N. Association of interleukin-2 and interferon-gamma single nucleotide polymorphisms with juvenile systemic lupus erythematosus. Allergol Immunopathol (Madr). 2016 Sep-Oct;44(5):422-6.

524.    Hirbod-Mobarakeh A, Mirghorbani M, Hajiju F, Marvi M, Bashiri K, DuBois RN, Wang D, Rezaei N. Myeloid-derived suppressor cells in gastrointestinal cancers: A systematic review. J Gastroenterol Hepatol 2016 Jul;31(7):1246-1256.

525.    Aryan Z, Aghamohammadi A, Rezaei N. Toward the stratification and personalisation of common variable immunodeficiency treatment. Expert Opin Orphan Drugs. 2016;4(8):823-830.

526.    Azizi G, Abolhassani H, Rezaei N, Aghamohammadi A, Asgardoon MH, Rahnavard J, Dizaji MZ, Yazdani R. The use of immunoglobulin therapy in primary immunodeficiency diseases. Endocr Metab Immune Disord Drug Targets. 2016;16(2):80-88. 

527.    Emami S, Ziaee V, Rezaei A, Sadr M, Maddah M, Amirzargar AA, Rezaei N. IL23R gene polymorphisms with juvenile idiopathic arthritis and its association with serum IL-17A. Int J Rheum Dis. 2016 Nov;19(11):1189-1196.

528.    Ziaee V, Maddah M, Moradinejad MH, Rezaei A, Zoghi S, Sadr M, Harsini S, Rezaei N. Association of interleukin-6 single nucleotide polymorphisms with juvenile idiopathic arthritis. Clin Rheumatol. 2017 Jan;36(1):77-81.

529.    Abolhassani H, Edwards ES, Ikinciogullari A, Jing H, Borte S, Buggert M, Du L, Matsuda-Lennikov M, Romano R, Caridha R, Bade S, Zhang Y, Frederiksen J, Fang M, Bal SK, Haskologlu S, Dogu F, Tacyildiz N, Matthews HF, McElwee JJ, Gostick E, Price DA, Palendira U, Aghamohammadi A, Boisson B, Rezaei N, Karlsson AC, Lenardo MJ, Casanova JL, Hammarström L, Tangye SG, Su HC, Pan-Hammarström Q. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency. J Exp Med. 2017 Jan;214(1):91-106.

530.    Fazel A, Kashef S, Aleyasin S, Harsini S, Karamizadeh Z, Zoghi S, Klaver Flores S, Boztug K, Rezaei N. Novel AICDA mutation in a case of autosomal recessive hyper-IgM syndrome, growth hormone deficiency and autoimmunity. Allergol Immunopathol (Madr). 2017 Jan-Feb;45(1):82-86.

531.    Azizi G, Abolhassani H, Asgardoon MH, Alinia T, Yazdani R, Mohammadi J, Rezaei N, Ochs HD, Aghamohammadi A. Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Rev Clin Immunol. 2017 Feb;13(2):101-115.

532.    Bahrami T, Soltani S, Moazzami K, Yekaninejad MS, Salmaninejad A, Soltaninejad E, Ziaee V, Rezaei N. Association of PTPN22 gene polymorphisms with susceptibility to juvenile idiopathic arthritis in Iranian population. Fetal Pediatr Pathol. 2017 Feb;36(1):42-48.

533.    Aryan Z, Rezaei N, Camargo CA. Vitamin D status, aeroallergen sensitization, and allergic rhinitis:  a systematic review and meta-analysis. Int Rev Immunol. 2017 Jan;36(1):41-53.

534.    Rezaei N. Universal scientific education and research network (USERN): to make the knowledge without borders. Acta Med Iran. 2017 Jan;55(1):1-5.

535.    Masoud S, Rajabi G, Delavari F, Rezaei N. Evaluating awareness of pediatricians and general practitioners on transformation of the health system in Iran. Acta Med Iran. 2017 Jan;55(1):49-52.

536.    Hirbod-Mobarakeh A, Gordan HA, Zahiri Z, Mirshahvalad M, Hosseinverdi S, Rini BI, Rezaei N. Specific immunotherapy in renal cancer: a systematic review. Ther Adv Urol. 2017 Feb;9(2):45-58.

537.    Yazdani R, Ganjalikhani-Hakemi M, Esmaeili M, Abolhassani H, Vaeli S, Rezaei A, Sharifi Z, Azizi G, Rezaei N, Aghamohammadi A. Impaired Akt phosphorylation in B-cells of patients with common variable immunodeficiency. Clin Immunol. 2017 Feb;175:124-132.

538.    Yousefi H, Rezaei N. A theory towards a measurable definition for health: introducing two variables. Acta Med Iran. 2017 Feb;55(2):85-86.

539.    Saghazadeh A, Hafizi S, Hosseini F, Ashrafi MR, Rezaei N. Early-onset Friedreich’s ataxia with oculomotor apraxia. Acta Med Iran. 2017 Feb;55(2):128-130.

540.    Baradaran Noveiry B, Hirbod-Mobarakeh A, Khalili N, Hourshad N, Greten TF, Abou-Alfa GK, Rezaei N. Specific immunotherapy in hepatocellular cancer: a systematic review. J Gastroenterol Hepatol. 2017 Feb;32(2):339-351.

541.    Gholami K, Laali E, Abolhassani H, Ahmadvand A, Mohebbi N, Javadi MR, Aghamohammadi A, Rezaei N. Costs of hospital admission on primary immunodeficiency diseases. Iran J Public Health. 2017 Mar:46(3):342-350.

542.    Reisi M, Jalilian R, Azizi G, Rashti A, Faghihinia J, Akbari M, Babaei N, Sayedi SJ, Rezaei N, Modarresi MR. Academic performance, sleep disorders and their association in middle school students in Iran. Int J Pediatr. 2017 Mar;5(3):4541-4549.

543.    Yazdani R, Seify R, Ganjalikhani-Hakemi M, Abolhassani H, Eskandari N, Golsaz-Shirazi F, Ansaripour B, Salehi E, Azizi G, Rezaei N, Aghamohammadi A. Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets. Allergol Immunopathol (Madr). 2017 Mar-Apr;45(2):183-192.

544.    Saghazadeh A, Rezaei N. Implications of toll-like receptors in ebola infection. Expert Opinion Therapeutic Targets. 2017 Apr;21(4):415-425.

545.    Saghazadeh A, Rezaei N. Brain-derived neurotrophic factor levels in autism: a systematic review and meta-analysis. J Autism Dev Disord 2017 Apr;47(4):1018-1029.

546.    Farrokhi S, Abbasirad N, Movahed A, Khazaei HA, Pishjoo M, Rezaei N. TLR9-based immunotherapy for the treatment of allergic diseases. Immunotherapy. 2017 Apr;9(4):339-346.

547.    Namazi S, Tajik N, Ziaee V, Sadr M, Soltani S, Rezaei A, Zoghi S, Rezaei N. APRIL gene polymorphism and serum sAPRIL levels in children with systemic lupus erythematosus. Clin Rheumatol. 2017 Apr;36(4):831-836.

548.    Mahmoodi M, Soleyman-Jahi S, Zendehdel K, Mozdarani H, Azimi C, Farzanfar F, Safari Z, Mohagheghi MA, Khaleghian M, Divsalar K, Asgari E, Rezaei N. Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of oncology department personnel handling anti-neoplastic drugs. Drug Chem Toxicol. 2017 Apr;40(2):235-240. 

549.    Aghamohammadi A, Abolhassani H, Puchalka J, Greif-Kohistani N, Zoghi S, Klein C, Rezaei N. Preference of genetic diagnosis of CXCR4 mutation compared with clinical diagnosis of WHIM syndrome. J Clin Immunol. 2017 Apr;37(3):282-286.

550.    Saghazadeh A, Mahmoudi M, Dehghani Ashkezari A, Oliaie Rezaei N, Rezaei N. Systematic review and meta-analysis shows a specific micronutrient profile in people with Down syndrome: lower blood calcium, selenium and zinc, higher red blood cell copper and zinc, and higher salivary calcium and sodium. PLoS ONE 2017 Apr;12(4): e0175437.

551.    Rezaei H, Yousefi A, Larijani B, Rezaei N, Adibi P. Road map of Iran’s internationalization of medical sciences education: Experience of Isfahan University of medical sciences. Iran J Med Edu. 2017 Apr; 17(12):125-133.

552.    Ataeinia B, Montazeri A, Tavakol M, Azizi G, Kiaee F, Tavakolinia N, Negahdari B, Mohammadi J, Abolhassani H, Rezaei N, Aghamohammadi A. Measurement of health-related quality of life in primary antibody-deficient patients. Immunol Invest. 2017 Apr;46(4):329-340.

553.    Abbasi F, Soltani S, Saghazadeh A, Soltaninejad E, Rezaei A, Zare Bidoki A, Bahrami T, Amirzargar AA, Rezaei N. PTPN22 single-nucleotide polymorphisms in Iranian patients with type 1 diabetes mellitus. Immunol Invest. 2017 Apr;46(4):409-418.

554.    Saghazadeh A, Rezaei N. Immunofluorescence: dyes and other haptens conjugated with antibodies. In: eLS. John Wiley & Sons, Ltd: Chichester 2017. DOI: 10.1002/9780470015902.a0002626.pub3

555.    Motamed F, Bagherian R, Adalat G, Moradinejad MH, Hajizadeh N, Vasei M, Mehdizadeh M, Rezaei N. Systemic amyloidosis in a teenage boy with inflammatory bowel disease. Acta Med Iran. 2017 Apr;55(4):265-267.

556.    Rezaei H, Mosavi A, Yousefi A, Larijani B, Rezaei N, Dehnavieh R, Adibi P. Strengths of Iran for internationalization of medical sciences education. J Educ Health Promot. 2020 Apr 28;9:92. doi: 10.4103/jehp.jehp_488_19. eCollection 2020.

557.    Mohammadzadeh I, Moazzami B, Ghaffari J, Aghamohammadi A, Rezaei N. Primary immunodeficiency diseases in northern Iran. Allergol Immunopathol (Madr). 2017 May;45(3):244-250.

558.    Khorasanizadeh M, Eskian, M, Rezaei N. Reduction of eosinophil biomarkers in asthma. Acta Med Iran. 2017 May;55(5):352-353.

559.    Shahrokhi A, Zare-Shahabadi A, Naeimi Poor M, Sajedi F, Soltani S, Zoghi S, Shervin Badv R, Ashrafi MR, Rezaei N. Association of the single nucleotide polymorphisms of the genes encoding IL-2 and IFN-γ with febrile seizure. Acta Med Iran. 2017 Jun;55(6):354-359.

560.    Aslani A, Mahmoudi M, Salmaninejad A, Poursani S, Ziaee V, Rezaei N. Lack of association between STAT4 single nucleotide polymorphisms and Iranian juvenile rheumatoid arthritis patients. Fetal Pediatr Pathol. 2017 Jun;36(3):177-183.

561.    Aflatounian M, Rezaei A, Sadr M, Saghazadeh A, Elhamian N, Sadeghi H, Motevasselian F, Farahmand F, Fallahi G, Motamed F, Najafi M, Rezaei N. Association of PTPN22 single nucleotide polymorphisms with celiac disease. Fetal Pediatr Pathol. 2017 Jun;36(3):195-202.

562.    Khorasanizadeh MH, Eskian M, Adcock IM, Rezaei N. Mitogen-activated protein kinases as therapeutic targets for asthma. Pharmacol Therapeut. 2017 Jun;174(4):112-126.

563.    Eslami N, Tavakol M, Mesdaghi M, Gharegozlou M, Casanova JL, Puel A, Okada S, Arshi S, Bemanian MH, Fallahpour M, Molatefi R, Seif F, Zoghi S, Rezaei N, Nabavi M. A gain-of-function mutation of STAT1: a novel genetic factor contributing to chronic mucocutaneous candidiasis. Acta Microbiol Immunol Hung. 2017 Jun;64(2):191-201.

564.    Aghamohammadi A, Abolhassani H, Kutukculer N, Wassilak SG, Pallansch MA, Kluglein S, Quinn J, Sutter RW, Wang X, Sanal O, Latysheva T, Ikinciogullari A, Bernatowska E, Tuzankina IA, Costa-Carvalho BT, Franco JL, Somech R, Karakoc-Aydiner E, Singh S, Bezrodnik L, Espinosa-Rosales FJ, Shcherbina A, Lau YL, Nonoyama S, Modell F, Modell V; JMF Centers Network Investigators and Study Collaborators, Ozen A, Berlin A, Chouikha A, Partida-Gaytán A, Kiykim A, Prakash C, Suri D, Cagdas Ayvaz D, Peláez D, da Silva EE, Deordieva E, Pérez-Sánchez EE, Ulusoy E, Dogu F, Seminario G, Cuzcanci H, Triki H, Shimizu H, Tezcan I, Ben-Mustapha I, Sun J, Mazzucchelli JTL, Orrego JC, Pac M, Bolkov M, Giraldo M, Belhaj-Hmida N, Mekki N, Kuzmenko N, Karaca NE, Rezaei N, Diop OM, Baris S, Chan SM, Shahmahmoodi S, Haskologlu S, Ying W, Wang Y, Barbouche MR, McKinlay MA. Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication. Front Immunol. 2017 Jun 13;8:685.

565.    Rahmani F, Aghamohammadi A, Ochs HD, Rezaei N. Agammaglobulinemia: comorbities and long-term therapeutic risks. Expert Opin Orphan Drugs. 2017 Jul;5(7):559-574.

566.    Mohammadi Ayenehdeh J, Niknam B, Hashemi SM, Rahavi H, Rezaei N, Soleimani M, Tajik N. Introducing a new experimental islet transplantation model using biomimetic hydrogel and a simple high yield islet isolation technique. Iran Biomed J. 2017 Jul;21(4):218-227.

567.    Sanjari Moghaddam H, Zare-Shahabadi A, Rahmani F, Rezaei N. Neurotransmission systems in parkinson’s disease. Rev Neuroscience. 2017 Jul 26;28(5):509-536.

568.    Mohammadi Ayenehdeh J, Niknam B, Hashemi SM, Rahavi H, Rezaei N, Soleimani M, Tajik N. Introducing a new experimental islet transplantation model using biomimetic hydrogel and a simple high yield islet isolation technique. Iran Biomed J. 2017 Jul;21(4):218-227.

569.    Shariat M, Abedinia N, Rezaei N, Farrokhzad N. Increase concentration of transforming growth factor beta (TGF-β) in breast milk of mothers with psychological disorders. Acta Med Iran. 2017 Jul;55(7):429-436.

570.    Saghazadeh A, Rezaei N. The role of timing in the treatment of spinal cord injury. Biomed Pharmacotherapy. 2017 Aug;92:128-139.

571.    Movahedi M, Tavakol M, Amirzargar AA, Rahmani F, Zare Bidoki A, Heidari K, Gharagozlou M, Aghamohammadi A, Nabavi M, Soltani S, Rezaei N. Single nucleotide polymorphisms of IL-2, but not IL-12 and IFN-γ, are associated with increased susceptibility to chronic spontaneous urticaria. Allergol Immunopathol (Madr). 2017 Aug;45(4):333-338.

572.    Ayenehdeh JM, Niknam B, Rasouli S, Hashemi SM, Rahavi H, Rezaei N, Soleimani M, Liaeiha A, Niknam MH, Tajik N. Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes. Immunol Lett. 2017 Aug;188:21-31.

573.    Azizi G, Abolhassani H, Mahdaviani SA, Chavoshzadeh Z, Eshghi P, Yazdani R, Kiaee F, Shaghaghi M, Mohammadi J, Rezaei N, Hammarström L, Aghamohammadi A. Clinical, immunologic, molecular analyses and outcomes of iranian patients with LRBA deficiency: A longitudinal study. Pediatr Allergy Immunol. 2017 Aug;28(5):478-484.

574.    Shabaninejad H, Asgharzadeh A, Rezaei N, Rezapour A. Estimating the cost of immunoglobulin replacement therapy in primary immunodeficiency patients. Iran J Pediatr. 2017 Aug; 27(4):e6294.

575.    Saghazadeh A, Rezaei N. Immuno-epileptology. Exp Rev Clin Immunol. 2017 Sep:13(9):845-847.

576.    Najafi S, Yousefi H, Mohammadzadeh M, Zare Bidoki A, Farhadi E, Rezaei N. Interleukin-2, interferon-gamma gene polymorphisms in recurrent aphthous stomatitis. Prague Med Rep. 2017;118(2-3):81-86.

577.    Taher M, Ebrahimi Daryani N, Hedayat M, Eslamian M, Farhadi E, Mahmoudi M, Shirzad S, Nouri Taromlou MK, Chaharmahali M, Nicknam MH, Bashashati M, Rezaei N. Association analysis of RAC1 single nucleotide polymorphisms with ulcerative colitis. Clin Res Hepatol Gastroenterol. 2017 Sep;41(4):487-489.

578.    Ebrahimi Daryani N, Saghazadeh A, Moossavi S, Sadr M, Shahkarami S, Soltani S, Farhadi E, Rezaei N. Interleukin-4 and interleukin-10 gene polymorphisms in patients with inflammatory bowel disease. Im Invest. 2017 Oct; 46(7):714-729.

579.    Saghazadeh A, Rezaei N. Systematic review and meta-analysis links autism and toxic metals and highlights the impact of country development status: higher blood and erythrocyte levels for mercury and lead, and higher hair antimony, cadmium, lead, and mercury. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct;79(Pt B):340-368.

580.    Yousefi H, Yuan J, Keshavarz-Fathi M, Murphy JF, Rezaei N. Immunotherapy of cancers comes of age. Expert Rev Clin Immunol. 2017 Oct:13(10):1001-1015.

581.    Saghazadeh A, Ahangari N, Hendi K, Saleh F, Rezaei N. Status of essential elements in autism spectrum disorder: systematic review and meta-analysis. Rev Neuroscience. 2017 Oct 26;28(7):783-809.

582.   Sotoudeh A, Rostami P, Nakhaeimoghadam M, Mohsenipour R, Rezaei N. Pericentric inversion of chromosome 9 in an infant with ambiguous genitalia. Acta Med Iran. 2017 Oct:55(10):655-657.

583.    Saghazadeh A, Rezaei N. The role of PIEZO2  in human mechanosensation. Acta Med Iran. 2017 Oct:55(10):664.

584.    Gorzin F, Amirzargar AA, Mahmoudi MJ, Rahnemoon Z, Varzaneh FN, Hedayat M, Sadati S, Eskandari V, Rahmati Z, Rezaei N. FOXP3, RORγt and IL-10 cytokine profile in chronic heart failure. Bratisl Med J. 2017:18(10):637-641.

585.    Roozbehkia M, Mahmoudi M, Aletaha S, Rezaei N, Fattahi MJ, Jafarnezhad-Ansariha F, Barati A, Mirshafiey A. The potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB signaling pathway in ankylosing spondylitis patients. Int Immunopharmacol. 2017 Nov;52:191-196.

586.    Rezaei S, Rezaei N, Mahmoudi M, Aryan Z. Is there sufficient evidence to support the use of vitamin supplements in the asthmatic patient? Expert Rev Resp Med. 2017 Nov:11(11):851-853.

587.    Sukalo M, Schäflein E, Schanze I, Everman DB, Rezaei N, Argente J, Lorda-Sanchez I, Deshpande C, Takahashi T, Kleger A, Zenker M. Expanding the mutational spectrum in Johanson-Blizzard syndrome: identification of whole exon deletions and duplications in the UBR1 gene by multiplex ligation-dependent probe amplification analysis. Mol Genet Genomic Med. 2017 Nov:5(6):774-780.

588.    Ganjalikhani-Hakemi M, Yazdani R, Esmaeili M, Abolhassani H, Rae W, Azizi G, Dizaji MZ, Shaghaghi M, Rezaei A, Abbasi-Rad F, Afshar-Qasemloo S, Mohammadi S, Rezaei N, Aghamohammadi A. Role of apoptosis in the pathogenesis of common variable immunodeficiency (CVID). Endocr Metab Immune Disord Drug Targets. 2017 Nov 16;17(4):332-340.

589.    Yousefi H, Najafi S, Mohammadzadeh M, Zare Bidoki A, Farhadi E, Rezaei N. Association of transforming growth factor-beta gene polymorphisms in recurrent aphthous stomatitis. Acta Med Iran. 2017 Nov;55(11):672-675.

590.    Mahmoudi M, Rezaiemanesh A, Harsini S, Salmaninejad A, Poursani S, Bahrami T, Ziaee V, Rezaei N. PDCD1 single nucleotide polymorphisms in Iranian patients with juvenile idiopathic arthritis. Acta Med Iran. 2017 Nov;55(11):676-682.

591.    Zaki-Dizaji M, Akrami SM, Abolhassani H, Rezaei N, Aghamohammadi A. Ataxia telangiectasia syndrome: moonlighting ATM. Expert Rev Clin Immunol. 2017 Dec; 13(12):1155-1172.

592.    Dehghan HR, Yazdani Shormasti N, Rezaei N. Comparison of tetropium and β2 agonist therapy in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis. J Shahid Sadoughi Univ Med Sci 2017; 25(6):485-500.

593.    Salmaninejad A, Mahmoudi M, Aslani S, Poursani S, Ziaee V, Rezaei N. Association of STAT4 gene single nucleotide polymorphisms with Iranian juvenile-onset systemic lupus erythematosus patients. Turk J Pediatr. 2017;59(2):144-149.

594.    Rahamani F, Rezaei N. Brain-derived neurotrophic factor role in autism remains elusive: a flash back on the route that has brought us here. Acta Med Iran. 2017 Dec;55(12):733-735.

595.    Shabaninejad H, Asgharzadeh A, Rezapour A, Rezaei N. Cost-effectiveness analysis of subcutaneous immunoglobulin replacement therapy in Iranian patients with primary immunodeficiencies. Med J Islam Repub Iran. 2017 Dec;31:94.

596.    Sharifi L, Aghamohammadi A, Mohsenzadegan M, Rezaei N, Towfighi F, Bokaie S, Sayedi SJ, Azizi G, Mirshafiey A. Immunomodulation of TLR2 and TLR4 by G2013 (alfa-L-Guluronic acid) in CVID Patients. Int J Pediatr. 2017 July;5(7):5327-5337.

597.    Sharifi L, Tavakolinia N, Kiaee F, Rezaei N, Mohsenzadegan M, Shariat M, Yazdani R, Azizi G, Mirshafiey A, Aghamohammadi A. A review on defects of dendritic cells in common variable immunodeficiency. Endocr Metab Immune Disord Drug Targets. 2017;17(2):100-113.

598.    Mahmoudi M, Aslani S, Hamzeh E, Ziaei V, Poursani S, Nicknam MH, Rezaei N. Association study of MECP2 gene single nucleotide polymorphisms in juvenile-onset systemic lupus erythematosus patients from Iran. Fetal Pediatr Pathol. 2017 Dec;36(6):423-431.Ebrahimiyan H, Aslani S, Rezaei N, Jamshidi A, Mahmoudi M. Survivin and autoimmunity; the ins and outs. Immun Letter. 2018 Jan;193(1):14-24.

599.    Bashashati M, Moossavi S, Cremon C, Barbaro MR, Moraveji S, Talmon G, Rezaei N, Hughes PA, Bian ZX, Choi CH, Lee OY, Coëffier M, Chang L, Ohman L, Schmulson MJ, McCallum RW, Simren M, Sharkey KA, Barbara G. Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterol Motil. 2018 Jan;30(1):1-13.

600.    Rezaei N. Universal scientific education and research network (USERN): twinkling stars unite to make the world glow. Acta Med Iran. 2018 Jan;56(1):1-3.

601.    Shamsi Gooshki E, Pourabbasi A, Akbari H, Rezaei N, Arab Kheradmand A, Kheiry Z, Peykari N, Momeni Javid F, Hajipour F, Larijani B. Internationalization of medical education in Iran: A way towards implementation of the plans of development and innovation in medical education. J Adv Med Educ Prof. 2018 Jan;6(1):43-48.

602.    Najafi S, Mohammadzadeh M, Zahedi A, Heidari M, Rezaei N. Association of serotonin transporter gene polymorphism with recurrent aphthous stomatitis. Avicenna J Med Biotechnol. 2018 Jan-Mar;10(1):56-60.

603.    Rezaei H, Yousefi A, Larijani B, Dehnavieh R, Rezaei N, Adibi P. Internationalization or globalization of higher education. J Educ Health Promot. 2018 Jan 10;7:8. 

604.    Agah E, Zarduei A, Saghazadeh A, Ahmadi M, Tafakhori A, Rezaei N. Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis. PLoS ONE. 2018 Jan 18;13(1): e0190252.

605.    Assari R, Aghighi Y, Ziaee V, Sadr M, Rezaei A, Rahmani F, Sadr Z, Raeeskarami SR, Moradinejad MH, Rezaei N. Interleukin-4 cytokine single nucleotide polymorphisms in kawasaki disease: a case-control study and a review of knowledge. Int J Rheumat Dis. 2018 Jan;21(1):266-270.

606.    Mahmoudi M, Hamzeh E, Aslani S, Ziaee V, Poursani S, Rezaei N. Single nucleotide polymorphism of methyl-CpG-binding protein 2 gene associates with juvenile idiopathic arthritis. Clin Rheumatol. 2018 Feb;37(2):375-381.

607.    Rashid Chehreh Bargh S, Rahmani F, Rezaei N. Regulatory T lymphocytes in amyotrophic lateral sclerosis: emerging evidence to support adaptive immunotherapy? Acta Med Iran. 2018 Feb;56(2):74-76.

608.    Fathollahi A, Massoud A, Amirzargar AA, Aghili B, Nasli-Esfahani E, Rezaei N. sICAM-1, sVCAM-1 and sE-selectin levels in type 1 diabetes. Fetal Pediatr Pathol. 2018 Feb;37(1):69-73.

609.    Dehghani R, Rahmani F, Rezaei N. MicroRNA in alzheimer disease revisited: implications for major neuropathological mechanisms. Rev Neuroscience. 2018 Feb 23;29(2):161-182.

610.    Farajzadeh Valilou S, Keshavarz-Fathi M, Silvestris N, Argentiero A, Rezaei N. The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer. Cytokine Growth Factor Rev. 2018 Feb;39:46-61.

611.    Ghanei N, Rezaei N, Amiri GA, Zayeri F, Makki G, Nasseri E. The probiotic supplementation reduced inflammation in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. J Functional Foods. 2018 Mar:42:306-311.

612.    Kordjazy N, Haj-Mirzaian A, Haj-Mirzaian A, Rohani MM, Gelfand EW, Rezaei N, Abdolghaffari AH. Role of toll-like receptors in inflammatory bowel disease. Pharmacol Res. 2018 Mar;129:204-215.

613.    Ashournia P, Sadeghi P, Rezaei N, Moradinejad MH, Ziaee V. Prevalence of family history of autoimmune disorders in juvenile systemic lupus erythematosus. Medica. 2018;13(1):21-24.

614.    Behniafard, Amirzargar AA, Gharagozlou M, Delavari F, Hosseinverdi S, Sotoudeh S, Farhadi E, Mahmoudi M, Khaledi M, Gholizadeh Moghaddam Z, Aghamohammadi A, Rezaei N. Single nucleotide polymorphisms of the genes encoding IL-10 and TGF-β1 in Iranian children with atopic dermatitis. Allergol Immunopathol (Madr). 2018 Mar-Apr;46(2):155-159.

615.    Bashiri K, Rezaei N, Nasi M, Cossarizza A. The role of latency reversal agents in the cure of HIV: a review of current data. Immunology Letters. 2018 Apr;196:135-139.

616.    Yousefi A, Mahmoudi E, Najmi-Varzandeh F, Zare Bidoki A, Sadr M, Motamed F, Najafi M, Farhmand F, Khodadad A, Fallahi GH, Rezaei N. Autoimmune hepatitis association with single nucleotide polymorphism of interleukin-2, but not interferon-gamma. Clin Res Hepatol Gastroenterol. 2018 April;42(2):134-138.

617.    Abolhassani H, Chou J, Bainter W, Platt CD, Tavassoli M, Momen T, Tavakol M, Eslamian MH, Gharagozlou M, Movahedi M, Ghadami M, Hamidieh AA, Azizi G, Yazdani R, Afarideh M, Ghajar A, Havaei A, Chavoshzadeh Z, Mahdaviani SA, Cheraghi T, Behniafard N, Amin R, Aleyasin S, Faridhosseini R, Jabbari-Azad F, Nabavi M, Bemanian MH, Arshi S, Molatefi R, Sherkat R, Mansouri M, Mesdaghi M, Babaie D, Mohammadzadeh I, Ghaffari J, Shafiei A, Kalantari N, Ahanchian H, Khoshkhui M, Soheili H, Dabbaghzadeh A, Shirkani A, Nasiri Kalmarzi R, Mortazavi SH, Tafaroji J, Khalili A, Mohammadi J, Negahdari B, Joghataei MT, Al-Ramadi BK, Picard C, Parvaneh N, Rezaei N, Chatila TA, Massaad MJ, Keles S, Hammarström L, Geha RS, Aghamohammadi A. Clinical, immunological and genetic spectrum of 696 patients with combined immunodeficiency in Iran. J Allergy Clin Immunol. 2018 April;141(4):1450-1458.

618.    Hanaei S, Abdollahzadeh S, Sadr M, Mirbolouk MH, Khoshnevisan A, Rezaei N. Association of IL10 and TGFB single nucleotide polymorphisms with intervertebral disc degeneration in Iranian population: A case control study. BMC Med Genet. 2018 Apr 10;19(1):59.

619.    Zaridoust A, Rabbani A, Hosseinverdi S, Hilbert P, Rezaei N. Novel homozygous mutation in the AGPAT2 gene in a child with Berardinelli-Seip Congenital Lipodystrophy syndrome. Acta Med Iran. 2018 Apr;56(4):278-280.

620.    Hedayat M, Mahmoudi MJ, Taghvaei M, Nematipour E, Farhadi E, Esfahanian N, Mahmoudi M, Sadr M, Nourijelyani K, Amirzargar AA, Rezaei N. Tumor necrosis factor-alpha and interleukin-6 gene polymorphisms in Iranian patients with ischemic heart failure. Avicenna J Med Biotechnol. 2018 Apr-Jun;10(2):105-109.

621.    Zare Bidoki A, Massoud A, Najafi S, Mohammadzadeh M, Rezaei N. Autosomal dominant deficiency of the interleukin-17F in recurrent aphthous stomatitis: possible novel mutation in a new entity. Gene. 2018 May;654:64-68.

622.    Farrokhi S, Shabani M, Aryan Z, Zoghi S, Boztug K, Rezaei N. MHC class II deficiency: Report of a novel mutation and special review. Allergol Immunopathol (Madr). 2018 May-Jun;46(3):263-275.

623.    Harsini S, Saghazadeh A, Nedjat S, Rezaei N. Associations between interleukin-10 polymorphisms and susceptibility to juvenile idiopathic arthritis: A systematic review and meta-analysis. Eur Cyt Netw. 2018 Mar;29(1):16-26.

624.    Sharifi L, Aghamohammadi A, Rezaei N, Yazdani R, Mahmoudi M, Amiri MM, Masoumi F, Bokaie S, Tavasolian P, Sanaei R, Moshiri M, Tavakolinia N, Alinia T, Azizi G, Mirshafiey A. The profile of toll-like receptor 2 (TLR2), TLR4 and their cytosolic downstream signaling pathway in common variable immunodeficiency (CVID) patients. Iran J Allergy Asthma Immunol. 2018 Apr;17(2):188-200.

625.    Fallah S, Mesdaghi M, Mansouri M, Babaei D, Karimi A, Fahimzad SA, Armin S, Rafiei Tabatabaei S, Azma R, Khanbabaee G, Bashardoost B, Amirmoeini M, Sadr S, Jalilianhasanpour R, Ghanaei R, Rezaei N, Chavoshzadeh Z. Severe combined immunodeficiency: a case series and review from a tertiary pediatric hospital. Iran J Allergy Asthma Immunol. 2018 Apr;17(2):201-207.

626.    Rezahosseini O, Hanaei S, Hamadani M, Keshavarz-Fathi M, Rezaei N. The promising role of monoclonal antibodies for Immunotherapy of the HIV associated cancer, non-Hodgkin lymphoma. Int Rev Immunol. 2018;37(3):165-173.

627.    Eskandari V, Amirzargar AA, Moazzami B, Mahmoudi MJ, Rahnemoon Z, Sadati S, Rahmati Z, Gorzin F, Hedayat M, Rezaei N. Increased levels of IL-23 in peripheral blood mononuclear cells of patients with chronic heart failure. Acta Med Iran. 2018 May;56(5):285-300.

628.    Sharifi L, Mohsenzadegan M, Aghamohammadi A, Rezaei N, Zavareh FT, Bokaie S, Moshiri M, Aghazadeh Z, Norouzbabaie Z, Azizi G, Mirshafiey A,. Immunomodulatory effect of G2013 (a-L-Guluronic acid) on the TLR2 and TLR4 in human mononuclear cells. Curr Drug Discov Technol. 2018;15(2):123-131.

629.    Eskandari V, Amirzargar AA, Mahmoudi MJ, Rahnemoon Z, Rahmani F, Sadati S, Rahmati Z, Gorzin F, Hedayat M, Rezaei N. Gene expression and levels of IL-6 and TNFα in PBMCs correlate with severity and functional class in patients with chronic heart failure. Ir J Med Sci. 2018 May;187(2):359-368.

630.    Assari R, Aghighi Y, Ziaee V, Sadr M, Rahmani F, Rezaei A, Sadr Z, Moradinejad MH, Raeeskarami SR, Rezaei N. Pro-inflammatory cytokine single nucleotide polymorphisms in Kawasaki disease. Int J Rheumat Dis. 2018 May;21(5):1120-1126.

631.    Hanaei S, Sadr M, Rezaei A, Shahkarami S, Ebrahimi Daryani N, Bidoki AZ, Rezaei N. Association of NLRP3 single nucleotide polymorphisms with ulcerative colitis: a case-control study. Clin Res Hepatol Gastroenterol. 2018 Jun:42(3):269-275.

632.    Béziat V, Li J, Lin JX, Ma CS, Li P, Bousfiha A, Pellier I, Zoghi S, Baris S, Keles S, Gray P, Du N, Wang Y, Zerbib Y, Lévy R, Leclercq T, About F, Lim AI, Rao G, Payne K, Pelham SJ, Avery DT, Deenick EK, Pillay B, Chou J, Guery R, Belkadi A, Guérin A, Migaud M, Rattina V, Ailal F, Benhsaien I, Bouaziz M, Habib T, Chaussabel D, Marr N, El-Benna J, Grimbacher B, Wargon O, Bustamante J, Boisson B, Müller-Fleckenstein I, Fleckenstein B, Chandesris MO, Titeux M, Fraitag S, Alyanakian MA, Leruez-Ville M, Picard C, Meyts I, Di Santo JP, Hovnanian A, Somer A, Ozen A, Rezaei N, Chatila TA, Abel L, Leonard WJ, Tangye SG, Puel A, Casanova JL. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity. Sci Immunol. 2018 Jun 15;3(24). pii: eaat4956.

633.    Hanaei S, Afshari K, Hirbod-Mobarakeh A, Mohajer B, Amir Dastmalchi D, Rezaei N. Therapeutic efficacy of specific immunotherapy for glioma: A systematic review and meta-analysis. Rev Neurosci. 2018 Jun 27;29(4):443-461.

634.    Eskian M, Khorasanizadeh MH, Zinzani PL, Rezaei N. Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma. Immunotherapy. 2018 Jun;10(8):699-711.

635.    Sadeghi-Shabestrai M, Dousti S, Rezamand A, Harsini S, Rezaei N. A single center survey of patients with congenital neutropenia: report from northwestern Iran. Acta Med Iran. 2018 Jun;56(6):372-378.

636.    Amanat M, Salehi M, Rezaei N. A guideline for early diagnosis of autoimmune epilepsy based on clinical manifestations and common para-clinical tests. Acta Med Iran. 2018 Jun;56(6):419-420.

637.    Sadeghi M, Keshavarz-Fathi M, Baracos V, Arends J, Mahmoudi M, Rezaei N. Cancer cachexia: diagnosis, assessment, and treatment. Crit Rev Oncol/Hematol. 2018 Jul:127:91-104.

638.    Azizi G, Abolhassani H, Zaki-Dizaji M, Habibi S, Mohammadi H, Shaghaghi M, Yazdani R, Anaya JM, Rezaei N, Hammarström L, Aghamohammadi A. Polyautoimmunity in patients with LPS-Responsive Beige-Like Anchor (LRBA) deficiency. Immunol Invest. 2018 Jul:47(5):457-467.

639.    Mahmoudi MJ, Harsini S, Farhadi E, Hedayat M, Taghvaei M, Mahmoudi M, Sadr M, Esfahanian N, Nematipour E, Nourijelyani K, Amirzargar AA, Rezaei N. Interleukin-2 and interferon-gamma single nucleotide polymorphisms in Iranian patients with chronic heart failure. Avicenna J Med Biotechnol. 2018 Jul-Sep;10(3):173-177.

640.    Shahrezaee M, Keshtkari S, Moradi-Lakeh M, Abbasifard M, Alipour V, Amini S, Arabloo J, Arzani A, Bakhshaei M, Barzegar A, Bijani A, Dianatinasab M, Eskandarieh S, Gheshlagh RG, Ghashghaee A, Heidari-Soureshjani R, Irvani SSN, Lahimchi A, Maleki S, Manafi N, Manafi A, Mansournia MA, Mohammadian-Hafshejani A, Bandpei MAM, Moradzadeh R, Naderi M, Pakshir K, Rafiei A, Rashedi V, Rezaei N, Rezapour A, Sahraian MA, Shahabi S, Shamsi M, Soheili A, Soroush A, Zamani M, Mohajer B, Farzadfar F. Burden of musculoskeletal disorders in Iran during 1990-2017: estimates from the Global Burden of Disease Study 2017. Arch Osteoporos. 2020 Jul 10;15(1):103. doi: 10.1007/s11657-020-00767-8.

641.    Abdollahzadeh A, Hanaei S, Sadr M, Mirbolouk MH, Fattahi E, Rezaei N, Khoshnevisan A. Significant association of TNF-α, but not other pro-inflammatory cytokines, single nucleotide polymorphisms with intervertebral disc degeneration in Iranian population. Clin Neurol Neurosurg. 2018 Aug;173(10):77-83.

642.    Eskian M, Khorasanizadeh M, Assa’ad AH, Rezaei N. Monoclonal antibodies for treatment of eosinophilic esophagitis. Clin Rev Allergy Immunol. 2018 Aug;55(1):88-98.

643.    Rahmati Z, Amirzargar AA, Saadati S, Rahmani F, Mahmoudi MJ, Rahnemoon Z, Eskandari V, Gorzin F, Hedayat M, Rezaei N. Association of levels of interleukin 17 and T-helper 17 count with symptom severity and etiology of chronic heart failure: a case-control study. Croat Med J. 2018 Aug;59(4):139-148.

644.    Alizadeh Attar MK, Anwar MA, Eskian M, Choi S, Keshavarz-Fathi M, Rezaei N. Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis. Medicinal Res Rev. 2018 Sep;38(5):1469-1484.

645.    Fathollahi A, Aslani S, Mostafaei S, Rezaei N, Mahmoudi M. The role of killer-cell immunoglobulin-like receptor (KIR) genes in susceptibility to inflammatory bowel disease: systematic review and meta-analysis. Inflam Res. 2018 Sep;67(9):727-736.

646.    Esmaeili Reykande S, Rezaei A, Sadr M, Shabani M, Najmi Varzaneh F, Ziaee V, Rezaei N. Association of interferon regulatory factor 5 (IRF5) gene polymorphisms with juvenile idiopathic arthritis. Clin Rheumatol. 2018;37(10):2661-2665.

647.    Abolhassani H, Kiaee F, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Yazdani R, Azizi G, Habibi S, Gharagozlou M, Movahedi M, Hamidieh AA, Behniafard N, Nabavi M, Bemanian MH, Arshi S, Molatefi R, Sherkat R, Shirkani A, Amin R, Aleyasin S, Faridhosseini R, Jabbari-Azad F, Mohammadzadeh I, Ghaffari J, Shafiei A, Kalantari A, Mansouri M, Mesdaghi M, Babaie D, Ahanchian H, Khoshkhui M, Soheili H, Eslamian MH, Cheraghi T, Dabbaghzadeh A, Tavassoli M, Kalmarzi RN, Mortazavi SH, Kashef S, Esmaeilzadeh H, Tafaroji J, Khalili A, Zandieh F, Sadeghi-Shabestari M, Darougar S, Behmanesh F, Akbari H, Zandkarimi M, Abolnezhadian F, Fayezi A, Moghtaderi M, Ahmadiafshar A, Shakerian B, Sajedi V, Taghvaei B, Safari M, Heidarzadeh M, Ghalebaghi B, Fathi SM, Darabi B, Bazregari S, Bazargan N, Fallahpour M, Khayatzadeh A, Javahertrash N, Bashardoust B, Zamani M, Mohsenzadeh A, Ebrahimi S, Sharafian S, Vosughimotlagh A, Tafakoridelbari M, Rahimi M, Ashournia P, Razaghian A, Rezaei A, Mamishi S, Parvaneh N, Rezaei N, Hammarström L, Aghamohammadi A. Fourth update on the Iranian National Registry of Primary Immunodeficiencies: integration of molecular diagnosis. J Clin Immunol. 2018 Oct;38(7):816-832.

648.    Najafi S, Mohammadzadeh M, Zare Bidoki A, Yousefi H, Farhadi E, Rajabi F, Rezaei N. Interleukin-4 and interleukin-4 receptor alpha gene polymorphisms in recurrent aphthous stomatitis. Immunol Invest. 2018 Oct;47(7):680-688.

649.    Zoghi S, Ziaee V, Hirschmugl T, Jimenez-Heredia R, Krolo A, Boztug K, Rezaei N. Exome sequencing revealed C1Q homozygous mutation in pediatric systemic lupus erythematosus. Allergol Immunopathol (Madr). 2018 Nov;46(6):594-598.

650.    Rashid Chehreh Bargh S, Tafakhori A, Masoumi F, Rahmani F, Ahmadi M, Namdar A, Azimi M, Tavasolian P, Habibi S, Zamani B, Maserrat M, Sadr M, Noorbakhsh F, Rezaei N. Evaluation of regulatory T lymphocytes and IL2Ra and FOXP3 gene expression in peripheral mononuclear cells from patients with amyotrophic lateral sclerosis. Irish J Med Sci. 2018 Nov;187(4):1065-1071.

651.    Eskian M, Khorasanizadeh MH, Isidori A, Rezaei N. Radioimmunotherapy-based conditioning regimen prior to autologous stem cell transplantation in non-Hodgkin lymphoma. Int J Hematol Oncol. 2018 Jun 13;7(1):IJH01.

652.    Rajabi F, Drake LA, Senna MM, Rezaei N. Alopecia areata: a review of disease pathogenesis. Br J Dermatol. 2018 Nov;179(5):1033-1048.

653.    Azizi G, Mirshafiey A, Abolhassani H, Yazdani R, Noorbakhsh F, Rezaei N, Aghamohammadi A. The imbalance of circulating T helper subsets and regulatory T cells in patients with LRBA deficiency: correlation with disease severity. J Cell Physiol. 2018 Nov;233(11):8767-8777.

654.    Imani D, Azimi A, Salehi Z, Rezaei N, Emamnejad R, Sadr M, Izad M. Association of nod-like receptor protein-3 single nucleotide gene polymorphisms and expression with the susceptibility to relapsing-remitting multiple sclerosis. Int J Immunogenet. 2018 Dec;45(6):329-336.

655.    Agah E, Saleh F, Sanjari Moghaddam H, Saghazadeh A, Tafakhori A, Rezaei N. CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis. Syst Rev. 2018 Dec 20;7(1):237.

656.    Daryabor G, Harsini S, Rezaei N. Immunopathogenesis of ankylosing spondylitis: An updated review. Acta Med Iran. 2018 Apr;56(4):213-225.

657.    Fallahi GH, Khatami GR, Esmailzadeha N, Najafi M, Farahmand F, Motamed F, Khodadad A, Rezaei N, Modarresi MR, Qorbani M, Bagherian R. Association of food allergy, cow’s milk allergy, and asthma with pediatric inflammatory bowel disease. Acta Med Iran. 2018 May;56(5):329-333.

658.    Baharlooi H, Rezaei N, Sharif-Paghaleh E. CXCR4 is important for lymphopoiesis not only in mice, but also in man. Acta Med Iran. 2018 Jul;56(7):482-483.

659.    Yousefi A, Najafi M, Motamed F, Mahmoudi E, Zare Bidoki A, Sadr M, Rahmani F, Farhmand F, Khodadad A, Fallahi G, Rezaei N. Association of interleukin-6 and interleukin-1 family gene polymorphisms in autoimmune hepatitis. Ann Hepatol. 2018 Oct;17(6):1021-1025.

660.    Eghbali A, Rahmani F, Aryan Z, Borkhardt A, Tanzifi P, Zoghi S, Rezaei N. Non-pathogenic heterozygous polymorphism in RAB27A gene in a case suspicious to Griscelli syndrome, type II. Acta Med Iran. 2018 Aug;56(8):494-497.

661.    Bahrami A,  Sadeghian M,  Sheikhvatan M, Foroudi A, Harsini S, Rezaei N. Cytomegalovirus infection in a patient with leukocyte adhesion deficiency type 1. Acta Med Iran. 2018 Aug;56(8):544-546.

662.    Zoghi S, Rezaei N. Whole exome sequencing could help to distinguish between pediatric systemic lupus erythematosus and primary immunodeficiency disease. Acta Med Iran. 2018 Sep;56(9):557-558.

663.    Amanat M, Salehi M, Rezaei N. The role of immune system dysfunction in co-existence of neurological disorders in psoriasis. Acta Med Iran. 2018 Sep;56(9):620-622.

664.    Rayzan E, Rezaei N. Cancer immunotherapy: the way to the Nobel Prize in medicine. Acta Med Iran. 2018 Oct;56(10):623-624.

665.    Saghazadeh A, Tonekaboni SH, Najmabadi H, Rezaei N. A novel homozygous ATP8A2 variant in a patient with phenotypic features of dysequilibrium syndrome. Acta Med Iran. 2018 Oct;56(10):677-680.

666.    Fallahi G, Rashtian P, Aflatoonian M, Babaei N, Gaisari M, Rezaei N. Gastrointestinal manifestations in a child with mastocytosis. Acta Med Iran. 2018 Oct;56(10):684-687.

667.    Yousefzadegan S, Tavakol M, Abolhassani H, Nadjafi A, Mansouri S, Yazdani R, Azizi G, Negahdari B, Rezaei N, Aghamohammadi A. Systematic investigation for underlying causes of recurrent infections in children: surveillance of primary immunodeficiency. Eur Ann Allergy Clin Immunol. 2018 Mar;50(2):72-80.

668.    Shahkarami S, Mehrasa R, Younesian S, Yaghmaie M, Chahardouli B, Vaezi M, Rezaei N, Nikbakht M, Alimoghaddam K, Ghavamzadeh A, Tavakkoly-Bazzaz J, Ghaffari SH. Minimal residual disease (MRD) detection using rearrangement of immunoglobulin/T cell receptor genes in adult patients with acute lymphoblastic leukemia (ALL). Ann Hematol. 2018 Apr;97(4):585-595.

669.    Azizi G, Mirshafiey A, Abolhassani H, Yazdani R, Ansariha FJ, Shaghaghi M, Mortazavi-Jahromi SS, Noorbakhsh F, Rezaei N, Aghamohammadi A. The circulating T helper subsets and regulatory T cells in patients with common variable immunodeficiency with no known monogenic disease. J Investig Allergol Clin Immunol. 2018;28(3):172-181.

670.    Shaghaghi M, Soleyman-Jahi S, Abolhassani H, Yazdani R, Azizi G, Rezaei N, Barbouche MR, McKinlay MA, Aghamohammadi A. New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data. Vaccine. 2018 Mar 20;36(13):1711-1719.

671.    Farzaei AH, ElSenduny F, Momtaz S, Parvizi F, Iranpanah A, Tewari D, Abdolghaffari AH, Rezaei N. An update on dietary consideration in inflammatory bowel disease: anthocyanins and more. Expert Rev Gastroenterol Hepatol. 2018;12(10):1007-1024.

672.    Sodagari HR, Aryan Z, Abdolghaffari AH, Rezaei N, Sahebkar A. Immunomodulatory and anti-inflammatory phytochemicals for the treatment of inflammatory bowel disease (IBD): - turning strong rationale into strong evidence? J Pharmacopuncture. 2018 Dec;21(4):294-295.

673.    Imani D, Rezaei R, Razi B, Alizadeh S, Jafari D, Bashashati M, Rezaei N. IL-6 174 G/C polymorphism in inflammatory bowel disease: a systematic review and meta-analysis. Acta Med Iran. 2018 Dec;56(12):740-749.

674.    Bahrami A, Soltani Z, Fazlollahi MR, Rahmani F, Mazinani M, Houshmand M, Rezaei N. Adenoid hyperplasia in a patient with a rare type of hyper immunoglobulin M syndrome due to CD40 deficiency. Acta Med Iran. 2018 Dec;56(12):811-814.

675.    Rahmani F, Saghazadeh A, Rahmani M, Teixeira AL, Rezaei N, Aghamollaei V, Ardebili HE. Plasma levels of brain-derived neurotrophic factor in patients with parkinson disease: a systematic review and meta-analysis. Brain Res. 2019; 1704:127-136.

676.    Abolhassani H, Aghamohammadi A, Fang M, Rezaei N, Jiang C, Liu X, Pan-Hammarström Q, Hammarström L. Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency. Genet Med. 2019 Jan;21(1):243-251.

677.    Ebrahimi Daryani N, Sadr M, Soltani S, Saghazadeh A, Moossavi S, Shahkarami S, Farhadi E, Rezaei N. Association of T helper 1 cytokine gene single nucleotide polymorphisms with ulcerative colitis and crohn’s disease. Dig Dis. 2019;37(1):21-32.

678.    Rahmani F, Keshavarz-Fathi M, Hanaei S, Aminorroaya A, Delavari F, Paryad-zanjani S, Ahmadi NS, Akbari P, Ashkevarian S, Barghi F, Ebadirad S, Jaberipour A, Kolahi MR, Moallemian M, Pourebrahimi A, Samimiat A, Vahedi Z, Ladi Seyedian SS, Rezaei N. Universal scientific education and research network (USERN): step strong in scientific networking. Acta Med Iran. 2019 Jan;57(1):1-4.

679.    Eskian M, Alavi A, Khorasanizadeh M, Viglianti BL, Jacobsson H, Barwick TD, Meysamie A, Yi SK, Iwano S, Bybel B, Caobelli F, Lococo F, Gea J, Sancho-Muñoz A, Schildt J, Tatcı E, Lapa C, Keramida G, Peters M, Boktor RR, John J, Pitman AG, Mazurek T, Rezaei N. Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements. Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):224-237.

680.    Spoor J, Farajifard H, Rezaei N. Congenital neutropenia and primary immunodeficiency diseases. Crit Rev Oncol/Hematol. 2019 Jan;133(1):149-162.

681.    Yazdani R, Shapoori S, Rezaeepoor M, Sanaei R, Ganjalikhani-Hakemi M, Azizi G, Rae W, Aghamohammadi A, Rezaei N. Features and roles of T helper 9 cells and interleukin 9 in immunological diseases. Allergol Immunopathol (Madr). 2019 Jan; 47(1):90-104.

682.    Razi B, Reykandeh SE, Alizadeh S, Amirzargar AA, Saghazadeh A, Rezaei N. TIM family gene polymorphism and susceptibility to rheumatoid arthritis: systematic review and meta-analysis. PLoS ONE. 2019 Feb 7;14(2):e0211146.

683.    Afshari F, Soleyman-Jahi S, Keshavarz-fathi M, Roviello G, Rezaei N. The promising role of monoclonal antibodies for gastric cancer treatment. Immunotherapy. 2019 Mar;11(4):347-364.

684.    Yazdani R, Abolhassani H, Kiaee F, Habibi S, Azizi G, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Gharagozlou M, Movahedi M, Hamidieh AA, Behniafard N, Nabavi M, Bemanian MH, Arshi S, Molatefi R, Sherkat R, Shirkani A, Amin R, Aleyasin S, Faridhosseini R, Jabbari-Azad F, Mohammadzadeh I, Ghaffari J, Shafiei A, Kalantari A, Mansouri M, Mesdaghi M, Babaie D, Ahanchian H, Khoshkhui M, Soheili H, Eslamian MH, Cheraghi T, Dabbaghzadeh S, Tavassoli M, Kalmarzi RN, Mortazavi SH, Kashef S, Esmaeilzadeh H, Tafaroji J, Khalili A, Zandieh F, Sadeghi-Shabestari M, Darougar S, Behmanesh F, Akbari H, Zandkarimi M, Abolnezhadian F, Fayezi A, Moghtaderi M, Ahmadiafshar A, Shakerian B, Sajedi V, Taghvaei B, Safari M, Heidarzadeh M, Ghalebaghi B, Fathi SM, Darabi B, Bazregari S, Bazargan N, Fallahpour M, Khayatzadeh A, Javahertrash N, Bashardoust B, Zamani M, Mohsenzadeh A, Ebrahimi S, Sharafian S, Vosughimotlagh A, Tafakoridelbari M, Rahim M, Ashournia P, Razaghian A, Rezaei A, Samavat A, Mamishi S, Khazaei HA, Mohammadi J, Negahdari B, Parvaneh N, Rezaei N, Lougaris V, Giliani S, Plebani A, Ochs HD, Hammarström L, Aghamohammadi A. Comparison of common monogenic defects in a large predominantly antibody deficiency cohort. J Allergy Clin Immunol Pract. 2019 Mar;7(3):864-878.

685.    El-Sayed ZA, Abramova I, Aldave JC, Al-Herz W, Bezrodnik L, Boukari R, Bousfiha AA, Cancrini C, Condino-Neto A, Dbaibo G, Derfalvi B, Dogu F, Edgar JDM, Eley B, El-Owaidy RH, Espinosa-Padilla SE, Galal N, Haerynck F, Hanna-Wakim R, Hossny E, Ikinciogullari A, Kamal E, Kanegane H, Kechout N, Lau YL, Morio T, Moschese V, Neves JF, Ouederni M, Paganelli R, Paris K, Pignata C, Plebani A, Qamar FN, Qureshi S, Radhakrishnan N, Rezaei N, Rosario N, Routes J, Sanchez B, Sediva A, Seppanen MR, Serrano EG, Shcherbina A, Singh S, Siniah S, Spadaro G, Tang M, Vinet AM, Volokha A, Sullivan KE. X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the world. World Allergy Organ J. 2019 Mar 22;12(3):100018.

686.    Sanaei R, Rezaei N, Aghamohammadi A, Delbandi AA, Teimourian S, Yazdani R, Tavasolian P, Kiaee F, Tajik N. Evaluation of the TLR negative regulatory network in CVID patients. Genes Immun. 2019 Mar;20(3):198-206.

687.    Yousefi A, Zare Bidoki A, Shafioyoun A, Sadr M, Shabani M, Motamed F, Farahmand F, Khodadad A, Fallahi G, Najafi M, Rezaei N. Association of IL-10 and TGF-beta cytokine gene polymorphisms with autoimmune hepatitis. Clinics Research Hepatol Gastroenterol. 2019;43:45-50.

688.    Pastaki Khoshbin A, Eskian M, Keshavarz-Fathi M, Rezaei N. Roles of myeloid-derived suppressor cells in cancer metastasis: Immunosuppression and beyond. Arch Immunol Ther Exp (Warsz). 2019;67(2):89-102.

689.    Razi S, Baradaran Noveiry B, Keshavarz-Fathi M, Rezaei N. IL-17 and colorectal cancer: from carcinogenesis to treatment. Cytokine. 2019 Apr;116:7-12.

690.    Khalili N, Keshavarz-Fathi M, Shahkarami S, Hirbod-Mobarakeh A, Rezaei N. Passive-specific immunotherapy with monoclonal antibodies for prostate cancer: A systematic review. J Oncol Pharm Pract. 2019;25(4):903-917.

691.    Aghamohammadi A, Akrami SM, Yaghmaie M, Rezaei N, Azizi G, Yaseri M, Nosrati H, Zaki-Dizaji M. Individual radiosensitivity assessment of the families of ataxia-telangiectasia patients by G2-checkpoint abrogation. Sultan Qaboos Univ Med J. 2018 Nov;18(4):e440-e446.

692.    Yazdani R, Amirifar P, Abolhassani H, Azizi G, Parvaneh N, Rezaei N, Aghamohammadi A. UNC13D deficiency associated with epileptic seizures and antibody deficiency: the first case from the Iranian National registry. J Investig Allergol Clin Immunol. 2019 Apr;29(2):160-162.

693.    Amanat M, Salehi M, Rezaei N. Autoimmune encephalitis in brief. Acta Med Iran. 2019 Feb:57(2):78-82.

694.    Tavasolian P, Aghamohammadi A, Noorbakhsh F, Sanaei R, Shabani M, Rezaei N. Toll like receptors pathway in common variable immune deficiency (CVID) and X-linked agammaglobulinemia (XLA). Eur Cyt Netw. 2018 Nov 1;29(4):153-158.

695.    Farajifard H, Zavvar M, Rajaei T, Noorbakhsh F, Nikougoftar-zarif M, Azadmanesh K, Kompani F, Rezaei N. In vitro study of HAX1 gene therapy by retro viral vector as a therapeutic target in severe congenital neutropenia. Eur Cyt Netw. 2018 Nov 1;29(4):146-152

696.    Kheiri G, Dolatshahi M, Rahmani F, Rezaei N. Role of P38/MAPKs in Alzheimer’s disease: implications for amyloid beta toxicity targeted therapy. Rev Neurosci. 2019;30(1):9-30.

697.    Shabani M, Aleyasin S, Kashef S, Zoghi S, Deswarte C, Casanova JL, Bustamante J, Rezaei N. A novel recessive mutation of interferon-γ receptor 1 in a patient with mycobacterium tuberculosis in bone marrow aspirate. J Clin Immunol. 2019 Feb;39(2):127-130.

698.    Ebrahimi Soltani Z, Rahmani F, Rezaei N. Autoimmunity in Guillain-Barrè syndrome revisited: review of pathomechanisms with eyes on therapeutic options. Eur Cyt Netw. 2019 Mar 1;30(1):1-14.

699.    Eskian M, Khorasanizadeh MH, Zinzani PL, Illidge TM, Rezaei N. Novel methods to improve the efficiency of radioimmunotherapy for non-hodgkin lymphoma. Int Rev Immunol. 2019;38(2):79-91.

700.    Mahmoudi MJ, Hedayat M, Taghvaei M, Harsini S, Nematipour E, Farhadi E, Mahmoudi M, Sadr M, Esfahanian N, Nourijelyani K, Amirzargar AA, Rezaei N. Interleukin-10 and transforming growth factor beta1 gene polymorphisms in chronic heart failure. Acta Biomed. 2019 May 23;90(2):221-227

701.    Saghazadeh A, Ataeinia B, Keynejad K, Abdolalizadeh A, Hirbod-Mobarakeh A, Rezaei N. A meta-analysis of pro-inflammatory cytokines in autism spectrum disorders: Effects of age, gender, and latitude. J Psychiatr Res. 2019 May 18;115:90-102.

702.    Tavassoli M, Abolhassani H, Yazdani R, Ghadami M, Azizi G, Abdolrahim Poor Heravi S, Moeini Shad T, Kokabee M, Movahedi M, Abdshahzadeh H, Gharagozlou M, Rezaei N, Esmaeilzadeh H, Aleyasin S, Aghamohammadi A. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: a long-term follow-up and genetic analysis. Ped Allergy Immunol. 2019 Jun;30(4):469-478.

703.    Jabbari P, Rezaei N. Artificial intelligence and immunotherapy. Expert Rev Clin Immunol. 2019:15(7):689-691.

704.    Mahmoudi M, Taghavi-Farahabadi M, Rezaei N, Hashemi SM. Comparison of the effects of adipose tissue mesenchymal stromal cellderived exosomes with conditioned media on neutrophil function and apoptosis. Int Immunopharmacol. 2019 Sep;74:105689.

705.    GBD 2017 Childhood Cancer Collaborators. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017. Lancet Oncol. 2019 Sep;20(9):1211-1225.

706.    Shahbazi Z, Yazdani R, Shahkarami S, Shahbazi S, Hamid M, Sadeghi-Shabestari M, Momen T, Aleyasin S, Esmaeilzadeh H, Darougar S, Delavari S, Mahdaviani SA, Ahanchian H, Behmanesh F, Kiaee F, Shariat M, Keramatipour M, Rezaei N, Abolhassani H, Parvaneh N, Mahdian R, Aghamohammadi A. Genetic mutations and immunological features of severe combined immunodeficiency patients in Iran. Immunol Lett. 2019;216:70-78.

707.    Saghazadeh A, Ataeinia B, Keynejad K, Abdolalizadeh A, Hirbod-Mobarakeh A, Rezaei N. Anti-inflammatory cytokines in autism spectrum disorders: A systematic review and meta-analysis. Cytokine. 2019 Nov;123:154740.

708.    Farahmand F, Ahmadi M, Khodadad A, Najafi M, Fallahi G, Motamed F, Movahedi M, Aghamohammadi A, Rezaei N, Javaherizadeh H. IgG4 subclass and gamma-glutamyl transferase in children with ulcerative colitis with primary sclerosing cholangitis and without sclerosing cholangitis. Clin Exp Hepatol. 2019 Nov;5(4):285-288.

709.    Mahalleh M, Shabani M, Rayzan E, Rezaei N. Reinforcing the primary immunotherapy modulators against acute leukemia; monoclonal antibodies in AML. Immunotherapy. 2019 Dec;11(18):1583-1600.

710.    Rahmani F, Ziaee V, Assari R, Sadr M, Rezaei A, Sadr Z, Raeeskarami SR, Moradinejad MH, Aghighi Y, Rezaei N. Interleukin 10 and transforming growth factor beta polymorphisms as risk factors for kawasaki disease: a case-control study and meta-analysis. Avicenna J Med Biotechnol. 2019 Oct-Dec;11(4):325-333.

711.    Mahmoudi M, Taghavi-Farahabadi M, Namaki S, Baghaei K, Rayzan E, Rezaei N, Hashemi SM. Exosomes derived from mesenchymal stem cells improved function and survival of neutrophils from severe congenital neutropenia patients in vitro. Hum Immunol. 2019 Dec;80(12):990-998.

712.    Rezaei H, Yousefi A, Larijani B, Dehnavieh R, Rezaei N, Kazemi M, Adibi P. Forecasting Iran’s international collaborative articles in medical sciences. Med J Islam Repub Iran. 2019 Aug 17;33:84.

713.    Pourvali A, Arshi S, Nabavi M, Bemanian MH, Shokri S, Shahrooei M, Rezaei N, Fallahpour M. Atypical Omenn syndrome due to RAG2 gene mutation, a case report. Iran J Immunol. 2019 Dec;16(4):334-338.

714.    Momtazmanesh S, Zare-Shahabadi A, Rezaei N. Cytokine alterations in schizophrenia: an updated review. Front Psychiatry. 2019 Dec 6;10:892.

715.    GBD 2017 Pancreatic Cancer Collaborators. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019 Dec;4(12):934-947.

716.    GBD 2017 Colorectal Cancer Collaborators. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019 Dec;4(12):913-933.

717.    Amirsardari Z, Rahmani F, Rezaei N. Cognitive impairments in HCV infection: from pathogenesis to neuroimaging. J Clin Exp Neuropsychol. 2019 Dec;41(10):987-1000.

718.    Sharifi L, Aghamohammadi A, Rezaei N, Yazdani R, Rezaei F, Bokaie S, Zavareh FT, Kiaee F, Kamali AN, Azizi G, Mirshafiey A. Interleukin-1β and interleukin-6 in common variable immunodeficiency and their association with subtypes of B cells and response to the Pneumovax-23 vaccine. Eur Cytokine Netw. 2019 Dec 1;30(4):123-129.

719.    Moazzami B, Moazzami K, Rezaei N. Early onset inflammatory bowel disease: manifestations, genetics and diagnosis. Turk J Pediatr. 2019;61(5):637-647.

720.    Bahrami T, Farajzadeh Valilou S, Soltani S, Sadr M, Salmaninejad A, Soltaninejad E, Yekaninejad MS, Ziaee V, Rezaei N. PTPN22 gene polymorphisms in pediatric systemic lupus erythematosus. Fetal Pediatr Pathol. 2019;39(1):13-20.

721.    Momtazmanesh S, Rahmani F, Delavari F, Vahedi Z, Ebadirad S, Keshavarz-Fathi M, Moallemian M, Ashkevarian S,  Kolahi MR, Samimiat A, Raei N, Rouzrokh P, Alesaeidi A, Jaberipour A, Bakhshi S, Paryad-Zanjani S, Perc M, Uddin LQ, Allali A, Sullivan K, Taher A, Baris S, Ozen A, Karakoc-Aydiner E, Aldave JC, Abdul Latiff AH, Al-Herz W, Phantumvanit P, Stashchak A, Kryvenko O, Stashchak M, Utomo D. Salunke D, Kelishadi K, Hedayati M, MirzaHosseini S, Bondarenko A, Goudouris E, Condino-Neto A, Nuno Vieira D, Ulrichs T, Pavalkis D, Rosivall L, Ochs HD, Rezaei N. U100: An innovative USERN platform for education and research without borders. Acta Med Iran. 2020 Jan. 58(1):1-3

722.    Rezaei A, Harsini S, Sadr M, Ziaee V, Rezaei N. Interleukin-23 receptor gene polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Allergol Immunopathol (Madr). 2020 Jan;48(1):62-66.

723.    GBD 2017 Stomach Cancer Collaborators. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol. 2020 Jan;5(1):42-54.

724.    GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30.

725.    Hanaei S, Abdollahzade S, Sadr M, Mirbolouk MH, Fattahi E, Khoshnevisan A, Rezaei N. The role of interleukin 4 and IL-4RA in intervertebral disc degeneration: investigation of single nucleotide polymorphisms in genes and a systematic review & meta-analysis of IL-4 expression level. Brit J Neurosurg. 2020 Jan;34(1):66-71.

726.    Nabavi M, Aryan Z, Shabani M, Keles S, Zoghi S, Chatila T, Rezaei N. Hypomorphic DOCK8 deletion causes hyper eosinophilia syndrome. Pediatr Blood Cancer. 2020 Feb;67(2):e28084.

727.    Ebrahimi M, Khalili N, Razi S, Keshavarz-Fathi M, Khalili N, Rezaei N. Effects of lead and cadmium on the immune system and cancer progression. J Environ Health Sci Eng. 2020 Feb 17;18(1):335-343. doi: 10.1007/s40201-020-00455-2.

728.    Sabahi M Jabbari P, Alizadeh Haghighi M, Soltani S, Soudi S, Rahmani F, Rezaei N. Proposing a tandem AND-gate CAR T cell targeting glioblastoma multiforme. Medical Hypotheses. 2020 Apr;137(109559):1-5.

729.    Seyedizade SS, Afshari K, Bayat S, Rahmani F, Momtaz S, Rezaei N, Abdolghaffari AH. Current status of M1 and M2 macrophages pathway as drug targets for inflammatory bowel disease. Arch Immunol Ther Exp (Warsz). 2020 Apr 1;68(2):10. doi: 10.1007/s00005-020-00576-4.

730.    Hanaei S, Sanati G, Sadr M, Salmanroghani R, Rezaei N. DNA methylation of SOCS3 in intestinal biopsy and peripheral blood samples of Iranian patients with ulcerative colitis. Eur J Gastroenterol Hepatol. 2020 Apr;32(4):540-541. doi: 10.1097/MEG.0000000000001604.

731.    Saadati S, Eskandari V, Rahmani F, Mahmoudi MJ, Rahnemoon Z, Rahmati Z, Gorzin F, Hedayat M, Amirzargar AA, Rezaei N. Gene expression and levels of TGF-β in PBMC is associated with severity of symptoms in chronic heart failure. Avicenna J Med Biotechnol. 2020 Apr;12(2):132-134.

732.    Taghavi-Farahabadi M, Mahmoudi M, Hashemi SM, Rezaei N. Evaluation of the effects of mesenchymal stem cells on neutrophils isolated from severe congenital neutropenia patients. Int Immunopharmacol. 2020 Apr 3;83:106463. doi: 10.1016/j.intimp.2020.106463.

733.    Dezfouli M, Bergström S, Skattum L, Abolhassani H, Neiman M, Torabi-Rahvar M, Franco Jarava C, Martin-Nalda A, Ferrer Balaguer JM, Slade CA, Roos A, Fernandez Pereira LM, López-Trascasa M, Gonzalez-Granado LI, Allende-Martinez LM, Mizuno Y, Yoshida Y, Friman V, Lundgren Å, Aghamohammadi A, Rezaei N, Hernández-Gonzalez M, von Döbeln U, Truedsson L, Hara T, Nonoyama S, Schwenk JM, Nilsson P, Hammarström L. Newborn screening for presymptomatic diagnosis of complement and phagocyte deficiencies. Front Immunol. 2020 Mar 17;11:455. doi: 10.3389/fimmu.2020.00455.

734.    Mahdavi Sharif P, Jabbari P, Razi S, Keshavarz-Fathi M, Rezaei N. Importance of TNF-alpha and its alterations in the development of cancers. Cytokine. 2020 Mar 21;130:155066. doi: 10.1016/j.cyto.2020.155066.

735.    Fekrvand S, Yazdani R, Olbrich P, Gennery A, Rosenzweig SD, Condino-Neto A, Azizi G, Rafiemanesh H, Hassanpour G, Rezaei N, Abolhassani H, Aghamohammadi A. Primary immunodeficiency diseases and Bacillus Calmette-Guérin (BCG)-vaccine-derived complications: a systematic review. J Allergy Clin Immunol Pract. 2020 Apr;8(4):1371-1386. doi: 10.1016/j.jaip.2020.01.038.

736.    Mojtabavi H, Saghazadeh A, Valenti VE, Rezaei N. Can music influence cardiac autonomic system? A systematic review and narrative synthesis to evaluate its impact on heart rate variability. Complement Ther Clin Pract. 2020 May;39:101162. doi: 10.1016/j.ctcp.2020.101162.

737.    Fekrvand S, Yazdani R, Olbrich P, Azizi G, Shirzadi R, Modaresi M, Sohani M, Delavari S, Kalantari A, Shariat M, Shafiei A, Lu N, Hassanpour G, Rahimi Hajiabadi M, Ashournia P, Razaghian A, Asgharyan M, Shahraki-Ghadimi Z, Rouhani R, Hoda Fallah F, Rezaei N, Abolhassani H, Aghamohammadi A. Evaluation of respiratory complications in patients with X-linked and autosomal recessive agammaglobulinemia. Pediatr Allergy Immunol. 2020 May;31(4):405-417. doi: 10.1111/pai.13228.

738.    Khanmohammadi S, Shabani M, Tabary M, Rayzan E, Rezaei N. Lymphoma in the setting of autoimmune diseases: a review of association and mechanisms. Crit Rev Oncol Hematol. 2020 Apr 22;150:102945. doi: 10.1016/j.critrevonc.2020.102945.

739.    Mohammadi S, Mayeli M, Saghazadeh A, Rezaei N. Cytokines in narcolepsy: A systematic review and meta-analysis. Cytokine. 2020 Apr 18;131:155103. doi: 10.1016/j.cyto.2020.155103.

740.    Yousefzadegan S, Rezaei N. Death due to COVID-19 in three brothers. Am J Trop Med Hyg. 2020;102(6):1203-1204.

741.    Momtazmanesh S, Ochs HD, Uddin LQ, Perc M, Routes JM, Vieira DN, Al-Herz W, Baris S, Prando C, Rosivall L, Abdul Latiff AH, Ulrichs T, Roudenok V, Aldave Becerra JC, Salunke DB, Goudouris E, Condino-Neto A, Stashchak A, Kryvenko O, Stashchak M, Bondarenko A, Rezaei N. All together to Fight Novel Coronavirus Disease (COVID-19). Am J Trop Med Hyg. 2020 Apr;102(6):1181-1183. doi: 10.4269/ajtmh.20-0281.

742.    Moradian N, Ochs HD, Sedikies C, Hamblin MR, Camargo CA Jr, Martinez JA, Biamonte JD, Abdollahi M, Torres PJ, Nieto JJ, Ogino S, Seymour JF, Abraham A, Cauda V, Gupta S, Ramakrishna S, Sellke FW, Sorooshian A, Wallace Hayes A, Martinez-Urbistondo M, Gupta M, Azadbakht L, Esmaillzadeh A, Kelishadi R, Esteghamati A, Emam-Djomeh Z, Majdzadeh R, Palit P, Badali H, Rao I, Saboury AA, Jagan Mohan Rao L, Ahmadieh H, Montazeri A, Fadini GP, Pauly D, Thomas S, Moosavi-Movahed AA, Aghamohammadi A, Behmanesh M, Rahimi-Movaghar V, Ghavami S, Mehran R, Uddin LQ, Von Herrath M, Mobasher B, Rezaei N. The urgent need of integrated science for fight COVID-19 pandemic and beyond. J Transl Med. 2020;18(1):205. doi: 10.1186/s12967-020-02364-2.

743.    LBD Double Burden of Malnutrition Collaborators. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017. Nat Med. 2020 May;26(5):750-759. doi: 10.1038/s41591-020-0807-6.

744.    Saghazadeh A, Rezaei M. Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids. International Immunopharmacology. 2020;84:106560. doi: 10.1016/j.intimp.2020.106560.

745.    Saghazadeh A, Rezaei N. Immune-epidemiological parameters of the novel coronavirus - a perspective. Expert Rev Clin Immunol. 2020;16(5):465-470. doi: 10.1080/1744666X.2020.1750954.

746.    Moazzami B, Razavi-Khorasani N, Dooghaie Moghadam A, Farokhi E, Rezaei N. COVID-19 and telemedicine: immediate action required for maintaining healthcare providers well-being. J Clin Virol. 2020 May;126:104345. doi: 10.1016/j.jcv.2020.104345.

747.    Momtazmanesh S, Rayzan E, Shahkarami S, Rohlfs M, Klein C, Rezaei N. A novel VPS13B mutation in Cohen syndrome: a case report and review of literature. BMC Med Genet. 2020 Jun 30;21(1):140. doi: 10.1186/s12881-020-01075-1.

748.    Hanaei S, Sanati G, Zoghi S, Gharibzadeh S, Ziaee V, Rezaei N. The status of FOXP3 gene methylation in pediatric systemic lupus erythematosus. Allergol et Immunopathologia. 2020 Jul;48(4):332-338. doi: 10.1016/j.aller.2020.03.014.

749.    Salzer E, Zoghi S, Kiss MG, Kage F, Rashkova C, Stahnke S, Haimel M, Platzer R, Caldera M, Ardy RC, Hoeger B, Block J, Medgyesi D, Sin C, Shahkarami S, Kain R, Ziaee V, Hammerl P, Bock C, Menche J, Dupré L, Huppa JB, Sixt M, Lomakin A, Rottner K, Binder CJ, Stradal TEB, Rezaei N, Boztug K. The cytoskeletal regulator HEM1 governs B-cell development and prevents autoimmunity. Sci Immunol. 2020 Jul 10;5(49):eabc3979. doi: 10.1126/sciimmunol.abc3979.

750.    Hanaei S, Abdollahzade S, Sadr M, Mirbolouk MH, Fattahi E, Khoshnevisan A, Rezaei N. Association of interleukin 2, interleukin 12, and interferon-γ with intervertebral disc degeneration in Iranian population. BMC Med Genet. 2020 Jul 3;21(1):143. doi: 10.1186/s12881-020-01081-3.

751.    Najdaghi S, Razi S, Rezaei N. An overview of the role of interleukin-8 in colorectal cancer. Cytokine. 2020 Jul 25;135:155205. doi: 10.1016/j.cyto.2020.155205.

752.    Rezaei N. COVID-19 and medical biotechnology. Avicenna J Med Biotechnol. 2020 Jul-Sep;12(3):139.

753.    Lotfi M, Hamblin M, Rezaei N. COVID-19: transmission, prevention, and potential therapeutic opportunities. Clinica Chimica Acta. 2020 Sept; 508:254-266. doi: 10.1016/j.cca.2020.05.044.

754.    Jahanshahlu L, Rezaei N. Monoclonal antibody as a potential anti-COVID-19. Biomedicine and Pharmacotherapy. 2020 Sep;129:110337. doi: 10.1016/j.biopha.2020.110337.

755.    Rzymski P, Nowicki M, Mullin GE, Abraham A, Rodríguez-Román E, Petzold MB, Bendau A, Sahu KK, Ather A, Naviaux AF, Janne P, Gourdin M, Delanghe JR, Ochs HD, Talmadge JE, Garg M, Hamblin MR, Rezaei N. Quantity does not equal quality: Scientific principles cannot be sacrificed. Int Immunopharmacol. 2020 Sep;86:106711. doi: 10.1016/j.intimp.2020.106711.

756.    Dabeheshti F, Rezaei N. Genetic predisposition models to COVID-19 infection. Med Hypotheses. 2020 Sep;142:109818. doi: 10.1016/j.mehy.2020.109818

757.    Yazdanpanah F, Hamblin MR, Rezaei N. The immune system and COVID-19: Friend or Foe? Life Sciences. 2020 Sep;256:117900:1-5. doi: 10.1016/j.lfs.2020.117900

758.    Rabiee N, Rabiee M, Bagherzadeh M, Rezaei N. COVID-19 and picotechnology: potential opportunities. Med Hypotheses. 2020 Nov;144:109917. doi:10.1016/j.mehy.2020.109917.

759.    Khazaei HA, Jalili A, Mousavi Gilani SR, Alidadi A, Safdari M, Moulaei N, Dehghan Haghighi J, Ramroudi N, Khosravi A, Solemani G, Sheikie V, Nahvi H, Bagheri H, Khazaei B, Khazaei E, Khazaei A, Dehbashi M, Salarzaei M, Rezaei N. The effect of 8 weeks aerobic training on serum levels of pro-inflammatory cytokines (IL-17) and immunoglobulins (IgA, IgM, IgG and IgE) levels in patients with type 2 diabetes. Annals of Medical and Health Sciences Research 2018 Nov;8(6):376-379.

760.    GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.

761.    GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.

762.    GBD 2019 Demographics Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1160-1203. doi: 10.1016/S0140-6736(20)30977-6.

763.    GBD 2019 Viewpoint Collaborators. Five insights from the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1135-1159. doi: 10.1016/S0140-6736(20)31404-5.

764.    GBD 2019 Universal Health Coverage Collaborators. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1250-1284. doi: 10.1016/S0140-6736(20)30750-9.

765.    Mohamed K, Rodríguez-Román E, Rahmani F, Zhang H, Ivanovska M, Makka SA, Joya M, Makuku R, Islam MS, Radwan N, Rahmah L, Goda R, Abarikwu SO, Shaw M, Zoghi S, Irtsyan S, Ling I, Cseprekal O, Faten AB, Hazar E, Tbalvandany CS, Grancini G, Rezaei N. Borderless collaboration is needed for COVID-19--a disease that knows no borders. Infect Control Hosp Epidemiol. 2020 Apr 22:1-2. doi: 10.1017/ice.2020.162.

766.    Nasab MG, Saghazadeh A, Rezaei N. SARS-CoV-2-A Tough Opponent for the Immune System. Arch Med Res. 2020 Aug;51(6):589-592. doi: 10.1016/j.arcmed.2020.05.020.

767.    Balibegloo M, Rezaei N. Development and clinical application of bispecific antibody in the treatment of colorectal cancer. Expert Rev Clin Immunol. 2020 Jul;16(7):689-709. doi: 10.1080/1744666X.2020.

768.    Gorji Z, Modaresi M, Yekanni-Nejad S, Rezaei N, Mahmoudi M. Comparing effects of low glycemic index/high-fat, high-calorie diet and high-fat, high-calorie diet on cytokine levels of patients with cystic fibrosis: A randomized controlled clinical trial. Eur Cytokine Netw. 2020 Mar 1;31(1):32-38. doi: 10.1684/ecn.2020.0442.

769.    Marodi L, The J Project Study Group, The Konya declaration for patients with primary immunodeficiencies. J Clin Immunol. 2020 Jul;40(5):770-773. doi: 10.1007/s10875-020-00797-4.

770.    Basiri A, Pazhouhnia Z, Beheshtizadeh N, Hoseinpour M, Saghazadeh A, Rezaei N. Regenerative medicine in COVID-19 treatment: real opportunities and range of promises. Stem Cell Rev Rep. 2021 Feb;17(1):163-175. doi: 10.1007/s12015-020-09994-5.

771.    Jabbari P, Jabbari F, Ebrahimi S, Rezaei N. COVID-19: A chimera of two pandemics. Disaster Med Public Health Prep. 2020 Jun;14(3):e38-e39. doi: 10.1017/dmp.2020.223.

772.    Jafari D, Noorbakhsh F, Delavari A, Tavakkoli-Bazzaz J, Farashi-Bonab S, Abdollahzadeh R, Rezaei N. Evaluation of the expression level of long non-coding RNA NKILA‐ miR103-miR107 inflammatory axis and its clinical significance as potential biomarker in patients with colorectal cancer. J Res Med Sci. 2020 Apr 13;25:41. doi: 10.4103/jrms.JRMS_943_19.

773.    Mahdaviani SA, Mansouri D, Jamee M, Zaki-Dizaji M, Aghdam KR, Mortaz E, Khorasanizadeh M, Eskian M, Movahedi M, Ghaffaripour H, Baghaie N, Hassanzad M, Chavoshzadeh Z, Mansouri M, Mesdaghi M, Ghaini M, Noori F, Eskandarzadeh S, Kahkooi S, Poorabdolah M, Tabarsi P, Moniri A, Farnia P, Karimi A, Boisson-Dupuis S, Rezaei N, Marjani M, Casanova JL, Bustamante J, Velayati AA. Mendelian susceptibility to mycobacterial disease (MSMD): Clinical and Genetic Features of 32 Iranian patients. J Clin Immunol. 2020 Aug;40(6):872-882. doi: 10.1007/s10875-020-00813-7.

774.    Ghosh S, Köstel Bal S, Edwards ESJ, Pillay B, Jimenez-Heredia R, Rao G, Erol Cipe F, Salzer E, Zoghi S, Abolhassani H, Momen T, Gostick E, Price DA, Zhang Y, Oler AJ, Gonzaga-Jauregui C, Erman B, Metin A, Ilhan I, Haskologlu S, Islamoglu C, Baskin K, Ceylaner S, Yilmaz E, Unal E, Karakukcu M, Berghuis D, Cole T, Gupta AK, Hauck F, Hoepelman A, Baris S, Karakoc-Aydiner E, Ozen A, Kager L, Holzinger D, Paulussen M, Krüger R, Meisel R, Oommen PT, Morris EC, Neven B, Worth AJJ, van Montfrans JM, Fraaij P, Choo S, Dogu F, Davies EG, Burns S, Dueckers G, Perez Becker R, von Bernuth H, Latour S, Faraci M, Gattorno M, Su H, Pan-Hammarström Q, Hammarström L, Lenardo MJ, Ma CS, Niehues T, Aghamohammadi A, Rezaei N, Ikinciogullari A, Tangye SG, Lankester AC, Boztug K. Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency. Blood. 2020 Dec 3;136(23):2638-2655. doi: 10.1182/blood.2020006738.

775.    Asgardoon MH, Azizi G, Yazdani R, Sohani M, Pashangzadeh S, Kalantari A, Shariat M, Shafiei A, Salami F, Jamee M, Rasouli SE, Mohammadi J, Hassanpour G, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Behniafard N, Nabavi M, Bemanian MH, Arshi S, Molatefi R, Sherkat R, Shirkani A, Alyasin S, Jabbari-Azad F, Ghaffari J, Mesdaghi M, Ahanchian H, Khoshkhui M, Eslamian MH, Cheraghi T, Dabbaghzadeh A, Nasiri Kalmarzi R, Esmaeilzadeh H, Tafaroji J, Khalili A, Sadeghi-Shabestari M, Darougar S, Moghtaderi M, Ahmadiafshar A, Shakerian B, Heidarzadeh M, Ghalebaghi B, Fathi SM, Darabi B, Fallahpour M, Mohsenzadeh A, Ebrahimi S, Sharafian S, Vosughimotlagh A, Tafakoridelbari M, Rahimi Haji-Abadi M, Ashournia P, Razaghian A, Rezaei A, Delavari S, Shirmast P, Babaha F, Samavat A, Mamishi S, Khazaei HA, Negahdari B, Rezaei N, Abolhassani H, Aghamohammadi A. Monogenic primary immunodeficiency disorder associated with common variable immunodeficiency and autoimmunity. Int Arch Allergy Immunol. 2020;181(9):706-714. doi: 10.1159/000508817. 

776.    Sahu KK, Siddiqui AD, Rezaei N, Cerny J. Challenges for management of immune thrombocytopenia during COVID-19 pandemic. J Med Virol. 2020 Nov;92(11):2277-2282. doi: 10.1002/jmv.26251.

777.    Rahmani F, Rayzan E, Rahmani MR, Shahkarami S, Zoghi S, Rezaei A, Aryan Z, Najafi M, Rohlfs M, Jeske T, Aflatoonian M, Chavoshzadeh Z, Farahmand F, Motamed F, Rohani P, Alimadadi H, Mahdaviani A, Mansouri M, Tavakol M, Vanderberg M, Kotlarz D, Klein C, Rezaei N. Clinical and mutation description of the first Iranian cohort of infantile inflammatory bowel disease: the Iranian Primary Immunodeficiency Registry (IPIDR). Immunol Invest. 2021 May;50(4):445-459. doi: 10.1080/08820139.2020.1776725.

778.    Bahrami A, Vafapour M, Moazzami B, Rezaei N. Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran. J Paediatr Child Health. 2021 Jun;57(6):922-925. doi: 10.1111/jpc.15048.

779.    Yazdani R, Aghamohammadi A, Rezaei N. Application of flow cytometry in predominantly antibody deficiencies. Endocr Metab Immune Disord Drug Targets. 2021;21(4):647-663. doi: 10.2174/1871530320666200721013312.

780.    Local Burden of Disease Diarrhoea Collaborators. Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17. Lancet Glob Health. 2020 Aug;8(8):e1038-e1060. doi: 10.1016/S2214-109X(20)30230-8.

781.    Jabbari P, Rezaei N. With risk of reinfection, is COVID-19 here to stay? Disaster Med Public Health Prep. 2020 Aug;14(4):e33. doi: 10.1017/dmp.2020.274.

782.    Bahreini F, Rayzan E, Rezaei N. microRNA-related single-nucleotide polymorphisms and breast cancer. J Cell Physiol. 2021 Mar;236(3):1593-1605. doi: 10.1002/jcp.29966.

783.    Mobasheri T, Rayzan E, Shabani M, Hosseini M, Mahmoodi Chalbatani G, Rezaei N.
Neuroblastoma-targeted nanoparticles and novel nanotechnology-based treatment methods. J Cell Physiol. 2021 Mar;236(3):1751-1775. doi: 10.1002/jcp.29979. 

784.    Sharifkashani S, Bafrani MA, Khaboushan AS, Pirzadeh M, Kheirandish A, Yavarpour Bali H, Hessami A, Saghazadeh A, Rezaei N. Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting. Eur J Pharmacol. 2020 Oct 5;884:173455. doi: 10.1016/j.ejphar.2020.173455.

785.    Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N. The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19. Life Sci. 2020 Oct 1;258:118185. doi: 10.1016/j.lfs.2020.118185.

786.    Pashaei M, Rezaei N. Immunotherapy for SARS-CoV-2: potential opportunities. Expert Opin Biol Ther. 2020 Oct;20(10):1111-1116. doi: 10.1080/14712598.2020.1807933.

787.    Babaha F, Rezaei N. Primary immunodeficiency diseases in COVID-19 pandemic: A predisposing or protective factor? Am J Med Sci. 2020 Dec;360(6):740-741. doi: 10.1016/j.amjms.2020.07.027.

788.    Yazdanpanah N, Saghazadeh A, Rezaei N. Anosmia: a missing link in the neuroimmunology of COVID-19. Rev Neurosci. 2020 Oct 25;31(7):691-701. doi: 10.1515/revneuro-2020-0039.

789.    Hemmati S, Sadeghi MA, Yousefi-Manesh H, Eslamiyeh M, Vafaei A, Foroutani L, Donyadideh G, Dehpour A, Rezaei N. Protective effects of leukadherin1 in a rat model of targeted experimental autoimmune encephalomyelitis (EAE): possible role of P47phox and MDA downregulation. Inflamm Res. 2020 Jul 31;13:411-420. doi: 10.2147/JIR.S258991. 

790.    Jenab Y, Rezaei N, Hedayat B, Naderian M, Shirani S, Hosseini K. Occurrence of acute coronary syndrome, pulmonary thromboembolism, and cerebrovascular event in COVID-19. Clin Case Rep. 2020 Jul 22;8(12):2414-7. doi: 10.1002/ccr3.3112.

791.    Pourahmad R, Moazzami B, Rezaei N. Efficacy of plasmapheresis and immunoglobulin replacement therapy (IVIG) on patients with COVID-19. SN Compr Clin Med. 2020 Jul 31:1-5. doi: 10.1007/s42399-020-00438-2.

792.    Heidarpour M, Vakhshoori M, Abbasi S, Shafie D, Rezaei N. Adrenal insufficiency in coronavirus disease 2019: a case report. J Med Case Rep. 2020 Aug 24;14(1):134. doi: 10.1186/s13256-020-02461-2.

793.    Rokni M, Hamblin MR, Rezaei N. Cytokines and COVID-19: friends or foes? Hum Vaccin Immunother. 2020 Oct 2;16(10):2363-2365. doi: 10.1080/21645515.2020.1799669.

794.    Pezeshki S, Hemmati S, Rezaei N. Novel treatments using PD1 inhibitors for advanced and metastatic cutaneous squamous cell carcinoma. Expert Rev Anticancer Ther. 2020 Oct;20(10):819-822. doi: 10.1080/14737140.2020.1812389.

795.    Momtazmanesh S, Perry G, Rezaei N. Toll-like receptors in Alzheimer's disease. J Neuroimmunol. 2020 Nov 15;348:577362. doi: 10.1016/j.jneuroim.2020.577362.

796.    Taghavi-Farahabadi M, Mahmoudi M, Mahdaviani SA, Baghaei K, Rayzan E, Hashemi SM, Rezaei N. Improving the function of neutrophils from chronic granulomatous disease patients using mesenchymal stem cells’ exosomes. Hum Immunol. 2020 Oct-Nov;81(10-11):614-624. doi: 10.1016/j.humimm.2020.05.009.

797.    Goudarzi S, Dehghani Firouzabadi F, Dehghani Firouzabadi M, Rezaei N. Cutaneous lesions and COVID-19: cystic painful lesion in a case with positive SARS-CoV-2. Dermatol Ther. 2020 Nov;33(6):e14266. doi: 10.1111/dth.14266.

798.    Sadeghmousavi S, Rezaei N. COVID-19 and multiple sclerosis: predisposition and precautions in treatment. SN Compr Clin Med. 2020 Sep 3:1-6. doi: 10.1007/s42399-020-00504-9.

799.    Hanaei S, Sarzaeim M, Yazdanpanah N, Rahimi Pirkoohi Z, Ziaei H, Mohammad K, Samieefar N, Keshavarz-Fathi M, Kolahchi Z, Moradian N, Momtazmanesh S, Seyedpour S, Jaberipour A, Ashkevarian S, Rezaei N. The hybrid USERN 2020 congress: new standards for events in practice. Acta Med Iran. 2021 Jan.59(1):1-3.

800.    Basiri A, Heidari A, Nadi MF, Fallahy MTP, Nezamabadi SS, Sedighi M, Saghazadeh A, Rezaei N. Microfluidic devices for detection of RNA viruses, including COVID-19. Reviews in Medical Virology. 2020: accepted for publication. Rev Med Virol. 2021 Jan;31(1):1-11. doi: 10.1002/rmv.2154.

801.    Seyran M, Pizzol D, Adadi P, El-Aziz TMA, Hassan SS, Soares A, Kandimalla R, Lundstrom K, Tambuwala M, Aljabali AAA, Lal A, Azad GK, Choudhury PP, Uversky VN, Sherchan SP, Uhal BD, Rezaei N, Brufsky AM. Questions concerning the proximal origin of SARS-CoV-2. J Med Virol. 2021 Mar;93(3):1204-1206. doi: 10.1002/jmv.26478.

802.    Seyedpour S, Khodaei B, Loghman AH, Seyedpour N, Kisomi MF, Balibegloo M, Nezamabadi SS, Gholami B, Saghazadeh A, Rezaei N. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: a systematic review of in vitro and in vivo studies. J Cell Physiol. 2021 Apr;236(4):2364-2392. doi: 10.1002/jcp.30032.

803.    Nejadghaderi SA, Heidari A, Shakerian N, Saghazadeh A, Rezaei N.  Cardiovascular system is at higher risk of affecting by COVID-19. Acta Biomed. 2020 Sep 7;91(3):e2020018. doi: 10.23750/abm.v91i3.9718.

804.    Mohamed K,  Rodríguez-Román E, Rahmani F, Zhang H, Ivanovska M, A Makka S, Joya M, Makuku R, Md Shahidul Islam, Nesrine Radwan, Laila Rahmah, Goda R, Sunny O Abarikwu, Mujtaba Shaw, Zoghi S, Irtsyan S, Ling I, Orsolya Cseprekal, Attig-Bahar F, Hazar Sayar E, Soloukey C, Grancini G, Rezaei N. International efforts to save healthcare personnel during COVID-19. Acta Biomed. 2020 Sep 7;91(3):e2020044. doi: 10.23750/abm.v91i3.9891.

805.    Mojtabavi H, Saghazadeh A, Rezaei N. Interleukin-6 and severe COVID-19: a systematic review and meta-analysis. Eur Cytokine Netw. 2020 Jun 1;31(2):44-49. doi: 10.1684/ecn.2020.0448.

806.    Shojaeefar E, Malih N, Rezaei N. The possible double-edged sword effects of vitamin D on COVID-19: A hypothesis. Cell Biol Int. 2021 Jan;45(1):54-57. doi: 10.1002/cbin.11469.

807.    Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N. Immune microenvironment in different molecular subtypes of ductal breast carcinoma. Breast Cancer Res Treat. 2021 Jan;185(2):261-279. doi: 10.1007/s10549-020-05954-2.

808.    Beigmohammadi F, Mahmoudi M, Karami J, Ahmadzadeh N, Ebrahimi-Daryani N, Rezaei N. Analysis of killer cell immunoglobulin-like receptor genes and their HLA ligands in inflammatory bowel diseases. J Immunol Res. 2020 Sep 19;2020:4873648. doi: 10.1155/2020/4873648.

809.    Sadeghmousavi S, Eskian M, Rahmani F, Rezaei N. The effect of insomnia on development of Alzheimer’s disease J Neuroinflammation. 2020 Oct 6;17(1):289. doi: 10.1186/s12974-020-01960-9.

810.    Sarzaeim M, Rezaei N. Kawasaki disease and multisystem inflammatory syndrome in children with COVID-19. SN Compr Clin Med. 2020 Oct 6:1-6. doi: 10.1007/s42399-020-00558-9.

811.    Samieefar N, Yari Boroujeni R, Jamee M, Lotfi M, Golabchi MR, Afshar A, Miri H, Khazeei Tabari MA, Darzi P, Abdullatif Khafaie M, Amirheidari B, Tamadon A, Rambod Rad N, Samimi N, Farjam M, Shiravi F, Farshidi N, Hedayati Ch M, Doostkamel D, Alikhani R, Razmkhah M, Abdollahifard S, Nasiri Kalmarzi R, Kelishadi R, Khazaei H, Aghamohammadi A, Jafari Mousavi FS, Shamsizadeh M, Khojasteh A, Rezaei N. Country quarantine during COVID-19: critical or not? Disaster Med Public Health Prep. 2020 Oct 13:1-2. doi: 10.1017/dmp.2020.384.

812.    Ahanchian H, Moazzen N, Joghatayi SH, Saeidinia A, Khoshkhui M, Aelami MH, Rezaei N, Haghi NSM. Death due to COVID-19 in an infant with combined immunodeficiencies. Endocr Metab Immune Disord Drug Targets. 2020 Oct 21. doi: 10.2174/1871530320666201021142313.

813.    Hanaei S, Takian A, Majdzadeh R, Maboloc CR, Grossmann I, Gomes O, Milosevic M, Gupta M, Shamshirsaz AA, Harbi A, Burhan AM, Uddin LQ, Kulasinghe A, Lam CM, Ramakrishna S, Alavi A, Nouwen JL, Dorigo T, Schreiber M, Abraham A, Shelkovaya N, Krysztofiak W, Ebrahimi Warkiani M, Sellke F, Ogino S, Barba FJ, Brand S, Vasconcelos C, Salunke DB, Rezaei N. Emerging standards and the hybrid model for organizing scientific events during and after the COVID-19 pandemic. Disaster Med Public Health Prep. 2020 Oct 26:1-6. doi: 10.1017/dmp.2020.406.

814.    Lundstrom K, Seyran M, Pizzol D, Adadi P, Mohamed Abd El-Aziz T, Hassan SS, Soares A, Kandimalla R, Tambuwala MM, Aljabali AAA, Kumar Azad G, Pal Choudhury P, Uversky VN, Sherchan SP, Uhal BD, Rezaei N, Brufsky AM. Viepoint: Origin of SARS-CoV-2. Viruses. 2020 Oct 22;12(11):1203. doi: 10.3390/v12111203.

815.    Seyedmirzaei H, Shobeiri P, Turgut M, Hanaei S, Rezaei N. VEGF levels in patients with glioma: a systematic review and meta-analysis. Rev Neurosci. 2020 Nov 2;32(2):191-202. doi: 10.1515/revneuro-2020-0062.

816.    Mojtabavi H, Saghazadeh A, van den Heuvel L, Bucker J, Rezaei N. Peripheral blood levels of brain-derived neurotrophic factor in patients with post-traumatic stress disorder (PTSD): A systematic review and meta-analysis. PLoS One. 2020 Nov 5;15(11):e0241928. doi: 10.1371/journal.pone.0241928.

817.    Lotfi M, Rezaei N. CRISPR/Cas13: A potential therapeutic option of COVID-19. Biomed Pharmacother. 2020 Nov;131:110738. doi: 10.1016/j.biopha.2020.110738.

818.    Aleebrahim-Dehkordi E, Soveyzi F, Deravi N, Rabbani Z, Saghazadeh A, Rezaei N. Human coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in children. J Pediatr Nurs. 2021 Jan-Feb;56:70-79. doi: 10.1016/j.pedn.2020.10.020.

819.    Ebrahimi Meimand S, Rostam-Abadi Y, Rezaei N. Autism spectrum disorders and natural killer cells: a review on pathogenesis and treatment. Expert Rev Clin Immunol. 2021 Jan;17(1):27-35. doi: 10.1080/1744666X.2020.1850273.

820.    Jabbari P, Taraghikhah N, Jabbari F, Ebrahimi S, Rezaei N.  Adherence of the general public to self-protection guidelines during the COVID-19 pandemic. Disaster Med Public Health Prep. 2020 Nov 18:1-4. doi: 10.1017/dmp.2020.445.

821.    Mohamed K, Rezaei N. COVID-19 pandemic is not the time of trial and error. Am J Emerg Med. 2020 Sep 14:S0735-6757(20)30814-7. doi: 10.1016/j.ajem.2020.09.020.

822.    Taghavi-Farahabadi M, Mahmoudi M, Rezaei N, Hashemi SM. Wharton’s jelly mesenchymal stem cells exosomes and conditioned media increased neutrophil lifespan and phagocytosis capacity. Immunol Invest. 2020 Aug 11:1-16. doi: 10.1080/08820139.2020.1801720.

823.    Rayzan E, Pouladfar G, Parvaneh N, Shahrooei M, Aryan Z, Rezaei N. Novel CYBA mutation in a family with BCGitis. Acta Microbiologica et Immunologica Hungarica. 2019: accepted for publication.

824.    Ebrahimiyan H, Rezaei N, Vojdanian M, Aslani S, Jamshidi A, Mahmoudi M. microRNA involvement in the regulation of survivin in peripheral blood mononuclear cells from rheumatoid arthritis patients. Int J Rheum Dis. 2019: accepted for publication.

825.    Aghamiri S, Fallah Mehrjardi K, Shabani S, Keshavarz-Fathi M, Rezaei N. Nanoparticle-siRNA: A potential strategy for ovarian cancer therapy? Nanomedicine. 2019: accepted for publication.

826.    Jabbari P, Hanaei S, Rezaei N. State of art in immunotherapy of neuroblastoma. Immunotherapy. 2019: accepted for publication.

827.    Saghazadeh A, Mahmoudi M, Shahrokhi S, Mojarrad M, Dastmardi M, Mirbeyk M, Rezaei N. Trace elements in schizophrenia: a meta-analysis of 39 studies (n = 5151). Nutr Rev. 2019: accepted for publication.

828.    Darbeheshti F, Rezaei N, Amoli MM, Mansoori Y, Tavakkoly Bazzaz J. Integrative analyses of triple negative dysregulated transcripts compared with non-triple negativetumors and their functional and molecular interactions. J Cell Physiol. 2019: accepted for publication.

829.    Tafakori Delbari M, Cheraghi T, Yazdani R, Fekrvand S, Delavari S, Azizi G, Chavoshzadeh Z, Mahdaviani SA, Ahanchian H, Khoshkhui M, Behmanesh F, Aleyasin S, Esmaeilzadeh H, Jabbari-Azad F, Fallahpour M, Zamani M, Madani SP, Moazzami B, Habibi S, Rezaei A, Lotfalikhani A, Movahed M, Shariat M, Kalantari A, Babaei D, Darabi M, Parvaneh N, Rezaei N, Abolhassani H, Aghamohammadi A. Clinical manifestations, immunological characteristics and genetic analysis of patients with hyper-immunoglobulin M syndrome in Iran. Int Arch Allergy Immunol. 2019: accepted for publication.

830.    Aghamohammadi A, Abolhassani H, Rezaei N. Primary immunodeficiency diseases in Iran: past, present and future. Arch Iran Med. 2019: accepted for publication.

831.    Global Burden of Disease Cancer Collaboration, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019: accepted for publication.

832.    Ghaemdoust F, Keshavarz-Fathi M, Rezaei N. Natural killer cells and cancer therapy, what we know and where we are going. Immunotherapy. 2019: accepted for publication.

833.    Valizadeh A, Sanaei R, Rezaei N, Azizi G, Fekrvand S, Aghamohammadi A, Yazdani R. Potential role of regulatory B cells in immunological diseases. Immunol Lett. 2019: accepted for publication.

834.    The Brain-derived neurotrophic factor: missing link between sleep deprivation, insomnia, and depression. Neurochemical Research. 2019: accepted for publication.

835.    A confusing manifestation: Wiskott-Aldrich syndrome coincidence with possible congenital CMV infection. National Med J India. 2019: accepted for publication.

836.    The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers. Expert Rev Clin Immunol. 2020: accepted for publication.

837.    GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020: accepted for publication.

838.    Evaluation of respiratory complications in patients with X-linked and autosomal recessive agammaglobulinemia. Pediatr Allergy Immunol. 2020: accepted for publication.

839.    Bahrami A, Sayyahfar S, Soltani Z, Khodadost M, Moazzami B, Rezaei N. Evaluation of the frequency and diagnostic delay of primary immunodeficiency disorders among suspected patients based on the 10 warning sign criteria: A cross-sectional study in Iran. Allergol Immunopathol (Madr). 2020 May 11. pii: S0301-0546(20)30064-1. doi: 10.1016/j.aller.2020.03.005.

840.    The Role of FOXP3 gene methylation in pediatric systemic lupus erythematosus. Allergol Immunopathol (Madr). 2020: accepted for publication.

841.    Association of ADAM33 T1 polymorphism with subgroups of pediatric asthmatic patients in Iran. Acta Med Iran. 2020: accepted for publication.

842.    GBD 2017 Oesophageal Cancer Collaborators. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020 Apr 1. pii: S2468-1253(20)30007-8. doi: 10.1016/S2468-1253(20)30007-8.

843.    Expression level of long noncoding RNA NKILA miR103‑miR107 inflammatory axis and its clinical significance as potential biomarker in patients with colorectal cancer. Journal of Research in Medical Sciences. 2020: accepted for publication.

844.    Rezaei N. COVID-19 affects healthy pediatricians more than pediatric patients. Infect Control Hosp Epidemiol. 2020 Apr 16:1. doi: 10.1017/ice.2020.139.

845.    Yousefzadegan S, Rezaei N. Death due to novel coronavirus disease (COVID-19) in three brothers. Am J Trop Med Hyg. 2020 Apr 10. doi: 10.4269/ajtmh.20-0240.

846.    DNA methylation of CD70 promoter in juvenile systemic lupus erythematosus. Fetal Pediatr Pathol. 2020: accepted for publication.

847.    Atabati H, Esmaeili SA, Saburi E, Akhlaghi M, Raoofi A, Rezaei N, Momtazi-Borojeni AA. Probiotics with ameliorating effects on the severity of skin inflammation in psoriasis: Evidence from experimental and clinical studies. J Cell Physiol. 2020 Apr 28. doi: 10.1002/jcp.29737: accepted for publication.

848.    Hanaei S, Rezaei N. COVID-19: Developing from an outbreak to a pandemic. Arch Med Res. 2020 May 13. doi: 10.1016/j.arcmed.2020.04.021.

849.    Lotfi M, Rezaei N. SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol. 2020 Jun 3:10.1002/jmv.26123. doi: 10.1002/jmv.26123.

850.    Fathi N, Rezaei N. Lymphopenia in COVID­19 and potential available treatment. Cell Biology International. 2020: accepted for publication.

851.    Jahanshahlu L, Rezaei N. Central nervous system involvement in COVID-19. Archives of Medical Sciences. 2020: accepted for publication.

852.    Nasrollahzadeh E, Razi S, Keshavarz-Fathi M, Mazzone M, Rezaei N. Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site. Cancer Immunol Immunother. 2020 Jun 4. doi: 10.1007/s00262-020-02616-6.

853.    In-depth investigation of emerging case reports uncovers the involvement of the central nervous system in patients with COVID-19. Reviews in the Neurosciences. 2020: accepted for publication.

854.    Lack of association between COL1A1 and COL9A2 single nucleotide polymorphisms and intervertebral disc degeneration. British Journal of Neurosurgery. 2020: accepted for publication.

855.    The COVID-19: developing from an outbreak to a pandemic. Archives of Medical Sciences. 2020: accepted for publication.

856.    Novel CD40LG mutation in two cousins with Immunoglobulin Class Switch Recombinant Deficiency. Acta Medica Iranica. 2020: accepted for publication.

857.    Griscelli syndrome type 2: A rare case with apparently normal skin and hair pigmentation. Acta Medica Iranica. 2020: accepted for publication.

858.    Significant association of TNF-α, but not other pro-inflammatory cytokines, single nucleotide polymorphisms with intervertebral disc degeneration in Iranian population. Clin Neurol Neurosurg. 2020: accepted for publication. doi: 10.1016/j.clineuro.2018.08.008.

859.    Association of NLRP3 single nucleotide polymorphisms with ulcerative colitis: A case-control study. Clin Res Hepatol Gastroenterol. 2020: accepted for publication. doi: 10.1016/j.clinre.2017.09.003.

860.    The role of interleukin 4 and IL-4RA in intervertebral disc degeneration: investigation of single nucleotide polymorphisms in genes and a systematic review & meta-analysis of IL-4 expression level. Br J Neurosurg. 2020: accepted for publication. doi: 10.1080/02688697.2019.

861.    Protective Effects of Laukadherin1 in a Rat Model of Targeted Experimental Autoimmune Encephalomyelitis (EAE); Possible Role of P47phox and MDA Downregulation. Journal of Inflammation Research. 2020: accepted for publication.

862.    Cytokine Release Syndrome: Inhibition of Pro-inflammatory Cytokines as a Solution for Reducing COVID-19 Mortality. European Cytokine Network. 2020: accepted for publication.

863.    Acute cardiac injury in COVID-19: A systematic review and meta-analysis. Archives of Iranian Medicine. 2020: accepted for publication.

864.    New hope for treatment of respiratory involvement following COVID-19 by bromhexine. Journal of Nephropharmacology. 2020: accepted for publication.

865.    Seyedmirzaei H, Shobeiri P, Turgut M, Hanaei S, Rezaei N. VEGF levels in patients with glioma: a systematic review and meta-analysis. Rev Neurosci. 2020 Nov 2;32(2):191-202. doi: 10.1515/revneuro-2020-0062.

866.    Association of PTPN22 Single Nucleotide Polymorphisms with Chronic Spontaneous Urticaria. Allergol et Immunopathol. 2020: accepted for publication.

867.    Analysis of killer-cell immunoglobulin-like receptors genes and their HLA ligands in inflammatory bowel diseases. Journal of Immunology Research. 2020: accepted for publication.

868.    Primary Immunodeficiency Associated with Hypopigmentation: A Differential Diagnosis Approach. Allergol et Immunopathol. 2020: accepted for publication.

869.    Association of the genetic polymorphisms in the inhibiting and activating molecules of immune system with Rheumatoid arthritis: systematic review and meta-analysis. Journal of Research in Medical Sciences. 2020: accepted for publication.

870.    Dynamic antibody response: a biomarker for COVID-19. Clinical Laboratory. 2020: accepted for publication.

871.    The role of angiotensin-converting enzyme 2 in COVID-19 induced lung injury. Acta Biomedica Atenei Parmensis. 2020: accepted for publication.

872.    Potential Prophylactic and Therapeutic Effects of Respiratory Physiotherapy for COVID-19. Acta Biomedica Atenei Parmensis. 2020: accepted for publication.

873.    COVID–19 infection and Stroke Risk. Reviews in the Neurosciences. 2020: accepted for publication.

874.    Cardiovascular Diseases Burden in COVID-19: Systematic Review and Meta-analysis. American Journal of Emergency Medicine. 2020: accepted for publication.

875.    Novel BTK Mutation in X-Linked Agammaglobulinemia: report of a 17-year-old male. Allergologia et Immunopathologia. 2020: accepted for publication.

876.    Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19? Phytomedicine. 2020: accepted for publication.

877.    The evolving landscape of biomarkers for immunotherapy with a focus on spatial mapping technologies. Clinical & Translational Immunology. 2020: accepted for publication.

878.    Computed Tomography Scan in COVID-19: A Systematic Review and Meta-analysis. Polish Journal of Radiology. 2020: accepted for publication.

879.    Death due to Covid-19 in a Patient with Diabetes, Epilepsy, and Gout comorbidities. Clinical Case Reports. 2020: accepted for publication.

880.    Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities on SARS-CoV-2 Cytokine Storm. Current Pharmaceutical Design. 2020: accepted for publication.

881.    Innate Lymphoid Cells Subsets and Their Cytokines in Autoimmune Diseases. European Cytokine Network. 2020: accepted for publication.

882.    Interleukin-10 in Oral Lichen Planus – Review and Meta-Analysis. Current Immunology Reviews. 2020: accepted for publication.

883.    The interplay between aryl hydrocarbon receptor, H. pylori, tryptophan, and arginine in the pathogenesis of gastric cancer. International Reviews of Immunology. 2020: accepted for publication.

884.    Computational Drug Discovery and Repurposing for the Treatment of COVID-19: A Systematic Review. Bioorganic Chemistry. 2020: accepted for publication.

885.    Lessons from the Embryo: An Unrejected Transplant and a Benign Tumor. Stem Cell Reviews and Reports. 2020: accepted for publication.

886.    Understanding the tumor microenvironment for effective immunotherapy. Medicinal Research Reviews. 2020: accepted for publication.

887.    Interleukin 9 serum level and single nucleotide polymorphism in patients with asthma. Acta Bio Medica Atenei Parmensis. 2020: accepted for publication.

888.    COVID-19 in a Child with Primary Antibody Deficiency. Clinical Case Reports. 2020: accepted for publication.

889.    Effect of Ligand Conjugation Site on the Micellization of Bio-Targeted PLGA-Based Nanohybrids: a Computational Biology Approach. Journal of Biomolecular Structure and Dynamics. 2020: accepted for publication.

890.    Dysregulation of the Immune Response in COVID-19. Cell Biology International. 2020: accepted for publication.

891.    Serological Tests for COVID-19: Potential Opportunities. Cell Biology International. 2020: accepted for publication.

892.    The Structural Basis of Accelerated Host Cell Entry by SARS-CoV-2. FEBS Journal. 2020: accepted for publication.

893.    Cancer Immunoprevention: Current Status and Future Directions. Archivum Immunologiae et Therapiae Experimentalis. 2020: accepted for publication.

894.    Potential Treatment of Parkinson's Disease Using Last-Generation Carbon Nanotubes: a Bimolecular In-Silico Study. Nanomedicine. 2020: accepted for publication.

895.    Possible transmission flow of SARS-CoV-2 based on ACE2 features. Molecules. 2020: accepted for publication.

896.    Cognitive Biases Affecting the Maintenance of COVID-19 Pandemic: COVID-19 Cognitive biases. Acta Bio Medica Atenei Parmensis. 2020: accepted for publication.

897.    Application of Platelet Rich Fibrin in Tissue Engineering: Focus on Bone Regeneration. Plateletes. 2020: accepted for publication.

898.    A Novel Homozygous RAG1 Mutation is Associated with Severe Combined Immunodeficiency and Neurological Presentations. Allergologia et Immunopathologia. 2020: accepted for publication.

899.    COVID-19 in a case with Kikuchi-Fujimoto disease. Clinical Case Reports. 2020: accepted for publication.

900.    The Prevalence of Post-Traumatic Stress Disorder Related Symptoms in Coronavirus Outbreaks: A Systematic-Review and Meta-Analysis. Journal of Affective Disorders. 2020: accepted for publication.

901.    BCGitis as the Primary Manifestation of Chronic Granulomatous Disease. IDCases. 2020: accepted for publication.

902.    Khazaei HA, Naderi M, Aliabad GM, Tabatabaei SMN, Alidadi A, Moulaei NA, Safdari M, Nahvi H, Cohan N, Dehghan J, Mehraban A, Jalili A, Khazaei A, Khazaei E, Khazaei B, Khazaei B, Rezaei N, Salarzaie M. The effect of T helper (Th)/T cytotoxic (Tc) ratio on disease severity in type A hemophilia patients. Hum Antibodies. 2021 Jan 4. doi: 10.3233/HAB-200434.

903.    Investigating the possible association between NLRP3 gene polymorphisms and myasthenia gravis. Muscle and Nerves. 2020: accepted for publication.

904.    Statins in Patients with COVID-19: A Retrospective Cohort Study in Iranian COVID-19 Patients. Translational Medicine Communications. 2021: accepted for publication.

905.    Recent Progress in Immunotherapy of Breast Cancer Targeting the Human Epidermal Growth Factor Receptor 2 (HER2). Journal of Oncology Pharmacy Practice.

906.    Health care policies and COVID-19 prevalence: Is there any association? International Journal of Health Services

907.    Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis. Reviews in the Neurosciences.

908.    MicroRNAs and diabetes mellitus type 1. Current Diabetes Reviews

909.    Role of fibroblast activation protein alpha (FAP-α) in fibroblast-like synoviocytes (FLSs) of rheumatoid arthritis (RA). Iranian Journal of Allergy, Asthma and Immunology

910.    Chimeric Antigen Receptor T-cell Therapy for Melanoma. Expert Review of Clinical Immunology

911.    Role of Toll-like receptors in the pathogenesis of COVID-19. Journal of Medical Virology

912.    COVID-19 in Patients with Cancer: Predisposition and Precautions. American Journal of Emergency Medicine

913.    The Overlap between Genetic Susceptibility to COVID-19 and Skin Diseases. Immunological Investigations

914.    SARS-CoV-2: From the Pathogenesis to Potential Anti-viral Treatments. Biomedicine & Pharmacotherapy

915.    Novel variants of DOCK8 deficiency in a case series of Iranian patients. Endocrine, Metabolic & Immune Disorders - Drug Targets

916.    Immune Checkpoint Inhibition in COVID-19: Risks and Benefits. Expert Opinion On Biological Therapy

917.    Current and future perspectives of PD-1/PDL-1 blockade in cancer immunotherapy: a review. Journal of Immunology Research

918.    Allicin and Gastrointestinal Cancers: From Chemical Structure to Its Therapeutic Opportunities. Frontiers in Oncology

919.    Modification of glial cell activation through dendritic cell vaccination: a novel approach for treatment of neurodegenerative diseases. Journal of Molecular Neuroscience

920.    Biosensing Surfaces and Therapeutic Biomaterials for the Central Nervous System in COVID-19. Emergent Materials

921.    Metabolic Profile in Patients with Narcolepsy: A Systematic Review and Meta-analysis. Sleep Medicine

922.    COVID-19 in Iran: Forecasting pandemic using deep learning. Computational and Mathematical Methods in Medicine

923.    Urgent Need for Field Surveys of Coronaviruses in Southeast Asia to Understand the SARS-CoV-2 Phylogeny and Risk Assessment for the Future Outbreaks. Biomolecules

924.    Novel Mutations of TYMP Gene in Mitochondrial Neurogastrointestinal Encephalomyopathy: Case Series and Review of Literature review. Journal of Molecular Neuroscience

925.    Narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications. Translational Lung Cancer Research

926.    Inter-individual Immunogenic Variants: Susceptibility to Coronavirus, Respiratory Syncytial Virus, and Influenza Virus. Reviews in Medical Virology

927.    Neurological Manifestations as the Predictors of Severity and mortality in Hospitalized Individuals with COVID-19: A Multicenter Prospective Clinical Study. BMC neurology

928.    RNA Language in Colorectal Cancer Using an Integrative Bioinformatics Approach. Gastroenterology and Hepatology From Bed to Bench

929.    Immune Checkpoint Inhibitors: Review of the Existing Evidence and Challenges in Breast Cancer. Immunotherapy

930.    ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19. International Immunopharmacology

931.    A Systematic Review of Pregnant Women with COVID-19 and Their Neonates. Archives of Gynecology and Obstetrics

932.    Autoimmune Manifestations among Patients with Monogenic Inborn Errors of Immunity. Pediatric Allergy and Immunology

933.    Novel Treatment for Congenital Disorder of Glycosylation in a Patient with novel homozygote mutation of PMM2: A Case Report and Review Literature. Endocrine, Metabolic & Immune Disorders - Drug Targets

934.    An inflammatory triangle in Sarcoidosis: PPAR-γ, Immune microenvironment, and Inflammation. Expert Opinion On Biological Therapy

935.    Notable sequence homology of the ORF10 protein introspects the architecture of SARS-COV-2. International Journal of Biological Macromolecules

936.    The role of autophagy / virophagy in the pathogenesis of SARS-CoV-2: An updated review with therapeutic implications. Cell Biology International

937.    Immune checkpoint inhibition in classical Hodgkin Lymphoma. Expert Review of Anticancer Therapy

938.    International Scientific Collaboration is Needed to Bridge Science to Society: USERN2020 Consensus Statement. SN Comprehensive Clinical Medicine

939.    Altered Immunoemotional Regulatory System in COVID-19 from the Origins to Opportunities. Journal of Neuroimmunology

940.    The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: A review. Reviews in Neurosciences

941.    The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19. Autoimmunity Reviews

942.    “Original Antigenic Sin”: A potential threat beyond the development of booster vaccination against novel SARS-CoV-2 variants. Infection Control & Hospital Epidemiology.

943.    Immunotherapy in AML: a brief review on emerging strategies. Clinical and Translational Oncology

944.    PFAPA (Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis) syndorme: An overview of genetic background. Clinical Rheumatology

945.    Coronavirus Disease 2019 (COVID-19): A Systematic Review of 81 Children Presented with Kawasaki-like Multisystem Inflammatory Syndrome. Journal of Medical Virology

946.    Novel G6PC3 Mutations in patients with Congenital Neutropenia: case reports and Review of the Literature. Endocrine, Metabolic & Immune Disorders - Drug Targets

947.    COVID-19 Vaccination: What Challenges Are We Going to Face with? Acta Biomedica

948.    Resistance Mechanisms To Programmed Cell Death Protein 1 and Programmed Death Ligand 1 inhibitors. Expert Opinion On Biological Therapy

949.    Molecular Insight into COF Monolayers for Urea Sorption in Artificial Kidneys. Scientific Reports

950.    Adverse Events Associated with Immune Checkpoint Inhibitors in Patients with Breast Cancer: A Systematic Review and Meta-analysis. International Immunopharmacology

951.    The Immune System and Autism Spectrum Disorder: Association and Therapeutic Challenges. Acta Neurobilogica Experimentalis

952.    Anti-inflammatory and M2 Macrophage Polarization-promoting Effect of Mesenchymal Stem Cells-derived Exosomes. International Immunopharmacology

953.    Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer: from Immunological Mechanisms to Clinical Evidence. International Immunopharmacology

954.    Interferon Therapy in Patients with SARS, MERS, and COVID-19: A Systematic Review and Meta-Analysis of Clinical Studies. European Journal of Pharmacology

955.    Circular RNA hsa_circ_0044234 as Distinct Molecular Signature of Triple Negative Breast Cancer: A Potential Regulator of GATA3. Cancer Cell International

956.    The association between tumor-associated macrophages and glioblastoma: a potential target for therapy. Current Pharmaceutical Design

957.    Long non-coding RNAs in diagnosis, treatment, prognosis, and progression of glioma: A State-of-the-Art Review. Frontiers in Oncology

958.    Antidepressants with Anti-tumor Potential in Treating Glioblastoma: A Narrative Review. Fundamental & Clinical Pharmacology

959.    Genetic Basis of Guillain-Barre Syndrome. Journal of Neuroimmunology

960.    Recent Advances in Regenerative Medicine Strategies for Cancer Treatment. Biomedicine & Pharmacotherapy

961.    Advances in pharmacotherapy for neuroblastoma. Expert Opinion On Pharmacotherapy

962.    COVID-19 Vaccines and Thrombosis – Roadblock or Dead-End Street? Biomolecules

963.    Lymphocytes Subsets in Correlation with Clinical Profile in CVID Patients without Monogenic Defects. Expert Review of Clinical Immunology

964.    How Stable Ischemic Heart Disease Leads to Acute Coronary Syndrome in COVID-19? Acta Biomedica

965.    Oral Manifestations of Patients with Inherited Defect in Phagocyte Number or Function. Clinical Immunology

966.    Molecular Tuning of the Nano-Bio Interface: Alpha-Synuclein’s Surface Targeting with Doped-Carbon Nanostructures. ACS Applied Bio Materials

967.    Aberrant DNA Methylation of the Promoters of JAK2 and SOCS3 in Juvenile Systemic Lupus Erythematosus. European Cytokine Network

968.    Association between Promotor hypomethylation of TFF1 and Crohn’s Disease. Acta Biomedica

969.    Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer. Pharmaceutics

970.    Association of pro-inflammatory genes polymorphism with Meniere’s disease in an Iranian sample. Iran J Allergy Asthma Immunol

971.    Anti-inflammatory Effects of GLP-1 in Patients with COVID-19. Expert Review of Anti-infective Therapy

972.    An overview of possible solutions putting an end to the COVID-19 pandemic. Acta Biomedica Atenei Parmensis

973.    Adverse Reactions in a Large Cohort of Patients with Inborn Errors of Immunity Receiving Intravenous Immunoglobulin. Clinical Immunology

974.    The role of noncoding RNAs in pituitary adenoma. Epigenomics

975.    CRISPR/Cas9 Revitalizes Adoptive T-cell Therapy for Cancer Immunotherapy. Journal of Experimental & Clinical Cancer Research

976.    Immune modulations and immunotherapies for Alzheimer's disease: a comprehensive review. Reviews in the Neurosciences

977.    Autoimmune Complications of COVID-19. Journal of Medical Virology

978.    The second brain: The connection between gut microbiota composition and multiple sclerosis. Journal of Neuroimmunology

979.    COVID-19 Delta variation; more contagious or more pernicious? Acta Biomedica

980.    The Role of Type I Interferon in the Treatment of COVID-19. Journal of Medical Virology

981.    Cutaneous Manifestation of COVID-19: What have we learned an year into the pandemic?  Actas dermosifiliograficas

982.    An Overview on Tumor Treating Fields (TTFields) Technology as a New Potential Subsidiary Biophysical Treatment for COVID-19. Drug Delivery and Translational Research

983.    Immune checkpoint inhibitors and cardiotoxicity: possible mechanisms, manifestations, diagnosis and management. Expert Review of Anticancer Therapy

984.    Delta Variant: The New Challenge of COVID-19 Pandemic, an Overview ofEpidemiological, Clinical, and Immune Characteristics. Acta Biomedica

985.    Implications Derived from S-Protein Variants of SARS-CoV-2 from Six Continents. International Journal of Biological Macromolecules

986.    Preclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy. Expert Opinion On Biological Therapy

987.    Potential Therapeutic Approach of Intravenous Immunoglobulin against COVID-19. Allergy, Asthma & Clinical Immunology

988.    The Immunologic Aspects of Cytokine Release Syndrome and Graft versus Host Disease Following CAR T cell Therapy. International Reviews of Immunology

989.    The prognostication potential of BRCA genes expression in gliomas: a genetic survival analysis study. World Neurosurgery

990.    Cardiovascular Diseases Burden in COVID-19. American Journal of Emergency Medicine

991.    Novel systemic inflammation markers to predict Covid-19 prognosis. Frontiers in Immunology

992.    The role of Autophagy in the Pathogenesis of SARS-CoV-2 Infection in Different Cell Types. Autophagy

993.    Hematological Parameters as Diagnostic Factors: Correlation with Severity of COVID-19. Acta Biomedica Atenei Parmensis

994.    Does the Reaction Size of Skin Prick Test Associated with the Allergic Rhinitis severity? Allergic Rhinitis and Skin Prick Test. Allergologia et Immunopathologia

995.    In-Silico Perusing the Inhibiting Role of Perovskite in Preventing the Covid19 Spread. Informatics in Medicine Unlocked

996.    Review of recent clinical trials for PD-1/PD-L1-based lung cancer immunotherapy. Expert Review of Anticancer Therapy

997.    Therapeutic applications of Biosimilar Monoclonal Antibodies: Systematic Review of the Efficacy, Safety, and Immunogenicity in Autoimmune Disorders. International Immunopharmacology

998.    Role of Toll-Like Receptor 4 in Diabetic Retinopathy. Pharmacological Research

999.    A case of autosomal recessive interferon alpha/beta receptor alpha chain (IFNAR1) deficiency with severe COVID-19. Journal of Clinical Immunology 

1000. Smart Biomaterials to Enhance the Efficiency of Immunotherapy in Glioblastoma: State of the Art and Future Perspectives. Advanced Drug Delivery Reviews

1001. Diagnostic Biomarkers of Dilated Cardiomyopathy. Immunobiology

1002. Germline biallelic mutation affecting the transcription factor Helios causes pleiotropic defects of immunity. Science Immunology

1003. COVID-19 vaccine boosters: The good, the bad, and the ugly. Vaccines

1004. Stem Cell Transplantation as a Progressing Treatment for Retinitis Pigmentosa. Cell and Tissue Research

1005. The Effect of Influenza Vaccination on COVID-19 Morbidity, Severity and Mortality: Systematic Review and Meta-Analysis. MJMS

1006. Effect of Paleolithic-based low-carbohydrate vs. moderate-carbohydrate diets with portion-control and calorie-counting on CTRP6, Asprosin and metabolic markers: A randomized clinical trial. Clinical Nutrition

1007. TGF-β signaling and the interaction between platelets and T-cells in tumor microenvironment: foes or friends? Cytokine

1008. Cancer-associated fibroblasts in colorectal cancer. Clinical and Translational Oncology

1009. Loneliness: An immunometabolic syndrome. International Journal of Environmental Research and Public Health

1010. COVID-19 vaccines Mix-and-Match: The Concept, the Efficacy and the Doubts. Journal of Medical Virology

1011. Teledentistry during COVID-19. International Journal of Clinical Practice

1012. The role of myeloid-derived suppressor cells in lung cancer and targeted immunotherapies. Expert Review of Anticancer Therapy

1013. Evaluating COVID-19–Environment Fit. Acta Biomedica Atenei Parmensis

1014. Cytokine alterations in psoriasis: an updated review. Expert Review of Clinical Immunology

1015. Long non-coding RNAs (lncRNAs) as prognostic and diagnostic biomarkers in multiple myeloma: a systematic review and meta-analysis. Pathology - Research and Practice

1016. COVID-19 vaccinations: The unknowns, challenges, and hopes. Journal of Medical Virology

1017. Expanding the clinical and immunological phenotypes and natural history of MALT1 deficiency. Journal of Clinical Immunology

1018. A 3-year- old boy with an Xp21 deletion syndrome: A case report. Endocrine, Metabolic & Immune Disorders - Drug Targets

1019. Central inflammatory cytokines in tuberculous meningitis: a systematic review and meta-analysis. Journal of Interferon and Cytokine Research

1020. Identification of Germline Monoallelic Mutations in IKZF2 in Patients with Immune Dysregulation. Blood Advances

1021. Long non-coding RNA HOTAIR could upregulate the PI3K/AKT/mTOR signaling pathway in MCF-7 breast cancer cells. Revista da Associação Médica Brasileira

1022. Efficacy of mRNA, Adenoviral Vector, and Perfusion Protein COVID-19 Vaccines. Biomedicine & Pharmacotherapy

1023. Evaluation of Specific Antibody Responses in Patients with Selective IgA Deficiency and Ataxia Telangiectasia. Endocrine, Metabolic & Immune Disorders - Drug Targets

1024. Gallium Components-Based Drug Delivery; a Potential Treatment for COVID-19. Infectious Disorders - Drug Targets(IDDT)

1025. Omicron (B.1.1.529) Variant: Development, Dissemination, and Dominance. Journal of Medical Virology

1026. Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis. Molecular Neurobiology

1027. The Role of Ral Signaling and Post Translational Modifications (PTM) of Ras in Cancer. Genome Instability & Disease

1028. The Importance of Accessory Protein Variants in the Pathogenicity of SARS-CoV-2. Archives of Biochemistry and Biophysics

1029. Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article. International Immunopharmacology

1030. Immunogenicity of COVID-19 mRNA Vaccines in Immunocompromised Patients: A Systematic Review and Meta-Analysis. European Journal of Medical Research

1031. Cytokine-Induced Killer Cells Mediated Pathways in the Treatment of Colorectal Cancer. Cell Communication and Signaling

1032. Determination of cytopenia in pediatric patients with acyanotic congenital heart disease: A cross-sectional study of 248 patients. Egyptian Journal of Medical Human Genetics

1033. Monoclonal antibodies in diabetic retinopathy. Expert Review of Clinical Immunology

1034. Echocardiographic findings in multisystem inflammatory syndrome in children (MIS-C), associated with COVID-19: A systematic review. Iranian Journal of Pediatrics

1035. Changes of symptoms of eating disorders (ED) and their related psychological health issues during the COVID-19 pandemic: A systematic review and meta-analysis. Journal of Eating Disorders

1036. Association of aberrant promoter methylation changes in the suppressor of cytokine signaling 3 (SOCS3) gene with susceptibility to Crohn's disease. Avicenna Journal of Medical Biotechnology

1037. Prenatal Risk Factors and Genetic Causes of ADHD in Children. World Journal of Pediatrics

1038. Optogenetics: Implications for Alzheimer's Disease Research and Therapy. Molecular Brain

1039. Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis: a systematic review and meta-analysis of exercise intervention trials. PLOS ONE

1040. Neurological Adverse Effects of SARS-CoV-2 Vaccines – Where Do We Stand? Reviews in the Neurosciences

1041. Cytokines levels in patients with β-thalassemia major and healthy individuals. Clinical Laboratory

1042. Central neuroinflammation in Covid-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies. Reviews in the Neurosciences

1043. Circulating Brain-Derived Neurotrophic Factor as a potential biomarker in stroke: a Systematic review and Meta-analysis. Journal of Translational Medicine

1044. Immunomodulatory Potential of Human Mesenchymal Stem Cells and their Exosomes on Multiple Sclerosis. Advanced Pharmaceutical Bulletin

1045. Novel NFkB mutation in a case of lymphoproliferative disorder. Endocrine, Metabolic & Immune Disorders - Drug Targets

1046. MGMT Gene Polymorphisms in Patients with Brain Glioblastoma. Avicenna Journal of Medical Biotechnology

1047. COVID-19, from Infection to Cancer. Acta Biomedica Atenei Parmensis

1048. Immunophenotypic and Functional Analysis of Lymphocyte Subsets in Common Variable Immunodeficiency Patients without Monogenic Defects. Scandinavian Journal of Immunology

1049. Shedding Light on Biological Sex Differences and Microbiota-Gut-Brain Axis: A Comprehensive Review of its Roles in Neuropsychiatric Disorders. Biology of Sex Differences

1050. N-methyl-D-aspartate (NMDA)-type Glutamate Receptors and Demyelinating Disorders: A Neuroimmune Perspective. Mini-Reviews in Medicinal Chemistry(MRMC)

1051. Hyper IgE Syndromes: A Clinical Approach. Clinical Immunology

1052. SARS-CoV-2 Omicron Variant: Why Global Communities should take it seriously? Immunity, Inflammation and Disease

1053. Cancer immunotherapy: diverse approaches and obstacles. Current Pharmaceutical Design

1054. The Yin and Yang of Toll-like Receptors in Endothelial Dysfunction. International Immunopharmacology

1055. Prospect of Exosomal Circular RNAs in Breast Cancer: Present and Future. Molecular Biology Reports

1056. SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait! Acta Biomedica Atenei Parmensis

1057. Recent developments in SARS-CoV-2 vaccines: A systematic review of the current studies. Reviews in Medical Virology

1058. Interleukin 17, the double-edged sword in atherosclerosis. Immunobiology

1059. Therapeutic Use of Natural Killer Cells in Acute Myeloid Leukemia: Promises and Challenges. Cancer Immunology, Immunotherapy

1060. HAX1-dependent control of mitochondrial proteostasis is essential for neutrophil granulocyte differentiation. Journal of Clinical Investigation

1061. Tumor-infiltrating lymphocyte therapy for lung cancer and its future paradigms. Expert Opinion On Biological Therapy

1062. A rose amongst the thorns: the mission of the J Project in a conflictual world. Journal of Clinical Immunology

1063. Vascular endothelial growth factor levels in tuberculosis: a systematic review and meta-analysis. PlosOne

1064. The Clinical and Molecular Assessment of Iranian Families with Severe Congenital Neutropenia, Identification of HYOU1 and SHOC2 as Potential Novel Gene Defects. Iranian Journal of Allergy, Asthma and Immunology

1065. Brain-derived Neurotrophic Factor in Diabetes Mellitus: A Systematic Review and Meta-Analysis. PLOS ONE

1066. Immune-based Therapeutic Approaches in COVID-19. Biomedicine & Pharmacotherapy

1067. The chimera of S1 and N proteins of SARS-CoV-2: Can it be a potential vaccine candidate for COVID-19? Expert Review of Vaccines

1068. Circular RNA MYLK as a prognostic biomarker in patients with cancers: A systematic review and meta-analysis. Cancer Reports

1069. COVID-19 in Iran: Forecasting Pandemic Using Deep Learning. Computational and Mathematical Methods in Medicine

1070. Allergic manifestations of inborn errors of immunity and their impact on the diagnosis: A Worldwide survey-based study. World Allergy Organization Journal

1071. Targeting signaling pathways involved in primordial follicle growth or dormancy: potential application in the prevention of follicular loss and infertility. Expert Opinion On Biological Therapy

1072. Body mass index as a predictor of symptom duration in COVID-19 outpatients. Disaster Medicine and Public Health Preparedness

1073. AMPK’s double-faced role in advanced stages of prostate cancer. Clinical and Translational Oncology

1074. Investigation of BRCAness Associated miRNA-gene Axes in Breast Cancer: Cell-free miR-182-5p as a Potential Expression Signature of BRCAness. BMC Cancer

1075. Blood Levels of Brain-Derived Neurotrophic Factor (BDNF) in People with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis. Multiple Sclerosis and Related Disorders

1076. Asthma and Vitamin D Deficiency: Occurrence, Immune mechanisms and New Perspectives. Journal of Immunology Research

1077. Artificial Intelligence in Rheumatoid Arthritis: current status and future perspectives. Rheumatology and Therapy

1078. COVID-19 starts the war, but neopterin fights the self: Anti-neopterin antibodies for COVID-19 treatment in severe cases. Acta Medica Iranica

1079. Aging, Testosterone, and Neuroplasticity; Friend or Foe? Reviews in the Neurosciences

1080. Clinical safety and efficacy of bispecific antibody in the treatment of solid tumors: a protocol for a systematic review. Plos One

1081. Oral antiviral treatments for COVID-19: Opportunities and challenges. Pharmacological Reports

1082. The relationship between GAD65 Autoantibody and the risk of T1DM onset. Journal of Diabetes & Metabolic Disorders

1083. Serum and Plasma Levels of Brain-Derived Neurotrophic Factor in Individuals with Eating Disorders (EDs): a Systematic Review and Meta-Analysis. Journal of Eating Disorders

1084. Commercialization and Regulations of Regenerative Medicine Products: Promises, Advances and Challenges. Biomedicine & Pharmacotherapy

1085. Seroconversion Following the First, Second, and Third Dose of SARS-CoV-2 Vaccines in Immunocompromised Population; A Systematic Review And Meta-Analysis. Virology Journal

1086. Evaluation of response to different COVID-19 vaccines in vaccinated healthcare workers in a single center in Iran. Journal of Medical Virology

1087. Immunological aspects of COVID-19-related skin manifestations: Revisiting pathogenic mechanism in the light of new evidence. Dermatologic Therapy

1088. Anaphylaxis and Allergic Reactions to COVID-19 Vaccines: a Narrative Review of Characteristics and Potential Obstacles on Achieving Herd Immunity. Health Science Reports

1089. Venous thromboembolism in cancer and cancer immunotherapy. Critical Reviews in Oncology / Hematology

1090. The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors. Cell Communication and Signaling

1091. Novel DNMT3B mutation in a patient with immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome and a bronchopulmonary collateral artery. Endocrine, Metabolic & Immune Disorders - Drug Targets

1092. Elevated neopterin in tuberculosis and co-infection with HIV and the effect of treatment: A systematic review, meta-analysis, and meta-regression. International Immunopharmacology

1093. Circular RNAs as prognostic and diagnostic biomarkers in renal cell carcinoma. Journal Of Clinical Laboratory Analysis

1094. Cytokines and Chemokines Profile in Encephalitis Patients: A Meta-Analysis. PlosOne

1095. MicroRNA expression profiles of peripheral blood and mononuclear cells in myasthenia gravis: a systematic review. International Immunopharmacology

1096. The role of Toll-like receptors and neuroinflammation in Parkinson's disease. Journal of Neuroinflammation

1097. Corticosteroids Therapy for COVID-19 Induced Hyposmia and Anosmia. B-ENT

1098. Biosensors for the detection of protein kinases. Microchemical Journal

1099. Novel mutation of SLC37A4 in a glycogen storage disease type Ib patient with Neutropenia, Horseshoe Kidney, and Arteriovenous Malformation: A Case Report. Immunologic Research

1100. The Pro-tumorigenic Responses in Metastatic Niches: an Immunological Perspective. Clinical and Translational Oncology

1101. Association between brain-derived neurotrophic factor levels and obstructive sleep apnea: A Systematic Review and Meta-analysis. Sleep and Breathing

1102. IL-6 and TNF-α Responses to Acute and Regular Exercise in Adult Individuals with Multiple Sclerosis (MS): a Systematic Review and Meta-analysis. European Journal of Medical Research

1103. BDNF and its signaling in cancer. Journal of Cancer Research and Clinical Oncology

1104. Advances in Therapeutic Targeting of Immune checkpoints Receptors within the CD96-TIGIT Axis: Clinical Implications and Future Perspectives. Expert Review of Clinical Immunology

1105. Diet Influences Immunotherapy Outcomes in Cancer Patients: A Literature Review. Nutrition and Cancer

1106. Evaluation of ABCB1 gene promoter methylation in patients with ulcerative colitis. Immunology and Genetics Journal

1107. Autoimmune disorders associated with common variable immunodeficiency: Prediction, Diagnosis, and Treatment. Expert Review of Clinical Immunology

1108. Immune checkpoint inhibitors plus chemotherapy versus chemotherapy alone as first-line therapy for advanced gastric and esophageal cancers: A systematic review and meta-analysis. International Immunopharmacology

1109. Cancer and allergy; molecular association and integrated therapies. Immunology and Genetics Journal

1110. Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021. Frontiers in Immunology

1111. Erenumab Efficacy in Migraine Headache Prophylaxis: A systematic review. International Immunopharmacology

1112. Poxviruses and the Immune System: Implications for Monkeypox Virus. International Immunopharmacology

1113. The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity. The Journal of Allergy and Clinical Immunology: In Practice

1114. Diversity of Malignancies in Patients with Different Types of Inborn Errors of Immunity. Allergy, Asthma & Clinical Immunology

1115. The Role of Dendritic cells in Neuroblastoma: Implications for Immunotherapy. Immunobiology

1116. Toll-like Receptor 7 Regulates Cardiovascular Diseases: A Narrative Review. International Immunopharmacology

1117. The dialogue between neuroinflammation and adult neurogenesis: mechanisms involved and alterations in neurological diseases. Molecular Neurobiology

1118. miR-124 enhances T cells functions by manipulating the lactic acid metabolism of tumor cells. Iranian Journal of Allergy, Asthma and Immunology

1119. Autoimmunity in monogenic combined immune deficiencies with associated or syndromic features. Frontiers in Immunology

1120. A rare PTPN11 mutation in a patient with juvenile myelomonocytic leukemia. Current Pharmacogenomics and Personalized Medicine

1121. Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases. Journal of Neuroinflammation

1122. VEGF Gene Polymorphisms in Iranian Patients with Intracranial Glioblastoma A Case–Control Study. J Neurosurg Sci

1123. Tau Immunotherapy in Alzheimer’s Disease and Progressive Supranuclear Palsy. International Immunopharmacology

1124. Loneliness and Health: An Umbrella Review. Heart and Mind

1125. Central Nervous System Hydatidosis around the World: A Systematic Review. J Neurosurg Sci

1126. Inosine, Gut Microbiota, and Cancer Immunometabolism. American Journal of Physiology-Endocrinology and Metabolism

1127. CAR-NK Cells: A promising cellular immunotherapy in lymphoma. Expert Opinion On Biological Therapy

1128. Diversity of Malignancies in Patients with Different Types of Inborn Errors of Immunity. Allergy, Asthma & Clinical Immunology

1129. Chronic Myeloid Leukemia Stem Cells: Targeting Therapeutic Implications. Stem Cell Research & Therapy

1130. Safety and efficacy of Elotuzumab combination therapy for patients with multiple myeloma: A systematic review and meta-analysis. Expert Review of Anticancer Therapy

1131. Immunosenescence and Inflamm-ageing in COVID-19. Ageing Research Reviews

1132. The Signaling and the Metabolic Differences of Various CAR T Cell Designs. International Immunopharmacology

1133. The role of cell membrane-coated nanoparticles as a novel treatment approach in glioblastoma. Frontiers in Molecular Biosciences

1134. Nanotechnology-based Diagnostics and Therapeutics in Acute Lymphoblastic Leukemia: A Systematic Review of Preclinical Studies. Nanoscale Advances

1135. The Role of Ketogenic Diet in the Treatment of Neuroblastoma. Integrative Cancer Therapies

1136. Post-discharge Thromboembolic Events in COVID-19 Patients: A Review on the Necessity for Prophylaxis. Clinical and Applied Thrombosis/Hemostasis

1137. Cryoablation for the palliation of painful bone metastasis: A systematic review. CardioVascular and Interventional Radiology

1138. Monogenic Primary Immunodeficiency Disorders Associated with Common Variable Immunodeficiency and Autoimmunity. International Archives of Allergy and Immunology

1139. Lack of association between COL1A1 and COL9A2 single nucleotide polymorphisms and intervertebral disc degeneration. British Journal of Neurosurgery

1140. Pulmonary Manifestations in a Cohort of Patients with Inborn Errors of Immunity: An 8-Year Follow-Up Study. Allergol Immunopathol (Madr)

1141. Evaluation of B cell and T cell Phenotypes in CVID Patients and its Correlation with the Clinical Phenotype of the Disease: Study Protocol. Immunology and Genetics Journal

1142. Clinical and Laboratory-based Diagnosis in Cases Suspected with COVID-19; A Comprehensive Systematic Review Study: Diagnosis of COVID-19 in Suspected Cases. Fortune J Health Sci

1143. Atypical Ataxia Presentation in Variant Ataxia Telangiectasia: A report of 3 Iranian patients and Review of the Literature. Front Immunol.

1144. COVID-19 in children with inborn errors of immunity: clinical scenarios. Am J Clin Exp Immunol

1145. Genetic Risk Variants for Class Switching Recombination Defects in Ataxia-Telangiectasia Patients. J Clin Immunol

1146. Recent Advances in Passive Immunotherapies for COVID-19: The Evidence-Based Approaches and Clinical Trials. Int Immunopharmacol

1147. Autoimmune manifestations among 461 patients with monogenic inborn errors of immunity. Pediatr Allergy Immunol

1148. The Effects of Stimulation with PMA/Ionomycin on CD4+ T cell Proliferation and Surface CD4 Molecule Modulation of Patients with LRBA Deficiency and CVID with the Unsolved Genetic Defect. Endocr Metab Immune Disord Drug Targets

1149. Comprehensive Assessment of Skin Disorders in Patients with Common Variable Immunodeficiency (CVID). J Clin Immunol.

1150. The spectrum of inborn errors of immunity: a single tertiary center retrospective study in Alborz, Iran. Eur Ann Allergy Clin Immunol

1151. Association of PTPN22 gene polymorphisms in patients with Graves’ disease in Iranian papulation. Immunology and Genetics Journal

1152. Anti-IgE monoclonal antibodies as potential treatment in COVID-19. Immunopharmacol Immunotoxicol

1153. Cell death pathways and viruses: Role of microRNAs. Mol Ther Nucleic Acids

1154. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant of concern breakthrough infections: Are vaccines failing us? Infection Control and Hospital Epidemiology

1155. Tumor immune microenvironment changes in response to different radiotherapy regimens. Avicenna Journal of Medical Biotechnology

1156. AMELX, ENAM Polymorphisms and Dental Caries. International Journal of Dentistry

1157. Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review. Vaccines

1158. The role of nutritional interventions in prostate cancer: A review. Journal of Research in Medical Sciences

1159. Investigation of the female infertility risk associated with anti-cancer therapy. Clinical and Translational Oncology

1160. Insights on Monkeypox Virus Infection Immunopathogenesis. Reviews in Medical Virology

1161. Immune checkpoint inhibition for pancreatic cancer. Acta Medica Iranica

1162. How do nuclear factor kappa B (NF-κB)1 and NF-κB2 defects lead to the incidence of clinical and immunological manifestations of inborn errors of immunity? Expert Review of Clinical Immunology

1163. Application of nano-radiosensitizers in combination cancer therapy. Bioengineering & Translational Medicine

1164. Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer’s Disease (AD): A systematic review and meta-analysis. PLOS ONE

1165. The role of Neurofilament light chain in COVID-19: A potential prognostic biomarker. Acta Neurobiologiae Experimentalis

1166. Immunogenicity of Different Types of Nano-adjuvants in Veterinary Vaccines: A Comprehensive Review. Vaccines

1167. Current Therapeutic Approaches and Promising Perspectives of Using Bioengineered Peptides in Fighting Chemoresistance in Triple-Negative Breast Cancer. Biochemical Pharmacology

1168. Clinical efficacy and safety of bispecific antibodies for the treatment of solid tumors: A systematic review and meta-analysis. Expert Review of Anticancer Therapy

1169. T helper 17 and regulatory T-cell profile and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia. Transplant Immunology

1170. Analysis of Lymphocyte and Clinical Profile among Non-monogenic Common Variable Immunodeficiency Patients with and without Class Switch Recombination Defect. Journal of Investigational Allergology and Clinical Immunology

1171. Blood levels of Brain-Derived Neurotrophic Factor (BDNF) in Systemic Lupus Erythematous (SLE): A Systematic Review and Meta-analysis. Advances in Rheumatology

1172. The novel ZBTB24 mutation identified in an Iranian patient with type 2 ICF syndrome. Immunology and Genetics Journal

1173. Historical Cohort of Severe Congenital Neutropenia in Iran: Clinical Course, Laboratory Evaluation, Treatment, and Survival. Journal of Pediatric Hematology and Oncology

1174. Inborn Errors of Immunity and Worries During the Monkeypox Outbreak. Journal of Medical Virology

1175. COVID-19 and MAFLD/NAFLD: an updated review. Frontiers in Medicine

1176. Study of NLRP3 Single Nucleotide Polymorphisms in Juvenile Systemic Lupus Erythematosus (JSLE). Immunological Investigations

1177. Non-Infectious Complications in B-Lymphopenic Common Variable Immunodeficiency. Journal of Investigational Allergology and Clinical Immunology

1178. The role of interleukins in pathogenesis and prognosis of atrial fibrillation. Expert Review of Clinical Immunology

1179. Organ-based clues for diagnosis of inborn errors of immunity: a practical guide for clinicians. Immunity, Inflammation and Disease

1180. Coronavirus disease 2019 (COVID-19) in pediatric patients with autoimmune disorders. European Journal of Pediatrics

1181. Impact of Helicobacter pylori infection on the efficacy of immune checkpoint inhibitors for cancer treatment: a meta-analysis. Immunotherapy

1182. DNAH11 and a Novel Genetic Variant Associated with Situs Inversus: A Case Report. Journal of Medical Case Reports

1183. Abnormal Promoter Methylation of nucleotide-binding oligomerization domain containing 2 (NOD2) gene in the Pathogenesis of Crohn’s Disease. Acta Medica Iranica

1184. Targeting Ferroptosis as a Cell Death Pathway in Melanoma: From Molecular Mechanisms to Skin Cancer Treatment. International Immunopharmacology

1185. Autoimmune versus Non-autoimmune Cutaneous Features in Monogenic Patients with Inborn Errors of Immunity. Biology

1186. Targeting the vital Non-Structural Proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and Inhibition of RNA Polymerase by Natural Bioactive Compound naringenin as a Promising Drug Candidate against COVID-19. Journal of Molecular Structure

1187. Mesenchymal stromal cells (MSCs) and CAR-T cells in regenerative medicine: the homing procedure and its effective parameters. European Journal of Haematology

1188. Nicotinamide N-methyl Transferase and Cancer-associated Thrombosis. Epigenomics

1189. Cord blood antibodies following BBIBP-CorV (Sinopharm) vaccination during pregnancy. Immunity, Inflammation and Disease

1190. Severe congenital neutropenia due to G6PC3 deficiency: early and delayed phenotype of a patient. Allergy, Asthma & Clinical Immunology

1191. Tumor immune microenvironment changes in response to different radiotherapy regimens. Avicenna Journal of Medical Biotechnology